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The bone remodelling process, performed by the Bone Multicellular Unit (BMU) is a key multi-
hierarchically regulated process, which provides and supports various functionality of bone tissue. It is 
also plays a critical role in bone disorders, as well as bone tissue healing following damage. Improved 
modelling of bone turnover processes could play a significant role in helping to understand the 
underlying cause of bone disorders and thus develop more effective treatment methods. Moreover, 
despite extensive research in the field of bone tissue engineering, bonescaffold development is still 
very empirical. The development of improved methods of modelling the bone remodelling process 
should help to develop new implant designs which encourage rapid osteointegration.  
 
There are a number of limitations with respect to previous research in the field of mathematical 
modelling of the bone remodelling process, including the absence of an osteocyte loop of regulation. It 
is within this context that this research presented in this thesis utilises a range of modelling methods to 
develop a framework for bone remodelling which can be used to improve treatment methods for bone 
disorders. The study concentrated on dynamic and steady state variables that in perspective can be used 
as constraints for optimisation problem considering bone remodelling or tissue remodelling with the 
help of the grafts/scaffolds.  
 The cellular and combined allosteric-regulation approaches to modelling of bone turnover, 
based on the osteocyte loop of regulation, have been studied. Both approaches have been studied 
different within wide range of rate parameters. The approach to the model validation has been 
considered, including a statistical approach and parameter reduction approach. From a validation 
perspective the cellular class of modes is preferable since it has fewer parameters to validate. The 
optimal control framework for regulation of remodelling has been studied. Future work in to improve 
the models and their application to bone scaffold design applications have been considered.  The study 
illustrates the complexity of formalisation of the metabolic processes and the relations between 
hierarchical subsystems in hard tissue where a relatively small number of cells are active.   
 Different types/modes of behaviour have been found in the study: relaxational, periodical and 
chaotic modes. All of these types of behaviour can be found, in bone tissue. However, a chaotic or 
periodic modes are ones of the hardest to verify although a number of periodical phenomena have been 
observed empirically in bone and skeletal development. Implementation of the allosteric loop into 
cellular model damps other types of behaviour/modes. In this sense it improves the robustness, 
predictability and control of the system. 
 The developed models represent a first step in a hierarchical model of bone tissue (system 
versus local effects). The limited autonomy of any organ or tissue implies differentiation on a 
regulatory level as well as physiological functions and metabolic differences. Implementation into the 
cellular phenomenological model of allosteric-like loop of regulation has been performed. The results 
show that the robustness of regulation can be inherited from the phenomenological model.  
 An attempt to correlate the main bone disorders with different modes of behaviour has been 
undertaken using Paget‘s disorder in bone, osteoporosis and some more general skeleton disorders 
which lead to periodical changes in bone mass, reported by some authors.  However, additional studies 
are needed to make this hypothesis significant.     
 
The study has revealed a few interesting techniques. When studying a multidimensional phenomenon, 
as a bone tissue is, the visualisation and data reduction is important for analysis and interpretation of 
results. In the study two novel technical methods have been proposed. The first is the graphical matrix 
method to visualise/project the multidimensional phase space of variables into diagonal matrix of 
regular combination of two-dimensional graphs. This significantly simplifies the analysis and, in 
principle, makes it possible to visualise the phase space higher than three-dimensional. The second 
important technical development is the application of the Monte-Carlo method in combination with the 
regression method to study the character and stability of the equilibrium points of a dynamic system. 
The advantage of this method is that it enables the most influential parameters that affect the character 
and stability of the equilibrium point to be identified from a large number of the rate 
parameters/constants of the dynamic system. This makes the interpretation of parameters and 
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The mathematical modelling of many biological processes is a powerful tool not in 
just verification of the understanding of these processes on systemic regulative and qualitative 
level, but also a generationg understanding and new biological engineering approaches for 
treatment/correction in metabolic networks and tissues. However, before any discussions of 
modelling, it needs to understand thorouphly the biological process involved in these 
processes, in particular of the remodelling process in bone tissue, which is of particular 
interest in this study. 
Bone, together with cartilage, forms the skeleton, which is the hard structural system 
that supports body locomotion and protects internal organs. Damage to the human skeleton 
can create significant problems leading to pain, reduced mobility, morbidity and may even 
give rise to life threatening medical conditions. The complex nature of bone has only been 
recognised relatively recently. Loveridge (1999) remarked that bone is ―more than a stick‖, it 
is a metabolic active tissue which is under a steady process of development and renewal 
called remodelling. An improved knowledge of the mechanisms at work during the 
remodelling of bone could play an important role of improving the health of patients, 
particularly in an aging population  
 Bone comprises of two types of tissue; cortical and trabecular bone. Cortical bone is 
very compact and provides 75% of the weight of the human skeleton, whereas trabecular bone 
has an open porous structure of lattice-shaped spicules. Trabecular bone tissue provides three 
quarters of the bone surface that is involved in bone remodelling. It is highly metabolically 
active and therefore sensitive to metabolic disorders.  
 Bone consists of both organic and inorganic material. The main organic component of 
bone tissue is osteoid which contains collagen and non-collagen proteins. Collagen is the most 







part of bone tissue contains hydroxyapatite (HA), a microcrystalline mineral which is initially 
deposited in layers as calcium phosphate and is later transformed into apatite crystals. Many 
other ions and minerals (carbonates, magnesium, potassium, calcium, fluorine etc) are present 
in the inorganic part of bone tissue and have an important metabolic role and influence the 
mechanical properties of the bone. The mineral components of bone are stored in both the 
cortical and trabecular bone. 
 Micro-damage or aging of bone tissue causes the release of molecular messengers and 
the bone multicellular unit (BMU) is activated; this is known as the damage signalling phase. 
Histologically, the shape of lining cells becomes cubic-like (originally flat). There are 
indications that osteocytes are also involved at the start of the remodelling process (Martin, 
2000). 
 In response, the osteocytes signal the osteoclasts, then the recruitment phase 
commences.  The osteoblast precursors start to synthesise messengers which interacts with the 
surface of osteoclasts precursors. As a result these differentiate into mature multinucleous 
osteoclasts, which develop the ―ruffled border‖ and start to resorb bone tissue.  During the 
resorption phase mature osteoclasts resorb bone within the resorption cavity. At every 
separate bone remodelling site resorption lasts about two weeks. At the end of this process the 
remaining osteoclasts die by means of apoptosis. In the osteoblast recruitment phase 
osteoblasts differentiate from bone marrow stromal cells. During the osteoid formation phase 
active osteoblasts fill the absorbed cavity forming the non-mineralised new tissue (osteoid). 
One can see a complex coordination and hierarchy between different osteo cells involved in 
bone remodelling.  
 This project concentrates on the two quite distant levels of biological organisation: 
one phenomenological, cellular level and molecular level, phenenologically formulated 
through the non-linear Michaelis-Menten transfer function. However, generally speaking, all 
biological systems are characterized by more complicated multilevel non-linear 







regulation. Due to these links between different biological levels of organization (e.g. cellular, 
molecular) new functionalities emerge as important life properties from this multileveled 
complexity. They can be characterized by complex organization, optimal adaptation, self-
replication and co-evolution. In general, biological systems are far from equilibrium due to 
multiple control loops maintaining the biological system homeostasis.  
 It could be noted that the complex hierarchical structure and control in biological 
systems have been developed during a long period of evolution. Many regulatory processes 
have a dynamic and cyclic nature manifesting different characteristic time scales. Just 
phenomenological behaviour and control in such a multileveled biological system can be 
considered in the framework of a dynamical system approach. Additionally, from an 
energetical (linked to the thermodynamic perspective), biological systems are too far from 
equilibrium state, therefore only a dynamic approach can be used to investigate their complex 
behaviour. Many attempts to describe the informational processes in bio-systems on the basis 
of entropy-informational principals have failed - possibly because bio-systems are really 
multileveled, autonomic, dissipative and intelligent systems. In this project the 
phenomenological method for deriving a nonlinear dynamical model is be adopted, which is 
used in a study of regulatory processes in the BMU. The experience available in the design 
and analysis of dynamic systems is exploited in this process.  
 
1.2 Aims and objectives 
The overall aim of the project was to develop the model of bone tissue resorption and 
formation that can explain the relaxation times of bone tissue restoring and therefore can be 
useful in further studies on bone graft remodelling. 
To achieve this in the project it was aimed:  
 To revise the existing mathematical models of remodelling. 
 To revise molecular mechanisms (Michaelis-Menten, Hill) involved in BMU 







 To develop a regulation model of BMU activities, based on the Optimal Control 
approach.   
 
1.3 Structure of the thesis 





2 Literature review The complexity if the regulation of bone 
remodelling is presented with particular 
attention to the existing mathematical models of 
bone remodelling. 
3 Objectives and methodology In this chapter the aims and objectives of the 
study are presented. The methodology of model 
development is then described and approach is 
justified. 
4 Cellular model The approach to develop cell-level 
phenomenological mathematical model is 
presented. Different ranges of the rate constants 
employed are studied. 
5 Allosteric  approach to bone 
turnover model 
The approach to implement the allosteric 
mechanism to a cell-level model is described 
and numerical experiment results are presented. 
6 Optimal control approach to 
the regulation of bone 
remodelling 
Dynamic optimal control approach to the 
control of bone remodelling is presented. 
7 Conclusions and Further 
Work  
The conclusions, recommendations and further 
work arising from results of Chapters 4-6 are 
presented. 
 








2  Bone tissue resorption and formation 
2.1  Bone tissue remodelling 
Bone is a tissue with a unique mechanism of regeneration (commonly referred to as 
remodelling or turnover).  It is one of the simplest examples of tissue regenerating processes 
in animals and so the study of it could help to form a foundation for understanding more 
sophisticated metabolic and cellular cycles in the body. However, it should be said that the 
bone remodelling process and skeletal growth are quite different processes. 
 
2.2  Basic multicellular unit (BMU) 
The BMU can be regarded as a team of cells, which are active in bone remodelling. 
The BMU is the active element of bone tissue, which over a period of time results in the local 
resorption and rebuilding of the bone tissue. This is referred to as remodelling. It is probably 
one of the simplest tissues due to the limited variety (only two types) of active cells which 
participate in bone regeneration.  The generally accepted concept of the Basic Multicellular 
Unit (BMU) is that it is comprised of two cell types; osteoclasts and osteoblasts (Compston, 
2002). In addition to these ―active‖ cells BMU also contains the active mesenchymal cells and 
capillary loops. The size of a BMU is 0.05-0.1 mm
3





 BMU function simultaneously. 
 
2.2.1  Osteoclasts  
Osteoclasts are multinucleous large bone tissue cells that are specialised microphages 
(Blair et al., 2008). Their main function is tissue resorption. Osteoclasts are only present in a 
small lacunes (cavities) on the surface of bone during the bone demineralisation/resorption 
phase. Osteoclasts are formed by the union of several mononucleosis originators of the 
monocytes family which originate from stem cells in the bone marrow.  Osteoclasts work 
together with osteoblasts to resorb and remodel the bone in a controlled process of 







properties of stiffness and elasticity. For a variety of reasons it is possible for resorption of the 
bone to become predominant and this can lead to many types of bone disorders.  
 The multistage process of osteoclast differentiation and maturation is triggering by 
integrin and is then controlled by many chemical signals, including receptor activator for 
nuclear factor κ B ligand (RANKL), macrophage colony-stimulating factor (M-CSF), and 
Osteoprotegerin (OPG), Blair et al. (2007). Stem cells and osteoblasts secrete RANKL and 
M-CSF. This process can be activated by Parathyroid hormone (PTH) and inhibited by OPG. 
RANKL and M-CSF interacts with the correspondent receptor on the membrane of precursor 
cells (a common precursor for both osteoclasts and monocytes-monofags) and triggers cell 
differentiation in favour of osteoclasts. This process can be inhibited by OPG.  
 Differentiated osteoclasts accumulate on the bone surface to form a cytoskeleton 
which enables a resorption cavity (microspace between the osteoclasts and bone tissue) to 
develop. This process involves a protein, integrin avb3. The osteoclast layer within the cavity 
forms folds and as a result the resorption surface is significantly enlarged. The media inside of 
the resorption cavity is acidic due to the addition of protons. The intercellular pH of 




 interchange across the antiresorptive membrane. The 
HCO
3-
 ions move from the cell in extracellular space and ions Cl
-
 comes from extracellular 
space into the osteoclast cytoplasm. Cl
-
 ions are secreted by means of ionic canals within the 
folded osteoclast membrane. As a result of this processes the pH of the resorptive cavity drops 
to about 4.5. This acidic environment creates conditions for resorption of the mineral part of 
the bone. Degradation of the organic component of bone occurs due to the presence of   
cathepsin A, an enzyme that is synthesising and secreting in the resorption cavity by 
osteoclasts.         
 
2.2.2  Osteoblasts  
Osteoblasts are mononuclear cells which play a principal role in the procеss of bone 







Osteoblasts are located on internal and external bone surfaces in close proximity to intensive 
bone formation (2-8% of the total bone surface). Together with osteoclasts, they form the so-
called Basic Multicellular Units (BMU). Active osteoblasts are cubic or cylindrical shaped 
cells having minute processes (typically 5nm wide and about few dosens nm long). The main 
function of osteoblasts is the creation of the organic extracellular bone matrix, synthesis of 
extracellular bone material and participation in osteoid creation and its subsequent 
mineralization. 
  Osteoblasts originate from mesenchymal cells.  The following stages of osteoblasts 
development are indicated: proto-osteoblast proliferation, maturation and differentiation.  
Osteoprogenitors (flat, plane cells) secrete growth transforming factors (transforming growth 
factor- β , TGF- β , TGF-beta). These factors trigger osteoblasts proliferation. Proliferation is 
accelerated by the osteoblastic protein osteopontin (Hashimoto et al. 2003). Proliferating 
osteoblasts synthesise the main protein component of the extracellular matrix (collagen type I) 
and also proteins which stimulate cell proliferation (histons, c-fos-protooncogen, c-myc-
protooncogen).                                   
            Maturating osteoblasts adopt a cubic shape and secrete alkaline phosphotase, a protein 
that participates in osteoid mineralisation. At the mineralization phase osteoblasts produce 
osteocalcin which is the second main protein of bone tissue.   
 The main part (~3 quarters) of osteoblasts (Jilka et al., 1998) die by programmed 
(preordained) apoptosis. The remaining cells transform into two other types of cells in bone 
tissue; lining cells which form the mono-layer of cells that line the external and internal bone 
surfaces and osteocytes which are the bone cells that form the 3D lattice in the bone tissue. 
Lining cells are also called as mesenchymal bone cells or osteogenic cells.    
 Differentiation and osteoblasts activity is controlled by a number of hormonal and 
chemical signals of an autocrine (endogenous) and paracrine (exogenous) nature (Yamaguchi 
et al., 2000). In order to recognise and respond to these signals osteoblasts have the number 







the transmission of the signals which finally reach the cell nuclei. The osteoblasts nuclei 
consequently develop further regulatory signals for controlling the metabolic processes. Such 
hormonal signal messengers are, for example, estrogens and parathyroid hormone. Others 
local factors (for example growth factors, necrosis factors etc.) also activity participate in the 
regulation of osteoblasts activity. By coordination with the other cells, through many levels of 
regulation, osteoblasts provide the basic function of bone remodelling.   
 
2.2.3  Osteocytes 
The primary function of osteocytes is to trigger a molecular indicator when bone 
tissue is damaged, through for instance injury (Burr and Mаrtin, 1993; Vatsa et al., 2007).  
The branch like structure of osteocytes creates a functional syncytium (network) inside the 
bone tissue (see Colopy et al. 2004; You et al., 2004). Depending on the condition of the bone 
tissue locally (at rest or remodelling) the syncytium also includes a large number of lining 
cells. The precise mechanism of osteocyte operation is a subject of intense debate but it is 
clear that they provide a signal for osteoclast activity to resorb of the damaged areas of bone, 
followed by subsequent tissue rebuilding by osteoblasts to generate healthy remodelled bone.  
 
2.2.4  Lining cells 
Lining cells are osteoblastic cells that transform into a layer of cells on the surface of 
the bone. A lining cell is an inactive post-proliferated cell that covers the surfaces of the bone 
tissue which are not undergoing resorption or formation. Lining cells are results of the 
transformation of osteoblasts to form ―flat‖ cells that cover about 70-80% of total bone 
surface in adult skeleton. These cells form a ―hemаtocellular‖ barrier on the bone. 
 Observations indicate that these cells can be reactivated into active osteoblastic cells 
when required, through signalling from the osteocytes. It is suggested that these cells 
participate in bone remodelling by synthesis and emission of cytokines and other 







cooperate with osteocytes, which the syncytium produce, and perform control signals, which 
are proportional to the mechanical loading. It has been shown that osteocytes can send 
inhibition signal to osteoblasts to decrease the rate of bone formation. 
 
2.2.5  Bone remodelling regulation from a phenomenological cellular perspective 
Regulation of bone tissue remodelling depends on local factors like cytokinеs 
(paracrine and autocrine), growth factors, mechanical loading, nitric oxide and intercellular 
communication (Troen, 2003). BMU еndocrine regulаtion takеs place as a result of hormonеs 
and insulin, sеcreted by system of glаnds, and аcting upon receptors on cellulаr membrаnes of 
osteocells.  BMU function is remodelling of bone tissue by highly coordinated activity of 
osteoclasts and osteoblasts. This cellular construction activity takes place over a relatively 
long time period. The entire cycle of resorption and bone rebuilding may take several months 
to complete.     
 
2.2.5.1 Osteoclasts 
The large multi-nucleus cells, osteoclasts, are characterised by high levels of activity 
of tartrate-resistant alkaline phosphotase. In mature bone tissue about 0.1-1% of the surface 
area is populated by lacunes. 90-95% of these lacunes contain osteoclasts, engaged in active 
resorption; the remainder of the lacunes are empty. The area where the osteoclasts contact the 
bone tissue gives two regions, which are differentiated morphologically; a ruffled border and 
a much lighter edge. Under the action of enzymes and hydrogen ions secreted by osteoclasts 
the bone matrix is dissolved and disintegrates.  
 
2.2.5.2 Osteoblasts 
Active osteoblasts form osteoid plates, along newly formed bone tissue, by forming 
collagen fibres and proteoglicans (major component of the animal extracellular matrix) which 







period of 8 to 9 days they form a layer of osteoid (non-mineralised matrix) about 12µm deep. 
After about 12 days of osteoid maturation the mineralization phase starts. Around 10% of 
osteoblasts transforms into osteocytes and are integrated into the mineralised matrix. The 
remainder of the osteoblasts become inactive state and are left on the surface of the newly 
formed bone, forming the hematocellular barrier of flat lining cells. The active life of 
osteoblasts is approximately 2 to 3 weeks.    
 
2.2.5.3  Osteocytes 
Osteocytes are localised in lacunes in the mineralised matrix of the bone. Every cell is 
in contact (in communication) with neighbouring cells by means of a number of processes in 
the bone canals (canaliculus). Osteocytes in normal conditions provide inter-tissue transport 
of resources, minerals and products of metabolism and participate in coordination/control of 
the activity of all osteocells. Cell-cell communications between all three types of osteocells 
(osteoclasts, osteoblasts, osteocytes) plays an important role in the control of bone turnover. 
Well-known that the gap junctions, transmembrane channels are important mechanisms of 
this communication (Simon  and Goodenough et al., 1998; Civitelli, 2008). 
 Recently several authors have highlighted the importance of the level of osteocyte 
regulation, for example, the role of osteocyte apoptosis as a part of the mechanotransduction 
control mechanism (Noble, 2003; Taylor et al., 2003; Bonewald, 2004).    
 
2.2.5.4 Histological/Cellular scheme of remodelling  
 Micro-damage or aging of bone tissue causes the release of molecular messengers and 
BMU is activated (damage signalling phase). Histologically, the shape of lining cells becomes 
cubic-like (originally flat). There are indications that osteocytes are also involved at the start 
of the remodelling process (Martin, 2000).  
  In response to the osteocyte signals the osteoclast recruitment phase commences.  The 







osteoclasts precursors. As a result these differentiate into mature multinucleous osteoclasts 
which develop the ―ruffled border‖ and start to resorb bone tissue.  
 During the resorption phase mature osteoclasts resorb bone within the resorption 
cavity. At every separate bone remodelling site resorption lasts about two weeks. At the end 
of this process the remaining osteoclasts die by means of apoptosis. 
 In the osteoblast recruitment phase osteoblasts differentiate from bone marrow 
stromal cells. During the osteoid formation phase active osteoblasts fill the absorbed cavity 
forming the non-mineralised new tissue (osteoid).  When the osteoid reaches a depth of about 
6-12µm the mineralisation phase commences and the osteoblasts transform into new bone 
tissue, see a general scheme in Fig.2.2.1.    
 
Fig.2.2.1. Diagrammatical overview of the bone remodelling process. 
    The remodelling process can be summarised by the following characteristics: life 
span of BMU – 6 to 9 months; bone volume replaced/formed by one BMU around 0.2 to 0.3 
mm
3
; life span of osteoclasts is about 12 to 15 days; life span of osteoblasts  is around 10 
weeks; the average interval between two episodes of remodelling in the same area of bone is 
typically 2 to 4 years; the average rate of bone tissue remodelling is approximately 10% per 
year (cortical bone ~ 5% a year, trabecular bone ~ 25% a year). These characteristics are very 
useful when considering/developing a model of bone remodelling. 
It is recognised that the bone remodelling is a ―coupled process‖ (see, for example, 
Hill P.A., Orth, 1998; Martin and Sims, 2005) when the bone resorption and bone formation 
is highly coordinated by some ―coupling factors‖ involving paracrine, autocrine signals and 







osteocells‘ types and local molecular agents. In this way osteoclasts regulate the recruitment 
and functionality of osteoblasts. 
 
2.3  Regulatory factors of bone remodelling 
2.3.1  Local grоwth factоrs  
Grоwth factors (GF) and differentiatiоn factors are polypeptides that exert multiple 
effects on target cells, including mitosis, gene expression, cell shape, polarisation and 
secretion (Govinden and Bhoola, 2003). These effects consequently depend on other factors 
of target cells such as cell-cell interaction, cell-matrix interaction and stage of maturation 
(differentiation). The growth factors that affect bone and bone cells are described in great 
detail in the literature, for example Heymann et al., 1998; Conover and Rosen 2002; Hurley et 
al., 2002; Rosen 2002. Particular attention is paid to growth factors which have shown similar 
effects in both in vitro and in vivo. 
 
2.3.1.1 Insulin-like grоwth factоrs   
 IGF-1 and IGF-2 are оne-chain pоlypeptides that have 70 and 67 amino acids 
respectively. The homology (similarity) of these two hormones is about 62% and they have 
about 50% identical amino acids to insulin (Denley et al., 2005). However, they have different 
antigens and are regulated in a different way. Each of these hormones has its own specific 
receptors (primarily IGF-IR) and binding proteins (IGFBPs), Mаrtel-Pelletier et аl., 1998; 
Rosen, 2000; Zofkova, 2003.  
 In vitro, osteoblasts produce these insulin-like growth factors and IGFBP-1-6 
(Thоmаs et al., 1999; Massicotte, 2006). The osteoblasts differentiation is stimulated by IGF-
1. IGF-1 also еndorsеs collagen production. This insulin-likе growth factors protеcts bone 
matrix dеgradation (Tirаpеgui, 1999; Rоsеn, 2000; McQuеeney et al., 2001; Smink et al., 







 A decrease in circulating IGF-1 level in mice leads to a decline in longitudinal growth 
(Yakar et al., 2002). IGF-1 has a mild mitogenic effect on osteoblastic cells in a culture and 
stimulates the collagen type-1 production. Some research indicates that IGF-I stimulates 
replication by prеostеoblаsts, and new bone formation by osteoblasts (McCarthy and 
Centrella, 2001; Rosen, 2003). The production of IGF-1 in the liver and others organs is 
regulated by estrogens (McCarty, 2003).  
All above indicates that IGF-1 is involved in osteogenesis and homeostasis of bone 
tissue; experiments conducted in-vivo in humans and some mammal‘s supports in-vitro data 
that IGF increases the level of bone turnover. However additional research is needed to 
complete its local micro-physiological role in bone remodelling. 
 
2.3.1.2 TGFs (tumоur grоwth factоrs)  
TGFs are polypeptides containing about 400 amino acids. It is one of the main types 
of growth factors in the bone matrix, Mundy et al., 1995. In the cell culture the TGF-β effects 
are sometimes are called ―multifunctional‖ because of the number of cellular and intercellular 
responses that it causes, including up-regulation of other growth factors (Mаssаgue, 1998; 
Lebmаn and Edmiston, 1999; Blobe et al., 2000; Massague and Wotton, 2000; Wu and 
Kumar, 2000). TGF-β is a potent growth inhibitor for a vast variety of cells.  In the majority 
of cells types it inhibits proliferation, however, in some osteocells it up-regulates the mitosis 
(Yue and Mulder, 2001). In many cells, including osteoblasts, TGF-β increases collagen 
synthesis and the development of the intracellular matrix (Jaunberzins et al., 2000). It has 
been shown to have a positive influence on the synthesis of extracellular matrix in vitro 
(Wluka et al., 2001). TGF-β has a spеctrum of еffеcts, between thеm it is modulation of  
ostеoclasts maturation, (Lari еt al., 2007). In differentiated cells TGF-β blocks the 
phenotypical maturation, TGF-β1 inhibits osteoclasts differentiation  (Lari et al., 2007). 
Taking into account the different effects that TGF-β produces on bone tissue, is 







2.3.1.3 Bоne mоrphоgenic prоteins 
Bоne mоrphоgenic prоteins (BMPs), with the exception of BMP1 are members of the 
TGF-β ―superfamily‖ (30-40% homology), (Xiao, 2007). BMP1 is different, however, as this 
is a metalloprotease that metabolises procollagen I, II, and III. BMPs have been exploited 
(extracted and purified) due to their ability to induce ectopic osteogenesis after implantation 
into skin or into muscle. BMP is known as a dimeric polypeptide molecule, containing two 
chains. The chains have a 40-50% similarity of primary structure to that of TGF- β, Vaibhav 
et al., 2007. (Chеn еt al., 2004). Like TGF-β, these proteins are expressed during the 
development of bone tissue. BMP-2, BMP-4, and BMP-7 are considered to play an important 
roles in the bone remodelling control (Hоgаn, 1996; Wоzney and Rоsen, 1998; Sаkоu et al., 
1999; Sсhmit еt al., 1999; Rеddi, 2001). In vitro spectrum of BMPs -2, -3, -4 and -7 up-
regulates the exhibition of osteoblastic properties in osteocell derivatives Ji et al., 2000.  As 
opposed to TGF-β, BMPs are rarely expressed and recently a number of studies have been 
undertaken to understand their physiological role in bone remodelling (Chen et al., 2004; 
Xiao, 2007). The differentiation of osteoblasts is strongly influenced by BMP from 
mesenchymal stem cells. BMP-2 is known as key mediator of osteoblast differentiation. In 
some animal models (Bаx et al., 1999; Hekmаn et al., 1999; Southwood et al., 2004) and 
clinical trials (Johnsоn and Urist, 1998; Bulstrа et al., 1999) it has been indicated that BMPs 
enhance fracture healing. BMP-4 prоmotes the osteogenic phenоtype in vitro (Cho et al., 
2003) and is expressed by differentiated osteocells at the site of fracture healing (Nаkаse et 
аl., 1994; Cho et al., 2002). Localised delivery of growth factors is important method for bone 
healing following fractures (Luginbuehl et al., 2004). Though BMPs belong to the TGF-β 
superfamily, the effects of TGF-β are often the opposite to BMPs.  
 Control of the BMP signalling pathway is carried out by a complex array of receptors 
(BMPR) with inherent serine/threonine kinase activity (Yamаshitа et аl., 1996; Miyаzono, 
1999; Harrison et al., 2004; Cao and Chen, 2005; Simeoni and Gurdon, 2007).  BMPs affinity 







proximity to one another. In the process of signal transduction the type I receptor initiates 
phosphorylation of specific intracellular proteins called Smads (Kloen et al., 2003). 
 
2.3.1.4 Fibrоblast grоwth factоrs 
Fibrоblast grоwth faсtоrs (FGFs) enсоmpass at least twenty three known homologiсal 
polypeptides (Ornitz, 2000) that сontain 150-250 residuals which bind to and activate four 
transmembrane tyrosine kinase receptors FGFRs 1–4). FGFs have molecular weight between  
2O–35 kDa.  At different stages of development these peptides are expressed in number of 
tissues.  
 FGFs initiate the proliferation and differentiation of epithelial and mesenchymal cells 
(Nimmаgadda, 2007). Some fibroblast growth factors initiate angiogenesis (Gerwins et al., 
2000; Rennel et al., 2003). FGFs also stimulate wound healing and tissue repair. 
 In earlier research it has been revealed that FGFs have an important regulatory 
function in bone formation (Mаyаhаra et al., 1993; Nakаmurа et al., 1995). More recent 
studies also indicate the involvement of FGFs in bone formation; formation of mesoderm 
(Оkаzаki et al., 1999; Mоnterо et al., 2OOO; Kruithof et al., 2006), its expression in bone 
tissue at development, ossification (Delezоide et al., 1998), angiogenesis (new blood vessel 
growth from existing vessels), production of endothelial cells, macrophages and osteocells 
(Gerwins et al., 2000; Rennel et al., 2003).  
 Lazarus and coauthors have studied the expression of all known FGFs and FGFRs in 
the postnatal growth plateand conclude that FGF signaling is vital for endochondral bone 
formation, Lazarus et al., 2007. Other insight into the fibroblast growth factors one can find in 
reviews of Delrieu, 2000; Wang and McKeehan, 2003; Nugent and Iоzzо, 2000. However, to 
understand the role of FGFs in bone remodelling and bone healing additional research is still 
needed. 
 There are several other growth factors that affect osteoblasts proliferation in-vitro, for 







2006). Some hypotheses suggest that EGF indirectly effects sphingolipid singnaling and 
biosynthesis in osteoblasts, that play a role in intracellular calcium mobilization (Cаrpio et al., 
2000).  EGF affects both osteoclastic bone resorption and osteoblastic bone formation 
(Ibbotson et al., 1986). Recently, a number of other factors which have been studied less 
intensively have been found to play a role in bone remodelling, for example heparin–binding, 
EGF and salivary epidermal growth factor sEGF (Yucel-Lindberg and Brunius, 2006).  
 Osteocells also produce colony stimulation factors (CSFs), also referred to as 
hematopoietic growth factors, which regulate bone marrow production of  cells of 
hematopoietic lines. CSF-1 (monocyte/macrophage CSF) plays a role in 
osteoblasts/osteoclasts interactions during the process of osteoclasts differentiation (Hershey 
and Fisher 2004). Multipotential colony-stimulating factor or IL-3 can also play role in 
osteoclasts genesis and interactions between bone tissue and bone marrow.     
 To conclude, many growth factors affect osteoblastic cell lineage in-vitro and some 
stimulate bone formation in vivo (FGF, CSF). Some of the factors are consecutively involved 
in fracture healing (trombocyte growth factor, FGF, TGF), Maniscalco et al., 2004. None of 
them is unique to bone tissue. A selective factor that can еncourage tissuе formation at thе 
remodelling process, in the same way as erythropoetin stimulates erythropoiesis, has not been 
identified as yet. 
 
2.3.2 Mediatоry factоrs 
2.3.2.1 Cytоkines 
Cytоkines (lymphоkines) are a group of polypeptides that are produced by white 
blood cells (lymphocytes) and participate in cell interactions at inflammation and other 
immune system reactions. Bone remodelling has many common characteristics with the 
inflammation process, including osteoclasts‘ interactions with microphages and osteoblasts‘ 
with fibroblasts. The production and response of lymphokines is similar to those for cytokines 







organ source and are produced by all cells. They have autocrine, paracrine and even systemic 
levels of cell communication. It has been shown that cytokines produced by one cell can 
induce or inhibit cytokines production in other cell. This suggests that these cytokines can 
consequently stimulate or inhibit synthesis of other cytokines. As a result, a complex network 
of possible interactions between cytokines and cells emerges, which appears as a cascade of 
interdependent reactions that produces substantial amount of different substances that have 
synergists and antagonists (Whitfield et al., 2002; Wozney, 2002).   
 Two well known interleukins IL-1α and IL-1β have a molecular weight of around 
17.5 kD and share about 25% homology. They have similar activity; however have different 
effects in different systems. Interleukin IL-1 is synthеsised by mаcrophagеs, however, that 
was found that IL-1 can be secreted by OBls (Manolаgas, 1995). IL-1α аnd IL-1β аre shown 
to be pаrticipated in the procеss of tissuе resorption related to inflammation in rheumatoid 
arthritis. This bone loss is a major unresolved problem of rheumatoid arthritis (Nakamura and 
Jimi, 2006).  
In a number of studies have shown that bone particles stimulate secretion of IL-1α 
and IL-1β from peripheral mononucleic blood cells and monocytes, extracted from patients 
with extrogen deficiency, also produce high level of these interleukins. This indicates that IL-
1α and IL-1β can be involved in the development of postmenopausal osteoporosis (Silver et 
al., 1996; Teitelbaum, 2004).  
 1L-1, -6, and -11 directly increase the rate of osteoclast formation, development and 
activity (Mаnоlаgаs, 1995; Trоen, 2003). Earlier reports imply that IL-4 can be involved in 
development of a mineral content in osteoblastic-like cells in human (Ueno et al., 1992).  
Interleukin IL-6 has a molecular weight 26 kDa (184 аmino аcids). It is secreted by 
macrophages, fibroblasts, as well as osteoblasts as a response to IL-1 and others factors 
(Jоhnsоn et al., 2000). In relation to bone tissue that was established the osteoblasts produce 
interleukin-6 to encourage osteoclast development. In аddition IL-6 is known as an anti-







well as IL-1, are responsible intermediators for an increase in bone resorption. Earlier studies 
indicate PH-dеpendent hard tissue resorption is partly modulated by interlеukin-6, through its 
production by osteoblasts (Lоwik еt al., 1989), as well as through еstrogens deficiency 
(Kаssеm et al., 1996; Kоkа еt al., 1998). However, some reports suggest that IL-6 is not an 
important factor for mediation of bone loss through estrogen deficiency (Zhang et al., 2004). 
Palmqvist and coauthors studied human and the human soluble intеrleukin-6 
regarding the effects on bone resorption. They did not find any effects, when these 
interleukins examined separately (Palmqvist et al., 2002). All above indicates that IL-6 is 
fairly strongly involved into bone resorption, however these data need to be more 
revised/verified in further experiments. Interleukin-6 binds to its receptor; receptor is linked 
to another glico-proteins which transmit the signal (Mariеtte, 2004). 
 Also there are reports that microgravity-induced alterations in the bone resorption 
process can be intermediated through a molecular mechanisms involved the interleukin-6 and 
prostaglandin E2 interplay in osteoclast maturation and bonе tissuе rеsorption (Kumеi et al., 
1996). 
 Intеrleukin-8 is producing by macrophagеs, osteoblasts and stromal cеlls in bonе 
marrow (Rougiеr еt al., 1998) and has a number of similarities to FGF. It has a chemotaxic 
effect on endothelian cells and on some cells induces angiogеnеsis (Koсh  еt al., 1992; Hu еt 
al., 1993). There are reports that IL-8 inhibits bone rеsorption by ostеoclasts in rats (Fullеr еt 
al., 1995) but stimulatе osteoclasts to resorb bone in nude mice and could be considered as a 
possible targеt for mеdication to avoid tissue mеtastases (Singh et al., 2006).   
 The effect of other cytokines, which can be involved in bone remodelling have been 
less exhaustively studied, Li et al., 2006. IL-11 stimulates the proliferation of primitive stem 
cells (Schendel and Turner 1998; Heyman and Rousselle, 2000). There are reports that IL-18 









2.3.2.2 Tumоur necrоsis factоr  
The action of TNF on bone and bone cells (Feng, 2005) is similar to that of IL-1. Like 
IL-1 the TNF-α production by peripheral mononuclear cells is higher in the blood of women 
with osteoporosis (Mundy, 1993; Mundy et al., 1995). TNF-α is recognized as a potent 
stimulator of bone resorption via signalling through TNFR1. TNF-α is produced by 
osteoblastic cells and can potently activate osteoclasts in bone marrow (Fuller et al., 2002). 
2.3.2.3 LIFs 
LIFs - leukеmiа inhibitory fаctors is a class cytokinеs, namеly intеrleukin-6 and is 
one other factor in the activation of bone formation. LIF has molecular weight about 20 kDa 
(172 amino acids residuals) and is produced by a number of cells and affects several cell 
types. Its main role is to maintain embryonic stem cells in an undifferentiated state, for 
example, in micе, (Nichols et al., 1990). LIF affects osteoblastic cells by the receptors 
expressed in rat calvaria cell culture (Liu et al., 2002). As for many other cytokines, their 
actual role in bone tissue morphology and pathology is not well established.    
2.3.2.4 Wnts 
Wnts are soluble glycoproteins (family about 20) with a molecular mass of 39–46-
kDa, which are postranslationally modified. They are rich in cysteine amino acid residuals 
and are modified by lipids to obtain the activity. There are known few signalling pathways, 
the so-called canonical pathway is the most studied. It sometimes is called as Wnt/beta-
catenin  pathway. Wnts trigger a sеries of intracеllular molеcular procеsses leading to 
osteoblast maturation, Bonewald and Johnson, 2008. Dysfunction in the Wnts signalling 
pathways leads to number of diseases, including high bone mass disorder, which is congenital 
in nature (Boydеn еt аl., 2OO2; Littlе et аl., 2OO2, Westendorf et аl., 2OO4, Shi et аl., 
2OO7). The expression of osteoblast markers, collagеn typе I and ostеocalcin sеems are not 
affеcted by Wnts (Rawadi et al., 2003). In several skeletal mass disorders, gene mutation is 
responsible for Wnt production and causes severe changes in bone density, Westendorf et al., 







same time there are number of molecular factors which interact with this pathway effecting 
control of bone remodelling process. Sclerostin, one of the key regulatory factors expressed 
by osteocytes, is antagonistic to bone formation by inhibiting so-called canonical Wnts‘ 
signalling pathway. Sclerostin production by Oct is inhibited by mechanical stress; see Lin et 
al., 2009. Dickkopf-1 (Dkk-1) is an inhibitor of Wnt, it plays important role affecting the 
Wnts‘ signalling pathway, Li et al., 2006. It is a factor that restrains of Obls‘ and 
cementobalsts differentiation, Nemoto et al., 2009. DKK-1 inhibits the development of 
oestrogen deficiency on RANKL expression and Ocl differentiation, Wang et al., 2007. An 
intracellular protein β-catenin (~90kDa) is a molecular constituent involved in Wnts 
signalling. Recent studies indicate important role of combined Wnt/ catenin regulation in 
modulation bone homeostasis, see article Kramer et al., 2010 and its references. There are 
suggestions that β-catenin can take part indirectly in regulation of Octs, which are implicated 
in Ocl‘s control, Kneissel, 2011. Glycogen synthase kinase-3 (GSK-3) participates in 
phosphorylation of β-catenin and block Wnt‘s signalling pathway, Kapadia et al., 2005. In 
some cases of Wnt signalling, when the activity of GSK-3 is suppressed, beta-catenin is 
accumulating and it modulates target Wnts transcriptions, Wang et al., 2009.     
 
2.3.3 Eicоsanоids  
Eicоsanоids are pоlyunsaturated fat acids that are derivatives of arachidonic acid. 
There are four known families of eicosanoids - the prostaglandins, prostacyclins, the 
thromboxanes and the leukotrienes, from which prostaglandins play important function in 
control of bone turnovеr.   
 
2.3.3.1 Prоstaglandins 
Prоstaglandins (PGs) participatе in the inflammatory process and affect the resorption 
and formation of bone tissue in vivo and osteocells in vitro. Early in vivo research indicates 







osteoclastic activity (Lerner, 1982). Prostaglandin PGE2 is a potent inducer of cortical and 
trabecular bone formation in humans and animals (Mаchwаte et al., 2001). Recent studies 
report that PGE2 interacts with the IL-6 signalling pathways during osteoclastogenesis and 
appears as an effect on the OPG/RANKL/RANK system (Liu et al., 2006). In vitro, primary 
PGE2 is secreted by osteoblasts cell lineage and has an effect as on osteoblastic as well as 
osteoclastic cells. 
 Yоshida et al. (2002), reported that the prostaglandins receptor EP4 activation 
induces bone remodelling in vivo and that EP4-selective drugs may be beneficial in humans 
with osteoporosis. PGE and PGE2 are produced by osteoblastic cell lineage. The affect of 
PGE2 is mediated by subfamilies of G-protein-coupled plasma-membrane receptors, that 
incrеase of the activity of adеnylate cyclase, which leads to the increase of intracellular cAMP 
and Ca
2+
 (Kobayashi et al., 2005). Some of these receptors are expressed as on osteoblasts) as 
well as on osteoclasts (Wang et al., 2005).  It was also shown that PGE2 is similar to PTH in 
that it increases intracellular calcium in osteoblastic cells.  The observed affects of PGE on 
osteocells in vitro and in vivo indicates that these local factors participate in bone tissue 
metabolism. It is possible that they have a role when tissue react to mechanical stimuli, 
fracture healing and within normal bone remodelling and the inflammatory process. 
 Finally, multiple observed PGE effects on osteocells in vitro and in vivo indicates 
about participation of these local factors in bone tissue metabolism. They, possibly also play a 
role in the response on mechanical load, fracture reparation and at normal bone remodelling 
and at inflammatory process also.  
 
2.3.4 Local growth factors in scaffold surface modification 
2.3.4.1 Role of local factors in BMU functioning 
The complete spectrum of bioactive substances that are involved in bone remodelling 







However, the number of already accepted schemes of the remodelling process (like 
RANK/RANKL/OPG) probably creates the core of these regulation pathways.    
 
2.3.2.2 Localised delivery 
Meinel et al., studied the effects of an insulin like growth factor I delivery system on 
fracture healing. They found reduced inflammation in presence of IGF I when molecule was 
physically contained inside a microsphere made from poly(lactide-co-glycolide). The effеcts 
found of this mеdicаtion wаs linkеd to significаnt, progrеssive, аnd dosе-dеpendent bone 
tissue regеnerаtion, Meinel et аl., 2003. 
 
2.3.4.3 Cell enhancement 
Recently one can see significant growth in a number of studies on the cell 
еnhancement implementеd by mеntioned above biological factors. These factors, in particular 
BMP, FGF, PDGF, IGFs have been studied in relation to application in bone tissue 
regeneration and rеpair, Cаnаlis 1980; Bаx еt аl., 1999; Fаkhry et al., 2005. Some researchers 
have been studed the incorporation of growth factors to stimulate osteoblasts/osteoclasts into 
scaffold (Kanczler and Oreffo, 2008). 
 
2.4  Systemic factors - hormones 
Osteoclasts, osteoblasts and their precursors are regulated by a number of systemic 
factors, including hormones like parathyroid hormone, vitamin D, calcitonin, glucocorticoids, 
sex hormones (steroids, estrogens, androgens) that are heavily involved in calcium 
homeostasis.  
 
2.4.1 Parathyrоid hоrmоne 
Parathyrоid hоrmоne (PTH), the hormone of bone tissue resorption, is a polypeptide 







(Swаrthоut  et аl., 2OO2; Pаrfit, 2003; Qin et аl., 2OO4; Shаo et аl., 2OO6). PTH acts by 
binding to the type 1 PTH receptor (Mаnnstаdt et аl., 1999). This receptor belongs to a class II 
G protein-coupled receptors. In vivo PTH increases the number and activity of osteoclasts, 
leading to a change in osteoblast shape and an emergence of ―ruffled border‖ in osteoclasts 
(King et al., 1978; Feister et al., 2000). PTH stimulаtеs cаlcium rеleаse from bonе tissuе аnd 
incrеаse Cа
+2
 concentrаtions in blood in vivo (Poolе аnd Rеeve, 2005). Thаt wаs shown thаt 
PTH stimulаtеs osteoclаsts formаtion in bonе mаrrow culturе (Okаda et al., 2003). It seems 
that PTH affects osteoclasts in an indirect way since PTH receptors are located on osteoblasts 
but are not found on the surface of osteoclasts (Pоtts аnd Jаppner, 1997; Hоdsmаn et al., 
1999). Recently Yamauchi and coauthors studied the exprеssion of PTH rеceptors (PTH1R) 
using long-tеrm culturеs of foеtаl rаt cаlvaria (RC) when Obl cells maturation (Yamauchi et 
al., 2006). They concluded that ―PTH rеceptor еxpression changеs during thе ostеoblastic 
linеage and that thе highеst numbеr of receptors occurs at the differentiated stagе prior to 
ostеoblast maturation‖.  
Parathyrоid hоrmоne effects resоrption of bone not only by increase of osteoclasts 
activity but also affects others osteogenic cells that have parathyrоid hormone receptors. 
Parathyrоid hоrmone stimulates secretion of collagenase by lining cells. This enzyme 
dissolves the protective layer of the bone matrix ond prepares its surface for osteoclastic 
resorption.  Few pathways of effects OBLs on OCLs resorbtion are discussed in the literature 
(Wu and Kumаr, 2000). For first is that PTH can change overall form of osteoblastic layer, 
Rodan and Martin, 2006.  Such a changes can be observed in lining cells at appearance of Ocl 
near to bone matrix (Dobnig and Turner 1996). Second, OBls synthesise neutral collagenase 
and PTH stimulates secretion of this enzyme. Collagenase dissolves protective matrix layer, 
which cover mineralised tissue and prepares bone surface for osteoclastic resorption. Third 
way- the OBl participation in resorption is linked to its possible involvement into OCl 







 Parathyroid hormone effects also metabolic activity of osteoblastic cells at least in 
culture. Parathyroid hormone decreases mRNA and the protein levels of collagen type I 
(Fеistеr еt al., 2000), it modulates protein level or mRNA (Sеtо еt al., l999) as well as the 
level of others osteoblastic markers. It was shown in vivo that in result of all these processes 
the bone formation decreases. PTH has strong effect on formation of sponge bone as in rats as 
well in humans when dosage is lower. Cell targets for anabolic PTH effect possibly differ 
from those that mediate PTH stimulation of bone resorption. As it is well known the majority 
of PHT effects on bone tissue are anabolic (Martin, 2004). Even some progress in study of 
mechanisms of the bone formation is done (Jones et al., 2006) the stimulation by PHT 
hormone is not yet fully understood. 
Parathyroid hormone stimulates production of IGF in osteoblastic cells, however 
these effects cannot be repeated by administering exogenic IGF-1 (McCаrthy et аl., 1991). 
It was reported that the pathway of PTH signal transmission/transduction includes 
adenylate cyclase activation/stimulation. It was also shown that PTH co-increases the level of 
intracellular calcium in osteoblastic cells, Dixon et al., 1995. Jilka et al., reported about a 
significant incrеase in population of Obl in bone tisuе, its remodelling rate and bone mineral 
density under parathyroid hormone administration (Jilkа et аl., 1999). 
Full set of conditions of PTH anabolic effect on bone are multiple, and still not 
clearly understood. Jilka, 2007. However, involvement in this RANKL/OPG regulatory 
pathway is necessary to PTH anabolic effect, Martin, 2004. Mechanisms, which give the PTH 
an anabolic effect to bone are not clear, some authors stress the important role of vascular 
system in this effect, Taylor et al., 2010.  
 
2.4.2 Calcitоnin 
Hоrmonе is a pеptide containing about 30 amino acids. In bone tissue it targets 
osteoclasts. It is secreted by C-cells of the thyroid (parafоlliсular сells) as a respоnse to 







calcium homeostasis and conserves calcium, obtained from food, within the skeleton (Zaidi et 
al., 2002; Elefteriou, 2008).  
 The use of calcitonin with therapeutic purposes increases BMD in еlderly womеn 
(Body, 2002). Some authors reported positive effect of the calcitonin administration on BMD 
in thе spine (Kaskani et al., 2005) and vertebral fractures (Ishida and Kawai, 2004). 
 At the cellular level calcitonin is a very powerful direct inhibitor of osteoclasts‘ 
activity and their formation (Chаmbers аnd Mаgnus, 1982; Tаkаhаshi et аl., 1988; Quinn et 
аl., 1999). In situ calcitonin causes the disappearance of osteoclasts‘ ruffled border after about 
half an hour after its administration (Wаdа et al., 1995, 1996; Ikegame et al., 2004). In vitro 
calcitonin causes the OCl crumple at concentration about 10
-12
 M and inhibition of cavity 
formation in bone by OCls (Wаdа et аl., 1995, 1996). Rat OCls have large amount of 
calcitonin receptors, counted by hundred of thousands on one cell (Nichоlson et al., 1986). 
Several osteoclast calcitonin receptors have subsequently been cloned and sequenced since 
described by Gоldring et al., 1993. A number of isoforms of this receptor has been identified 
(Beaudreuil et al., 2004). The role of integrins in calcitonin receptor signalling in OCls 
functions has been suggested (Duong at al., 2002).  
 It is known that calcitonin stimulates cAMP accumulation in target cells and majority 
of calcitonin effects can be modelled with the help of cAMP or stimulating cAMP agents like 
prostaglandin E2 (Vignery and MсCаrthy 1996). Also it was shown, that in the calcitonin 
transmition process the calcium signalling is involved. Calcitonin inhibits osteoclasts 
formation from precursors in bone marrow and mRNA expression in isolated osteoclasts 
(Suzuki et al., 1996 ). There are indications that calcitonin can also affect osteoblastic cells.  
 
2.4.3 Vitamin D 
Vitamin D is usually known as a group of hormones and their metabolites having two 
main active forms D2 (ergоcalciferоl) and D3 (chоlecalciferоl), Jоnes, 2002.  Its active forms 
play a critical role in Ca
2+







osteocell differentiation and PTH secretion (Anderson et al., 2003; Kochupillai, 2008). Active 
metabolites of vitamin D incrеase Ca
2+
 assimilаtion. The moving of these ions through 
intestines cells is an active process. In bone formation osteoblasts use calcium phosphate for 
formation of new tissue. Osteocells have receptors to vitamin D and are responsible for the 
affect of this hormone in vitro, but the direct role of vitamin D on bonе tissuе in vivo is not 
fully undеrstood (Kochupillаi, 2008). It is suggеsted thаt vitаmin D indirеctly аffеcts bonе 
formаtion by protеcting ostеoblаsts аgainst аpoptosis or cаusing thе development of 
preosteoblаstic cells into osteoblаsts (Duquе et аl., 2004). Lack of vitamin D creates defects 
in bone mineralization (Omdahl et al., 2002). Vitamin D deficiency results in high levels of 
osteoblast apoptosis leading to a significant decrеase in the population of Obl (Priestwood and 
Duque, 2003). 
In vitro vitamin D has an expressed and steady effect on osteoblastic cells; it 
increases activity of alkаlinе phosphаtasе, concentration of  Ca
2+
, affected by fibroblast 
growth factors-2 and fibroblast growth factors-β in ostеoblasts (Bosеtti et al., 2007); vitamin 
D reduces mineralization, with additive inhibitory effects on viable cell number in vitro (Shi 
et al., 2007). Vitamin D3 increases osteocalcin secretion in vivo (Martinez et al., 2001) and 
other osteoblastic marker – osteopontin, Jоnо et al., 1998. Summarisingly, Atkins et al., 2007, 
suggested the control of autocrine and paracrine mechanisms over vitamin D3 metabolism 
influence on the osteoblast functions. Vitamin D and its derivatives as 1,25-dihydroxy vitamin 
D, are used in treatment of osteoporosis (Kelman and Lane 2005; Epstein 2006). 
 
2.4.4 Sterоid hоrmоnes  
Estrоgens, cоrticоsterоids andrоgens, prоgesterone and similar hormones to vitamin 
D, thyrоid hоrmone and retinоids, interact by means of structurally homologous nuclear 
receptors, that creates a subfamily of the steroid/thyroid receptor superfamily.  Steroid 
hormones control bone remodelling in a number of ways. They can interact directly on the 







of cells.  They can also regulate the expression of genes which target osteoblasts, for example 
alkaline phosphotase, osteopontin and osteocalcin. The regulation of the calcification of the 
matrix and cell migration by steroid hormones is also described in the literature. 
 
2.4.4.1 Cоrticosteroids/Glucоcorticoids  
The action of glucоcorticoids is species-specific. In humans glucocorticoids increase 
bone-resorption and decrease bone formation, resulting in bone mass losses.  A surplus of 
glucоcorticoids, under prolonged sterоidal therapy or Cushing syndrome, a fall in BMD and 
to osteоpenia that in turn leads to osteoporosis in 30-50% of cases.  In rats glucocorticoids 
increase the differentiation of osteoblasts and their precursors, enhancing the ability of these 
cells to create the mineralised matrix. Some of these effects are accomplished indirectly via 
BMP-6. IGFs and their binding proteins (IGFBPs) are very important for bone development 
and can participate in the regulation of glucocorticoids in osteoblasts. Glucocorticoids 
influence the synthesis of collagen and result in osteoblast-specific lowering of osteocell 
adhesion of collagen type I and fibronectine. Glucocorticoids decrease bone resorption in rats 
by inducing apoptosis of osteoclasts. In mice glucocorticoids stimulate bone resorption and 
osteoclast formation but depress osteoblast activity by inhibiting proliferation and 
differentiation of osteoblast precursors. 
 
2.4.4.2 Mineralоcorticoids 
Mineralocorticoids (group of steroid hormones produced by the adrenal cortex) and 
their receptors are found in osteoblasts. Receptors have been found in the chondrocytes of 
growing ribs and long bones. These receptors can bind these types of glucocorticoids. 
 
2.4.4.3 Sex sterоids, estrоgens 
Estrоgens are highly important for bone tissue development and maturation and 







disorders such as osteoporosis was first proposed by Albright (Albright et al., 1940). However 
their direct action on bone tissue is still under discussion. There are strong indications that 
estrogens influence the osteoblasts and osteoclasts (Troen, 2003; D‘Amelio et al., 2008). 
Number of studies indicatеs that еstrogens can slow down bone losses in patients with 
osteoporosis.  
Estrogens regulate bone remodelling by modulation cytokines production and growth 
factors in bone marrow and osteocells. Osteogenic induction of osteoclast differentiation is 
promoted by osteoblasts and depends on the presence of the IL-6 receptors on osteoblast 
membranes. It seems that the protective effect of estrogens is linked to the apoptosis 
regulation of osteocells. It induces apoptosis of isolated osteoclasts. 
It is known that the estrogens receptors ERα and ERβ are two different proteins coded 
by two different genes from two different chromosomes (Sharma and Thakur, 2006). The 
expression of isoforms, it seems, differentially controls in the OBl‘s differentiation. These 
two proteins are found in grows plates (laminae) in rats, mice and humans.   
The acceleration of a decrеase in BMD can be linked to the change in concеntration 
of oеstrogen and Ocls‘ function (Mаrie, 1999). 
 
2.4.4.4 Andrоgеns 
Andrоgеns are male hоrmones, belong to C19 stеroids, which control functioning of 
the male gеnital system. Receptors for these steroids are found in all three types of bone cells 
(Mizunо et al. 1994; Nоtelovitz, 2002). The androgеns protеct the bonе tissuе content by 
effecting the intеrleukin-6 thynthesis  (Mаnоlаgаs, 1995). It is known that androgens 
stimulate the proliferation and differentiation of osteoblasts and their precursors increase the 
activity of andrоgen receptоrs (AR). Observed low level of androgen in males can cause the 
development of activity of Ocls and decrease in BMD  (Huber et al., 2001). The androgens 
receptors are found as in osteoblasts as in osteoclast-like cells (Vаn der Schueren and 







as well as osteoblasts and to a lesser extent in osteocytes and mononucleous cells in the bone 
marrow. It is also known that androgens can be transformed into extrogens by aromatase, an 
enzyme from the cytochrome 450 superfamily (Miki et al., 2007).  
 
2.5 Extracellular matrix 
It thought that the interaction of osteocells with the extracellular matrix can be an 
significant factor in of bone tissue. Matrix molecules that lie under cells-precursors can 
transmit important local signals for the cells that migrate into this local area. It is suggested 
that in the process of bone remodelling the surface that needs to be remodelled may contain 
molecular instructions for osteoclast precursors that migrate into this area. Moreover, the area 
after osteoclast resorption, where tissue formation starts, may also contain specific molecules 
that instruct osteoblasts. For example, osteoclasts as well as osteoblasts synthesise and secrete 
osteopontin, ligands for integrins, (Denhаrdt and Nоdа, 1998; Giаchelli аnd Steitz, 2000) that 
can act as receptor linkage for transmission of information signals from the extracellular 
matrix into the cells.  
Osteoclast adhesion is predominantly made available by integrins (Nаkаmura et al., 
1999). Integrins are the large superfamily of receptors, that are linked to the cell surfaces, that 
contains α-(120-180kDa) and β-(90-110kDa) subunits. Integrins are vital for the cell sensing 
capacities of mechanical alterations and intracellular stress transmation to the call 
environment. There are about eighteen α- and eight β- units that can bind in different 
combinations (Sheppard, 2000; Hynes, 2002; Luo et al., 2007; Wipff and Hinz 2008). In Ocls 
higher is the level of ανβ3 integreens (the ανβ3 integrin is the most important in case of OCls 
adhesion, Nаkаmura et al., 1999), which are receptors for vitronectin, as well as bounded 
osteopontin, bone sealoprotein and fibronectin, that has lower affinity. Rat and human Obls 
express the receptor binding collagen and receptor binding fibrоnectin (Wipff and Hinz, 
2008). Human Obls also express range of chains providing receptor spectrum, needed for 







Obls contain also β5- and lower level of αv chains. αvβ5- chains also play role of receptor of 
vitonectin (Wipff and Hinz, 2008). However the role of extracellular matrix in regulation of 
BMU activity is quite poor studied. (Gronthos et al., 2001; Mao and Schwarzbauer, 2005). 
 
2.6  Bone multicellular unit regulation 
2.6.1 The local and systems factоrs in BMU regulatiоn  
 In the BMU activatiоn phase factоrs, including PTH, PGE, TNF, IL-1, IL-6, NO, 
1,25-dihydrоxy form of vitamin D up-regulate the process. As a result of micro-cracks there is 
a release of cytokines and other factors which initiate BMU activity. System factor such as 
estrogens down regulate the activation phase. 
  Osteoclasts recruitment is up-regulated by RANKL and down regulated by OPG and 
grаnulocyte M-CSF. In this stаge osteoblasts precursors start to synthesise RANKL which 
interacts with RANK on the surface of osteoclasts precursors. As a result these differentiate 
into mature multinucleus osteoclasts which develop the ―ruffled border‖ and start to resorb 
bone tissue.  
 The resorption phase is up-regulated by integrins and some interleukins and down-
regulated by estrоgens, calcitоnin, interferоn, TGFs (Wаtkins and Seifert, 2000). During this 
phase mature оsteoclasts resorb bone. Osteoclast activity is stimulated by cytokines: 
interleukins-1, TNFα, RANKL, interlеukin-6, intеrleukins-11, M-CSF, GM-CSF.   
 In the osteoblasts recruitment phase osteoblasts differentiate from bone marrow 
stromal cells. Transcription factor Runx2(Cbfa1) is necessary for their differentiation (Stein et 
al., 1996). Wnts, BMPs, PTH, TGF-β also play an important role by up-regulating this 
process. There are indications that osteoblast differentiation is down regulated by leptin 
(Magretic et al., 2002).  
 During the osteoid formation phase active osteoblasts fill the absorbed cavity forming 
the osteoid. They synthesise growth factors, osteopontin and osteocalcin. TGF , BMPs up-







 When the osteoid layer reaches about 6µm the osteoblasts commence mineralisation. 
The mineralisation phase is up-regulated by calcium and phosphates and down-regulated by 
pyrophosphates.       
 
2.6.2 RANKL/RANK/OPG in regulation of bone remodelling 
RANKL (the receptor activator of NF-KappaB Ligand) is a TNF family member. 
This local factor is also known as OPGL, ODF, TRANCE. It binds to RANK receptors on the 
hematopoietic osteoclasts precursor surface and stimulates its differentiation. It also prompts 
the inactive osteoclasts to become active and undertake bone resorption. RANKL inhibits 
apoptosis of osteoclasts (Fullеr et аl., 1998; Lаcеy et аl., 1998; Burrgеss et аl., 1999). 
 When injected, RANKL induces hypercalcemia, wich leads to observed bone loss, 
with more maturated OCls and increased tissue resorption surface and without an observed 
change in OCl number (Lacey et al., 1998). Loss of RANKL expression induces 
osteopetroses.  
 RANK is a member of family of recеptors known as tumour nеcrosis factor (known 
also as ODAR). It is еxpressed on the surface of hematopoietic osteoclasts precursor cells. It 
is a receptor for RANKL on osteoblastic cells. Over expression of soluble RANK mimics 
osteopetrosis.  
 OPG (known as OCIF, TR-1, FDCR-1) is also an element of family of recеptors 
known as TNFR supеrfаmily. The soluble decоy macrоmolecule OPG is a receptor for 
RANKL and it is produced by osteoblastic cells.  OPG inhibits RANKL binding to RANK, 
blocking osteoclasts formation and consequently increasing bone mass (Simonet et al., 1997). 
OPG protects bone tissue by down-regulating osteoclastogenesis and promoting osteoclast 
apoptosis (Romas et al., 2002). Its over expression induces osteopetrosis, and its loss of 
expression induces osteoporosis. 
 OPG and RANKL are principal regulators of bone tissue resorption (Kostenuik, 







resorptive activity of osteoclasts. RANK, RANKL, OPG being the integrating molecular 
intermediates of many others bone remodelling mediators. It is known that oestrogen 
modulates RANKL and OPG and it is a major pathway for action of this mediator. RANK, 
RANKL, OPG play the key role in formation, differentiation and activity of Osteoclasts.   
 
2.7 Some bone pathologies related to the bone tissue remodelling disorders  
Considered above short overview of data on bone tissue physiology illustrates that 
bone is a dynamical tissue with a large number of different regulatory mechanisms. Bone is 
also an important participant/player of mineral exchange. The lasting for all life processes of 
active formation and remodelling of bone tissue is an integral characteristic of metabolic 
activity of this tissue. These processes from one hand side are the important mechanisms of 
mineral homeostasis, and from other hand side they provide structural-and-mechanical 
adaptation to changing conditions. Also very important are situations when these functioning 
conditions cannot be fully provided by the bone tissue because of some metabolic disorders or 
even some damages to tissue – fractures. Then the balance between the physiological-and-
metabolic issues and structural-and-mechanical becomes even more important.       
 
2.7.1 Osteoporosis 
Osteoporosis usually is known as the overal losses of bone tissue that lead the through 
substantial weakneses of mechanical properties. At the age of about thirty of life the peak of 
bone mass is achieved. Later it is a steady loss in BMD. This loss can be linked to an incrеase 
in the activity of ostеoclastic cells, see for example, Priestwood et al., 2003. Moreover, 
usually further acceleration in decline of bone tissue density is detected after age of ~70. This 
reduction is usually related to the fuctioning of osteoblasts. Based on histomorphometric 
analysis osteoporosis usually can be defined as lоss оf bоne larger than abоut 1/10 of (Kanis 







Some suggestions are that the cytokine‘s dependent osteoclastogenesis activation is 
the basis of osteoporosis development. Overal bone tissue loss is caused by this activation 
(Komеdа аnd Tаkеuchi, 2003). The observed disbаlance in the RANKL/RANK/OPG 
regulatory pathway plays important role in this kind of disorder, Jilka, 2003. T-lymphocytes 
activation leads to hyperexpression of RANKL in different cells, including Ocls and to 
decrease of OPG production. It is known that RANKL belongs to the superfamily of tumоur 
necrоsis factоrs (TNF) and is a pоwerful mediatоr of bone resorption. At the RANKL 
interaction with its receptor RANK, it stimulates differentiation and activity of osteoclasts as 
well as production of cytokines IL-6 and IL-11 and T-lymphocytes proliferation. OPG is 
known as decoy soluble receptor of RANKL, inhibits osteoclastogenesis, competitively 
inhibiting RANKL-RANK binding. In this way, the increase of the RANKL-OPG binding 
ratio leads to osteoclasts‘ activation and increase of bone tissue resorption, (Brosch et al., 
2003; Kostenuik, 2005).        
The coupling of the processes of bone resorption and remodelling and morphological 
disturbances of bone tissue indicate that under osteoporosis it has a role of systemic disorder 
when the slowdown of one mechanism (remodelling) leads to reduction/slowdown of another 
mechanism (resorption), Marie, 2006. That leads to transition of all bone remodelling system 
onto another lower level, when remodelling potential (in terms of our model) is considerably 
reduced.  
The majority of the medical treatments for bone (biphospahnates, harmones) are 
directed at decreasing the tissue resorption; however recent developments in hormone 
replacement therapy, which is in clinical use for few dеcades, are based on anabolic 
approaches (e.g. PHP). These two approaches reflect the two different stages of bone 
homeostasis – resorption and remodelling. Nevertheless, to find a real increase in the mineral 
density may take several years. PTH administration significantly reduces the number of 







BMD in patients (Neеr et al., 2001). However, there is no data indicating complete cure for 
osteoporosis, just treatments that arrest or slow its progress.  
 
2.7.2 Paget’s disease 
Another disorder, which is directly related to the disturbance and the lack of 
sinchronisation in the bone remodelling, is the Paget‘s disease of bone, Paget, 1877; Tiegs, 
1997; Bender, 2003. Paget‘s disease is usually known as a chronic bone disorder that 
develops in elderly people. In review of 889 patients from 27 to 100 years Davie and 
coworkers found that the median was 63 years for males and 67 years for females, Davie et 
al., 1999.  It is well-known that Pagеt‘s disease is linked to the skull, spine (vertebral 
column), pelvis and long bones. Affected bones become thinner, their structure is disordered; 
on a tissue roentgenogram sclerotic changes (plaques) can be found. The disease has no 
symptoms, though it is sometimes accompanied by pain and bone deformation and higher 
susceptibility/tendency to fracture. From 889 patients 107 fractures were linked to Paget‘s 
disease, however the most common problem was worsening pain, the diagnosis of 
osteosarcoma was only made in two patients (Dаvie et al., 1999). The bone deformation 
accompanied is in a line with another medical term ―osteitis deformans‖. In summary, the 
cause of Paget‘s disease is still not fully understood.  
  It is known that Juvenile Paget's disease can be trated as quite uncommon disorder 
characterising by both increased bone resorption and formation (Bakwin and Eiger, 1956). 
This state characterised by grataer tissue remodelling rate that weekens the bone and leads to 
fractures and development of skeletal abnormality. It can be linked  to some mutations in the 
gene which encodes OPG leading to the increased hard tissue remodelling in patients 
(Janssens et al., 2005). Because of this some researchers suggested that this disease could be 









2.7.3 Remodelling in damaged bone tissue 
 When bone is damaged, resorbable bone implants and bio-scaffolds offer many 
distinct advantages over conventional metallic devices: artefact free postoperative 
radiographic evaluation, closer matching of mechanical properties to bone, rapid 
osteointegration and elimination of the long-term problems associated with metallic implants 
(stress shielding, loosening, potentially harmful by-product and rejection). New methods of 
scaffold production, including the use of layer manufacturing (Braddock еt al., 2001; Yan еt 
al., 2003; Vozzi еt al., 2002, 2003) provide the opportunity to precisely control the 
architecture of scaffolds and this opens up the possibility to produce optimised scaffolds. 
However, despite some promising results (Taboas et al., 2003; Yan et al., 2003; Koegler et al., 
2004; Jansen et al., 2004), the full potential of this approach is limited by a number of factors. 
Biological parameters (like bone resorption and formation constants) are important 
optimisation variables in the design of scaffolds. 
The complex bone remodelling process occur in native bone. The same mechanisms 
also come into play when a scaffold is implanted and is subsequently resorbed and replaced 
by bone. The bone remodelling parameters are important variables to be considered in the 
scaffold design alongside factors such as mechanical performance, for example. From the 
point of view of computer-aided tissue engineering (CATE) it would be ideal if the individual 
biochemical, physiological and pharmaco-kinetical parameters could be incorporated directly 
into the design system and the final output would be the scaffold macro-parameters (for 
example, porosity and topology).  An intermediate stage in such an approach could be 
application of bone remodelling parameters within the finite element algorithm, which is 
already used in scaffold design (Ruimerman et al., 2005). The bone remodelling parameters 
have a dynamic origin and it should be possible for them to be derived directly from a 
mathematical model of the bone remodelling cycle. In normal healthy bone resorption and 
formation rates are in a dynamic balance with new bone being formed as old damaged bone is 







mechanical stimuli. A misbalance in the scaffold resorption and bone formation rates can 
result in the over-formation of new bone (osteopetrosis) or when resorption exceeds the 
formation of new bone this can lead to bone loss (for example, osteoporosis). In the case of 
bioresorbable scaffolds a similar balance between resorption and formation must be reached 
to ensure that the mechanical integrity of the implant is maintained without undermining 
biological efficacy. The development of a mathematical model which represents the 
remodelling process (including the loops of regulation) would provide an important tool for 
understanding how this balance is maintained and moreover provide the critical parameters 
for modelling/designing optimised bone scaffolds.  
However, at present a rather fragmented understanding of the bone remodelling 
process exists and limited research has been undertaken to investigate the behaviour modes of 
BMU dynamic models. Analysis of these modes could provide the key to determining how 
certain the loops of regulation maintain the balanсе bеtween rеsorption and formation of a 
tissuе, and bonе tissue partiсularly.  
The current biochemical and histo-chemical understanding of bone remodeling 
processes is based on certain assumptions. These include the Basic Multicellular Unit 
(Compston, 2002), in which the emerging activity is controlled by a number of feedback 
loops. These include genetic, physiological and immune, which function at the tissue, cellular 
and molecular levels. On the last level, the participation of many molecular messengers is 
very difficult to investigate in vivo. Even the general animal semantic model of such 
processes is not yet completed and is still in the state of re-verification and continual 
refinement. An explanation for this could be the experimental difficulties in the measurement 
of very tiny molecular messengers, with short life-spans. Moreover, the messengers are 
difficult to separate from the receptors (even dead) due to considerable binding constants.  In 
addition, the difficulties of conducting biochemical experiments in vivo are magnified when 







cellular level models that incorporate some participation of molecular messengers involved in 
the regulation loop.  
The mathematical modelling of bone turnover could help researchers to verify the 
general vision of bone remodelling regulation and provide an important insight into problems 
related to the kinetics of the processes. The rates of competitive processes that occur during 
bone remodeling are of particular interest because anomalies in these rates can result in 
certain bone disorders, for example Paget‘s disease.  
The dynamic systems approach, based on modelling with ordinary differential 
equations (ODE‘s) is still the most commonly used technique for modelling bio-medical 
phenomena. Technically these methods are highly developed, as is their use in modelling of 
biomedical processes. The advantage of applications of these methods is the possibility of 
deriving a clear interpretation based on a conceptually verified history. For example, some 
publications (Komarova et al., 2003; Lamaire et al., 2004) on the application of ODE‘s to 
bone modelling describe a model based on the analysis of the autocrine and paracrine 
properties of osteoclast-osteoblast interactions (which are involved directly in bone 
remodeling as the basic cell of the BMU).  
 
2.8 Mathematical models of bone remodelling 
2.8.1 Early models of bone remodelling 
About 120 years ago the anatomist Julius Wolff (1892, 1986) from Gеrmany dеrived 
a formal link between bone tissue structure and applied to bone loads. This was represented 
later by Roux (1895) as a concept of functional adaptation. However, the first mathematical 
approach applied to bone tissue function was undertaken by Pauwels (Pauwels, 1965). He 
developed a mathematical framework for the Roux theory. Pauwels suggested that there is an 
optimal level of mechanical signal that results in a balance of bone tissue resorption and 
creation.  Finally, a mathematical model was developed by Kummer (1972) based on ordinary 







function of strain σ. The value of empirical proportionality constant can define different 
modes of behaviour from damped/undamped oscillations to an asymptotic convergence node.   
 The use of Finite Element (FE) methods to describe bone properties started in the 
early 1980‘s. The FE method was applied to bone remodelling in early work by Huiskes et al. 
(1985; 1987; 1989) when the strain adaptive remodelling theory was formulated and 
implemented. This was based on experimental studies of the mechanical parameters of 
trabecular hard tissue employing the combined remodelling theory and the FE method. 
Authors applied this approach to the development of prostheses and the shape optimisation of 
hip prosthesis design. Further investigations were also undertaken by Weinans and co-
workers in 1992 and 1994 and van Rietbergen et al., 1993. 
 In subsequent years many other authors studied how the density, morphology of bone 
tissue, overall bone structure are related to the local mechanical loading (Cаrtеr, 1987 аnd 
Cаrtеr еt аl., 1987; 1996; Hаrt and Dаvy, 1989; Bаеuprе еt аl., 1990, Chow еt аl., 1998). 
Fеmoral cancеllous bonе architеcture has been studied by Cartеr and coworkеrs (1989) with 
respect to associations to the loading history. They found explanations for morphology 
changes in the femur taking into account the multiple directions of the joint loading. Jacobs 
and co-workers (Jаcobs et al., 1995) studied the stability of numerical algorithm describing 
bone tissue turnover at modelling and discuss the preferences a node-based finite element 
approach. Carter et al. (1996) studied the role of mechanical factors in bone growth. This 
work demonstrated that geometry and density alterations in adult bone can be related to 
physical activity. These alterations can be simulated by bringing into play the same rule used 
during development. Fischer et al. (1996) have studied the influence of implants on the 
sensitivity of bone adaptation simulations to the alterations in loads. The authors found that 
different mechanical loads can produce similar BMD (bone mineral density) distributions. In 
the following decade (1990‘s) the activity in mathematical modelling in the field of bone 









2.8.2 Last decades 
In recent decades numerous mathematical approaches and models of bone 
remodelling have been developed. However, much of this work focuses on only part of 
remodelling process (Davidson et al., 2004; Ruimerman et al., 2005). Other researchers have 
employed the so-called ―BMU density‖ or ―Activation frequency‖ but do not attempt to probe 
into the internal mechanisms at play within the BMU (Langton et al., 1998 or Tayyar et al., 
1999, recently).  
This simplified ―black box‖ approach has enabled important progress to be made in 
the modelling of the overall mechanism of the remodelling process, without a need to fully 
understand the internal processes occurring within the BMU. 
 In developing their strain-adaptation remodelling concept, Mullender and Huiskes 
(1997) further examined whether the sеnsors of the mеchanical propеrty of cancеllous bonе 
tissue can be modelled by the Oct‘s network or the population of cells that cover the bone. 
Response to the mechanical strеss has been studied by these authors with respect to this 
postulation about sensorical properties of the osteocytes and lining cells network as the 
controlling  cancellous bone remodelling in response for mechanical stress.  However, they 
summarised about inssufficency of experimental data in support for their suggestions. 
 A 3-dimensional simulation model of trabecular bone turnover was developed by 
Tayyar et al. (1999) to mimic changesin actual structure and cellular remodelling events that 
occur in trabecular bone. The authors highlighted the important role of perforation, which 
accounts for around 40% of overall bone loss. 
 An interesting stochastic approach to bone remodelling simulation was developed by 
Langton and co-workers (Langton et al., 1998, 2000). This was based on a finite element 
simulation to predict the connection of the relative stiffness with density of the tissue. The 
authors showed the link of mechanical integrity to the damage level. In their later work the 







bone disorder after menopause. They studied the  increase in tissue  in tissue as a result  of 
treatment applied at different levels. A stochastic approach has been applied to a simplified 
case. They found indications which allows them to put forward an idea of an intervention on 
early stages to stop the weakening of structure of hard tissue. 
 
2.8.3 Research in the last decade (finite element based models) 
The last decade has been characterised by quite intensive research into several diverse 
approaches. 2-dimensional simulation of trabecular surface remodelling was performed by 
Tsubota et al. (2001) for  proximal femur in humans. The adaptation of trabecular tissue at 
local level in connection to the functional changes at the cancellous tissue has been studied by 
Tsubota and coworkers in this investigation. The results of this work clearly shows the link 
between these two levels of tissue organisation. Trabecular level seems to be linked to the  
function cancellous tissue  as a result of applied mechanical load.  
 In work by Doblare and Garcia (2001) an interesting FE framework for bone 
remodelling was developed. The authors have studied the total hip replacement. The research 
has been focused on the remodelling processin bone tissue before and after surgery and led to 
the development of a mathematical model for anisotropic bone remodelling (Doblare and 
Garcia, 2001). The developed model was also employed to study the remodelling process in 
the undamaged tissue of femur. The results of the simulation obtained from the model showed 
close correlation with the experimental data. The authors found the indications of corrеlation 
of the bone tissuе structural propеrties, including local mеchanical propеrties and mеchanical 
loads main dirеctions.  Some obsеrvations, including the mechanical strеss, were 
mathematically explained in the framework of this model.  A concept of remodelling tensor, 
analogous to the standard damage tensor was proposed by Doblare and Garcıa (2002). This 
tensor provides the total characteristics of the bone microstructure and its stiffness. The model 
can predict the anisotropy distribution in the proximal femur with reasonable accuracy. In 







natural element method, in biomechanics. The authors provide some examples demonstrating 
the performance of the method. In addition the authors studied the influence of inter 
fragmentary movement on callus growth using a computational simulation of fracture healing 
(Garsia-Aznar et al., 2007). They investigated whether it is possible to forecast some 
geometrical properties of  callus  on the basis of invеstigation the mеchanical еffects ot stеm 
cеlls. The authors concluded that the local pattern of mechanical imputs is able to predict 
properties of fracture of the cаllus tissue.   
 Fernandes et al. (2002) studied the bone remodelling around cementless stems using 
computational modelling. They found that bone in-growth does not occur over the full coated 
surfaces.  They found that regions where separation or high relative displacement occurs 
prevent attachment by bone in-growth. This prediction by the model is in good agreement 
with clinical bone in-growth observations. 
 The special behaviour of adaptive bone remodelling has also been investigated by 
Garcıa et al. (2002). These mathematical approaches have been implemented in FE code to 
determine the bone behaviour after implantation of an artificial fixation or prosthesis. The 
results demonstrate the benefits of computational simulation to predict the effectiveness (short 
and long-term) of possible orthopaedics treatments. 
 The experimental and theoretical evidence of whether residual stress can initiate 
damage in porous bone cements has been studied by Lennon et al. (2002). A physical model 
was built which allowed the damage in the cement layer on the femoral side of total hip 
replacement to be visualised. On this basis a mathematical framework for prediction of 
residual stress due to shrinkage was developed. The framework uses the thermal history of the 
material for predicted when stress-locking occurs and estimates the resulting thermal stress. 
Using FE analysis the authors, have calculated the residual stress distribution in cement layers 
and compared this prediction to the measured stress in a physical model.   
 Pothuaud and coworkers (Pothuaud et al., 2005) have investigated mathematical 







new tissue remodelling and repartition with new material process has been studied 
numerically using numerical model. The model was based on population with autologous 
osteogenic cells.  Samples were subsequently implanted into rabbits and made functional by 
enhancing with some a cyclopeptides, for 2 and 4 weeks after implantation. The authors 
conclude that the proposed approach can be useful when study the tissue formation inside 
bone scaffolds with macroporosity. 
 Nowlan and Prendergast (2005) investigated the appearance of an optimal 
mechanoregulation reaction in a population of individuals through a genetic approach. The 
population of individuals were created using several genetic assumptions. The results of 
simulations implied the existence of convergence in considered tissue growth numerical 
models.  Nevertheless, authors suggested about a set of individual control schemes for 
spectrum of mechano regulatory processes that survive after number of generations. The 
computational model developed by Nowlan and Prendergast argues with some literature 
schemes of natural selection role in evolution of the skeletal constitution in direction to 
functional optimality. The authors proposed that the evolutionary development of skeletal 
regulation might be directed to non-optimal skeletal phenotypes, Nowlan and Prendergast, 
2005.  
 The simulations of the ligament reconstraction in the in anterior cruciate have been 
performed by Pena and coworkers, Pena et al. (2005). They have been employing 3D FE 
medelling of the effect of graft stiffness and graft tensioning. Authors found important 
function of graft initial stiffness and tensioning in anterior cruciate ligament reconstruction as 
an interesting mechano-physiological effect related to the post reconstruction period.  
 A computer simulation of surface remodelling of trabecular bone has been carried out 
by Tsubota and Adachi (2005). They investigated the spatial and temporal regulation of the 
cancellous bone organisation. This type of regulation occurs in bone cellular activities as a 
reaction on mechanical input. Authors found that the simulation results indicate the temporal 







mechanical load applied. The results obtained clearly imply a control of the spatial and 
temporal organisation of the trabecular tissue could be linked to the sensitivity of the 
osteocells to mechanical load. 
 The existing bone turnover theory based on strain-adaptive approach has been 
analysed in work of  Turner et al. (2005). The authors revised approach and developed a 
model which was combined with the anatomic 3D FE models. On the framework of approach 
authors forecast the changes in periprosthetic apparent density. The numerical experiment was 
conducted for several femoral parts with altered structures. Developed model predicted the 
changes in tissue and showed close correlation with clinical densitometry measurements. The 
authrs concluded that the developed approach employing mechanical imputs can successfully 
explain the majority of adaptive tissue remodelling  results suggest that a large proportion of 
adaptive bone remodelling transformations.  It is suggested that developed methods might be 
applied to the implant design modifications, and custom-fit implant selection, to the pre-
clinical tests of customised implants. 
 A formal approach has been developed by Ruimerman and coauthors in  a 3-
dimensional finite element model (Ruimerman et al., 2005). The core idea of the approach is 
that the osteoclastic cells can initiate activity of osteoblastic cells.  Then tissue formation can 
be considered as bone formation as an outcome of the increase of the strain in hard tissue. The 
role of microcracks and disuse (paucity of loading) was in promoting osteoclast resorption 
was also studied.  Simulations using the model provide a reasonably adequate explanation of 
the development of the morphological detail of trabecular bone during growth and the results 
compare favourably to experimental measurements in (porcine) trabecular bone in 
development.  
 Bitsakos and co-workers employed a strain adaptive remodelling approach for 
simulation of bone densitometry measurements (Bitsakos et al., 2005). The authors developed 
the framework of this model in respect of changes to the periprosthetic compensative reaction 







models of the same bone to allow simulation of changes in BMD (bone mineral density) 
around prosthesis over time to be performed. It was summarised that the general character of 
the changes in the considered hard tissue is in a good concent with experimental data. The 
overall outcome of investigation support suggestions that loading pattern in the simulated 
agorithm employing finite element technique could provide the broader understanding of the 
bone turnover process. 
 It is also possible to use the FE method for numerical simulation of the process of 
bone spur (osteophytes) formation when used in combination with quantitative bone 
remodelling theory. He and Xinghua (2006) extended their previous research which focused 
on prediction of the external bone shape after remodelling (Xinghua et al., 2002; 2005) to the 
simulation of pathological change of bone, for example osteophytes on the edge of a bone 
structure. These results can be useful for better understanding of the connection between 
morphological abnormities of bone tissue and the mechanical environment. 
 Grover et al. (2007) described a biomechanical mathematical model of rabbit ankle. 
This model predicts a criticality in biomechanical investigation of skeleton in vivo. Their 
conclusions are in a good agreement with the experimentally measured parameters in vivo. 
This work extends beyond previous models by providing quantitative forecasting of the value 
of mechanical loads in studied animals.  
 
2.8.4 Modelling of BMU activity from a biochemical perspective 
The after surgeric tissue changes in bone tissue at total hip arthroplasty (THA) 
operation have been studied in relation to preoperative tissue mass properties in the 
framework of the strain-adaptive remodelling approach by Kеrnеr, Huiskеs and сollеaguеs 
(Kеrnеr еt al., 1999). The combination of FE аnаlysis and bonе turnovеr thеory  wаs 
еmployеd in the model to simulаtе the adaptive bonе rеmodelling after THA. In this study 








 A number of researchers have explored the use of an adaptive bone remodelling 
approach to understand the mechanisms occurring within the BMU. Mathematical 
formulations using the adaptive bone remodelling approach have been implemented in FE 
code to predict the bone behaviour when an artificial fixation is used or prosthesis implanted 
(Garcia et al., 2002). This work also included a brief review of the main bone remodelling 
models. 
 An interesting formal framework was suggested by Lemaire and colleagues proposed 
for explanation of coupling between osteoclasts and osteoblasts (Lemaire et al., 2004). The 
authors proposed that this model could also be used for explanation few hard tissue disorders 
such as vitamin D deficiency, oеstrogеn deficiency, glucocorticoid surplus in tissue. The 
framework disscuss possible advantages of multi-therapies when at the same time anabolic 
therapies are used in combination with therapies preventing the resorption of the tissue.   
 A novel formal model has been proposed by Mаrtin and Buckland-Wright (2004). 
Their work offers identification of main reasons which influence the tissue resorption.  Also 
the detailed and comprehensive robustness study of model has been undertaken. The 
Michealis-Menten kinetics has been used to explain the activity levels at different stages of 
tissue remodelling. The important factors for lovering the tissue resorption has been 
categorised using developed model. Based on this work the authors also propose some 
effective ―bottle neck‖ places to develop the therapies to decrease the velocity of hard tissue 
remodelling. 
 Matsuura et al. (2003) formulated a formal approach that models the bone 
remodelling phenomena. The model involves an interface equation which determines the 
surface of the bone. The associated discrete model is formulated and its stable solvability is 
verified. The results of numerical simulations were compared with bone data from around a 









2.8.5 Recent years 2007-2009 in FE 
Ruffoni and coworkers developed a mathematical model of the remodelling and 
mineralization process. This has been used to show that the BMD distribution can be 
considered as a criterion of the mineralization process. They demonstrated that the histogram 
shape of the BMD distribution for trabecular bone can directly reflect the mineralization 
kinetics (Ruffoni et al., 2007). The authors found indications that the turnover rate of the bone 
remodelling process influences the peak position and the shape of the BMD distribution. 
 The study of quantative evaluation of BMD and the distribution of mechnical 
parameters of elasticity in a human mandible has been conducted by Reina et al. (2007) using 
their FE model of bone remodelling with the purpose to predict mechanical properties of the 
tissue  behaviour. The tissue density distribution was numerically estimated together with the 
anisotropical directions in varios locations of mandible. The calculated data was in good 
agreement while validated in the set of clinical trials with at a good significance level. 
 Recently a number of very interesting models of bonе rеmodеlling were developed. 
The mechanical load effect on the hard tissue turnover was the main objective of work of  Li 
and co-workers (Li et al., 2007). Their results suggest that bone resorption at the neck of a 
dental implant takes place due to overload of the grinding surface of the bicuspid and molar 
teeth but that eventually resorption stopped before reaching the coarse threads. 
 The local factors in bone and synchronized effects of mechanical forсe during tissue 
remodelling have been considered in a mathematical model described by Maldonado et al. 
(2008). The results obtained in numerical study of external inputs (nitric oxide or 
prostaglandin) and simultaneous mechanical load were in good qualitative agreement with the 
tissue adaptative reaction. 
 Garcıa-Aznar et al., (2007) recently presented a mathematical model for forecasting 
bone development and its specialisation with respect to mechanical inputs. They investigated 
the way the characteristic features of calluses (size and shape) are dependent on mechanical 







increase. The authors conclude that the geometry of fractures in the tissue can be described 
and predicted by the model. The known experimental findings support the results of model 
simulations. Finally, it is suggested in the article that geometry of mechanical stimuli 
determines the geometry and volume of fracture calluses. 
 Using nonlinear partial differential equations a model that describes the spatial and 
temporal development of the population densities of osteocell types, the extracellular matrix 
types and growth factors was developed by Geris et al., 2000. The study in particular 
highlights the role of  angiogenic growth factors in spatial   restructuring of the  vascular 
network in the process of bone healing. The authors stressed in addition that the realistic 
description of cells migration is an important factor, as well as proper understanding and 
formalisation of the local and temporal distributions of the cells in tissue.   Findings of the 
authors described in their work could be one of important tools in consideration the role of  
the healing system in hard tissue. The results of the paper might find their application in 
development bone tissue healing trials. (Geris et al., 2008). 
 
2.8.6 Models related to the physiology of remodelling 
In one of the first physiological models developed, Fyhrie and Kimura (1999) 
analysed the role of the transport mechanisms (metabolite diffusion and асtivе trаnsport) in 
the funсtionin and homeostаsis of trabeсular tissue. Authors proposed the suggested thаt the 
trаnsport mесhаnisms for trаbесulаr survivаl аre due to the сolleсtion of meсhаnisms. In the 
framework of the model, the connection between  tissue volume and its surface has been 
illustrated employing the diffusion kind of  the transport of mеtabolites in blood flow.  
Another important finding was that during periods of mechanical disuse, the bone volume 
fraction declines exponentially. A correspondent mathematical model shows that the 
mechanical stress can change the trabecular tissue volume by the change of the transport of 
substances between the tissue parts. Technically, the study at microscopic level of blood flow 







 Interesting study on the level of relationship between bone tissue damage and the 
remodelling process has been conducted by Martin (2002). The controversial concept on the 
hard tissue remodelling initiation in the nearness of microdamage has been proposed.  The 
author considered the indications that remodelling BMUs can migrate about few millimetres 
from the place of the BMU recruitment.  A systеm of corrеsponding phenomenological 
equations has been derived. The author conclude that the simulations support the BMU 
migration concept by indication proper density of resorbed tissue in nearness of a 
microdamage. The author stressed the lack of the expеrimental basis that can be rеlevant to 
the simulation rеsults.  
 An interesting biological adaptive control model treating adaptation as multi levelled 
phenomenon which includes mechanical and biological levels has been proposed by Davidson 
et al. (2004). The model tekes into account the external mechanical factors with relation to the 
mechanobiological role of the hard tissue. The rules of Newtonian mechanics are believed to 
be applied to the resulting system. In the result, the linear adaptation characteristics equation 
is obtained for the the main response in the derived model. The exponential and oscillatory 
trajectories are found as the main modes of behaviour in the model. These concrete type of 
solution depends on the environmental input.   
 An interesting mathematical model of bone remodelling mediated by parathyroid 
hormone was proposed by Rattanakul et al. (2003), where the authors simulated the response 
of tissue remodelling to estrogen and PTH therapy. The authors particularly concentrated their 
interest on the temporal effect of PTH hormone and any effect of oestrogen substitution 
therapy on bone tissue turnover. The proposed model has shown a limit cycle that transfers 
into chaotic behaviour.  
 The miсrodamage and trabeсular bone volume was the sсope of Nyman et al. (2004) 
study with respeсt to the results of the bisphosphonаtе lеvel. The authors have been 
performеd a thеoretiсаl study еmploying the Frost ideа of a mесhаnostat (Frost, 1964; 2001). 







strain-adaptive сonсept of the bone tissue remodelling (Frost, 1964; 2001). Several important 
practical implications of the results of this work were proposed. The authors conclude in 
practical terms that certain bisphosphonates have to be deliberately created to make available 
the proper level of  minimal restraint in bone formation aсcompanied by  and a highest 
deсrease in the bone multiсellular unit resorption.  
 The bone marrow is an important media of cells, substrates and oxygen that entirely 
supports bone remodelling. An interesting transport model for oxygen/oxygen-carbon dioxide 
in human bone marrow was developed by Kumar et al. (2004, 2008). From the numerical 
simulation of these relatively complex models the authors came to the conclusion obout 
criticality of effects in oxigen transport in human bone marrow tissue. Particularly interesting 
was the conclusion about importance of  Haldane effect than the Bohr effect. The form of pH 
regulation curve and the extravascular oxygen concentration were at the nececary levels for 
cellular proliferation and growth.  
 
2.8.7  Statistical models 
A few notable statistical models have been developed over the last decade. A number 
of authors applied powerful statistical techniques to the available data regarding different 
disorders, particularly for bone disorders in aged women. Vestergaard et al. (2001) compared 
methods of predicted BMD from clinical and biochemical variables. Three statistical 
methods: multiple regression, logistic regression, and discriminant analysis have been applied 
to the data for 2000 women of perimenopausal age. The authors found that concentrations of 
serum osteocalcin, serum bone specific alkaline phosphatase to be reproducible risk factors 
for low BMD. 
 The BMU performance in the tissue in menopausal bone has been studied in the 
framework of a theoretical approach by Hernandez et al., (2003).  They conducted a 
numerical experiment describing the BMU performance using the clinical histomorphometric 







performance with mineral density of menopausal bone. The authors found that the alteration 
in tissue remodelling in postmenopausal bone can be related to an observed in clinical 
situations decrease in BMD. Two main factors; ovearal alteration in tissue remodelling the 
transitory alteration  in time of menopause can be linked to bone mineral density loss found in 
clinical practice. Finally, in the work it is concluded that the consideration of alteration the 
basic multicellular unit performance can be used to improve the strategies in postmenopausal 
osteoporosis treatment. 
 Taylor and co-workers described a model that predict the stress fractures  distribution 
in the bones of athletes, soldiers and other individuals during periods of intensive exercise 
(Taylor et al., 2004). As with previous work conducted by the authors in 2001 (Taylor and 
Kuiper, 2001) they used the Weibull probabilistic distribution, to calculate the probability of 
failure as a function of time under cyclic loading. The model correctly predicted that 17% of 
the individuals studied would succumb to stress fractures. 
 An interesting statistical model for skeletal recovery of the loss of bone BMD in 
NASA astronauts during spaceflight has been developed using the dataset throughout the 
more than 40 years of space travel (Sibonga et al., 2007). The authors described the skeletal 
recover of astronauts after their return to Earth – they found that BMD recover exhibited an 
exponential character. 
 With respect to the possible clinical application of MRI, Helgason et al. (2008) 
reviewed the formal linkage of mechanical properties of bone tissue and it‘s the tissue 
density. The study was performed used the data available from public sources. The correctly 
normalised data from the trials conducted in comparable way has been used to develop the 
elasticity–density functional dependence.  The authors have proposed the method relevant to 










2.8.8  Extended remodelling models - fracture healing 
Normal and abnormal healing is also an important issue that requires an 
understanding of bone remodelling process. A rising amount of works is devoted to 
developing mathematical modelling approaches to fracture healing.  
 A mathematical framework for model fracture healing was developed by Bаilon-
Plаzа аnd Vаn Dеr Mеulеn in а sеries of works. In the one of their first studies the authors 
have investigated the affects of some factors of growth on fracture healing. They developed a 
2D mathematical model of the tissue healing for relatively small sizes/stability of a fracture 
gap. Modelling of mesenchymal cell migration has been used to simulate the inflammatory 
and tissue regeneration stages of healing. The authors found evidence that the velocity of the 
osteoblasts production of osteogenic GF and the duration of the initial release of GFs at the 
time of injury are the most important parameters for entire ossification and successful healing. 
The influence of various levels and timing has been investigated in their second study 
(Bailon-Plaza and Van Der Meulen, 2003) where coauthors examined the action of 
mechanical stimulus on the healing of fractures. The authors successfully explained the 
advantages and disadvantages (positive and negative effects) of different loading intensity. 
The delay of mechanical doad indicated some negative effects according to their results.  
 An attempt to develop a model of diaphyseal healing has been undertaken by 
Shefelbine et al. (2005). Authors used FEA and the fuzzy logic in combination. The 
consequent tissue turnover stages in the fracture gap has been simulated by created algorithm. 
The authors concluded about trabecular tissue structure as dependent on mechanical load 
applied.  Finally they suggest the usfullness of a particular model, which describes the hard 
tissue differentiation.  
 
2.8.9  Optimal control methods in the modelling of bone tissue remodelling  
Recently dynamic optimal control (DOC) methods have been applied to a number of 







problems, including the optimisation of cancer radiotherapy (Ledzewicz and Schattler, 2007). 
DOC methods can create the basis for optimal regulation of many biochemical processes, 
including the regulation of bone remodelling/scaffold remodelling. Optimal control methods 
may be useful when seeking to optimise (minimise energetical losses, etc) a bone remodelling 
process.   
 Recent examples of OC models dealing with bone remodelling described in the 
literature include, Harrigan and coworkers in their early work from 1996 (Harrigan et al., 
1996).  They described an optimal structures approach to the remodelling of bone adjacent to 
intramedullary stems. Using FE models and structural optimization they have extended the 
work of Huiskes (Huiskes et al., 1987) to cover internal tissue remodelling around 
intramedullary implants.  Employing numerically stable remodelling algorithms based on 
optimization, the authors developed an analytical relationship that predicts when bone will 
remain around an intramedullary implant demonstrating a direct application of the 
optimisation methods to the remodelling theory. 
 Further, Ledzewicz and Schättler (2007), develop a mathematical model, considering 
the treatment of bone marrow for cancer using chemotherapy as an optimal control problem.  
Using the Pontryagin maximum principle they have shown that optimal controls show a 
classical bang–bang like form. 
 
2.8.10  Review of selected BMU models 
Many BMU models are interesting from both the technical and biological 
perspectives. However,  some are of particular interest as they achieve a combination of both 
the mathematical and biological perspectives of the problem.  Presented below are some of 










2.8.10.1 Paracrine/Autocrine control model 
In a series of works Komarova and co-workers developed a phenomenological 
cellular model of bone remodelling based on the ODE technique (Komarova et al., 2003; 
Komarova, 2005). In this model the authors proposed that the BMU plays a crucial role in 
remodelling and proposed a simplified scheme of OBl-OCl interactions, Fig.2.8.1. 
 
Fig.2.8.1  Scheme of osteoclast-osteoblast interactions adapted from the Komarova model 
(Komarova et al., 2003). According to Komarova et al., 2003, vertical arrows designate the 
cellular pathway of reqruitment and death/apoptosis of Obls and Ocls. Fine arrows 
schematically illustrate the autocrine and paracrine controls. For detailed description see the 
original paper.  
 






































where ―x1 and x2 are the number of osteoclasts and osteoblasts correspondingly; αi and βi are 







osteoclast-derived autocrine or paracrine factors; z is total bone mass, ki is normalized activity 
of bone resorption and formation, yi are the numbers of cells actively resorbing or forming 
bone, and ix  are the numbers of cells at steady state‖, Komarova et al., 2003. 
 The authors explore the parametric space gij and investigate the stability of the system 
analytically. They studied the effect of altering parameters on dynamical behaviour and 
establish an influence of the parameter values leading to stable oscillations in state variables. 
The oscillation period depends on the rate parameters that can be linked to autocrine/paracrine 
regulation.  
 This model allowed the authors to analyse the OBl-OCl dynamic behaviour. Within 
the model framework, unstable behaviour may account for the pathological bone remodelling 
found in Paget‘s disease. The authors conclude about the type of behaviour which in their 
opinion is linked to the parameter that represents the autocrine regulation of osteoclasts.  
 However, the authors admitted that the model has several limitations, one of which is 
that the only types of cell included are osteoblasts and osteoclasts. From a number of studies 
it follows that OCts also play an important role in tissue remodelling, producing the molecular 
signals to initiate the process.  
 
2.8.10.2 The Osteoblasts/Oosteoclasts differentiation model 
Rattanakul et al. (2003) developed a model for the differentiation of osteoblasts and 
osteoclasts in bone, based on the effect of PTH control.  The model behaviour has a limit 
cycle and a chaotic pattern for a range of parameter values in accordance with some clinical 



































where P(t) denotes the level of PTH above the basal level,  C(t) - the number of active 
osteoclast cells,  B(t) -  the number of active osteoblast cells;  c1 and k1 being positive 
constants,  d1 the removal rate constant; c4 is the specific rate at which PTH stimulates 
reproduction of active osteoblasts; c2, c3, and k2 are positive constants; d1, d2, and d3 are 
rate constants. The authors demonstrated that several types of nonlinear dynamic behaviours 
can be deduced from the model, which closely simulates available clinical data. The model is 
exhibits limit cycle behaviour, which can evolve into chaotic dynamics.   
 
2.8.10.3 Model incorporating RANK-RANKL-OPG pathway 
Compared to the Komarova model, the scheme mechanism (Fig.2.8.2) proposed by 
Lemaire et al. (2004) is considered more detailed in the sense of the role of PTH in bone 
remodelling control. This model is the first which incorporates the RANK-RANKL-OPG 
pathway which, as mentioned previously, is widely accepted as being essential for the 
regulation of osteoclast formation.  
 
Fig. 2.8.2  Schematic diagram of osteoclast-osteoblast interactions from Lemaire et al., model 
(Figure adapted from Lemaire et al., 2004).  The ovals represent osteobast cells. The solid 
arrows represent streams of material., eg. TGFβ. For detailed description see the original 




























where R is the concentration of responding osteoblasts, B is the concentration of active 











and πL is the complex function of the number of parameters (Lemaire et al., 2004). 
 Lemaire et al. (2004) formulated a model of the interactions between osteoblast and 
osteoclast functions within the limits of the known bone remodelling molecular-and-cellular 
framework.  The ODE model formulates the assumption that the relative proportions of 
immature and mature osteoblasts can control the degree of osteoclast activity. The main 
suggestion is that the regulation of the osteoblasts by the osteoclasts depends on their stage of 
differentiation.  Within the framework of this model, the authors found number of therapies. 
The model also predicts that increasing in the preosteoblast pool size can be an important 
factor for bone formation therapies. The authors proposed a scheme for the cellular control of 
bone remodelling based upon the RANK/RANKL/OPG core cytokine system to examine 
osteoclast functions. Based on their model the authors have considered some different 
therapeutic interventions against major bone diseases - oestrogen deficiency, 1,25(OH)2D3 
deficiency, senescence, glucocorticoid excess and their recommended therapies. They 
suggested that the absence of any therapy is particularly efficient against oestrogen deficiency 
or 1,25(OH)2D3 deficiency. The authors suggest that almost all effective therapies are 
correlated to ―an increase in a given parameter which is related to an essential ingredient of 








2.8.10.4 Biological adaptive control model 
A mechanical analogue of multi-factorial bone density adaptation has been developed 
by Davidson et al. (2004).   
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where, x = current value of bone density (response of the system);  x = desired value of bone 
density of cellular trait number ―i"  (positions arbitrarily chosen); ki = stiffness of cellular trait 
number i ; c = damping of the system;  m = inertia of the system; FE(t) = external forces 
dependent on time 
A        
B 
Fig.2.8.3 A, the components of the linear harmonic oscillator model, adapted from Davidson 
et al. (2004). B, model solutions. For detailed description see the original paper.   
 
 
 The solutions indicate over-(solid line)  and under-damped (dashed line) kinetics in 









2.8.10.5 A bioregulatory model  
An interesting bioregulatory model, implementing major characteristical features of 
bone regeneration  angiogenesis and cell migration, has been developed by Geris et al., 
(2008). Schematically the model is presented in Fig.2.8.4. 
 
Fig.2.8.4 A schematic overview of the mathematical model. Model variables (detailed 
explanation of model development can be found in Geris et al., 2008): cm - mesenchymal 
stem cells, cc- chondrocytes, cb - osteoblasts, mb - bone extracellular matrix and a gb - 
generic osteogenic growth factor, gc - chondrogenic growth factor, cv - the density of 
endothelial cells, mv - vascular matrix and gv- generic angiogenic growth; cf - concentration 
of fibroblasts variable, mf - fibrous tissue,  mc - cartilage density. For detailed description see 
the original paper. 
 
The taxis–diffusion–reaction type (Geris et al., 2008) model is a partial differential 
equation system which deals with parameters designated in Fig.2.8.4. It describes complex 
processes in bone during the fracture healing as well as the response to biochemical imputs.   






























































































For detailed description see the original paper, Geris et al., 2008. The model predicts results 
similar to experimental observations in a number of compromised fracture healing cases. 
 
2.8.11 Conclusions 
 As one can see there is a number of mathematical and statistical methods and 
approaches for the modelling of mechanical and biological properties of bone tissue have 
been developed. However, even though there has been considerable success in bone tissue 
modelling many limitations still remain. One of the most important is that there is no one, 
global, consistent single framework that can create a micro-physiological phenomenological 







 This probably follows from the fact that any tissue, including bone tissue, has a 
number of levels of regulation that are made up of a system level of control (body level of 
organisation, physiological level) and a local tissue level. The balances of these levels are 
highly important for proper tissue functioning and supporting other organs in their 
physiological function. The study of the hierarchical co-interaction of the integrative 
phenomenological cellular level of bone remodelling organisation versus molecular loops of 
local control and the implementation of this into a formal framework is an important issue in 
finding a balanced mathematical model. 
 The models described above go some way to illustrate the complexity of the bone 
remodelling mechanism.  However, the simplifications intrinsic in the modelling process may 
allow us to clarify the process further by ranking the levels of regulation (according to the 
hierarchy of regulation) and in addition allow insights into the basic modes of the 
microphysiological behaviour of the bone turnover process (at the tissue level).  Such models 
also give us an overview of the remodelling process and its part in the overall physiologically 
balanced homeostasis and even highlight a specific topic or mechanism.  
 Alongside the difficulties of modelling the bone remodelling process many FE 
models treat the BMU as a ‗black-box‘ having some phenomenological properties. 
Biochemico-physiological models of BMU are over simplified and are therefore limited in 
scope, dealing with only selected regulation loops.  
In particular all models to date have failed to contain osteocite activity. We can see 
that the implementation of new regulation loops (e.g. osteocytes) creates a more complete 
picture of regulation but increases the number of qualitative modes increasing the descriptive 
complexity.  
 The sheer number of local and systemic control factors found at a local level, as 
discussed in section three, mean that although it may be possible to model local conditions 










3.1  Aims and objectives 
The literature review was undertaken with respect to the mechanisms of bone resorption and 
formation, its control and existing mathematical models of bone remodelling. The results of the 
literature review were presented in Chapter 2 and some of the key findings are listed below: 
 Previously developed models demonstrate a limited and unclear interpretation of 
autocrine and paracrine regulation. Moreover, there is also an unclear interpretation of 
information from the population biokinetics approaches.  
 The role of osteocytes in terms of regulative feedback has largely been overlooked and 
there has only been a limited approach to consider the allosteric regulation. 
 Previous work has demonstrated the difficulties in analysing the effects of the rate 
parameters on the stability of the equilibrium points. 
 The dynamic systems and population biokinetics approach are not well enough 
understood in modelling of bone remodelling.  
 The approach employed for the control/optimal regulation of BMU and bone 
remodelling is insufficiently clear.  
The relaxational modes are quite well studied and understood in bone remodelling. 
However, other types of behavioural modes, like cyclic or chaotic, are less well understood but 
could be as important in explanation of disorders in  bone remodelling, like Paget‘s disease or 
osteoporosis. Therefore one of the main objectives of this study was the investigation of the role 
of modes of behaviour in bone remodelling, using mathematical modelling.  
 Regeneration of tissue is one of the most important issues when tissue is damaged. 
There are different approaches to support this regeneration, for example structural support by 
providing a tissue scaffold is an important method which is directly linked to tissue engineering. 
Optimisation of scaffold properties, so called scaffold variables, is a task that can be derived 
from studying bone tissue remodelling properties.  The model can be developed to provide a 








 Any tissue, including bone tissue has a number of levels of regulations that can be 
divided as system level of control (body level of organisation, physiological level) and local 
tissue level. The balance of this level is highly important for proper tissue functioning and 
supporting other organs by its physiological function.  Studying of hierarchical co-interaction of 
integrative phenomenological cellular level of bone remodelling organisation versus molecular 
loops of local control and implementation of this into formal model was one of the tasks of the 
present study. 
 Because of multivariable character of data that can be obtained from experiments, and 
multivariable character of studying tissue and processes and description, the approach to data 
reduction and visualisation was an important technical issue that was included in this study also. 
The overall aim of this project is to develop a model of bone remodelling (BMU) 
containing the osteoclast‘s level of regulation and study approaches to formulate the control of 
bone remodelling within this model in an optimal way. 
Specific objectives are: 
 To revise the existing mathematical models of bone remodelling to provide a more 
complete picture of cellular interactions of the Basic Multicellular Unit (BMU) with the 
network of osteocytes in bone tissue. Formulate the mathematical model to incorporate 
the osteocyte level of regulation.  
 To revise important allosteric mechanisms involved in BMU regulation and develop 
approaches to incorporate formally these mechanisms within the framework of existing 
models.  
 Study the steady solutions of this model, which have a physiological sense. Analyse the 
behaviour of the models developed across a wide range of biologically relevant 
constants in order to assess the validity of the models. 
 Formulate an optimal control approach to regulate the BMU model behaviour regarding 








3.2  Population kinetic methodology and model formulation 
The population kinetics approach methods are based on few assumptions.  
The first assumption is that there is a positive feedback characteristic for any biological 
species from viruses to humans. This positive feedback reflects the basic, principal property of 
any bio-system – autocatalysis, self-replication, self-multiplication. In the population dynamics 
ODE models, this is formally introduced as a first order term with a positive coefficient. In a 
classical one-dimensional Malthus model (1798) it is formalised as the velocity of self-





     (3.1) 
where n is population size (population density), a is a positive coefficient.  The first order of the 
term is sometimes linked to assumption of an unlimited resource of substrate/energy, which is 
in-line with the chemical kinetics models of autocatalysis. 
The second assumption is that when the substrate and energy resource is limited, it can 
be treated as a tightening of competition for this resource. It can be implemented formally as a 
negative second order-term in the differential equation. In fact it is reflecting a situation when a 
biospecies comes close to total consumption of a substrate-energetical resource of its existance. 
Then, a combination of these two terms in the one dimensional case gives the well known 




     (3.2) 
where a, b are positive coefficients. In this study we applied similar ideology.  
When this approach/ideology is extended to the interaction of two or more biospecies, 


















 where n1 , n2 are population densities of two different species, a1, a2, b1, b2 are positive 
coefficients. The second term in the first equation and first term in the second equation describe 
the so-called predator-pray, or producer-consumer relations, when the biomass produced at the 
first level, biomass of a producer (n1) is consumed by the species of the second level (n2).  

















   (3.4) 
The methodology, based on these three main assumptions with different variations, is 
implemented into different models within models of biological/population kinetics based on 
ODE.  
Such a relation as discussed in the models above, from the regulatory perspective can be 
treated as a positive or negative feedback in the regulation of population (population density) of 
the species. In a tissue, this feedback, is not represented by a predator-pray mechanisms but by 
the apoptosis or death of the cells expressed by the second terms in the equations with b 
coefficients.  In fact similar ideology was employed in other mathematical models of bone 
remodelling (Komarova et al., 2003, Putra et al., 2010). In this study similar methodology, 
based on combination ODE methods in modelling and population dynamics ideology has also 
been implemented.  
 
3.3 Optimal control methodology employed 
The optimal control methodology was implemented based on the fundamental work of 
Pontryagin et al., 1962, Gelfand and Fomin 1963. 
In a general case the optimal control problem accordingly to Pontryagin maximum 











11  (3.5a) 





i ..1,...1),,...,...,...,...( 11   (3.5b) 
and 00 )( ii xx  and end-point condition xi(τ) is free, 
where Ni xxx ...,...1  are the state variables, Mi uuu ,...,...1  are the control variables, 
),...,...,...,...( 11 MiNii uuuxxxf  is a function, J is objective functional, 
),...,...,...,...( 11 MiNi uuuxxxll  is the ―running cost‖ of the optimal control that is referred as 
instantaneous costs/losses for optimal control. Then accordingly to the Pontryagin maximum 






ii     (3.6) 
where pi are the Lagrange multipliers or costate variables. 
Then  the canonical equations are 


















    (necessary conditions for optimality),        
and transversality condition: pi(τ)=0  (since time τ is free, so no terminal condition is specified, 
the constant pi(τ) could be assumed equal to zero). Also, since the Hamiltonian function (3.6) is 
not dependent on time explicitly, the first integral of this problem is H=Const.  
The alternative approach to this optimal control problem is directly based on variational 
calculus, see, for example, Gelfand and Fomin, 1963, because the control could be chosen as 







as (3.5a) subject to constraints (3.5b) and boundary conditions 00 )( ii xx  and free end-point 
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.  (3.9) 
Although the technique of variational approach looks different from the maximum principle 
formulation, they lead to the same results. The system (3.9) in fact coincides with (3.7) 
reflecting the point that the maximum principle is the non-classical method for solving the 
variational problem in the case of open-loop control. In the case the Lagrange function (3.8) is 
not explicitly dependent on time so an another form of the first integral of the problem could be 










),(    (3.10) 
which could significantly simplify the process of finding analytical solution and play important 
role on the stage of interpretation. On the basis of this general approach two different enzyme 
control models were investigated. In the OC developments of the project, the OC applications to 
biokinetics in works of (Van Impe and  Bastin, 1995; Rahman, and Palanski, 1996; Van Riel  et 
al., 2000; Giuseppin and van Riel, 2000; Cacik et al., 2001; Sengupta and Modak, 2001; 
Keesman and Stigter, 2002; Srinivasan et al., 2003; Smets, et al. 2002, 2004; Visser et al, 2004; 
Gadkar et al., 2006); Mohseni et al., 2009; Yüzgeç et al., 2009; Liang et al., 2008; Itik et al., 








3.4  Rubustness, character of equilibrium of the equilibrium points. Numerical 
methods 
The robustness of equilibrium points were studied by calculation of the Jacobian matrix, 
and analysis its eigenvalues. For some models, the points of equilibrium were found 
analytically, the elements of Jacobian matrix were found analytically as well. Then the 
eigenvalues were calculated numerically used standard procedure in Matlab and the scatterplots 
were produced and analysed. For the optimal control models, the numerical calculation of points 
of equilibrium were performed using the FSOLVE procedure in Matlab.  For numerical methods 
to solve the formulated dynamic systems the Matlab and Mathcad software were used. The 
statistical calculations were performed using the SAS software version 9.1. 
Numerical integration of the differential equation systems was done by a fourth-order 
the Dormand-Prince pair Runge-Kutta based ode45 Matlab® algorithm (v7, the MathWorks Inc, 
1998). Recalculations were performed using MathCad® Runge-Kutta subroutine rkfixed, 
MathCad 2000 Professional, MathSoft Inc., 1999. 
 
5.5       Statistical methods. Canonical correlation analysis 
Principal component analysis (PCA) is employed when the reduction of the 
dimensionality of a vector is needed. In this case the principal components are the orthogonal 
system of the linear combinations of measured variables. Application of PCA finds the first 
principal component as a linear combination along which the total dispersion obtains maximum. 
The second principal component is calculating in the way that the total dispersion obtains 
maximum subject to the orthogonality to the first principal component. As the result, the 
principal components are chosen as the linear combinations of original variables to maximise 
the total dispersion.       Canonical correlation analysis (CCA) is an analogical method to PCA 
for analysis the relationship between two linear combinations of variables (Hotelling, 1935; 







variables (independent variables) is analysed in respect to a single variable (dependent variable), 
CCA is a generalisation of multiple correlation/regression. Canonical weights show the unique 
impacts of every variable while the factor loads are the simple summary correlations.  
CCA is a powerful method to study the structure of two sets of variables. For example, 
this method could be used in study of the correlation between two sets of concentrations of 
amino acids in blood. One of the sets can be the neurotransmitter amino acids and another set 
can be the amino acids characteristic to the transport in the blood.    
 
 
3.6       Statement of novelties 
 The literature review conduction let to state the novelties expected in this project: 
 Modification/development of the existing mathematical model (Komarova et al., 2003) 
of bone remodelling in sense of more completed cellular interactions of basic 
multicellular unit with osteocytes, the cells incorporated into bone tissue. 
 Development of an approach to phenomenological formulation of the molecular 
mechanisms regulation the BMU activity and approach to incorporate these 
mechanisms into the expected model. 
 Formulation of the criteria related to the energetical/metabolic optimisation losses for 
the development a regulation model of BMU activities. 
It was expected that the results would increase the understanding of bone remodelling 

















4   Cellular approach to bone remodelling model 
 
4.1  The osteocyte loop control introduction into the BMU model 
This study investigates a possible dynamic systems option based on known modelling 
approaches, but with a reduced number of parameters and employing a rather general 
assumption of the relationship between bone cells and bone material mass. The prototype of 
such an approach is implemented in works Komarova and coauthors (2003, 2004).        
Although the model developed by Komarova et al. (2003) predicts different modes of 
dynamic behaviour of the BMU in bone remodeling control, a number of limitations to this 
model were identified by the authors of this model. Among these limitations is a need for 
improvement to the autocrine regulation loop, whilst at the same time the paracrine regulation 
loops employ quite a wide range of parameters (e.g. power ~ -0.5) rather beyond the 
biologically relevant range.  Additionally, many publications indicate the importance of the 
level of osteocyte regulation, for example, the role of osteocyte apoptosis as a part of the 
mechanotransduction control mechanism (Noble, 2003; Taylor et al., 2003; Bonewald, 2004), 
and role of stress (Nakamura, 2003). 
For this reason the role of osteocyte‘s apoptosis in the bone remodelling regulation loop 
and the requirement to redevelop the model in such a way that the autocrine and paracrine 
control would be more biologically relevant from a generalised point of view were critical 
aspects to the development of the model. The regulation loops that control the activity of the 
BMU were refined and attempted to introduce the cybernetic point of view that the control 
should be minimised from both the (catabolic) energetic point and metabolic point of view. For 
example, a reason for this could be the limitation of the transport into the bone of the energetic 
substrates such as, for example, ATP and oxygen, as well other substrates. The changes from 
basic bone turnover rate could destabilise the metabolic optimality not only on the local (bone) 
level but could also create a supply problem for the body. The whole number of molecular 







avoid overloading the metabolic process of remodelling, both at the local tissue level and the 
body level. 
  Additionally, it is believed that in order to produce a robust bone remodeling process 
the regulation needs robustness at a number of regulation levels, and indeed cellular levels. The 
molecular biochemical regulation loops at the tissue level are only organised by cell interactions 
via common compartments (body or tissue media) such as marrow-media, lacunocanalicular 
microcirculatory system of periosteocytic fluid in the case of bone. The active interaction units 
are the osteocells. Phenomenological cellular models must reflect the tissue infrastructure of 
regulation and function in the whole body and, from the other side the very robust biochemical 
pathways. To answer what is the primary controlling factor is akin to answering what is the first, 
the chicken or the egg. In the case of a multicellular organism and tissue, an evolutionary 
process is taking place. Probably, from the evolutionary point of view, the cellular level is even 
more important, because the multicellular body evolved from cellular colonies with initially 
poor communication. Taking into account this point, this section attempts to develop and 
analyse the possibility of a cellular model and robustness at this level.      
 
Fig. 4.1  Schematic representation of interaction between the cells in BMU. Arrows represent 
the control loops of regulation in BMU on the cellular level.  
 
The resulting cell-level control scheme based on the introduction of the osteocytes 
control loop could be presented as in Fig.4.1, where osteocytes‘ apoptosis initiates the 







A dynamical model, which generalises the Komarova model (Komarova et al., 2003) and 





















   (4.1) 
where 1x  is the population density of osteoclasts (Ocls), 2x  is the  population density of 
osteoblasts (Obl), 3x  is the population  density of osteocytes (Octs), 4x  is the bone mass of a 
volume unit (BM). In Komarova et al., 2003, the changes in bone mass was presented ―as 
relative change from initial value (100%)‖. In this study the parameter x4 follows Komarova et 
al., 2003 definition in the changes in bone mass, however initial value was taken as 1.0. The 
quantity s is the level of mechanical stress. Functions  
)(),,(),,(),,,( 24221321 xfxxfxxfxxxf BOCtOBlOCl   (4.2) 
describe the paracrine and autocrine positive feedback loops of regulation,  
)(),,(),,,(),,( 1343221 xfxsfxxxfxxf BOctOblOcl   (4.3) 
describe negative regulation feedbacks. This model appears as certain generalisation of models 
by Komarova et al. (2003), Lemaire et al. (2004) and Putra et al. (2010). The dependence in 
these feedback functions is undertaken with the purpose of reducing the number of parameters 
based on the following assumptions: ),,( 321 xxxfOCl - osteoclasts regeneration has autocrine 
properties and is initiated by osteocyte‘s apoptosis, following Noble (2003), Taylor et al. (2003), 
Bonewald (2004); osteoclasts degradation function, ),( 21 xxfOCl  - depends on regulation by 
osteoblasts and osteocytes; ),( 21 xxfOBl - osteoblast activation positive feedback loop related to 
the bone material density, ),,( 432 xxxfOBl - osteoblast‘s transformation to osteocytes, lining cells 
and their apoptosis; ),( 42 xxfOCt  - osteocytes differentiation from osteoblasts depends on the 







the bone density; and, finally, )( 2xfB - the bone mass formation is dependent on the osteoblasts 
density and the bone resorption function )( 1xfB  depends on osteocytes level.  
In fact, the Komarova model implicitly contains the predator-pray elements. In case 
when the power coefficients are integer (1,2) the model would similar to the second-order 
predator pray model.   
 
4.2  Model simplification: BMU regulation by Ocls-Octs interactions 
4.2.1 Model formulation  
The system (4.1) can be further simplified when the particular functions (4.2-4.3) are 
chosen.  Based on the model developed by Komarova et al. (2003) and Putra et al. (2010), it can 














   (4.4) 
where 12b , 01a , 21a , 3a  are the autocrine and paracrine constants formalising the positive 
regulation loops, 12b , 01b , 2b , 23b  are the removal constants and negative regulation loop 
constants, and 1k , 2k  are constants of direct bone resorption by osteoclasts and formation by 
osteoblasts,  s – the attitude of the mechanical stress.  
In the first equation of the model, which describes the osteoclasts kinetics, the first term 
formalises the positive feedback, e.g. autocrine regulation of osteoclasts, the second term 
describes negative paracrine feedback by osteocytes and the third term describes degradative 
regulation on osteoclasts by osteoblastic cells (when the role of osteoclasts is considered and the 
bone formation starts). An explanation of the negativity of the second term in this equation 
follows. The main suggestion of this model is that the osteoclasts are regulated/initiated by 







proportional to the population density (amount) of osteoclasts, x1 and the difference )( 33
Stxx , 
where 
Stx3 is stationary concentration of osteocytes. When damage to the bone happens, then  
Stxx 33  and the )( 33
Stxx  is negative and the product of x1 and the bracket )( 331
Stxxx  
should be a positive to create positive feedback, so, since  03x  this term should have a 
negative coefficient –b12, then   )( 33112
Stxxxb will create a positive feedback relatively to an 




Stxba 3121 . This in fact is an 
explanation of first and second terms in the differential equation for osteoclasts. 
 In the second equation, the first term describes positive feedback in osteoclasts-
osteoblasts regulation, the second term formalises the decrease of the osteoblasts due to their 
change into osteocytes and the last quadratic term describes their apoptosis/death.  The third 
equation describes the changes in the population density of osteocytes. The first term in the right 
part suggests that the surplus rate of osteocytes is proportional to the bone mass when the bone 
mass formed. The removal/apoptosis of osteocytes is proportional to the 
microgravitation/mechanical stress or ―metabolic fatigue‖ of the bone tissue with the rate 
constant s. Increased mechanical stress (microgravity) will increase the apoptosis of osteocytes. 
The last equation is adopted from Komarova model (Komarova et al, 2003). Taking into 
account considerations by Komarova et al., 2003, in this study the same range of the rate 
constant was adopted, extended for a decimal order in the widest case. 
The concrete link of molecular factors, (GFs, cytokines, hormones) to the reta 
parameters of the model is difficult to suggest. The cellular models, described in literature 
(Komarova et al. (2003), Lemaire et al. (2004) and Putra et al. (2010) have also problems with 
this. That can be explained by microscopic character of action of factors and macroscopic, 








4.2.2 Equilibrium points 
 To find the equilibrium points of the system (4.4) one needs to make the right parts of 














   (4.5) 
 Then starting from the last equation one can find 1212 / xxkx . Substituting this into the others 
equations of (4.5) one can find the nontrivial solution. Designating  






















1  (4.6) 
and the trivial solution:  
a
sxxxxxx **,,0,0 4321 ,    (4.7) 
where x* can have any value; ],0[*x . The latter means that all the axes x3 and x4 are the 

























































































Employing (4.8) it is possible to study the character of equilibrium for the trivial (4.7) and 
nontrivial (4.6) points. Let us note that the quantity z plays very significant role in determination 








 4.3      The character of stability in a wide range of the rate constants 
As one can see from previous section, the system (4.5) has two solutions the point of 
equilibrium which give two points of equilibrium; one is the trivial point (4.7),  and the second is 
the non-trivial point (4.6), axis x4 which formalises the total bone mass. The nontrivial point is of 
particular interest for this study because it gives the non-zero values for population densities of 
osteocells in bone tissue.  The range of parameters that cover the possible physiological values of 
the system has been studied numerically by the Monte-Carlo method by generating random 
combinations of rate parameters, uniformly and exponentially distributed in certain range. The 
consideration of the rate constants has been made on the basis of the Komarova model 
(Komarova et al., 2003).  The upper and lover estimates were extended to the following range: a1, 
200.0- 30000. day
-1





















; a3, 1000-66000 day
-1





; k1, 0.01-1.0 day
-1
; k2, 0.00003-0.003 day
-1
.  The range of the rate parameters has been 
chosen to satisfy the population densities of osteocells in one cubic millimetre. According to 
some authors the population concentration of osteoclasts in one cubic millimetre is about 20; of 
osteoblasts in one cubic millimetre is about 10
3
; osteoclasts in one cubic millimetre is about 20; 
the population concentration of osteocytes in one cubic millimetre is about 10
4
. As in was 
mentioned above, the parameter x4characterising the bone mass (which in figures is designated as 
BM)  was chosen following the Komarova et al works, 2003; 2005 as relative bone mass of one 
cubic millimetre, which was chosen as equal to unit in the steady state. 
The values of the nontrivial steady state are shown graphically in Fig.4.2.  One can see 
the scatter plot of non-trivial equilibrium points in the projection from 4-dimensional space of 
Ocl, Obl, Oct and BM (total bone mass of a volume unit). A more detailed scatter-plot of the 
population densities (variables Ocl, Obl, Oct  and total bone mass of a unit) against each other  is 
shown in Fig.4.3. One can see the scatter of Ocl density in the range of 5 to 50, Obl from several 
hundreds to several thousands, Osteocytes from hundreds to thousands. The bone mass variable 







 Since the relationship between the location of the main stability point and the rate 
constants, indicated in (4.6) is quite complicated, in order to study the influence of these constants 
on the position and the character of equilibrium, the Monte Carlo method (Metropolis and  Ulam, 
1949) and further regression analysis (Pearson, 1901) was applied to establish the link.  The 
application of Monte Carlo method in combination with regression analysis is shown in Tables 
4.1-4.7 and the results are summarized in Tables 4.8-4.11.  
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1000.001 BMn  
Fig. 4.2 Scatterplot of calculated positions of equilibrium of osteocells (OCl, osteoclasts; OB, 
osteoblasts; OCt, osteocytes) against the total bone mass (BM) for the system (4.4). 
Calculations were performed using the following set of parameters: a1, 200.0- 30000. day
-1






















; a3, 1000-66000 day
-1




; k1, 0.01-1.0 day
-
1






















































































Fig.4.3 Detailed graphical matrix showing a scatter plot of population densities of 
Ocl,Obl,Oct,bone in 4D space of these quantities. Exponential distribution of the rate 































Fig. 4.4 Scatter plot of the eigenvalues (4.8) for the system (4.4). Calculations were performed 
using the set of parameters, Fig.4.2. 
 
 
One can see from Fig.4.2-4.3, that the values of the state variables are scattered in 
several decimal orders, so the logarithm of these values has been used in calculations.  
ln(Ocl) BETA St. Err. of BETA B St. Err. of  B t(2951) p-level 
Intercept 
  
0.2670 0.0562 4.7493 0.0000 
a1 1.0478 0.0165 0.0005 0.0000 63.6954 0.0000 
b12 -0.0548 0.0068 -17.5487 2.1738 -8.0730 0.0000 
b01 -0.6599 0.0174 -0.2688 0.0071 -37.9813 0.0000 
a01 -0.2248 0.0181 -0.0105 0.0008 -12.4430 0.0000 
b2 0.1352 0.0195 0.0022 0.0003 6.9531 0.0000 
a3 -0.0636 0.0068 0.0000 0.0000 -9.3522 0.0000 
s 0.2028 0.0157 1.5680 0.1218 12.8788 0.0000 
k1 -0.7857 0.0166 -13.9157 0.2935 -47.4150 0.0000 
k2 0.8896 0.0174 4416.50 86.4404 51.0930 0.0000 
a1^2 -0.5598 0.0164 0.0000 0.0000 -34.1445 0.0000 
b01^2 0.3364 0.0173 0.0073 0.0004 19.4088 0.0000 
a01^2 0.1243 0.0179 0.0000 0.0000 6.9357 0.0000 
b2^2 -0.0713 0.0195 0.0000 0.0000 -3.6662 0.0003 
s^2 -0.1322 0.0157 -1.2238 0.1456 -8.4053 0.0000 
k1^2 0.4147 0.0164 18.2681 0.7243 25.2227 0.0000 
k2^2 -0.5117 0.0173 -1841851.4 62441.18 -29.4974 0.0000 
Table 4.1 Quadratic regression analysis: the logarithm of the population density of the 









Ln(Obl) BETA St. Err. of BETA B St. Err. of  B t(2950) p-level 
Intercept 
  
5.996 0.051 118.494 0.000 
a1 1.304 0.018 0.000 0.000 72.333 0.000 
b12 -0.070 0.007 -17.914 1.899 -9.435 0.000 
b01 -0.838 0.019 -0.272 0.006 -43.988 0.000 
a01 -0.255 0.020 -0.010 0.001 -12.853 0.000 
b2 0.157 0.021 0.002 0.000 7.352 0.000 
a3 -0.134 0.017 0.000 0.000 -7.956 0.000 
s 0.253 0.017 1.557 0.106 14.641 0.000 
k1 0.254 0.018 3.590 0.256 14.003 0.000 
k2 -0.180 0.019 -713.331 75.514 -9.446 0.000 
a1^2 -0.699 0.018 0.000 0.000 -38.900 0.000 
b01^2 0.436 0.019 0.008 0.000 22.942 0.000 
a01^2 0.134 0.020 0.000 0.000 6.801 0.000 
b2^2 -0.078 0.021 0.000 0.000 -3.680 0.000 
a3^2 0.064 0.017 0.000 0.000 3.796 0.000 
s^2 -0.166 0.017 -1.222 0.127 -9.612 0.000 
k1^2 -0.154 0.018 -5.403 0.633 -8.541 0.000 
k2^2 0.071 0.019 203957.451 54545.224 3.739 0.000 
Table  4.2 Quadratic regression analysis: the logarithm of population densities of osteoblast as a 
function of the rate constants. The range of the constants as in Fig.4.2. 
 
ln(Oct) BETA St. Err. of BETA B St. Err. of  B t(2949) p-level 
Intercept 
  
9.185 0.092 100.365 0.000 
a1 0.753 0.019 0.000 0.000 40.650 0.000 
b12 -0.047 0.008 -20.992 3.387 -6.197 0.000 
b01 -0.446 0.020 -0.252 0.011 -22.873 0.000 
a01 0.744 0.020 0.048 0.001 36.671 0.000 
b2 -0.329 0.022 -0.007 0.000 -15.049 0.000 
b23 -0.067 0.008 -16.549 1.909 -8.667 0.000 
a3 0.492 0.017 0.000 0.000 28.608 0.000 
s -0.785 0.018 -8.422 0.190 -44.382 0.000 
k1 -0.625 0.019 -15.372 0.457 -33.602 0.000 
k2 0.765 0.020 5271.252 135.282 38.965 0.000 
a1^2 -0.395 0.018 0.000 0.000 -21.460 0.000 
b01^2 0.233 0.019 0.007 0.001 11.986 0.000 
a01^2 -0.422 0.020 0.000 0.000 -20.996 0.000 
b2^2 0.147 0.022 0.000 0.000 6.738 0.000 
a3^2 -0.244 0.017 0.000 0.000 -14.192 0.000 
s^2 0.422 0.018 5.415 0.227 23.868 0.000 
k1^2 0.287 0.018 17.522 1.129 15.523 0.000 
k2^2 -0.444 0.020 -2218402.2 97533.478 -22.745 0.000 
Table 4.3 Quadratic regression analysis: the logarithm of the osteocytes populational density as 









ln(BM) BETA St. Err. of BETA B St. Err. of B t(2950) p-level 
Intercept 
  
-1.9178 0.0794 -24.1524 0.0000 
a1 0.8962 0.0199 0.0005 0.0000 44.9695 0.0000 
b12 -0.0441 0.0082 -16.2801 3.0266 -5.3791 0.0000 
b01 -0.5430 0.0210 -0.2549 0.0099 -25.8516 0.0000 
a01 0.8800 0.0218 0.0475 0.0012 40.3077 0.0000 
b2 -0.4125 0.0235 -0.0078 0.0004 -17.5491 0.0000 
b23 -0.0839 0.0083 -17.2415 1.7061 -10.1060 0.0000 
a3 -0.0544 0.0082 0.0000 0.0000 -6.6255 0.0000 
s 0.1772 0.0190 1.5798 0.1695 9.3180 0.0000 
k1 -0.7715 0.0200 -15.7488 0.4087 -38.5310 0.0000 
k2 0.9305 0.0211 5324.9 120.8 44.0609 0.0000 
a1^2 -0.4738 0.0198 0.0000 0.0000 -23.8979 0.0000 
01^2 0.2715 0.0209 0.0068 0.0005 12.9660 0.0000 
a01^2 -0.5024 0.0216 -0.0002 0.0000 -23.2073 0.0000 
2^2 0.1926 0.0235 0.0000 0.0000 8.1938 0.0000 
s^2 -0.1141 0.0190 -1.2169 0.2027 -6.0030 0.0000 
k1^2 0.3683 0.0199 18.7006 1.0086 18.5419 0.0000 
k2^2 -0.5406 0.0210 -2242797 87136.6 -25.7389 0.0000 
 
Table. 4.4 Quadratic regression analysis: the logarithm of the BM as a function of the rate 
constants. The range of the rate constants as in Fig.4.2. 
 
ln(Re1) BETA St. Err. of BETA B St. Err. of B t(2952) p-level 
Intercept 
  
-1.364 0.068 -19.948 0.000 
a1 1.130 0.022 0.001 0.000 52.385 0.000 
b12 -0.052 0.009 -18.313 3.109 -5.889 0.000 
b01 -0.694 0.023 -0.309 0.010 -30.468 0.000 
a01 -0.035 0.009 -0.002 0.000 -3.879 0.000 
b23 0.950 0.019 185.101 3.755 49.290 0.000 
a3 -0.054 0.009 0.000 0.000 -6.111 0.000 
s 0.254 0.021 2.145 0.174 12.326 0.000 
k1 0.077 0.022 1.489 0.416 3.575 0.000 
k2 -0.160 0.023 -869.602 123.732 -7.028 0.000 
a1^2 -0.616 0.021 0.000 0.000 -28.674 0.000 
b01^2 0.337 0.023 0.008 0.001 14.834 0.000 
b23^2 -0.482 0.019 -2199.329 87.449 -25.150 0.000 
s^2 -0.186 0.021 -1.883 0.208 -9.047 0.000 
k1^2 -0.074 0.021 -3.576 1.031 -3.470 0.001 
k2^2 0.074 0.023 289096.048 89296.697 3.237 0.001 
 
Table   4.5 Quadratic regression analysis: the logarithm of the real part of Re1 eigenvalue of 
matrix the non-trivial equilibrium point as a function of the rate constants. The range of the rate 







Re4 BETA St.Err. of BETA B St.Err. of B t(2961) p-level 
Intercept 
  
-0.0015 0.0020 -0.7216 0.4706 
a01 0.0224 0.0035 0.0001 0.0000 6.4558 0.0000 
b2 -0.0166 0.0035 0.0000 0.0000 -4.8031 0.0000 
s -0.9808 0.0034 -0.9465 0.0033 -284.2997 0.0000 
k1 -0.0461 0.0084 -0.1020 0.0185 -5.5170 0.0000 
k2 -0.0238 0.0035 -14.7722 2.1474 -6.8791 0.0000 
k1^2 0.0317 0.0083 0.1745 0.0457 3.8150 0.0001 
 
Table 4.6 Quadratic regression analysis: the real part of Re4 eigenvalue as a function of the rate 
constants. The range of the rate constants as in Fig.4.2.  
 
 
ln(Im1) BETA St.Err. of BETA B St.Err. of B t(2950) p-level 
Intercept 
  
4.135 0.051 81.825 0.000 
a1 1.441 0.020 0.000 0.000 72.019 0.000 
b12 -0.077 0.008 -17.702 1.896 -9.335 0.000 
b01 -0.355 0.021 -0.104 0.006 -16.810 0.000 
a01 0.411 0.022 0.014 0.001 18.702 0.000 
b2 0.198 0.024 0.002 0.000 8.371 0.000 
a3 -0.148 0.019 0.000 0.000 -7.951 0.000 
Ss 0.286 0.019 1.584 0.106 14.910 0.000 
k1 -0.375 0.020 -4.767 0.256 -18.619 0.000 
k2 0.496 0.021 1764.8 75.415 23.402 0.000 
a1^2 -0.769 0.020 0.000 0.000 -38.551 0.000 
b01^2 0.180 0.021 0.003 0.000 8.531 0.000 
a01^2 -0.227 0.022 0.000 0.000 -10.432 0.000 
b2^2 -0.107 0.024 0.000 0.000 -4.520 0.000 
a3^2 0.070 0.019 0.000 0.000 3.739 0.000 
s^2 -0.187 0.019 -1.241 0.127 -9.769 0.000 
k1^2 0.183 0.020 5.765 0.632 9.125 0.000 
k2^2 -0.298 0.021 -769127 54473.237 -14.119 0.000 
 
Table 4.7 Quadratic regression analysis: the logarithm of the imaginary part of Im1 eigenvalue 
of matrix the non-trivial equilibrium point as a function of the rate constants. The range of the 
rate constants as in Fig.4.2. 
 
Using the MC/regression method, the dependence of the relaxation constants to the 
equilibrium state can also be characterized. The results of the regression analysis are shown in 
Tables 4.2-4.7. The determination coefficient R-square for the osteocells‘ regression R
2 
is in the 
range 0.77-0.87, which gives the confidence level between 0.13-0.23. The effect of the rate 








ln(Ocl) ln(Obl) ln(Oct) ln(BM) ln(Re1) ln(Re3) Re4 ln(Im1) 
R-square 0.870 0.84 0.830 0.800 0.770 
 
0.960 0.800 
a1 1.0478 1.304 0.753 0.8962 1.130 
  
1.441 
b12 -0.0548 -0.070 -0.047 -0.0441 -0.052 
  
-0.077 
b01 -0.6599 -0.838 -0.446 -0.5430 -0.694 
  
-0.355 
a01 -0.2248 -0.255 0.744 0.8800 -0.035 -1.285 0.022 0.411 
b2 0.1352 0.157 -0.329 -0.4125 
 
0.738 -0.016 0.198 
b23 
  
-0.067 -0.0839 0.950 
   a3 -0.0636 -0.134 0.492 -0.0544 -0.054 
  
-0.148 
s 0.2028 0.253 -0.785 0.1772 0.254 0.106 -0.980 0.286 
k1 -0.7857 0.254 -0.625 -0.7715 0.077 1.144 -0.046 -0.375 
k2 0.8896 -0.180 0.765 0.9305 -0.160 
 
-0.023 0.496 




        b01^2 0.3364 0.436 0.233 0.2715 0.337 
  
0.180 











    
-0.482 
   a3^2 
 
0.064 -0.244 
    
0.070 
s^2 -0.1322 -0.166 0.422 -0.1141 -0.186 -0.074 
 
-0.187 
k1^2 0.4147 -0.154 0.287 0.3683 -0.074 -0.591 0.031 0.183 
k2^2 -0.5117 0.071 -0.444 -0.5406 0.074 
  
-0.298 
Table 4.8 Summary table on the Monte-Carlo application. 
 
 
Mean Minimum Maximum Range Variance Std.Dev. St.Error 
OCL 6.102881 0.01788 291.5624 291.5445 215.0817 14.66566 0.269197 
OBL 986.3794 3.78394 18773.52 18769.74 1680265 1296.25 23.79342 
OCT 96076.13 5.64747 2676867 2676861 4.85E+10 220306.7 4043.857 
BM 1.09865 0.00101 56.45885 56.45784 12.19788 3.492546 0.064108 
Table 4.9 The average population concentrations, maximum and minimum values and statistical 
deviations  for the osteocells (cell/mm
3




Mean Minimum Maximum Range Std.Dev. Error 
RE1 -4.119 -125.912 -0.001 125.911 7.759 0.142 
RE2 -4.119 -125.912 -0.001 125.911 7.759 0.142 
RE3 -0.545 -14.365 -0.007 14.357 0.804 0.015 
RE4 -0.203 -1.575 -0.001 1.574 0.187 0.003 
IM1 566.545 3.358 8787.537 8784.179 757.616 13.906 
IM2 -566.545 -8787.537 -3.358 8784.179 757.616 13.906 
IM3 0.018 0.000 0.408 0.408 0.042 0.001 
IM4 -0.018 -0.408 0.000 0.408 0.042 0.001 
Table 4.10 Resulting statistics on the real and imaginary parts of the eigenvalues for the range 








Mean Minimum Maximum Range 
a1 3557.5 201.0 26532.3 26331.3 
b12 0.007 0.002 0.044 0.042 
b01 4.675 1.050 29.257 28.207 
a01 38.364 1.542 234.659 233.117 
b2 138.091 50.005 830.721 780.716 
b23 0.010 0.001 0.093 0.092 
a3 7676.2 1302.1 65052.6 63750.5 
s 0.200 0.001 1.576 1.575 
k1 0.093 0.010 0.646 0.636 
k2 0.00035 0.00003 0.00231 0.00228 
Table 4.11  The mean values of the rate constants, used in the study the wide range of the rate 
parameters. 
 
Nevertheless, in the linear segment, Table 4.1 indicates that the a1, s and k2 rate constants 
have a significant positive effect of on the osteoclastic population density, whereas b01, a01 and k1 
have a negative effect. In the quadratic region, the same coefficients have an opposite effect. 
Similar results are observed for the regression analysis of the population concentration of the all 
osteocells, Tables 4.2-4.7. Regression for the logarithm of Obl, Table 4.2, indicates that a1, b2, k1 
and s have a positive influence on the Obl population density, while the b01, k2 have a negative 
impact. These constants have an opposite effect of in the quadratic sector. Table 4.3 indicates the 
positive effect of a1, a01, a3 and k1 on the Oct population density and their negative effect in 
quadratic sector. Table 4.4 shows that a1, a01, k2 have positive effect on the logarithm of total bone 
mass and a negative effect in quadratic sector. The rate parameters a1, b01, b23 and s have a strong 
impact on the real part of the first eigenvalue Re1, Table 4.5, which is linked to the relaxation 
constant. The rate parameter s indicates a strong negative effect on the real part of fourths 
eigenvalues, Table 4.6. Table 4.7 indicates that the a1, b01, a01, s and k1 and k2 have effects on the 
imaginary part of first eigenvalues.  
The results of the Monte Carlo method application are summarised in Tables 4.8-4.11. 
One can see the different effects of the rate parameters on the rate constants and the real and 
imaginary part of the eigenvalues. The rate constant a1 has a positive effect on the level of all state 
variables, osteocells and BM. Parameter b01 has a negative impact on the osteocells and BM. The 







and minimum values and statistical deviations for the osteocells (cell/mm
3
) for the model (4.5) 
and the relative bone mass, BM. It indicates reasonable agreement with the experimental 
estimation of the osteocells concentration in the bone tissue, which can be considered as the 
validation of the model. Also some disagreement is seen in the relaxation time (Table 4.10, 
Re4=0.2, which gives the characteristic time about 10 days), and quite poor statistical significance 
(R-square less than 0.9, Table 4.8), can be related to the very wide range of the rate parameters 
employed (Table 4.11), so it was a need to short this range.    
 
4.4  Middle range of the rate constants 
As was mentioned in Section 4.2, the application of a wide range of rate constants, (even 
though this is quite a good in description of overall population densities and total bone mass, see  
Table 4.9), leads to poor statistical significance and gives a characteristic time lower than the 
relaxation time to the equilibrium/steady state. Taking this into account the range of rate constants 
was reduced to a1, 1200-4300 day
-1




























; k1, 0.01-0.04 day
-1
; k2, 0.0002-0.0006 day
-1 
and the uniform distribution of the rate 
constants within these intervals was applied.  
Using the Monte Carlo method and regression analysis described in the Section 4.3, the 
dependence of the position of the equilibrium point (Fig. 4.5-4.7, and Tables 4.12-4.22) and the 
relaxation to this equilibrium point has been numerically characterized. However, even for a 
reduced range of the rate parameters, the linear regression of Ocl on the rate constants gives just 
R
2
=0.75 in the evaluation of the rate constants effect on bone mass. After the logarithmisation of 
osteocells population densities and total bone mass, the linear regression significantly improves 
the statistical significance (R-squared for Ocl is 0.90, for Obl R
2





=0.95), as well as it was seen for wide range of parameters. In Tables 4.12-4.18 the results 







parameters improves the significance of the model. The different impact of the rate constants on 



























Fig. 4.5 Scatteplot of calculated positions of equilibrium of osteocells (Ocl, osteoclasts; Obl, 
osteoblasts; Oct, osteocytes) against the total bone mass (BM) for the system (4.4). 
Calculations were performed using the following set of parameters: a1, 1200-4300 day
-1






















; a3, 1300-20000 day
-1





































































Fig. 4.6 Detailed graphical matrix illustrating scatterplot of populational densities of Ocl, Obl, 
Oct, total bone mass(Bone)  in 4D space of these quantities.  Calculations were performed using 































Fig. 4.7 Scattreplot of the eigenvalues (4.8) for the system (4.4). Calculations were performed 
using the set of parameters, Fig.4.2. 
 
ln(BM) BETA St.Err. of BETA B St.Err. of B t(9981) p-level 
Intercept 
  
-1.248 0.062 -19.986 0.000 
a1 0.818 0.017 0.001 0.000 49.303 0.000 
b12 -0.175 0.012 -30.588 2.026 -15.100 0.000 
b01 -0.426 0.024 -0.659 0.036 -18.101 0.000 
a01 1.181 0.012 0.175 0.002 96.088 0.000 
b2 -0.878 0.012 -0.007 0.000 -72.463 0.000 
a3 -0.206 0.011 0.000 0.000 -18.776 0.000 
s 0.601 0.011 4.926 0.086 57.000 0.000 
k1 -0.621 0.016 -64.424 1.640 -39.293 0.000 
k2 0.645 0.019 5004 145.917 34.298 0.000 
a1^2 -0.436 0.017 0.000 0.000 -26.254 0.000 
b12^2 0.044 0.012 346.411 90.417 3.831 0.000 
b01^2 0.219 0.024 0.068 0.007 9.315 0.000 
a01^2 -0.707 0.012 -0.004 0.000 -57.532 0.000 
b2^2 0.440 0.012 0.000 0.000 36.328 0.000 
b23^2 0.070 0.011 0.000 0.000 6.353 0.000 
a3^2 -0.422 0.011 -8.021 0.200 -40.075 0.000 
k1^2 0.287 0.016 589.297 32.426 18.174 0.000 
K2^2 -0.371 0.019 -3573669 181331 -19.708 0.000 
 
Table 4.12 Quadratic regression analysis: the logarithm of the BM as a function of the rate 










ln(Ocl) BETA St.Err. of BETA B St.Err. of B t(9981) p-level 
Intercept 
  
1.804 0.060 30.191 0.000 
a1 1.117 0.021 0.001 0.000 52.221 0.000 
b12 -0.239 0.015 -30.938 1.938 -15.965 0.000 
b01 -0.575 0.030 -0.660 0.035 -18.964 0.000 
a01 -0.269 0.016 -0.030 0.002 -16.982 0.000 
b2 0.572 0.016 0.004 0.000 36.588 0.000 
a3 -0.273 0.014 0.000 0.000 -19.232 0.000 
s 0.808 0.014 4.917 0.083 59.483 0.000 
k1 -0.826 0.020 -63.580 1.568 -40.536 0.000 
k2 0.803 0.024 4620.920 139.591 33.103 0.000 
a1^2 -0.601 0.021 0.000 0.000 -28.117 0.000 
b12^2 0.063 0.015 365.633 86.497 4.227 0.000 
b01^2 0.297 0.030 0.068 0.007 9.796 0.000 
a01^2 0.101 0.016 0.000 0.000 6.374 0.000 
b2^2 -0.386 0.016 0.000 0.000 -24.697 0.000 
b23^2 0.088 0.014 0.000 0.000 6.189 0.000 
a3^2 -0.567 0.014 -7.990 0.191 -41.727 0.000 
k1^2 0.397 0.020 604.454 31.020 19.486 0.000 
k2^2 -0.453 0.024 -3237376 173470 -18.662 0.000 
Table 4.13 Quadratic regression analysis: the logarithm of the population density of the 





Obl BETA St.Err. of BETA B St.Err. of B t(9983) p-level 
Intercept 
  
1350.985 38.976 34.662 0.000 
a1 0.650 0.004 0.323 0.002 181.973 0.000 
b12 -0.316 0.017 -27308.006 1486.295 -18.373 0.000 
b01 -1.153 0.035 -883.135 26.701 -33.075 0.000 
a01 -0.332 0.018 -24.297 1.335 -18.200 0.000 
b2 0.538 0.018 2.241 0.075 29.955 0.000 
a3 -0.332 0.016 -0.027 0.001 -20.344 0.000 
s 0.709 0.016 2877.731 63.396 45.393 0.000 
k1 0.323 0.023 16585.051 1202.949 13.787 0.000 
k2 -0.114 0.004 -438798.973 13707.687 -32.011 0.000 
b12^2 0.126 0.017 484661.875 66339.057 7.306 0.000 
b01^2 0.755 0.035 115.255 5.319 21.669 0.000 
a01^2 0.143 0.018 0.382 0.049 7.861 0.000 
b2^2 -0.348 0.018 -0.003 0.000 -19.344 0.000 
a3^2 0.131 0.016 0.000 0.000 8.051 0.000 
s^2 -0.461 0.016 -4333.782 146.847 -29.512 0.000 
k1^2 -0.187 0.023 -190104.046 23790.710 -7.991 0.000 
 
Table 4.14 Quadratic regression analysis: the osteoblasts‘ population densities as a function of 









ln(Oct) BETA St.Err. of BETA B St.Err. of B t(9981) p-level 
Intercept 
  
9.628 0.065 147.082 0.000 
a1 0.648 0.014 0.001 0.000 47.767 0.000 
b12 -0.133 0.009 -29.775 2.123 -14.024 0.000 
b01 -0.332 0.019 -0.659 0.038 -17.288 0.000 
a01 0.928 0.010 0.176 0.002 92.364 0.000 
b2 -0.681 0.010 -0.007 0.000 -68.773 0.000 
a3 1.108 0.009 0.000 0.000 123.265 0.000 
s -0.892 0.009 -9.375 0.091 -103.508 0.000 
k1 -0.475 0.013 -63.096 1.718 -36.717 0.000 
k2 0.494 0.015 4915.7 152.9 32.142 0.000 
a1^2 -0.347 0.014 0.000 0.000 -25.579 0.000 
b12^2 0.031 0.009 310.310 94.768 3.274 0.001 
b01^2 0.170 0.019 0.067 0.008 8.831 0.000 
a01^2 -0.558 0.010 -0.004 0.000 -55.562 0.000 
b2^2 0.339 0.010 0.000 0.000 34.265 0.000 
a3^2 -0.680 0.009 0.000 0.000 -75.679 0.000 
S^2 0.472 0.009 11.499 0.210 54.812 0.000 
k1^2 0.214 0.013 563.192 33.986 16.571 0.000 
k2^2 -0.280 0.015 -3456342 190056 -18.186 0.000 
Table 4.15 Quadratic regression analysis: the logarithm of the osteocytes population densities 




Re1 BETA St.Err. of BETA B St.Err. of B t(9982) p-level 
Intercept 
  
-0.882 0.142 -6.211 0.000 
A1 -0.651 0.004 -0.001 0.000 -163.665 0.000 
B12 0.322 0.019 83.659 4.980 16.798 0.000 
B01 1.142 0.039 2.632 0.089 29.420 0.000 
A01 -0.084 0.020 -0.019 0.004 -4.142 0.000 
B2 -0.442 0.020 -0.006 0.000 -22.093 0.000 
B23 -0.198 0.004 -460.22 9.229 -49.871 0.000 
A3 0.348 0.018 0.000 0.000 19.172 0.000 
S -0.710 0.017 -8.673 0.212 -40.826 0.000 
K1 -0.242 0.026 -37.283 4.031 -9.250 0.000 
K2 0.114 0.004 1312.3 45.99 28.586 0.000 
B12^2 -0.129 0.019 -1497.3 222.5 -6.736 0.000 
B01^2 -0.743 0.039 -0.341 0.018 -19.131 0.000 
A01^2 0.158 0.020 0.001 0.000 7.762 0.000 
B2^2 0.350 0.020 0.000 0.000 17.489 0.000 
A3^2 -0.147 0.018 0.000 0.000 -8.121 0.000 
S^2 0.462 0.017 13.072 0.492 26.567 0.000 
K1^2 0.180 0.026 550.93 79.73 6.912 0.000 
Table 4.16 Quadratic regression analysis: the value of the real part of the first eigenvalue 
(Re1=Re2) of the of equilibrium point as a function of the rate constants. R
2
=0.84.  The range 







Using the regression method, the dependence of the relaxation constants to the 
equilibrium state can also be numerically/quantitatively characterized. In Tables 4.12-4.18 the 
results of the regression analysis are shown. The determination coefficient R-square for this 
regression is in the range 0.86-0.96, which gives a confidence level of between 0.14-0.04. The 
effect of the rate parameters can be still characterized as a ―tendency‖.  
In the linear segment, Table 4.12 indicates that the a1, a01, s and k1 rate constants have a 
significant positive effect on the total bone mass, whereas b01, b2 and k1 have a negative effect. 
In the quadratic region, the same coefficients have an opposite effect. That was one of the 
reasons for the further reduction of the rate constant range to obtain a good linear regression that 
simplifies the interpretation. Similar results are observed for the regression results of the 
population concentration of the osteocells, Tables 4.13-4.15. Regression of the logarithm of Ocl, 
Table 4.13, indicates that of a1, b2, s and k2 have a positive character of influence on Ocl 
population density, while the k1 has an negative effect. These constants have an opposite effect 
in the quadratic sector. Table 4.14 indicates the positive effects of a1, b2, s and k1 on Obl 
population density and their negative effect in quadratic sector. Table 4.15 shows that a1, a01, a3, 
k2 have a positive effect on the logarithm of population density of osteocytes and a negative 
effect in the quadratic sector.  
The real (Re1-Re4) and imaginary (Im1-Im4) parts of the four eigenvalues of the 
Jacobian matrix (4.8) determine the character of stability of system (4.4) in the equilibrium 
(4.6). The regression analysis of the effect of the rate parameters on the logarithm of the real 
part Re1 of the first eigenvalue is shown in Table 4.16. The rate parameter a1 has a negative 
impact on the real part of the first eigenvalue, Table 4.16, which is linked to the relaxation 
constant, as well as the rate parameters b2 and s. Parameters b12, b01 and a3 indicate a positive 
effect. It is important to note that the parameter b12 plays a role describing the Ocl-Oct paracrine 
effect, while the rate constant b01 plays a role of decaying paracrine parameter for osteoclasts 







impact on the Re1. The rate parameter k2 produces a positive impact on the real part of the first 
eigenvalues, Re1.   
There is little point in describing the dependence of state variables as a linear 
dependence on the rate parameters, as the dependence is essentially nonlinear, which in fact is 
also proved by the description in the framework of the quadratic regression (Tables 4.12-4.16).  
Ln(Re3) BETA St.Err. of BETA B St.Err. of B t(9987) p-level 
Intercept 
  
-1.990 0.027 -72.827 0.000 
b12 -0.021 0.003 -3.363 0.401 -8.381 0.000 
b01 0.012 0.003 0.016 0.004 4.571 0.000 
a01 -1.497 0.013 -0.200 0.002 -115.502 0.000 
b2 1.027 0.013 0.008 0.000 80.352 0.000 
s 0.188 0.011 1.391 0.082 16.889 0.000 
k1 0.713 0.017 66.813 1.562 42.761 0.000 
k2 -0.011 0.003 -78.697 17.803 -4.421 0.000 
a01^2 0.904 0.013 0.004 0.000 69.752 0.000 
b2^2 -0.466 0.013 0.000 0.000 -36.510 0.000 
a3^2 -0.023 0.003 0.000 0.000 -9.184 0.000 
s^2 -0.068 0.011 -1.170 0.191 -6.136 0.000 
k1^2 -0.302 0.017 -560.668 30.901 -18.144 0.000 
 
Table   4.17 Quadratic regression analysis: the logarithm of the real part of Re3 eigenvalue of 
the Jacobian matrix for the non-trivial equilibrium point as a function of the rate constants. 
R
2
=0.95. The range of the constants as in Fig.4.5.  
ln(Re4) BETA St.Err. of BETA B St.Err. of B t(9986) p-level 
Intercept 
  
-3.794 0.032 -117.695 0.000 
b12 0.188 0.020 20.182 2.167 9.313 0.000 
b01 -0.043 0.004 -0.041 0.004 -10.227 0.000 
a01 0.204 0.021 0.018 0.002 9.502 0.000 
b2 0.535 0.021 0.003 0.000 25.328 0.000 
a3 0.110 0.004 0.000 0.000 26.295 0.000 
s 1.764 0.018 8.880 0.092 96.076 0.000 
k1 0.310 0.028 19.718 1.754 11.241 0.000 
k2 0.054 0.004 256.434 19.985 12.831 0.000 
b12^2 -0.097 0.020 -462.960 96.727 -4.786 0.000 
a01^2 -0.235 0.021 -0.001 0.000 -10.962 0.000 
b2^2 -0.435 0.021 0.000 0.000 -20.613 0.000 
s^2 -0.936 0.018 -10.919 0.214 -50.998 0.000 
k1^2 -0.256 0.028 -322.482 34.691 -9.296 0.000 
 
Table  4.18 Quadratic regression analysis: the logarithm of the real part of Re4 eigenvalue of 
matrix the non-trivial equilibrium point as a function of the rate constants. R
2
=0.85. The range 








The regression analysis results for the real part of the third eigenvalue Re3 are shown in 
Table 4.17. It can be seen, that the parameters b2, and k1 have a positive effect, while the rate 
parameters a01 and k1
2
 have the negative effect. A similar pattern of rate constant effects can be 
seen for the logarithm of the real part of the fourth eigenvalue, Re4. The rate parameters b2, s 








 show a negative one.  
As it was already mentioned, the rate parameter b12 describes the negative feedback of 
the osteocytes on osteoclasts, and from the regression analysis, it follows that it will only have a 
moderate effect on the relaxation constants Re3 and Re4. It can be concluded that the increase 
of this parameter (strengthening of this feedback) decreases the time of system relaxation to 
steady state. It should be noted that the parameter s has the largest effect on Re4, which has the 
lowest level between all real parts of the eigenvalues, and because of this can be treated as the 
relaxation of the system to the steady state. The effect of this parameter on the steady state 
variables is also moderate.      
 Thus, for the relaxation parameter Re4, the rate parameters b2, s and k1 have the most 
significant effect (Table 4.18). As in the case for Re1-Re2, b12 plays a role describing the Ocl-
Obl paracrine effect, while the rate constant b23 plays a role of decaying autocrine parameter for 
osteoblasts. The rate parameters k1 and k2 have a significant positive effect on the relaxational 
time. 
Since the first two imaginary parts of the eigenvalues are equal and have an opposite 
sign, Im1=-Im2, and Im3=Im4=0, this equlibrium point can be classified as a stable focus. The 
analysis of the eigenvectors indicates that the fourth eigenvector is loaded by the osteocytes‘ 
population concentration and BM, which indicate that the slowest relaxation occurs in the linear 
combination of Oct and BM, which can be treated as the bone tissue.      
It is easy to see from Table 4.11 that the slowest relaxation constant, Re4, related to the 
relaxation time of whole system, is about a month with a quite large standard deviation.   
However, the regression of the imaginary part gives R-square<0.9, which means that the results 









Mean Minimum Maximum Range Std.Dev. Error 
OCL 16 0 111 111 11 0 
OBL 897 15 2690 2675 445 4 
OCT 23361 306 1130000 1129694 71221 712 
BM 1 0 15 15 1 0 
 
Table 4.19 The average population concentrations, maximum and minimum values and 
statistical deviations for the osteocells‘ (cell/mm
3
) for the model (4.5) and the relative bone 




Mean Minimum Maximum Range Std.Dev. 
RE1 -2.40 -8.46 1.01 9.47 1.34 
RE2 -2.40 -8.46 1.01 9.47 1.34 
RE3 -0.56 -5.37 -0.03 5.34 0.55 
RE4 -0.23 -0.61 -0.02 0.59 0.11 
IM1 613.84 13.50 2830.00 2816.50 312.06 
IM2 -613.84 -2830.00 -13.50 2816.50 312.06 
IM3 0.06 0.00 0.35 0.35 0.07 
IM4 -0.06 -0.35 0.00 0.35 0.07 
 
Table 4.20 Resulting statistics on the real and imaginary parts of the eigenvalues for the 




Mean Minimum Maximum Range 
a1 2759.5 1200.0 4300.0 3100.0 
b12 0.011 0.002 0.020 0.018 
b01 2.494 1.500 3.500 2.000 
a01 13.4 3.0 24.0 21.0 
b2 235.8 50.0 420.0 370.0 
b23 0.006 0.005 0.007 0.002 
a3 10675.9 1300.0 20000.0 18700.0 
s 0.210 0.020 0.400 0.380 
k1 0.025 0.010 0.040 0.030 
k2 0.000 0.000 0.001 0.000 
 











ln(Ocl) Obl ln(Oct) ln(BM) Re1 ln(Re3) Ln(Re4) ln(Im1) 
R-square 0.900 0.870 0.960 0.950 0.840 0.950 0.820 0.850 
a1 1.117 0.650 0.648 0.818 -0.651 
  
1.359 
b12 -0.239 -0.316 -0.133 -0.175 0.322 -0.021 0.188 -0.289 
b01 -0.575 -1.153 -0.332 -0.426 1.142 0.012 -0.043 -0.256 
a01 -0.269 -0.332 0.928 1.181 -0.084 -1.497 0.204 0.731 
b2 0.572 0.538 -0.681 -0.878 -0.442 1.027 0.535 0.704 
b23 
    
-0.198 
   a3 -0.273 -0.332 1.108 -0.206 0.348 
 
0.110 -0.337 
s 0.808 0.709 -0.892 0.601 -0.710 0.188 1.764 0.988 
k1 -0.826 0.323 -0.475 -0.621 -0.242 0.713 0.310 -0.285 




   
-0.729 
b12^2 0.063 0.126 0.031 0.044 -0.129 
 
-0.097 0.075 
b01^2 0.297 0.755 0.170 0.219 -0.743 
  
0.136 
a01^2 0.101 0.143 -0.558 -0.707 0.158 0.904 -0.235 -0.466 
b2^2 -0.386 -0.348 0.339 0.440 0.350 -0.466 -0.435 -0.476 
b23^2 
        a3^2 0.088 0.131 -0.680 0.070 -0.147 -0.023 
 
0.110 
s^2 -0.567 -0.461 0.472 -0.422 0.462 -0.068 -0.936 -0.694 




   
-0.251 
Table.4.22 Summary table for meddle range set of the rate parameters.  
 
 
Summarisingly, the effect of the rate constants in medium range, Table 4.22 shows the same 
pattern as in the wide range with an improved confidence. However, this is still in quadratic 
regression, and to study a linear effect of the rate constants needs a further reduction in the 
range of the rate constants. It also needs to note that the ranges of some rate parameters have 









4.5 The reduced (short) range of the rate constants 
The wide and middle ranges of the rate parameters applied to the simulation, lead to 
quite a low confidence of the regression model. The R-square value for wide range parameters 
was about 0.75, R-square for middle range of the rate parameters was about 0.90. Therefore, the 
shorted range of the rate constants has been applied to illustrate ability of the method to obtain a 
























; a3, 1100-1700.0 day
-1










   
The scatterplot of the population concentrations of osteocells against the total bone 
mass is shown in Fig.4.8. The scatterplot of the osteocells againt each other and the total bone 
mass is illustrated in Fig.4.9. Finally, in Fig.4.10, the stability characteristics for the points 
calculated are presented. One can see that these scatterplots are quite a good much the 
scatterplots for the wide and medium case. Expected good statistical significance was found for 




























Fig. 4.8. Scatterplot for the system (4.4). Calculations were performed using the following set 
of parameters: a1, 3000-5000. day
-1




























; k1, 0.20-0.30 day
-1








































































Fig.4.9 The graphical matrix illustrating a scatterplot of population densities of Ocl, Obl, Oct, 
BM (Bone) in 4D space of these quantities. The uniform distribution for the rate parameters of 


















Fig. 4.10 Scattreplot of the eigenvalues (4.8) for the system (4.4). Calculations were performed 


































Fig. 4.11 Relaxation of the system to the steady state at following rate constants: a1, 
4590 day
-1





















; a3, 1100 day
-1




; k1, 0.257 day
-1
; k2, 0.00353 day
-1
. 






BETA ln(Ocl) BETA 
St.Err. of 
BETA 
a1 0.807 0.005 a1 0.403 0.001 
b12 -0.024 0.000 b12 -0.024 0.001 
b01 -1.329 0.003 b01 -0.668 0.001 
a01 -0.037 0.000 a01 -0.036 0.001 
b2 0.048 0.005 b2 0.018 0.001 
b23 
  
b23 -0.016 0.001 
a3 0.080 0.004 a3 0.024 0.001 
s -0.572 0.006 s -0.306 0.001 
k1 1.055 0.004 k1 0.511 0.001 
a1^2 -0.404 0.005 
   b01^2 0.666 0.003 
   b2^2 -0.031 0.005 
   b23^2 0.002 0.000 
   a3^2 -0.016 0.000 
   s^2 -0.056 0.004 
   k1^2 0.268 0.006 
   k2^2 -0.545 0.004 
   Table 4.23 The comparison of quadratic and linear regression for the osteoclasts population 











BETA ln(Obl) BETA 
St.Err. of 
BETA 
a1 1.022 0.006 a1 0.509409 0.00104 
b12 -0.031 0.000 b12 -0.03155 0.00104 
b01 -1.679 0.003 b01 -0.84344 0.001041 
a01 -0.046 0.000 a01 -0.04582 0.00104 
b2 0.060 0.006 b2 0.022908 0.00104 
b23 
  
b23 0.003715 0.001041 
a3 -0.020 0.000 a3 -0.02034 0.00104 
s 0.099 0.004 s 0.030956 0.00104 
k1 0.060 0.007 k1 0.019374 0.00104 
k2 -0.035 0.000 k2 -0.03528 0.001041 
a1^2 -0.512 0.006 
   b01^2 0.841 0.003 
   b2^2 -0.038 0.006 
   b23^2 0.002 0.000 
   s^2 -0.068 0.004 
   k1^2 -0.038 0.007 
   Table 4.24 The comparison of quadratic and linear regression for the osteoblast population 






BETA ln(Oct) BETA 
St.Err. of 
BETA 
a1 0.521 0.007 a1 0.263 0.001 
b12 -0.016 0.000 b12 -0.016 0.001 
b01 -0.872 0.004 b01 -0.438 0.001 
a01 1.229 0.004 a01 0.531 0.001 
b2 -0.469 0.008 b2 -0.238 0.001 
b23 -0.032 0.000 b23 -0.033 0.001 
a3 0.423 0.008 a3 0.216 0.001 
s -0.648 0.005 s -0.337 0.001 
k1 -0.398 0.009 k1 -0.241 0.001 
k2 0.912 0.005 k2 0.404 0.001 
a1^2 -0.257 0.007 
   b01^2 0.438 0.004 
   a01^2 -0.703 0.004 
   b2^2 0.232 0.008 
   a3^2 -0.206 0.008 
   s^2 0.313 0.005 
   k1^2 0.159 0.009 
   k2^2 -0.509 0.005 
   Table 4.25 The comparison of quadratic and linear regression for the osteocytes population 









n(BM) BETA St.Err. of BETA ln(BM) BETA St.Err. of BETA 
a1 0.570 0.008 a1 0.287 0.001 
b12 -0.018 0.000 b12 -0.018 0.001 
b01 -0.952 0.005 b01 -0.478 0.001 
a01 1.342 0.005 a01 0.580 0.001 
b2 -0.511 0.008 b2 -0.259 0.001 
b23 -0.035 0.000 b23 -0.036 0.001 
a3 
  
a3 -0.012 0.001 
s 0.069 0.006 s 0.017 0.001 
k1 -0.434 0.010 k1 -0.263 0.001 
k2 0.996 0.006 k2 0.442 0.001 
a1^2 -0.282 0.008 
   b01^2 0.478 0.005 
   a01^2 -0.767 0.005 
   b2^2 0.252 0.008 
   a3^2 -0.012 0.000 
   s^2 -0.052 0.006 
   k1^2 0.173 0.010 
   k2^2 -0.557 0.006 
   Table 4.26 The comparison of quadratic and linear regression for total bone mass (BM) for the 
short range of the rate parameters as in Fig.4.8. 
 
BETA St.Err. of BETA Re1 BETA St.Err. of BETA 
a1 -0.437 0.002 a1 -0.434 0.002 
b12 0.026 0.002 b12 0.027 0.002 
b01 2.249 0.015 b01 0.744 0.002 
a01 -0.863 0.015 a01 -0.250 0.002 
b2 0.136 0.002 b2 0.136 0.002 
b23 -0.297 0.002 b23 -0.298 0.002 
a3 0.018 0.002 a3 0.020 0.002 
s -0.094 0.019 s -0.027 0.002 
k1 0.109 0.002 k1 0.113 0.002 
k2 0.032 0.002 k2 0.032 0.002 
b01^2 -1.514 0.015 
   a01^2 0.617 0.015 
   s^2 0.066 0.019 
   Table 4.27 The comparison of quadratic and linear regression for real part of the first 
eigenvalues for the short range of the rate parameters as in Fig.4.8. 
 
Re3 BETA St.Err. of BETA Re3 BETA St.Err. of BETA 
a01 2.481518 0.014681 a01 0.797 0.002 
b2 -0.41725 0.001618 b2 -0.418 0.002 
k1 -0.35266 0.001618 k1 -0.352 0.002 
a01^2 -1.69487 0.014681 
   Table 4.28 The comparison of quadratic and linear regression for real part of the third 







Re4 BETA St.Err. of BETA Re4 BETA St.Err. of BETA 
b12 -0.048 0.000 b12 -0.048 0.000 
b01 0.200 0.004 b01 0.064 0.000 
a01 -0.071 0.000 a01 -0.071 0.000 
b2 0.093 0.008 b2 0.034 0.000 
b23 
  
b23 0.004 0.000 
a3 -0.031 0.000 a3 -0.031 0.000 
s -0.991 0.000 s -0.991 0.000 
k1 0.099 0.009 k1 0.034 0.000 
k2 -0.054 0.000 k2 -0.054 0.000 
b01^2 -0.137 0.004 
   b2^2 -0.059 0.008 
   b23^2 0.004 0.000 
   k1^2 -0.065 0.009 
   Table 4.29 The comparison of quadratic and linear regression for real part of the fourth 
eigenvalues for the short range of the rate parameters as in Fig.4.8. 
 
BETA St.Err. of BETA ln(Im1) BETA St.Err. of BETA 
a1 1.192 0.006 a1 0.597 0.001 
b12 -0.036 0.000 b12 -0.037 0.001 
b01 -0.912 0.004 b01 -0.471 0.001 
a01 1.008 0.004 a01 0.470 0.001 
b2 0.073 0.007 b2 0.026 0.001 
b23 
  
b23 -0.024 0.001 
a3 0.117 0.005 a3 0.036 0.001 
s -0.386 0.008 s -0.214 0.001 
k1 0.759 0.005 k1 0.359 0.001 
A1^2 -0.595 0.006 
   B01^2 0.445 0.004 
   A01^2 -0.542 0.004 
   B2^2 -0.047 0.007 
   B23^2 0.003 0.000 
   A3^2 -0.024 0.000 
   S^2 -0.080 0.005 
   K1^2 0.174 0.008 
   K2^2 -0.402 0.005 
   Table 4.30 The comparison of quadratic and linear regression for the imaginary part of the first 
eigenvalues for the short range of the rate parameters as in Fig.4.8. 
 
Mean Minimum Maximum Range Std.Dev. 
OCL 21.88258 6.38 64 57.62 8 
OBL 1804.408 894 3600 2706 530 
OCT 25431.74 5520 313000 307480 34489 
BM 1.074085 0.156 5.28 5.124 0.65 
Table 4.31 The average population densities, maximum and minimum values and statistical 
deviations for the osteocells (cell/mm
3
) for the model (4.5) and the relative bone mass, BM, for 








Mean Minimum Maximum Range Std.Dev. Ch.Time 
RE1 -3.4 -10.7 1.74 12.44 1.77991 0.27 
RE2 -3.4 -10.7 1.74 12.44 1.77991 0.27 
RE3 -3.99 -9.23 -1.68 7.55 1.307088 0.25 
RE4 -0.031 -0.0459 -0.0203 0.0256 0.005788 33.33 
IM1 528.9 223 1060 837 128.8082 1.288082 
IM2 -528.9 -1060 -223 837 128.8082 1.288082 
IM3 0 0 0 0 0 0 
IM4 0 0 0 0 0 0 
Table 4.32 Resulting statistics on the real and imaginary parts of the eigenvalues for the short range of 




ln(Ocl) ln(Obl) ln(Oct) ln(BM) Re1 Re3 Re4 ln(Im1) 
R-square 0.99 0.99 0.99 0.99 0.95 0.94 0.998 0.99 
a1 0.403 0.509 0.263 0.287 -0.434 
  
0.597 
b12 -0.024 -0.032 -0.016 -0.018 0.027 
 
-0.048 -0.037 
b01 -0.668 -0.843 -0.438 -0.478 0.744 
 
0.064 -0.471 
a01 -0.036 -0.046 0.531 0.580 -0.250 0.797 -0.071 0.470 
b2 0.018 0.023 -0.238 -0.259 0.136 -0.418 0.034 0.026 
b23 
 
0.004 -0.033 -0.036 -0.298 
 
0.004 
 a3 -0.016 -0.020 0.216 -0.012 0.020 
 
-0.031 -0.024 
s 0.024 0.031 -0.337 0.017 -0.027 
 
-0.991 0.036 
k1 -0.306 0.019 -0.241 -0.263 0.113 -0.352 0.034 -0.214 
k2 0.511 -0.035 0.404 0.442 0.032 
 
-0.054 0.359 




4.6  Discussion and possible extension of the model 
In the introduction, it is stressed that the mathematical model developed by Komarova 
et al., (2003) predicts different modes of dynamic behaviour of the BMU, while demonstrating 
the critical role for osteoclast regulation in the control of bone remodelling. In their work, this 
role has been investigated in the framework of a dynamic system, where the osteocyte 
regulation at the cellular level was not formally considered. In fact, the osteocytes play a vital 
role in signalling mechanical damage (Compston, 2002, Taboas at al., 2003; Yan et al., 2003; 
Koegler et al., 2004; Jansen et al., 2004).  
The introduction to the model of the osteocytes regulation loop obviously increases the 







section, is still controlled with a minimal collection of cellular regulation loops and has just one 
non-trivial equilibrium point. The total number of regulation loops in the system that can be 
phenomenologically called paracrine is four. They can be classify as the term 1)modelling effect 
the Oct on Ocl, 2)formal modelling mutual regulative paracrine interaction of Ocl and Obl, and 
3)the term effecting transformation of Obl into Oct when the new bone forms. In this sense, the 
number of terms (links) can be considered a minimal one.  
From the technical perspective, the model presents quite good stability characteristics of 
the nontrivial point, which is also an advantage of this model. The stability point can be 
classified as a stable focus. This can be seen throughout, from Fig.4.4 and Fig.4.7 for the middle 
range of the rate parameters to the short range of parameters, Fig.4.10. For the short range of 
parameters from the 10,000 generated combination of the rate constants, the number of 
equilibrium points, different from stable focus, was less that 70. This illustrates the robustness 
of the system in sense of the stability of the solutions.  
Finally, it can be seen that this minimal model gives a quite reasonable population 
densities of osteocells, Table 4.31, for a volume unit of 1 mm
3
. The characteristic time of the 
relaxation is about 33 days, Table 4.32, which as well is can be considered physiologically as 
reasonable. 
Again, since the relations between the state variables and the rate constants are quite 
complicated, the regression analysis in combination with the Monte-Carlo method is shown as 
being usable in studying the relations between osteocells, BM and characteristics of relaxation. 
The results show good statistical significance when applying this method, particularly for the 
short range of the rate constants, Table 4.34. However, the results from the short range constants 
and the wide range of constants show a very good consistency.  
Indeed, over a range of the rate constants that have realistic biological cellular time 
scales for the bone model, regression method in combination with the Monte-Carlo method, can 







space, see Fig.4.2-4.3, Fig.4.5, Fig.4.7-4.9 and Tables 4.1-4.34 at different ranges of the rate 
parameters. 
However, different state variables, population concentrations of Ocl, Obl, Oct and total 
bone mass (BM) indicate different R-square (R
2
), which determines the quality of the statistical 
model. The linear regression of the relative bone mass BM in case of wide range of the rate 
parameters gives a poor R
2
 value about 0.75, which in fact, only allows one to speak about a 
tendency. The logarithmisation of the state variables and reduction of the range of the rate 
constants gives R
2
 about 0.90, see Table 4.34, which indicates a good significance level. The 
regression of logarithm of concentration of osteoclasts on the set of the rate parameters gives 
R
2
=0.99 with a confidence level of 0.01. The linear regression of osteosites‘ population density 
and BM indicates R-square values: Obl, R
2
=0.99 and Oct, R
2
=0.99. For BM, the most 
influential parameters are a1, b01, a01 b2 and k1, k2. The last parameters, k1 and k2 influence in an 
opposite way: k2 has very strong positive effect, while k1 has negative effect. Parameters a01 and 
b01 have the strongest effect on the population density of Ocl, Table 4.34. Parameters a1 and b01 
have similar but opposite effect on the Obl population density. The osteoclast‘s population is 
affected by the a1, b01 and k1, k2 rate constants. Finally, performing linear regression that only 
includes the first order of the parameters, gives the R-square mainly as R
2
=0.99, which gives the 
significant level about 0.01, Table 4.34. 
About 15% of all points generated by the Monte-Carlo method in the wide rate 
parameters range shown in Fig.4.4, give a different stability type than the stable focus, which 
have a periodical character or are even chaotic. This type of processes also can be considered as 
likely taking place in the bone resorption-formation. Simplification of the model, as it was done 
in Moroz and Wimpenny, 2006, 2007 can describe periodical and chaotic character of 
behaviour. 
Within the framework of this rather phenomenological level of modelling, the role of the 
diverse molecular factors in bone regulation, such as receptors and mediators, the state of the 







or any other molecular messenger or substrate remain the subject of discussion in the 
biochemical literature, even for the generalised animal model, and so the development of a 
mathematical model, based on the molecular level of regulation in the bone, awaits more precise 
biochemical and biophysical data. 
An interesting result obtained from the model described, is that by adjusting the rate 
control of particular model parameters, for example, by the mechanical stress/microgravity 
parameter s (Table. 4.34, Re4 column), it is possible to reduce the relaxation time to the steady 
state. This indicates that by increasing the mechanical stress (in a certain interval) in the 
framework of this model the recovering time rises. 
The model described in this section has mainly the relaxational character of behaviour. 
The periodic modes of behaviour that take place in some region of the rate parameters, could be 
seem less real in such a dense tissue as bone is. On the other hand, they might be interesting 
from an energetical perspective. However, there is a lack of experimental evidence for such a 
sort of behaviour in hard tissue, apart from in the case of Paget‘s disease. The above result leads 
to the conclusion that a cyclic process, which is an optimal from the regulation point of view 
and should be taken into consideration.  
Another crucial assumption is that the models have no spatial dimensions; they consider 
tissue as a homogeneous material with a quite fast diffusion of cells, substances and signals. 
Taking this into account methodologically, these models are rather more useful in describing the 
relaxation effects that are much easier to validate than in bone tissue.     
One of disadvantages of this model is that the model describes the ―multiplicative‖ 
osteoclasts‘-osteoblasts‘ relations, that means it is rather limited to the ideology similar to 
―predator-pray‖ in population biomodelling. Because of this, it is interesting to introduce the 
nonlinear, non-multiplicative, Oct-Ocl relations into the model, which can be interpreted as the 
allosteric regulation modelling. The next section is devoted to studying such a simplest non-








5 Allosteric approach to bone remodelling model 
 
5.1       On an allosteric model of bone remodelling 
Paracrine and autocrine relations are very important parts of the cellular model of the 
bone remodelling cycle (Komarova et al, 2003). In order to study the possibility to change the 
focus by giving cell relationships based on the formal allosteric form, starting from classic 
Michaelis-Menten one-site molecular control and extending to the well known Hill pattern. 
All these forms of regulation have the potential to represent allosteric regulation and this 
could be very interesting when studying the RANKL/OPG balance regulation, for example, 
Lemaire et al., 2004. 
Classical Michaelis-Menten kinetics (Michaelis and Menten, 1913) is one the most 
important working approximation of nonlinear regulation in many models in different fields 
of biochemistry, microbiology and biotechnology, for example, in pharmacological models 
(Kakuji and Akapi, 1994), chemostat models (Lenas and Pavlou, 1995), or batch-kinetics 
models (Tohyama et al., 2002; Srinivasan et al., 2003; Smets et al., 2004). A number of 
research publications discuss the Michaelis-Menten control approach applied to the enzyme 
network (Heinrich et al., 1985; Hofmeyr et al., 1993; Fell and Thomas, 1995; Elsner and 
Giersch, 1998; Ortega and Agenda, 1998; Yildirim, 2003). Recently, Michaelis-Menten 
kinetics has been used to describe the changing rates of cellular activity during bone 
resorption, Martin and Buckland-Wright, 2004. At the same time, there are models discussed 
with respect to modelling of the molecular feedback control in ligand-receptor regulation and 
in ligand transport regulation (Maalmi et al., 2001; Komarova et al., 2003; Rattanakul et al., 
2003). In this study the Michaels-Menten control have been chosen, as a first-stage of the 
allosteric control extension of cellular model, section 2.2. Based on this result the model can 
be adapted to employ other well known molecular control mechanisms, like the Hill  (Hill, 







Koshland-Nemethy-Filmer (Koshland et al., 1966), Monod-Wyman-Changeux (MWC), 
Monod et al., 1965) ones.  
 Effectively a study was undertaken to find prospective paracrine and autocrine 
parameters, following in some sense Komarova et al., 2003, but in the form of allosteric 
regulation terms. Such approach could probably produce the intermediate model from cellular 
to biochemical one. 
 
5.2  Allosteric model development 
It is well known that steoclastic and osteoblastic formation activities are well 
coordinated in framework of BMU and this coordination effectively balances calcium 
homeostasis with skeletal modeling and repair. Recently few BMU-related models are 
developed (Komarova et al., 2003; Lemaire et al., 2004), including based on predator-pray 
elements  ideology (Putra et al, 2010). Models described by these authors predict many 
different modes of dynamic behaviour of the BMU in bone remodeling control. However 
there are some limitations.   
 
5.2.1 Model development  
These limitations have driven modification of the initial model, section 4. Firstly, 
osteocyte‘s apoptosis in the bone remodeling regulation loop has been considered, and 
secondly the autocrine and paracrine control has been enhanced to make it more biologically 
relevant. At third stage the autocrine and paracrine feedback function were chosen not in pure 
cellular form but more akin to the ligand-receptor response/binding function (Michaelis-
Menten/Monod). Such function can be linked to the allosteric, competitive inhibition and 
other control degrees of freedom with a clear biochemical sense (rather than fractal values 
which are purely theoretical, Komarova et al., 2003). The regulation loops that control the 
activity of the BMU can be refined and attempted to introduce the cybernetic-like  point of 







metabolic point of view. For example, a reason for this could be the limitation of the transport 
into the bone of the energetic substrates such as ATP and oxygen, as well others substrates. 
Changes from the physiologically normal bone resorption and formation rates could 
destabilise the metabolic optimality not only on the local (bone) level but could also create a 
supply problem for the body as a whole.  
 
 
Fig. 5.1  Schematic representation of the cell interaction pattern in the extended BMU. 
Arrows represent the control loops of regulation in BMU on the cellular level. Dashed arrows 
represent molecular control pattern. PG, prostaglandin;  TGFβ,  TGFβ1, tumor growth factor; 
RANKL, receptor activator of nuclear factor κB ligand; OPG, osteoprotegerin; IGF, insulin-
like growth factor; PTH, parathyroid hormone; 1,25(OH)2 D3, vitamin D; M-CSF, 
macrophage-colony stimulating factor. 
 
 
Additionally, the robustness is important at all levels of regulation.  Therefore in 
order to produce a robust remodelling process the control should be tough at molecular level, 
indeed. Phenomenological cellular models can affect the tissue infrastructure of regulation 
and function in the whole body, as well as the very robust biochemical pathways. In the case 
of a multicellular organism and tissue, an evolutionary process is taking place. Probably, from 







multicellular body evolved from cellular colonies with initially poor communication. Taking 
into account this point it has attempted to develop and analyse the possibility of a cellular 
model and robustness at this level.  
The resulting cell-level control scheme based on the introduction of the osteocytes  
control loop could be presented as in Figure 5.1, where Oct apoptosis initiates the osteoclasts 
maturation from osteoclasts precursors (continues arrows). On the other hand, the terms 
paracrine and autocrine are just macroscopic formalisation of the action of microscopic local 
factors, resulting in a form of feedback control of the dynamic system model. The number of 
reported local factors is quite wide and shows the complexity of regulation at the micro-level.  
It is widely accepted that OPG-RANK-RANKL pathway is the major pathway 
involved in bone remodelling, see for example, Hofbauer et al., 2000; Kong and Penninger, 
2000; Theoleyre et al., 2004. The autocrine effect occurs due to pre-Ocl expression of RANK 
which is targeted by RANKL. It is interesting that RANKL can exist as a soluble protein 
about 31kDa so that Obl/stromal cells can induce Ocl formation in the absence of direct cell-
to-cell contact, Horowitz, 2001. This forms another paracrine/autoctine degree of freedom in 
BMU regulation. Effectively, the RANK-RANKL balance is regulated by osteoprotegerin. 
The first incorporation of this pathway in a mathematical model was described by Lemair et 
al., 2004. However, as it follows from number of studies many others hormones, like PTH, 
growth factors, cytokines, vitamins and ions are involved in autocrine/paracrine regulation of 
BMU, e.g. in of bone resorption and formation. There are many indications that the number of 
factors (BMP-3, BMP-7, IGF I, IGF II, TGF-β3, FGF-2, VEGF) expressed by osteocytes are 
involved in outocrine/paracrine regulation of OBL and OCL, Table 1, Heino et al., 2004, 
reported on Oct factor that suits of the growth factor with stimulatory effect on Obl. There is a 
suggestion that Oct plays a fine-tuning role in bone remodelling. Bakker et al., 2001, who 
studied the possible role of nitric oxide in bone remodelling, suggests that Oct apoptosis 
attracts Ocl thereby activating remodelling. Westendorf et al., 2004, stressed the role of 







et al., 2003, discussed role of Interleukin-17 family (IL-17) cytokines, secreted by T-cells and 
their role cancer metastasis to bone and regulatory effects in Ocl precursor maturation. 
Additionally, bone cells also express a wide range of the neurotransmitter receptors as 
glutamate, γ-aminobutyric acid, purines and pyrimidines. The overall complexity of the 
regulation pattern of these local and homeostatic factors participating in differentiation, 
maturation and osteocells activity is illustrated in Table 5.1 and Fig.5.1, (dashed arrows).   
Despite the fact that the effect of the majority of these factors is not direct and is 
mediated sometimes by a long sequence of other molecular intermediates/stages, the effective 
action could follow basic regulative forms, such as Michaelis-Menten one. For example, in 
the model incorporation of OPG-RANK-RANKL pathway, described by Lemaire et al., 2004, 
PTH involvement is essentially nonlinear and rather Michaelis-Menten in nature. 
Furthermore, Martin and Buckland-Wright, 2004, described an effective model based on the 
premise that the inhibitory effect on TGFb1 (TGFb1 – induced production of OPG by marrow 
osteoblasts stromal cells) reducing effectively RANKL accordingly to Michaelis-Menten 
kinetics, when the effective Michaelis-Menten constant for osteoclast‘s activity was 
introduced.  
During development of the model an attempt was made to compromise between the 
level of microscopic interacting molecular factors and the macroscopic form of feedback 
function in the phenomenological model of regulation. Taking into account that in order to 
produce a robust bone remodelling process, the regulation needs robustness at all levels of 
control, and indeed at cellular and molecular levels. The final loop of regulation links together 
(in some way) the participating cells and their precursors, as well as the bone material and 















Local Factor/Receptor Reference 
Hormones: 
Parathyroid hormone (PTH)/PTHrP 




Transforming GF β superfamily: 
   BMP-3, BMP-7 
   TGF-β3 
Insulin-like GF 
    IGF I, IGF II 
PDGF 
Vascular endothelial GF (VEGF) 
FGF (FGF-2) 
Cytokines: 
IL-1, IL-6 IL-11,1317 






Low molecular weight factors 
Cystatin B 
Calcium 
Nitric Oxide (NO) 
 
Goltzman, 1999  
Hofbauer et al., 1998  
Gao et al., 1998  
Komarova et al., 2003b 
 
 
Linkhart et al., 1996 
Thomadakis et al., 1999  
 
Linkhart et al., 1996  
Zhang et al, 2002 
Wang et al., 1996; 1997  
Kawaguchi et al., 1994  
 
Moseley et al., 2003  
Hofbauer et al., 1998, 1999; Nanes, 2003 
Chen et al., 2003  
Suda et al., 1999  
Farnworth et al., 2001  
Westerndorf et al., 2004  
Denhardt and Noda, 1998  
 
Laitala-Leinonen et al., 2006  
Sanjay et al., 2001  
Bakker et al., 2001;  Fan et al., 2004 
Vatsa, 2007 
 
Table 5.1 Some important local factors in Ocl, Obl and Oct activity regulation that could play 
paracrine and/or autocrine role. Adopted from Moroz and Wimpenny, 2007. 
 
A dynamical model, that includes Michaelis-Menten type of feedback mechanisms 




























where 1x  is the populational concentration of osteoclasts, 2x  is the populational 
concentration of osteoblasts, 3x  is the populational concentration of osteocytes, 4x  is the 
total bone mass, s is the level of mechanical stress. 
 
Fig. 5.2  The Hill (logit) plot of some important in bone regulation molecular ligands: data 
adopted from Hoare et al., 1999 for hPHT, from Beaudreuil  et al., 2004 for calcitonin and 



















Kxf ,    (5.2) 
describe different types of non-linear feedback loops of regulation, Michaelis-Menten one-site 
molecular control (Michaelis and Menten, 1913) and other well known: Hill, Adair, Monod-
Wyman-Changeux and Koshland-Nemethy-Filmer, and functions )( 4xfOBl , ),( 3xsfOCt , 
)( 1xfB  describe negative regulation feedbacks due to apoptosis, death or transformation the 
cells. This study has been operating with population densities of cells. All constants were 
normalised (Michaelis-Menten, p50 concentration) to unity. All initial rate constants were 
chosen following Komarova et al., 2003. The feedback functions parameters were chosen that 







Using a range of feedback control functions it is possible to model diverse molecular 
mechanisms of regulation. It is known that the molecular local factors act by a number of very 
specific molecular mechanisms, finally expressed in certain non-linearities in kinetic equations. 
Different allosteric (―other site‖) forms of factor-receptor regulation is a important molecular 
mechanism control of cell functions, and, particularly, cooperativity is the interesting degree of 
freedom in such a regulation, because it characterises the degree (sharp or gentle) with which 
the regulation reaches a threshold. 
  The highest cooperativity gives more robust regulation with a distinct threshold 
behaviour which is typical of many physiological parameters. For example this behaviour is 
seen in oxygen regulation when cooperativity of haemoglobin that posses 4 interacting binding 
sites, with cooperativity about 2.73 calculated accordingly to Hill, 1962. It can be suggested that 
it is more likely that the ideal cooperativity in the case of receptors exposed on osteocells, is 
limited to 2. This means that the number of binding centres on a receptor is also equal to 2. For 
example, TGF-b has two subunits, which bind to type II and type I receptors. Binding to the 
binding site on type II receptor causes the receptor to recruit by binding to second binding site 
on type I receptor, (Wingsfield et al., 1987; Thompson et al., 2004). After phosphorylation type 
I receptor it recruits and phosphorylates Smad2 or Smad3 in the long chain in targeting the 
TGF-B response element on DNA. In that way the entire process is cooperatively regulated. So 
Type I and type II TGF-β receptors are likely dimmers that could be associated with inhibitory 
factors and follow allosteric models of regulation having a cooperative character. TNF-α factor 
is a trimer (Wingsfield et al., 1987) and NF-kB regulatory receptor-activator protein it is likely 
that it has three binding sites exposed into extracellular medium. The existence of RANKL in a 
soluble form about 31kDa is interesting explanation that OBl/Stromal cells could induce OCl 
formation in the absence of direct cell-to-cell contact, Horowitz et al., 2001. This is another 
argument for considering molecular models of binding in BMU regulation. 
Thus, it is very reasonable to choose the feedback functions that are capable of 







good interpretable control degrees of freedom, in contrast to fractal models, which are 
sometimes very difficult to interpret from the point of view of the molecular control. 
Taking into account the importance of osteoclasts-osteocytes interaction, the 





















  (5.3) 
where the designations are as for (2.1.4). In this model the Michaelis-Menten kinetics is only 
present in one term, due to insufficient experimental evidence to suggest that it should be 
present elsewhere. 
 
5.2.2  Equilibrium state 
To find the equilibrium points of system (2.2.1) one must set the right parts of the 





















  (5.4) 
 Then starting from the last equation it can be seen that 1212 / xxkx . Substituting this into 
the equations of (2.1.5) one can find the nontrivial solution and can finally obtain the second 
order algebraic equation 
03
2
3 CBxAx     (5.5) 
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),(3     (5.6) 
when 0)4(
2 ACB  the roots are real. Calculations of the equilibrium point when the 
sign ―-―  is in equation (5.6) yields the negative values for x3 and other state variables. 























    (5.7) 
and the trivial solution:  
asxxxxxx **,,0,0 4321 , where  ],0[*x ,  (5.8) 
which indicates that the plane x3, x4 is the solution when x1=x2=0. Designating right parts of 











































































































Employing (2.2.5) it is possible to study the character of equilibrium in trivial (2.2.4) and 
nontrivial (2.2.3) points. Both these equilibrium points are interesting, however, to study the 
character of the trivial point, which in fact is the axis, further investigation is necessary. 
 
5.3 Results of calculations in a wide range of constants 
The behaviour of the mathematical model was evaluated using the Michaelis-Menten 
function in order to examine whether the model repeats the modes of the system, described in 
Section 2. In the majority of cases it produces the character of behaviour as in model (2.4) 
within a wide range of constants. The timescale for the model is linked to the unit of time in 
days, as in the model of Section 4. As mentioned in that section, the choice of initial constants 
was based on experimental histomorphometric data (Parfitt, 1994; Kato et al., 2001; 
Vashishth et al., 2002), which has also been estimated also by Komarova et al., 2003. One 
should note that even for the linear systems similar to above Eq.(5.2), the value of the rate 
constants is not directly related to the value of the formation or resorption rates that could be 
measured in experimental conditions. In this case it is expectedly difficult to validate the 
model constants, although, some general results like the character of local steady state remain 
topologically the same. The change of the rate parameters in Eq.(5.3) in wide range does not 
change the character of equilibrium, Figure 5.4 shows that it is quite robust.  
Over the employed range of rate parameters, the trajectories have demonstrated a 
tendency to behave as a stable focus  – in line with the findings for pure cellular model (4.4). 
One can possibly say that the stable focus prevails after the introduction of the Michaelis-
Menten kinetics. The range of the rate parameters was slightly changed compared to the pure 
cellular model (4.4) and in addition they were also modified by introduction of the Michaelis-
Menten control and other constants like KOct. Range of parameters used: KOct, 100-100000.0; 
a1, 200.0- 30000. day
-1




























; k1, 0.01-1.0 day
-1









Direct application of the similar range of rate parameters as in Section 4 gives the 






























Fig.5.3 The scatterplot of numeric calculations for system (5.3) Calculations were performed 
using the range of parameters: KOct, 100-100000.0 cell mm
-3
























; a3, 1000-66000 day
-1




; k1, 0.01-1.0 
day
-1































































Fig. 5.4 Scatterplot of eigenvalues (5.9) at (5.6a) for system (5.3). A, large scale; B, small 

































































































Fig.5.5 Detailed graphical matrix illustrating scatterplot of population densities of Ocl, Obl, 
Oct, bone in 4D space of these variables. The range of parameters as in Fig.5.3. 
 
 As seen in Figure 5.3, the population density of Ocl and Obl change in the range 
0.01-100 and 10-10000 cells*mm
-3
 respectively. The Oct‘s population density varies from 10 
to 10
7
 and total bone mass varies from 0.001 to 100 cells*mm
-3
. The graphical matrix 
diagram, Fig.5.5, indicates the individual scatterplots of all pairwise combinations of the state 
variables and illustrates wide range of rate constants. From Fig.5.4 can be seen that the main 
equilibrium point can be characterised as a stable focus. Indeed, from 3681 generated by 
Monte Carlo method combinations about 11%  (410) were unstable having two conjugate 
eigenvalues with positive real part. Thus, from the point of view of stability the dynamical 
model is reliable, even when a wide range of rate constants was employed.  
Application of regression methods to this dataset, where a wide range of rate 
constants was applied, returns poor determination coefficients for individual regressions. This 
can be explained by the fact that the relations in such a wide range can be significantly 







5.4 Model fitting in the middle range of the rate parameters 































; k1, 0.01-0.040 day
-1
; k2, 0.0002-0.0006 day
-1
, Fig.5.6, does not change the 
character of the stability of the equilibrium point, see Fig. 5.7, preserving the imaginary part 
for the first eigenvalue. The existence of an imaginary part indicates that for the points of 
equilibrium, the trajectories comprise the periodical character of movement with decaying 
amplitude. It also compacts the position of these points around the same region, Fig.5.8. 
However, the ranges of state variables‘ values of the generated data set can be considered as 
having an enhanced physiological regulatory meaning, Fig.5.7-5.8. 



















1000.01 BMn  
Fig.5.6  The scatterplot of osteocells against BM for system (5.3) with an extended range of 
rate parameters: KOct, 5000-500000 cell mm
-3
























; a3, 1300-20000 day
-1
; s, 0.02-0.4 day
-1
; k1, 0.01- 0.04 day
-1
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Fig. 5.7 The stability characteristics of the equilibrium point after extending the range of the 





























































Fig.5.8 Detailed graphical matrix illustrating scatterplot of population densities of Ocl, Obl, 










ln(Ocl) ln(Obl) ln(Oct) ln(BM) Re1 Re3 ln(Re4) Im1 
R-square 0.98 0.98 0.92 0.95 0.93 0.70 0.90 0.90 














-0.377 -0.509 0.087 -0.467 
  b23 
   
-0.007 -0.220 
   a3 
  
0.448 
     s 
 
0.005 -0.481 
   
0.944 
 k1 -0.580 
 






   
0.290 
Table 5.2 Summary table for MC/regression results for a set of the rate parameters from 
Fig.5.6. 
 
From summary Table 5.2 one can see a good statistical significance for just the 
osteocells and total bone mass, however, the R-square for the relaxation parameters, in fact 
eigenvalues, is quite poor. Therefore the numerical experiment was again repeated for a 
shorter range of the rate parameters. 
 
 
5.5  Short range of the rate parameters 
The behaviour of the model has been studied in the short range of parameters aiming 
to improve the output of the regression analysis. Calculations were performed using the range 
of parameters: KOct, 100-100000; a1, 3000.0-5000.0 day
-1




























; k1, 0.2 0.30 day
-1
; k, 0.002  0.004 day
-1
. The 
























100.1 BMn  
Fig. 5.9 The scatterplot of numeric calculations for system (5.3) Calculations performed 
using the range of parameters: KOct, 100.0-100000.0; a1, 3000.0-5000.0 day
-1






















; a3, 1100.0-1700.0 day
-1




; k1, 0.2 0.30 day
-1


































































Fig.5.10 Detailed graphical matrix illustrating scatterplot of population densities of Ocl, Obl, 




























Fig.5.11 The scatterplot of real and imaginary parts of the four eigenvalues of system (5.4) 
in the range of parapeters indicated in Fig.5.9.  

























Fig.5.12 Relaxation of the system to the steady state at following rate constants: a1, 4590 day
-
1





















; a3, 1100 day
-1




; k1, 0.257 day
-1





. Re4=0.002, τ~50days 
ln(Ocl) BETA St.Err.of BETA B St.Err.of  B t(9988) p-level 
Intercept 
  
3.0649 0.0079 387.18 0.0000 
KOct -0.0007 0.0010 0.0000 0.0000 -0.74 0.0456 
a1 0.3881 0.0010 0.0003 0.0000 401.58 0.0000 
b12 0.0004 0.0010 0.2640 0.6320 0.41 0.6761 
b01 -0.6740 0.0010 -0.4617 0.0007 -697.75 0.0000 
a01 -0.0001 0.0010 0.0000 0.0004 -0.06 0.9466 
b2 -0.0006 0.0010 0.0000 0.0001 -0.57 0.5674 
b23 0.0010 0.0010 0.6423 0.6288 1.02 0.3070 
a3 0.0007 0.0010 0.0000 0.0000 0.73 0.4609 
s 0.0002 0.0010 0.0102 0.0622 0.16 0.8695 
k1 -0.3045 0.0010 -4.0017 0.0127 -315.1 0.0000 
k2 0.5221 0.0010 341.0841 0.6312 540.3 0.0000 
Table.5.2 Linear regression analysis: the logarithm of population density of osteoclasts as a 









ln(Obl) BETA St.Err. of BETA B St.Err. of B t(9988) p-level 
Intercept 
  
7.524 0.007 1117.821 0.000 
KOct -0.0012 0.0010 0.0000 0.0000 -1.1069 0.2684 
a1 0.4955 0.0010 0.0003 0.0000 472.0264 0.0000 
b12 0.0007 0.0010 0.3594 0.5374 0.6688 0.5036 
b01 -0.8614 0.0010 -0.4618 0.0006 -820.8940 0.0000 
a01 -0.0004 0.0010 -0.0001 0.0004 -0.3748 0.7078 
b2 -0.0012 0.0010 0.0000 0.0000 -1.1346 0.2566 
b23 0.0003 0.0010 0.1391 0.5346 0.2603 0.7947 
a3 0.0006 0.0010 0.0000 0.0000 0.5670 0.5707 
s -0.0004 0.0010 -0.0192 0.0529 -0.3630 0.7166 
k1 0.0018 0.0010 0.0188 0.0108 1.7394 0.0820 
k2 0.0011 0.0010 0.5485 0.5367 1.0220 0.3068 
Table.5.3 Linear regression: the logarithm of  population density of  osteoblasts as a function 
of the rate constants. The range of the constants as in Fig.5.9. R
2
=0.99. 
ln(Oct) BETA St.Err. of BETA B St.Err. of B t(9988) p-level 
Intercept 
  
10.9040 0.0143 763.9473 0.0000 
Oct 0.0024 0.0011 0.0000 0.0000 2.1542 0.0312 
a1 0.2536 0.0011 0.0003 0.0000 223.9967 0.0000 
b12 -0.0017 0.0011 -1.6823 1.1396 -1.4762 0.0399 
b01 -0.4388 0.0011 -0.4626 0.0012 -387.7189 0.0000 
a01 0.5283 0.0011 0.3550 0.0008 466.4802 0.0000 
b2 -0.2407 0.0011 -0.0192 0.0001 -212.6448 0.0000 
b23 -0.0319 0.0011 -31.9348 1.1338 -28.1666 0.0000 
a3 0.2179 0.0011 0.0007 0.0000 192.4627 0.0000 
s -0.3451 0.0011 -34.1780 0.1122 -304.6964 0.0000 
k1 -0.2386 0.0011 -4.8238 0.0229 -210.7183 0.0000 
k2 0.4054 0.0011 407.5504 1.1382 358.0760 0.0000 
Table.5.4 Linear regression analysis: the logarithm of the osteocytes‘ population density as a 





ln(BM) BETA St.Err. of BETA B St.Err. of B t(9988) p-level 
Intercept 
  
0.123 0.014 9.011 0.000 
Oct 0.003 0.001 0.000 0.000 2.374 0.018 
a1 0.276 0.001 0.000 0.000 234.248 0.000 
b12 -0.001 0.001 -1.353 1.089 -1.243 0.214 
b01 -0.478 0.001 -0.463 0.001 -405.716 0.000 
a01 0.575 0.001 0.355 0.001 488.228 0.000 
b2 -0.262 0.001 -0.019 0.000 -222.187 0.000 
b23 -0.035 0.001 -31.912 1.083 -29.457 0.000 
k1 -0.259 0.001 -4.818 0.022 -220.247 0.000 
k2 0.442 0.001 407.6 1.088 374.871 0.000 
Table.5.5 Linear regression analysis: the logarithm of the total bone mass (BM) as a function 










Re1 BETA St.Err. of BETA B St.Err. of B t(9988) p-level 
Intercept 
  
-0.1442 0.1017 -1.4173 0.1564 
KOct 0.0001 0.0024 0.0000 0.0000 0.0314 0.9749 
a1 -0.4235 0.0024 -0.0014 0.0000 -175.84 0.0000 
b12 -0.0030 0.0024 -10.267 8.1215 -1.2642 0.2062 
b01 0.7558 0.0024 2.6695 0.0085 313.95 0.0000 
a01 -0.2675 0.0024 -0.6024 0.0054 -111.06 0.0000 
b2 0.1442 0.0024 0.0386 0.0006 59.886 0.0000 
b23 -0.2834 0.0024 -951.09 8.0799 -117.78 0.0000 
k1 0.1182 0.0024 8.0057 0.1631 49.073 0.0000 
 
Table.5.6 Linear regression analysis: the real part of the first eigenvalues as a function of the 





Re3 BETA St.Err. of BETA B St.Err. of B t(9988) p-level 
Intercept 
  
-0.1806 0.0686 -2.6343 0.0084 
KOct 0.0084 0.0024 0.0000 0.0000 3.4512 0.0006 
a1 -0.0016 0.0024 0.0000 0.0000 -0.6622 0.5079 
b12 -0.0012 0.0024 -2.5942 5.4740 -0.4739 0.6356 
b01 -0.0020 0.0024 -0.0047 0.0057 -0.8270 0.4082 
a01 0.8011 0.0024 1.2058 0.0037 329.8478 0.0000 
b2 -0.4244 0.0024 -0.0759 0.0004 -174.8040 0.0000 
b23 0.0017 0.0024 3.7660 5.4460 0.6915 0.4893 
k1 -0.3584 0.0024 -16.2324 0.1100 -147.6230 0.0000 
Table 5.7 Linear regression analysis: the real part of the third  eigenvalues as a function of the 




ln(Re4) BETA St.Err. of BETA B St.Err. of B t(9988) p-level 
Intercept 
  
-4.5545 0.0039 -1178.1 0.0000 
KOct 0.0001 0.0009 0.0000 0.0000 0.0754 0.9399 
a1 -0.0004 0.0009 0.0000 0.0000 -0.4943 0.6211 
b12 0.0006 0.0009 0.2044 0.3086 0.6623 0.5078 
b01 0.0002 0.0009 0.0001 0.0003 0.2556 0.7982 
a01 -0.0004 0.0009 -0.0001 0.0002 -0.4446 0.6566 
b2 0.0013 0.0009 0.0000 0.0000 1.5102 0.1310 
b23 0.0003 0.0009 0.1174 0.3071 0.3822 0.7023 
a3 -0.0001 0.0009 0.0000 0.0000 -0.0799 0.9363 
s 0.9961 0.0009 34.1427 0.0304 1123.8 0.0000 
k1 0.0010 0.0009 0.0068 0.0062 1.0953 0.2734 
k2 -0.0002 0.0009 -0.0730 0.3083 -0.2369 0.8128 
Table 5.8 Linear regression analysis: the real part of the logarithm of fourth eigenvalue as the 











Im1 BETA St.Err. of BETA B St.Err. of B t(9988) p-level 
Intercept 
  
0.8543 5.8152 0.1469 0.8832 
KOct -0.0003 0.0018 0.0000 0.0000 -0.1655 0.8686 
a1 0.5467 0.0018 0.1394 0.0005 300.3238 0.0000 
b12 -0.0010 0.0018 -265.6 464.3005 -0.5721 0.5673 
b01 -0.4864 0.0018 -129.9 0.4861 -267.3223 0.0000 
a01 0.4737 0.0018 80.67 0.3101 260.1905 0.0000 
b2 -0.0010 0.0018 -0.0198 0.0368 -0.5375 0.5909 
b23 0.0018 0.0018 452.2 461.9222 0.9791 0.3275 
a3 0.0023 0.0018 0.0019 0.0015 1.2573 0.2087 
s 0.0017 0.0018 41.48 45.7003 0.9078 0.3640 
k1 -0.2174 0.0018 -1113.89 9.3266 -119.4317 0.0000 
k2 0.3684 0.0018 93865. 463.7086 202.4233 0.0000 
Table 5.9 Linear regression analysis: the imaginary part of the first eigenvalues as a function 





Mean Minimum Maximum Range Std.Dev. St.Error 
OCL 23.2 6.78 68.1 61.32 8.98 0.090 
OBL 1904. 958 3820 2862 578.0 5.781 
OCT 25791 7860 311000 303140 39611 396.1 
BM 1.15 0.184 5.77 5.586 0.728 0.007 
Table 5.10 The average population concentrations, maximum and minimum values and 
statistical deviations for the osteocells for the model (5.3) and the total bone mass, BM.  
 
Mean Minimum Maximum Range Variance Std.Dev. Std.Error R.Time 
RE1 -3.7 -11.8 1.45 13.25 3.77 1.94 0.019 0.27 
RE2 -3.7 -11.8 1.45 13.25 3.772 1.94 0.019 0.27 
RE3 -4.0 -9.6 -1.70 7.90 1.685 1.298 0.013 0.25 
RE4 -0.03 -0.04 -0.02 0.020 0.00003 0.00585 0.00006 33.3 
Table 5.11. Resulting statistics of the real parts of the eigenvalues for the short range of rate 
parameters from Fig.5.9. 
 
 
ln(Ocl) ln(Obl) ln(Oct) ln(BM) Re1 Re3 ln(Re4) Im1 
R-square 0.99 0.99 0.99 0.99 0.95 0.95 0.99 0.99 
KOct -0.0007 -0.0012 0.0024 0.003 0.0001 0.0084 0.0001 0.001 
a1 0.3881 0.4955 0.2536 0.276 -0.4235 -0.0016 -0.0004 0.555 
b12 
    
-0.0030 -0.0012 0.0006 -0.001 
b01 -0.6740 -0.8614 -0.4388 -0.478 0.7558 -0.0020 0.0002 -0.483 
a01 
  
0.5283 0.575 -0.2675 0.8011 -0.0004 0.486 
b2 
  
-0.2407 -0.262 0.1442 -0.4244 0.0013 0.000 
b23 
  










0.0004 0.9961 0.000 





0.0003 -0.0002 0.374 







Tables 5.2-5.11 indicate a significant improvement in the R-square of the linear 
regression.  The final table shows that only Re1 and Re3 have the R-square values less than 
0.99.  
 The results of numerical calculations for different feedback, shown above, indicate that 
the stable focus prevails irrespective of the Michaelis-Menten feedback function, Figure 5.11.  
Thus the s-shaped Michaelis-Menten function, well-known in many regulatory 
networks, for example, in neural networks as the neuro-somatic threshold function (Demongeot 
et al., 2000) can be interesting for a cellular cooperative formation such as the BMU. Moreover, 
the employment of this nonlinear function in the BMU model can lead to stabilisation of 
equilibrium states which could explain some periodic relaxative modes. In comparison to fractal 
spaces, allosteric models have additional degree of freedom and very clear, interpretable values 
from the point of view of molecular control. 
 
5.6  Discussion 
In the introduction it was stressed that recently developed mathematical models of bone 
turnover (Komarova et al., 2003; Lemaire et al., 2004; Moroz et al., 2006) predict various 
modes of dynamic behaviour of the BMU. In this section the allosteric-like feedback control 
function has been investigated with respect to an extended dynamic system from Komarova et 
al, 2003, where 1) the osteocyte regulation at the cellular level is formally involved and 2) 
autocrine and paracrine regulations are chosen in an allosteric-like form. In fact, as mentioned, 
regarding the first development, osteocytes play a vital role in signalling mechanical damage 
(Compston, 2002; Skerry et al., 1989; Lanyon, 1996; Tomkinson et al., 1997; Noble et al., 1997; 
Burger and Klein-Nulend, 1999).  Introduction this cellular regulation loop to the model has 
increased the dimension of the dynamic system. However, the designed system is still controlled 







applicable to other types of allosteric regulation controls, for example to the Hill-like feedback 
function. 
One of the major developments of this section is that the formulation and interpretation 
of paracrine and autocrine control is attempted in terms of allosteric regulation rather than a 
fractal form, when it is formulated as a regulator of the degree parameters. Concerning the Oct 
regulation loop, one can see from Eq. (5.2) and Figure 5.2 that it could be suggested that the 
feedback function which regulates Ocl response to OCt apoptosis is S-shaped (akin to many 
control feedback functions) and could have the Michelis-Menten or generally the Hill form. 
Such formulated models have an additional advantage - allosteric control degrees of freedom, 
clearly interpretable from the point of view of molecular control. In such a case the system 
could be described in terms of losses (metabolic losses), like in the problem of optimal control, 
when the bone remodelling is at the demand of minimising the substrate-energy losses for bone 
remodelling by balancing the metabolic cost of regulation against shortening the response time 
to mechanical/aging damage and physiological function of the skeleton. From the results of the 
numerical calculations (Section 5.3-5.5) it is possible to see the survival of a stable focus type of 
equilibrium (Fig. 5.4, 5.7, 5.11.) in the four dimensional phase space over different ranges of 
constants. 
Obviously, within the framework of this quite phenomenological model, the role of the 
diverse molecular factors in bone regulation, such as receptors and mediators, the state of the 
membrane, and hormonal or genetic system, are difficult to include and discuss. The roles of 
these or any other molecular messenger or substrate remain the subject of broad discussion in 
biochemical literature (Section 1, literature review), even for a generalised animal model, and so 
the development of a mathematical model, based on the molecular level of regulation in the 
bone, awaits more precise biochemical and biophysical data.  
The models above are just one subset of BMU models, within one combination of 
parameters, that could have other types of equilibrium (for example, the attracting limit cycle) in 







parameters, which result in a local minimum for the system, a stable focus steady state was 
found. This set is relevant to the combination for the pure cellular model, Section 2. This 
set/combination model has one decaying cyclic mode with large differences in frequencies.  
The next stage of the development of this model is the derivation of an equation for 
scaffold material, which employs specific constants for sorption and resorption. It could be 
possible to model the integration of resorbable implant into the bone in such a way. The an 
equation could include the material parameters, scaffold design (porosity) parameters via 
fractality of the bone scaffold, surface modification parameters and cell enhancement 
parameters. Based on the above, one can suggest that in the framework of the generalised model 
(Eq.5.1) it is possible to find other steady states with a sound biological/biochemical 
interpretation. Moreover, the transformation bifurcation between these states could model the 
major mechanisms of the control of BMU and bone remodelling. The existence of such 
decaying periodical oscillations could be linked to a Paget‘s-disease-like physiological situation, 
when the overfeeding of the remodelling cycle occurs.    
 
5.7   On the validation of the model  
Validation of the bone remodelling models is a critical issue. The most important factor, 
preventing practical verification/validation of any model of bone tissue remodelling is that bone 
is a hard tissue and thus very difficult to experiment upon. The measurement of molecular 
parameters (concentrations, activities, binding constants etc.) is a timely process, so measured 
values can be significantly distorted from the in vivo values.  
The models considered in this study account for the number of tiny regulatory 
processes, mentioned in the literature review section and are therefore predictably complicated. 
However, from the kinetic measurement perspective, the kinetic parameters usually measured 








The models described in the Section 4 and 5.1-5.6, are the relaxation types of models, 
so they can be preferable from the validational perspective. These models have been studied 
numerically within the range of the rate constants having the same order as the Komarova et al. 
(2003) model. The mean relaxational time has the order of month.      
Validation of allosteric constants incorporated into the model is even more difficult than 
in the case of the rate constants of the cellular model. The models considered (cellular, Section 
4, and combined molecular-and-cellular models, Section 5) are very simplified, rather 
phenomenological models. In these circumstances the verification can be considered to be 
related to the main conclusions of the modes, like for example the character of behavioural 
modes. Considering the spectrum of behavioural modes some indications in recent literature can 
be found.  
Some statistical studies, which have been performed on pre- and postmenopausal 
women, show the cyclic (periodical) behaviour of bone remodelling, Mazuoli et al., 2002; 2006. 
Authors even titled their paper from 2002 as ―Cyclical behaviour of bone remodeling and bone 
loss in healthy women after menopause: results of a prospective study‖ which stressed that there 
is a periodical effect as it is possible to see from Fig.5.12-5.12. In this prospective study, the 
annual changes in lumbar bone mineral density (LBMD) and bone remodeling markers were 
measured in 238 healthy pre- and postmenopausal women, aged 45–74 years. The results 
obtained indicate that bone loss is not a constant process over time but rather exhibits cyclical 
damping oscillations. The harmonic regression model indicates the presence of a cyclical 
component of 7 years.  
In their second work, Mazzuoli and coauthors (2006) studied a sample of 200 healthy 
women, aged 45–74 years, recruited by written invitation from a community-based listing of all 
residents, living locally, which made the trial quite homogeneous, 136 were enrolled in the 
follow-up study and 120 completed a year of the study. The experimental work was based on 
measurement of biochemical parameters and annual anterior vertebral body heights changes 








Fig.5.12 Mean annual percent changes in LBMD. YSM, years since menopause; YSM 0, 
premenopausal group. Number of observations given in parentheses. Adopted from Mazzuoli et 
al., 2002. 
 
In the study of Tayyar and coauthors (Tayyar et al., 1999), a 3D simulation was 
employed for the modelling of trabecular bone remodelling. The modelling bone volume was 
about 50 mm
3
 containing about 200 basic multicellular units. The authors proposed the 
periodical modes in basic multicellular units activation responses, see Fig.5.15. 
 
Fig.5.13 Mean annual percent changes in LBMD, in OHPr/Cr and ALP observed (dashed 
line/open circles) and predicted (solid lines). YSM, years since menopause; YSM 0, 









Fig.5.14  Mean annual percent changes in AVHs. Observed values (solid line/open circles) and 
predicted values (solid line). YSM, years since menopause; YSM 0, pre-menopausal group. 






Fig. 5.15 The three BMU activation responses to the abrupt step change in estrogen at 
menopause. Adopted from Tayyar et al., 1999.  
 
 
One of the mechanisms which can be employed to explain of periodic type modes was 
proposed by Martin, 2007, suggests the spatial character of microdamage removal /remodelling. 
This mechanism to some extent indirectly supports the results observed in this project, that 
BMU arranged for the repairing of one area of microdamage can be employed/used to remove 







The results in the work of Martin 2007 considers the possibility that microdamage is not 
only able to activate new BMUs, but may also attract or ―steer‖ existing BMUs as they continue 
to tunnel through the bone matrix, Fig.5.16. This suggestion is in line with the results of Vatsa 
et al, 2007. In their it study has been demonstrated that a single osteocyte can transfer 
information of a local mechanical signal to its surrounding cells at a distance ranging from 33 to 
175 μm. This in fact supports the consideration of a cyclic mode in bone remodelling presented 
in this project. 
 
Fig.5.16 Schematic diagram of BMU being diverted to a microcrack (μck) surrounded by 
apoptotic osteocytes (filled circles). Filled squares are apoptotic osteocytes in the low stress area 
in front of BMU, and empty circles are healthy, intact osteocytes. Adopted from Martin, 2007.  
 
 
In summary, verification of models is quite limited (perharps the most limited of the 
tissue types). The applicability of periodical modes of behaviour to the real situation in vivo in 
living hard tissue or to engineered prototypes is linked to the verification and is also limited. 
The relaxational mode could be applicable when taking into account the hierarchy of relaxation 
modes through the evaluation of the resorptional biological rates of hard tissue, implant 
resorption and natural bone tissue reformation/development.  However, even the models having 
the problems with validation, they are important stage in developing an approach to 







6 On Optimal Control applications to BMU models 
 
 
The models in the Sections 6.1-6.3 are to demonstrate the introduction of the optimal 
control via some parameters manipulation. In these sections (6.1-6.3) the optimal control 
problems are formulated following Moroz, 2011.One of the most known kinetic process is the 
binding a low molecular ligand to a macromolecule, generally having several binding sites.  
 
6.1 Optimal control model of binding cooperativity  
6.1.1 Importance of low molecular binding and its cooperativity  
Cooperativity phenomenon (in its wide sense, auto-modulation) has been documented 
and studied for more than a century (Verhulst, 1838; Bohr et al., 1904; Hill, 1910; Pearl & 
Reed, 1920 ). It is believed to be one of the most intriguing properties of biological regulation, 
particularly in molecular binding. 
Molecular binding is the simplest sort of chemical reactions/kinetics that demonstrate 
cooperativity, however it is very important in the overall regulation of cellular, tissue and body 
functioning. Cooperativity in the binding of low molecular weight ligands to a macromolecule 
(e.g. a transport molecule, like albumin, haemoglobin; numbers of receptors) is still of growing 
interest because of the non-linear cooperative molecular effects. It is very important for 
molecular gain and can trigger many effects at the level of cell and the body response. Different 
allosteric mechanisms (Perutz, 1990; Klotz 1997) are also involved in molecular binding and 
signal generations. Allosteric effects in binding, which can be defined as a coupling, synergism 
of conformational changes between spatially separated binding sites of a macromolecule.  
 The most advanced models of binding are developed for oxygen binding to 
heamoglobin (Hb), so we will concentrate on oxygen binding to this macromolecule. A 
classical example of cooperativity in binding, is in the binding of a low molecular weight ligand 
to a macromolecule, for example, O2 binding to Hb, when cooperativity can be defined as a 







curve characterises as a ―sigmoid‖ or ―S‖-shaped. Physiologically cooperativity allows control 
over the concentrations of a ligand, in this case oxygen in tissues. 
 There are three well-known models of cooperativity in binding oxygen to Hb. They are 
the Adair model (Adair, 1925), the Monod-Wyman-Changeux (MWC) model (Monod, Wyman 
& Changeux, 1965), sometimes referred as concerted model, and Koshland-Nemethy-Filmer 
(KNF) model (Koshland, Nemethy & Filmer, 1966), referred also as ―induced-fit model. The 
MWC model is based on assumption that a binding macromolecul can be in two states: a low-
affinity state T and a high-affinity state R. The KNF model assumes that ligand binding leads to 
the conformational change, which consequently changes the affinity to the next binding site. A 
lot experimental data through number of decades (e.g. extracellular Hb has coperativity n~6 and 
higher, Fushitani et al., 1986; 1992; Marques & Meirelles (Erythrocruorin), 1995; Mozarelli et 
al., 1996; Weber et al., 2003; Hellmann et al., 2003) and  number of theotetical efforts 
(Acerenza and Mizraji, 1997; Eaton  et al., 1999; Tsuneshige et al., 2002; Qian, 2003, 2008; 
Onufriev and Ullmann, 2004; Agnati et al., 2005; Olivier et al., 2006) indicate inexhaustible 
interest to the cooperativity and O2 binding as a good model to study cooperativity. 
 In summary, the cooperativity phenomena are represented at all levels of biologival 
regulation, molecular, cellular, tissue and body. It is no surprise that, if the transitional 
processes of species replacement, change in a trophic niche also have the cooperative character. 
Therefore, it is very inportant to understand the cooperativity, and cooperativity of molecular 
binding, in particular from the optimal control perspective. In this section, we illustrate the 
nonlinearity effects when macromolecular ligands bind to a large macromolecule in terms of 
optimal control.  
 
6.1.2 Binding kinetics, cooperativity and its representation  
The standard representation of binding of any low-molecular-weight ligands, molecular 
factors mentioned above, is widely interpreted in terms so-called Hill‘s model (Hill, 1910; 







logit transformation to the experimental saturation data in order to linearise and produce a 
graphical representation (Hill plot), Fig.6.1.1. The coefficient of slope in the Hill plot 
establishes the so-called cooperativity. In a certain sense cooperativity characterizes the degree 
of rigidity of regulation for the local maintenance of concentration at some optimum in the case 
of binding. Let us therefore proceed to relate this parameter to a control parameter in the 
molecular concentration regulation. That means that one needs to investigate whether the 
problem of optimal control can be formulated for the molecular binding, where the Hill 
coefficient would play the role of a control parameter. 
 As was mentioned above, the allosteric model for the oxygen binding to haemoglobin 
is the most successfully studied from many perspectives. An obvious explanation for this comes 
from the exclusive role of oxygen in any biological process. As we mentioned, there is a 
various number of formal models for oxygen binding: Hill, 1962; Adair (Adair, 1925); Monod-
Wyman-Changeux (Monod et al., 1965) and Koshland -Nemethy-Filmer (Koshland et al.,1966) 
and even recently global allostery of Hb has been reviewed (Yonetani at al, 2002; 2003).  
 If one considers a generalized scheme of the low molecular weight ligand L (NO, 
Oxygen, etc.) binding at N centers of macromolecule A (receptor, transport protein, enzyme, 
etc.), 
 







i                (6.1.1) 
is the value, referred to as the equilibrium constant of binding at the j-s stage, which for 
simplicity we can consider as equal for all binding centers, so Kj=K. 

















 is the relative binding, [A]bind, [A]total are the bounded and total 
concentrations of a macromolecule, [L] - the ligand concentration, n is the number of binding 
centers, Kj =K is  the constant of binding to the j-s center. Fig.6.1.1 illustrates the dependences 
of relative binding on the concentration for some theoretical scheme expressed in (6.1.2) at n 
=0.5, 1.0, 2.0, 4.0, 8.0.  
 
Fig.6.1.1 Graphical illustration of the relative binding; n=2.0-8.0 – positive cooperativity, n=1.0 
– no cooperativity, and n=0.5 – negative cooperativity.  - fraction of maximum value 
(saturation). Insert - the scheme of the optimal regulation at a ligand concentration shown by 
vertical line ―2‖. Curve 3 – the saturation curve  from figure A for n=2, curve ―1‖ is 1-  . 
Designations:  ―a‖ (under the curve ―1‖)- the area of relative free ligand; ―b‖ – area under the 
curve ―2‖ relative binding of the ligand ν; ―c‖ – the area indicating the relative binding of the 
ligand, when the ligand is bonded, however, does not needed relatively to ideal binding 
indicated by line ―2‖. ―d‖ the area where the ligand is still free, comparably to ideal binding 
indicated by line ―2‖. Figure adopted from Moroz, 2011.  
 
One can show that the expression for relative binding is related to the logistic curve, 







simplicity, let us apply the natural logarithm. By substitution of 
]ln[][ Xnn eL  into (6.1.2) one 
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 .   (6.1.4) 






























,     (6.1.6) 
that, in fact, should be shown. Thus, from the formal structure of the last equation the n may be 
treated as an ―autocatalytical‖ coefficient in the well-known differential equation of Verhulst-
Pearl. The result acquired can be interpreted in the following way: in the presence of n 
binding sites, the increase in relative binding dzd /  is proportional to the relative binding . 
This means that the process of binding complex formation is autocatalytical-like, one which is 
very important in binding regulation of low ligand concentrations. Thus, the Hill constant n can 
be interpreted as an autocatalytic parameter of the ligand binding to a macromolecule control, 
in respect to the relative binding . 
 
6.1.3     Dynamical optimal control outline 
 As was discussed in (Moroz, 2009), similar equation as (6.1.6) can be obtained as a 
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GH    (6.1.9) 
Then the system will be 











    (6.1.10) 
together with the additional Pontryagin maximum principle demand H( *,p*,u*)=0 for the 











    (6.1.11) 





GpH    (6.1.12) 
The surface plot and contour plot of the Lagrangian (6.1.7) and Hamiltonian (6.1.12) for 




G     (6.1.13) 
is shown in Fig.6.1.2 for n=2.0. The Hamiltonian (6.1.12) can also be written as a dependent on 
dz
d, , which for optimal trajectory (*) is equal to zero, when the final state is not specified. 







haven‘t a time variable, instead we have the logarithm of ligand concentration, z=ln[X]. The 
open-end problem in this model is when the concentration reaches infinity, which has no real 
meaning. This consequently means that we need a different optimal control problem, rather 
than the open-end problem. However, assuming that the concentration is, in an ideal case, very 
high, we can follow our method to formulate the optimal control problem. This means that we 
can accept all states, not just the optimal and we can therefore choose from these states the real, 
optimal state, when H*=0. Following this approach let us write the Hamiltonian which is 
dependent on relative binding ,  and its derivative 
dz












H   (6.1.14) 













 .   (6.1.16) 
This equation at certain values of constants coincides with the form given by (6.1.6). The 
analytical solution of this equation is  
*1
*
lnCnz      (6.1.17) 
which is known as the Hill equation which is widely used for calculation the cooperativity n. It 
indicates a straightforward linear relation between variable z and the so-called logit: 
1
ln)(logit   .  
The numerical solutions of the system of equations (6.1.11) at quadratic potential are 
shown in Fig.6.1.3. Fig.6.1.3A shows the relative binding for different values of n. Fig.6.1.3B 







values of costate variable p, interpreted as the thermodynamic (kinetic) momentum of the 
binding process. This indicates that the solution (6.1.16) provides the maximum of the 
functional from the equation (6.1.7). The relative binding effectively strives to unity with the 
unlimited increase of the ligand concentration. However, one can take into account that the 
search for the maximum of a functional is equivalent to the search of its minimum with the 
negative sign. Additionally, the problem is symmetrical, which can be easily seen from 
Fig.6.1.2. It can also be illustrated by Fig.6.1.1 that the maximization of area ―a‖ is the 
minimization of area ―b‖. Minimization of area ―c‖ is, in fact, the tightening the regulation 
around the regulatory point (vertical line ―2‖, the concentration of the ligand at ν=0.5), which 
leads to increase of cooperativity and consequently can be considered as the rigidity of 
regulation of the concentration of the ligand in the surrounding medium. Thus, the 
maximization the area under curve ―3‖, Fig.6.1.1, is equivalent to the minimization of area ―c‖. 
This can be interpreted from the optimal control perspective as characterizing the regulatory 
losses between logistic curve ―3‖ and the vertical line of desired concentration, z0, that should 
be minimized. 
  
Fig.6.1.2 The contour plot of the Hamiltonian (6.1.12) for quadratic approximation of the 
potential G, (6.1.13). 0=1.0, n=2. Figure adopted from Moroz, 2011. 
 
One can see from Fig.6.1.2, that the Hamiltonian of the problem (6.1.12) is 







the kinetic (thermodynamic) momentum becomes infinite, approaching ν=1. Then the optimal 
control problem looks rather incorrect as a problem of minimization, however, as one can see 
from Fig.6.1.2, the minimization and maximization problems are symmetrical.   
A     B 
Fig. 6.1.3 Kinetics by solving system (6.1.11). A, plots of  against z; insert - phase plane of 
costate variable p versus . B, phase plot of decimal logarithm of –p versus state variable ; 
insert -  plot of logit( ) versus z/2.30, which, in fact, is transformed to a decimal logarithm in 
this way. Figure adopted from Moroz, 2011. 
 
One can compare Fig.6.1.3A to Fig.6.1.1A and Fig.6.1.3D to Fig.6.1.1C. The form of 
the curves for n=1,2,4 from Fig.6.1.3d is identical to curves 1,2,4 in Fig.6.1.1C. In fact, this 
result validates the approach based on the optimal control methodology. 
 
6.1.4 Optimal control Lagrange method  





























    (6.1.19) 
which is, in fact, the system (6.1.10) that gives (6.1.11). Since this is an open-end problem, the 
transversality condition is applied. 
 
6.1.5    Conclusions 
 It has been illustrated above, how the equation (6.1.16) can be obtained by employing 
the optimal control/variational technique. It is coinciding in a form with the logistical 
differential equation (6.1.6). Initially, the variable u was the proportionality coefficient in the 
control equation (6.1.8). Finally, in the transformed equation (6.1.16), the control u linearly 
depends on ν and the coefficient n, which characterizes cooperativity. So, in this way, the 
artificially introduced control u in the kinetic equation (6.1.8) later ―materialises‖ into a 
function of state variable (saturation) ν with a characteristic constant n that can be considered as 
cooperativity.  
 One shall note that with an increase of cooperativity n, the rigidity of the regulation 
also increases, which results in an increase in the slope coefficient in the equation (6.1.16). 
Fig.6.1.1B and Fig.6.1.3A illustrate this graphically. It indicates that the binding and the 
binding control, expressed as its cooperativity, can be considered in terms of optimal control in 
an un-contradictory manner. It also means that the binding description can be formulated as an 
optimal control problem and also a variational problem.  This consequently suggests the 
methodology of the least action principle. The coefficient of inclination which describes 
cooperativity is related to the control amplitude - this also being the specific cost of control. 
 However, one can note that the consideration presented here was based on assumptions 
of an ideal cooperativity. A disadvantage with this consideration is the phenomenological 







saturation.  For other well known cooperativity models, like Adair (Adair, 1925); Monod-
Wyman-Changeux (Monod et al., 1965) and Koshland -Nemethy-Filmer (Koshland et al., 
1966)  the optimal control formulations certainly will be much more sophisticated.  
The methodology shown above demonstrates that the cooperative macroscopic binding 
behaviour can be explained from the OC perspective by considering the elementary binding as 
an optimal energetical process.  In some sense, it extends the understanding of the control 
process, its evolution in adaptive systems, particularly. In mechanics, as we have seen, the 
formal introduction of the control by the rate allowed the OC formulation (Moroz, 2009), when 
the control appears as a dummy-like variable. Here, in biological and biochemical kinetics, 
when considering the OC formulation of binding, the control variable u does not look like an 
absolute dummy, see Fig.6.1.3B. The optimal control is involved in an optimal control 
regulation loop, when the Hill cooperativity constant can be interpreted from the OC 
perspective, as the rigidity of control and kinetic momentum (costate variable). It is an 
energetical-like partial penalty/price/cost of deviation from the optimal state. 
 
 
6.2 Michaelis-Menten kinetics and optimal control 
 
In this section the optimal control problem for Michaelis-Menten-like kinetics is 
formulated following Moroz, 2011. 
 
6.2.1 The Michaelis-Menten model 
 Enzyme kinetics is one of the lowest regulatory levels in the complex hierarchy of 
metabolic regulation. The fundamental kinetic model of the enzyme kinetics, the Michaelis-
Menten model, is based on the assumption of the intermediate complex (Michaelis and Menten, 
1913). It is the basic approximations for many complex models in different fields of 







Heinrich et al., 1991; Giersch, 1998; Schuster and Heinrich, 1987, 1991) or pharmacological 
models (Kakuji and Akapi, 1994). A number of research publications discuss the Michaelis-
Menten control approach applied to the enzyme network (Heinrich and Holzhutter, 1985; 
Hofmeyr et al., 1993; Fell and Thomas, 1995; Fell, 1997; Elsner and Giersch, 1998; Ortega and 
Agenda, 1998; Yildirim at al., 2003). Recently, Michaelis-Menten kinetics has been used to 
describe the changing rates of cellular activity during bone resorption, Martin and Buckland-
Wright (2004).  
At the same time, there is the number of the Michaelis-Menten based models on 
optimization that are discussed with respect to modelling the feedback control - chemostat 
models or batch-kinetics models (Lenas and Pavlou, 1995; Rahman and Palanski, 1996; 
Sengupta and Modak, 2001; Keesman and Stigter, 2002; Srinivasan et al., 2003; Smets et al., 
2002), with the perspective of overall output control in the biotechnological production. 
However, even from this perspective, it is very essential to investigate the optimal aspects of 
the regulation within the metabolic networks as an optimal control problem. Later it could be 
extended as a metabolic engineering approach to the optimization of the metabolic regulation in 
vivo from point of view of minimization of metabolic expenses for regulation and energetic 
optimisation in sense of processing at the minimum of thermodynamic potentials. In this sense 
the Michaelis-Menten kinetics is one of the basic model and studies are needed to revise and 
extend the understanding in the sense of optimal control and compare the results within others 
regulation approaches. 
 It is well known that enzymes are those structures indeed that affect the rate of 
chemical reactions without any shifting of the thermodynamic equilibrium (see, for example, 
Cannon, 2002). Therefore, it is even more reasonable to consider the enzyme kinetics in terms 
of optimal control technique, by the rates of chemical transformations. One of the simplest 
cases is the optimal control introduction into enzyme kinetics within the elementary Michaelis-
Menten pattern when the possible results could be easy to interpret and expand on the number 







 The Michaelis-Menten model also is the basic model in this section. The goal of the 
present investigation is to revise the spectrum of dynamical behaviour after the introduction of 
optimal control into classic enzyme kinetic based on this equation. The optimal control 
interpretation in terms of metabolic costs/losses is another spotlight of our consideration. In this 
section we review the Michaelis-Menten kinetics regarding to the introduction of the optimal 
control methods in the way appropriate to this class of biochemical systems. 
 Standard Michaelis-Menten formal scheme of the reaction where the substance S 
transforms to substance P, is based on suggestion of so-called intermediate complex ES 
(Michaelis and Menten, 1913; see also Cornish-Bowden, 1995). If suppose that the first stage 
of this reaction is reversible, and the second one irreversible, then one can write classical design 
(see, for example, Cornish-Bowden, 2004) 
 
 
       . 
In the case, when the stoichiometric factor of the substrate S transformation to the product P is 
equal to unity, the kinetics of substrate S transformation described by the well known 








max ,     (6.2.1) 





KM  is the Michaelis constant, 02max EkV   is the maximal reaction 
velocity. 
 











Fig.6.2.1 Double reciprocal plot of kinetics for Michaelis-Menten model (6.2.1), Lineweaver 
and Burk, 1934.  dtdSV / , s0=1.0, Vmax=1.0. Insert, the kinetic curves. Figure adopted from 
Moroz, 2011. 
 
 It can be seen from (6.2.1) that the velocity of enzymatic transformation can be 
formally controlled by means of the values for the KM and Vmax constants in the Michaelis-
Menten equation (6.2.1).  The kinetic properties of an enzyme reaction could be considered also 
in the so-called double reciprocal plot (Lineweaver and Burk, 1934). The latter 
representation has the convenience, which permits to determine directly the Michaelis constant 
KM and the maximal reaction velocity Vmax (Cornish-Bowden, 2004). 
 Let us formulate OC problem for enzyme kinetics represented by the above Michaelis-
Menten equation. From the form of the kinetic equation (6.2.1) one can alter the Michaelis 
constant KM or the maximal reaction velocity Vmax. We are suggesting that such a control can 
take place in vivo in the cell, and that it is carried out in an optimal manner, and it follows, for 








6.2.2    General optimal control approach to Michaelis-Menten kinetics 
In a general one-dimensional case the optimal control problem accordingly to 
Pontryagin principle maximum principle, Pontryagin et al., 1962, can be written following 




dtuTsGdtuslJ    (6.2.2a) 




      (6.2.2b) 
and 00 )( sts  and end-point condition s(τ)=seq, 
where s is state variable (substrate concentration), u is control variable (Michaelis constant KM, 
maximal reaction velocity Vmax), ),( usf  is Michaelis-Menten function (as we mentioned, 
sometimes referred as Monod function) from equation (6.2.1), J is objective functional, l(s,u) is 
the ―running cost‖ of the optimal control that can have a metabolic sense and also sometimes is 
referred as instantaneous costs/losses for optimal control. Then accordingly to the Pontryagin 
maximum principle, the Hamiltonian function is  
),(),( usluspfH      (6.2.3) 




































  (necessary conditions for optimality),       








The alternative approach to this optimal control problem is directly based on variational 
calculus, see, for example, Gelfand and Fomin, 1963, because the control could be chosen as 
formally unlimited: the Michaelis constant KM or the maximal reaction velocity Vmax could 
formally vary from 0 to . The objective functional could remain as (6.2.2a) subject to 
constrains (6.2.2b) and boundary conditions 00 )( ss  and free end-point condition. Then the 
Lagrange method can be applied 
),(),( usfspuslL      (6.2.5) 

































.  (6.2.6) 
The system (6.2.6) in fact coincides with (6.2.4). Once again one can note that the maximum 
principle is the non-classical method for solving the variational problem in the case of open-
loop control. In the case the Lagrange function (6.2.5) is not explicitly depend on time so the 







sE ),(     (6.2.7) 
which could significantly simplify the process of finding analytical solution and play important 
role on the stage of interpretation. On the basis of this general approach two different enzyme 
control models were investigated. 
 In order to get some insight into the mechanisms driving the optimal control dynamics 
pattern of the Michaelis-Menten system, the effect of the optimal control introduction into 
Michaelis-Mention equation has been considered in this part, which is divided into the two 
contributions: control by Michaelis-Mention constant KM and maximal reaction velocity 







terms denoted by KM in system (6.2.1), which constitute the binding contribution, are 
considered and, on the other hand, the maximal reaction velocity term Vmax was formally used 
as opposite way of activity regulation. 
 
6.2.3  Control by means of maximal reaction velocity Vmax 
 In this section the optimal control problem is formulated following Moroz, 2011 by 
means of the maximal reaction velocity in equation (6.2.1), where the study of the influence of 
control introduction is made by Vmax on usual kinetic pattern of Michaelis-Menten system. 
Formally it is the simplest way of the OC introduction into the Michaelis-Menten kinetic 
equation. It can be formally carried out by alteration of the maximal reaction velocity Vmax . 






,    (6.2.8a) 
where u is the control, KM is the Michaelis constant; s is the concentration of substrate. The 











sGJ .   (6.2.8b) 
The G(s) is the cost function describing the instantaneous metabolic, free energy 
related losses, for the deviation of the substrate concentration s from the metabolic optimum. 
The second term describes the metabolic cost for the regulation by alteration of the maximal 
reaction velocity from an optimal maxV . Applying the Pontryagin maximum principle 
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         ,  (6.2.11) 
which allows us to write dynamical system for state variable s and co-variable p . 
 
General application to Michaelis-Menten kinetics 
Let us employ general approach to Michaelis-Menten kinetics. In the case, when the 







)( max      (6.2.12) 




OC dtuTsGdtusL    (6.2.13) 










where LOC is the optimal control Lagrangian, which we can choose in form more specific for 
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sKM    (6.2.21) 
where C2 can be found from initial condition 00 )( ss . 












VA    (6.2.22) 






























  .   (6.2.23) 
This equation coincides with Eq.(6.2.11).  


















  (6.2.24) 
The contour plot of the first integral of this example is shown in Fig.6.2.2. The contour plot of 
the Lagrangian is shown in Fig.6.2.2, upper insert and the Hamiltonian is shown in the lower 
insert of Fig.6.2.2. In this figure the first integral as the function of state coordinate and its 
derivative is illustrated. 
 
Fig.6.2.2. The first integral as the function of state coordinate and its derivative at quadratic 
approximation of the potential G and s0=0.1, l=0.1, Vmax=0.1, KM=0.01. Upper insert - the 
contour plot of the Lagrangian LVA (6.2.24). Lower insert - the Hamiltonian (6.2.22). Figure 









Fig.6.2.3. The first integral as the function of state coordinate and its derivative at the 
logarithmic approximation of the potential G (6.2.26) and seq=0.1, l=0.1, Vmax=0.1, KM=0.01. 
Insert A – the contour plot of the Lagrangian LVA (6.2.16). Insert B - the Hamiltonian for 
logarithmic approximation of the potential. Figure adopted from Moroz, 2011. 
 
Fig.6.2.4. The phase plot (s,p) of the numerical solutions of Eq(6.2.23) for pure variational 
formulation is shown for seq=0.1, l=0.1, Vmax=0.1, KM=0.01 for different values of numerically 
calculated Hamiltonian, t – dimensionless time. Insert left - phase plot (s,ds/dt); Insert right, the 
trajectories of the state variable s (substrate concentration) scale versus time t.  The curve 
designed as (*) is the closest approximation of real trajectory (H*=0). Figure adopted from 
Moroz, 2011.   
 
 In the plots indicated in Fig.6.2.2 the squared-law penalty (potential) is employed. This 







    2)()(
2
eqsssG    .   (6.2.25) 
However, as we mentioned previously, in natural case of kinetics when only positive 
concentrations only are accepted, and effectively the consideration of system is not limited by 
to be closed to steady state, it is reasonable to introduce the form of cost (here it is the 
instantaneous cost/penalty for the deviation of this concentration from the optimum) in the 
logarithmic approximation (which is related to a form sometime used for the Lyapunov 
















k , then the first integral (that could be interpretable as energy-like value of this 
process). Comparing (6.2.25) and (6.2.26) at different equilibrium state shows small differences 
near to the equilibrium. Using the logarithmic form of the cost we have calculated and shown 
the Lagrangian (6.2.16) and the Hamiltonian Eq (6.2.9), in Fig.6.2.3 as a contour plot of the 
first integral and Fig.6.2.3 (insert A and B) as a contour plot of the Lagrangian and  
Hamiltonian for the logarithmic form of the cost (6.2.26), where state variable is seq=0.1 and 
control variable is 0.1maxV .  
 For the comparison of the results based on the Lagragian/Hamiltonian calculations 
(6.2.13)/(6.2.22) shown in Fig.6.2.2 with the results of numerical calculation for dynamic 
system (6.2.23/6.2.11) the calculations were performed using Runge-Kutta method. The plots 
of the phase trajectories lines for some initial values for the system (6.2.23) when the square-
low penalty approximation G(x) employed, are indicated in Fig.6.2.4 for the square-low form 
(Vmax = 1.0, seq = 0.0).  
 In the Fig.6.2.4 the phase plot of co-state variable p against the state variable s is 
shown. In the figure Fig. 6.2.4(lest insert), the graphs show also the phase trajectories of the 
concentration derivative and state variable s. The Fig.6.2.4 (right insert) shows the relaxation 







same character of extreme trajectory (designated as *) as in Fig.6.2.2 (lower insert, H=0), 
correspondingly. So, the results shown in Fig.6.2.4 are in good agreement with the results in 
Fig.6.2.2.  
Thus, one can see that all these phase plots coincide with the contour plots for the 
Hamiltonians that obtained by the direct numerical calculations from the dynamic system 
(6.2.22), which indicates correctness of the approach. 
  
6.2.4   Optimal control formulation in terms of state and control variables 
However, let us not that the consideration of a problem in terms of state and co-state 
variables is somewhat difficult in the interpretation, in particular, in interpretation of the costate 
variable. From this perspective, the consideration of problem in terms of control variable is 
more convenient and interesting. Let us then reconsider the optimal control by Vmax when the 
control variable is explicitly covered in the dynamic equations.   
Employing the Lagrange method we can construct the Lagrangian of the optimization 















,          (6.2.27)  





























 By excluding p from this system one can get the system, describing the process in 
terms of state variable s and control variable u. As it was mentioned above by this method, 
because Lagrangian does not depend explicitly on time, it is possible to find so-called first 
integral (6.2.7) of the system that means that there is a conservative value, which duplicates in 







mechanics) energy (first integral) and Hamiltonian not always formally match.   Excluding p 











,  .   (6.2.28)  
Since u> 0, KM > 0 , s + KM > 0 , the denominator does not give any singularity, therefore it is 





 .         (6.2.29) 
Having solved this differential equation it is possible to find clear relationships between the 
concentration s and the amplitude of control u and consider some interpretations. On the other 






sGH .         (6.2.30) 
Let us now come back to the special cases of penalty for deviation from equilibrium. So, if it 










.    (6.2.31) 
The surface plot and the contour plots of the lines of an identical level for the first integral are 
indicated in Fig.6.2.5 for Vmax = 1.0, seq = 1.0 and  seq = 0.0. The Fig. 6.2.6 shows the lines of 
identical level E in case of the logarithmic form of cost (6.2.26) when k=seq , G0 =1, seq = 0.10 










.    (6.2.32) 
Let us note that these quantities (6.2.31, 6.2.32) cannot be associated with the energy of the 
process. Finally after elimination of p , both systems are shown below for state variable s and 

































 ,   (6.2.34) 
and at the Michaelis constant KM=1 , what indicates that the systems are scaled.  
A B 
Fig. 6.2.5 First integral H (6.2.31) contour plots corresponding to the systems (6.2.33). A, 
contour plot of the first integral described by the expression (6.2.31) at value seq=1.0 and Vmax 
=1.0; B, the contour plot of the first integral described by the expression (6.2.31) when seq=0 
and Vmax =1.0. Figure adopted from Moroz, 2011. 
 
The numerical solutions of these systems (6.2.33,34) repeat the solution of system 
(6.2.11) for state variable s and costate variable p, however in terms of state variable and 
control variable u. Performing the numerical calculations using these two representations (s,p) 
and (s,u) to obtain trajectories of these two-dimensional dynamical systems obviously shows no 
difference in the results. Interesting indication comes up when the kinetic data obtained is 
shown in so-called double-reciprocal Lineweaver-Burk (1934) plot (also see for example recent 
linearization development in [96]).  
It is known that double-reciprocal plot is widely used in enzyme kinetics for estimation 
of Vmax and KM, where the slope is KM/Vmax and y-intercept is 1/Vmax , see the dotted line on 







intercept of this curve is equal to unity and slope in the case when Vmax = 1.0 is equal to unity, 
too.  
The figures Fig.6.2.7 and Fig.6.2.8 show the trajectories of (6.2.31) and (6.2.32) in 
double-reciprocal plot for square-law and logarithmic potential. The inserts A in figures 
Fig.6.2.7, Fig.6.2.8  indicate the phase plots in terms of p and s and inserts B –in terms of s and 
u  in case of the square-law approximation of the potential and for the logarithmic form of cost.  
   
 
A  B 
Fig. 6.2.6 The first integral contour plot corresponding to the Eq.(6.2.32) and the systems 
(6.2.34). A, contour plot of the first integral E(S,p) described by the expression (6.2.32) at value 
Vmax =1.0 and seq=1.0 ; B, contour E(s,u) plot of (6.2.32) described employing expression 
(6.2.26) when G0=k=1 and values seq=0.1, Vmax =1.0.  Figure adopted from Moroz, 2011. 
 
 
One can see from Fig.6.2.7 and Fig.6.2.8 that the trajectories ―a‖ are the closest to the 
curves H=0, in Fig.6.2.5 and Fig.6.2.6 correspondingly. For both forms of cost when seq= 1.0 
the dotted curve is the tangent line to the E=0 kinetic curve designed as ―a‖ in all Fig.6.2.7 and 
Fig.6.2.8. The tangent curve not just touches the kinetic curve ―a‖ corresponding to H=0, but 
coincides with this kinetic curve in long range of values.  
That in fact indicates good reliability of consideration of Michaelis-Menten kinetics in 
the optimal control terms. Moreover, it illustrates that the Michaelis-Menten kinetics is an 








Fig.6.2.7 Solutions of the system (6.2.33) obtained numerically for the quadratic form of cost at 
values seq=0.0 and Vmax =1.0:  The trajectories in double reciprocate coordinates. Curves ―a‖ in 
corresponds to H*=0 level of Fig.6.2.5B, for the quadratic form of cost, dotted line corresponds 
to the Michaelis-Menten equation scaled to Vmax=1 and KM = 1. Insert A, shows the phase 
trajectories in  (s,p) plane; Insert B, the phase trajectories in (u,s) plane. Figure adopted from 
Moroz, 2011. 
 
Fig.6.2.8 Solutions of the system (6.2.34) obtained by numerical method for the logarithmic 
form of the cost at values seq=0.1 and ueq=1.0. The trajectories in double reciprocate 
coordinates. Curves ―a‖ correspond to H=0 level of Fig.6.2.3 (insert B), for the logarithmic 
form of cost. The dotted line in figure A corresponds to Michaelis-Menten equation scaled to 
Vmax=1 and KM = 1. Insert A, shows the phase trajectories in (S,p) plan; insert B, the phase 







6.2.5     Control by the Michaelis constant KM 
Formally there is another, much more important way of the optimal control 
introduction into the Michaelis-Menten kinetic equation because of its link to allosteric 
regulation. Let us now amend the Michaelis-Menten equation, where the Michaelis constant KM 




ds max  ,        (6.2.35) 
where u(t)  is a control variable formally from unlimited area [0, ], Vmax   is  the maximal 
reaction velocity, state variable s  is the substrate concentration. We can define the objective 










sG ,     (6.2.36) 
where G(s) is cost function that formally describes the instantaneous metabolic cost for the 
excessive deviation of the substrate concentration s from the optimum. The second term is the 
cost function describing the metabolic expenses for the regulation.  
When formulating the variational outline for control by the Michaelis-Menten constant 
the situation is more complicated. Let us follow our scheme/outline. From (6.2.35) we can find 
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 ,  (6.2.42) 
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   (6.2.44) 
where C2 can be found from initial condition 00 )( ss . To find the Hamiltonian, using the 
Legandre transform it is not easy. From general expression for the Hamiltonian we can write 













    (6.2.45) 
where derivatives have to be changed by expression in terms of momentum p. To find the 
numerical solution of Euler-Lagrange equation it is useful to go to the transformation qs . 

















































In Fig.6.2.10 the numerical solutions of this system are shown.   
A               B 
Fig.6.2.9 The contour plots of Hamiltonian (6.2.45) for pure variational formulation 
corresponding to the optimal control by the Michaelis constant, seq=0.0, l=0.2, Vmax=1.0, 
KM=0.01 . Insert - the contour plot for the Lagrangian LVA (6.2.38) the at square law potential 
G. Figure adopted from Moroz, 2011. 
A   B 
Fig.6.2.10 The numerical data obtained as results of numerical calculation of equation (6.2.45) 
at seq=0.0, l=0.1, Vmax=0.1, KM=0.01 for different values of the first integral. Insert - the 







Comparing Fig.6.2.9 and Fig.6.2.10 one can see clear topological similarities. Let us 
note that quantity q in the case of system (6.2.46-47) is not the Lagrange multiplier 
(momentum) because is not obtained using the Legandre transformation. One can also see, that 
the kinetic curves in Fig.6.2.10 (insert) clearly indicate the sigmoid character of relaxation; the 
derivative has the negative sign. Since it was difficult to apply directly the Legandre transform 
and formulate the Hamiltonian approach let us formulate problem in terms of state variable (the 










sGH M .    (6.2.48) 
Then applying the Pontryagin maximum principle we can write the necessary conditions; the 






























,    (6.2.49) 


















.      (6.2.50) 
Since u> 0, s> 0, u + s> 0, therefore it is possible to subdivide the right parts of the equations. 










 .             (6.2.51) 
Having solved this differential equation one can find clear relationships between the state 







Since the Hamiltonian function (6.2.48) is not dependent on time explicitly, the first 
integral of this problem is H=Const. On the other hand the first integral that could be calculated 





sGH   .          (6.2.52) 
Let us consider some special cases. One specific case arises when objective function describing 
the formal penalty for the deviation of the substrate from the optimal/steady state has squared 
approximation (6.2.25), then the first integral H (in fact, the Hamiltonian of process) could be 





MMeq KsuKussH     .     (6.2.53) 
The contour plot of the lines of an identical levels of H (6.2.53) are indicated in Fig.6.2.11A 
and B for values seq =0.1, KM = 1.0.  
C 
Fig.6.2.11 Double-reciprocal plot in the case of the square-law cost for the substrate deviation 
from equilibrium/steady-state at value KM =1.0 and seq=0.1, calculated by Runge-Kutta method.  
phase trajectories in (s,u) plane from system (6.2.55). Insert A, the first integral H (6.2.53) 
contour plot. Insert B, the trajectories (6.2.55) in double reciprocate coordinates. Curves ―a‖ 
correspond to H*=0 level of insert A for the quadratic form of cost, dotted line corresponds to 









 At the logarithmic approximation form (form that qualitatively coincide to form of 
thermodynamic potential in an ideal one-dimensional case, see Fig.2.1.6) then the first integral 




MM KsuKuGsssH .              (6.2.54) 
The surface plot and the contour plot of the lines of its identical level for logarithmic form of 
cost  (6.2.54) are indicated in Fig.6.2.12 for when G0 =k=1 and KM = 1.0 . 
A   B  
 
Fig.6.2.12 The first integral H (6.2.54) contour plot corresponding to the systems (6.2.56) at the 
logarithmic cost for the deviation (6.2.26). A, contour H(s,u) plots of the first integral at values 
KM =1.0 and seq=1.0 ; B, contour plot H(s,u) described by the expression (6.2.52) when values 
are G0=k=1 and seq=0.1, KM =2.0. Figure adopted from Moroz, 2011. 
 
Let us have a more detailed look on the system (6.2.50) at the square-law form of cost 












.         (6.2.55) 
Fig.6.2.11 shows double-reciprocal plot of corresponding kinetic curves of system (6.2.55). 
Fig.6.2.11 (insert B) demonstrates some phase trajectories for this dynamical system obtained 
by the numerical method, when control u>0. One can see that topologically the picture poorly 







the Fig. 6.2.11(insert A) that the curve ―a‖ in Fig. 6.2.11 corresponds most closely to the zero 
value curve for which the first integral H* =0. 
A B 
Fig.6.2.13 The double reciprocal plot of the numerical calculations of the systems (6.2.50) at 
the logarithmic cost for the deviation (6.2.26) that finally described by (6.2.56). A, double 
reciprocal plot of numerical solutions (S,u) described by the expression (6.2.56) when the 
values in G0 =k=1 and  KM =1.0,  Vmax=1.0; insert in A -phase trajectories of the system 
(6.2.56) with the logarithmic form of cost (6.2.26), u>0 domain. B, double reciprocal plot of 
trajectories of system (6.2.55), when KM=2.0, Vmax=1.0 ; insert in B – corresponding phase 
trajectories of the system (6.2.56) with the logarithmic form of cost (6.2.26), u>0 domain. 
Figure adopted from Moroz, 2011. 
 
 At the logarithmic approximation of the metabolic cost (6.2.26) for the substrate 











.           (6.2.56) 
The numerical solution of this system is represented in Fig.6.2.13. The curves designated as ―a‖ 
in Fig. 6.2.13 correspond most closely to the zero value for energy (contour plot is shown in 
Fig.6.2.12A,B correspondingly). One can see, if to extend the curve s designated as ―a‖  to the 
ordinate, it gives the Vmax value equal to KM=1.0 (Fig. 6.2.13A) or to KM =2.0 (Fig. 6.2.13B) as 
it was initially set in the system (6.2.56), accordingly. 










dtuTsG      (6.2.57) 
subject to the dynamical constrains Eq(6.2.35) and  0)0( ss . 

























.     (6.2.58) 




uTsGH      (6.2.59) 
In the case of logarithmic approximation for the cost for the metabolic control T(u), as well as 
logarithmic approximation for G(s), see Eq.(6.2.26), )1)1(ln()( uukuT u the first 
integral H will be  
constusukuukGsskusH uus ln)()1)1(ln()1(ln),( 0 .  (6.2.60) 
The double-reciprocal plot of (6.2.58) at (6.2.60) is shown in Fig. 6.2.14. The contour plot 
corresponding to this equation that contains the logarithmic cost approximation for the substrate 
deviation and for the control at the values ku=0.5 and ks=1.0 is shown in Fig. 6.2.14(insert A). 
The numerical solution of the system (6.2.56) is shown in Fig. 6.2.14 (phase plot, insert B).  
One can see that curve denoted as ―a‖ in the double-reciprocal plot plane, Fig. 6.2.14 
corresponds to H=0 curve in Fig.6.2.14(insert B). The expansion of this curve ―a‖ in double-
reciprocal plot plane, Fig.6.2.14 from area near to equilibrium gives Vmax =1.0 and average KM 








Fig. 6.2.14 The plot in double reciprocal coordinates of the system (6.2.58), dotted line 
corresponds to the Michaelis-Menten equation scaled to Vmax=1.0  and KM = 1.0 . Insert A, the 
first integral H (6.2.60) contour plot corresponding to the system (6.2.58) with the logarithmic 
form of cost (6.2.26) for the substrate deviation s and for the control  u, ku=1.0; ks=1.0. Insert B, 
phase trajectories of the system (6.2.58) with the logarithmic form of the cost, obtained by the 
numerical method. Curves ―a‖ in main figure and insert B correspond to H*=0 level of insert B. 
Figure adopted from Moroz, 2011. 
 
Simultaneous optimal control by the Vmax and the Michaelis constant K  
In the general case the control could be implemented by the maximal velocity Vmax and 




dtvuTsGJ     (6.2.61) 





      (6.2.62) 
and  0)0( ss , where v  is the control variable responsible for regulation by Vmax, and u – is the 
control variable responsible for control by Michaelis constant KM. Then employing the 
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vuT M      (6.2.65) 
we can simplify the Euler-Lagrange system. The results of the numerical calculations for 
simplified system are shown in Fig.6.2.15A as a Lineweaver-Burk plot for seq=0.01, Vmax=1.0, 
KM=1.0 at initial values of the state variable s(t0)=0.9, costate variable p(t0)=-0.285, and 
control variables v(t0)=1.1, u(t0)=0.9 for the optimal trajectories (H*=0). One can see that 
curves remain linear but slope and intercept, characterised kinetics are to some extent changed 
from the standard Michaelis-Menten kinetics without control.  
Fig.6.2.15B shows the plot of the control variables u and v in time  when logarithmic 
form (6.2.26) of function G(s) is employed for seq=0.01, Vmax =1.0, KM =1.0 and different initial 
values of state and control variables for H*=0. All curves have linear character, slope and 
intercept of them are different from the reciprocal curves for ideal systems when Vmax and KM 

















































Fig.6.2.15 Phase trajectories of the problem (6.2.61-64) in double reciprocal coordinates with 
the square form of cost (6.2.25) in the case of logarithmic form of potential, obtained by the 
numerical method. A, curve corresponds to H*=0. Curve corresponds to the equation (6.2.1) 
when v(t0)=1.1, u(t0)=0.9. B, kinetic curves u and v in time. C, decimal logarithm of –p in time. 
Relaxation of the calculated Hamiltonian in time. Figure adopted from Moroz, 2011.  
 
6.2.6 The link to the biochemical mechanisms 
 The method of optimal control implementation we want to bring into focus is, that all 
types of the OC introduction that are suggested in this section can find their analogy in vitro in 
batch kinetics control or in vivo in the enzyme activity regulation in the cell. First important 
note should be indicated, as was already specified according to (6.2.1), the maximal reaction 
velocity is equal to 02max EkV , where Е0  is the  enzyme concentration, 2k  is the rate constant 
of substrate-enzyme complex disintegration, then the control by means of changing Vmax can be 
related both to the regulation by particular enzyme synthesis (the increase or the reduction of 







enzyme complex into the enzyme and the final product. In terms of enzyme kinetics the control 
by maximal reaction velocity is associated to non-competitive inhibition formally introduced by 
the substitution in the equation (6.2.1) of maximal reaction velocity Vmax by the so-called 
effective velocity 
/








V   ,        (6.2.66)      
where  [i]  are the concentrations of the i-s inhibitors, ki    are the binding constants. 
 Secondary, it should also be noted, that the regulation formally expressed through the 
control by means of the Michaelis constant KM, has an enzymologic equivalence to the 
competitive inhibition. In the case of allosteric mechanisms of enzyme activity regulation, such 
inhibition by means of the alteration in the Michaelis constant KM is expressed formally by the 
so-called effective constant Km
/
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ki   ,           (6.2.68) 
and [E] is the enzyme concentration. Thus, the optimal control by means of the Michaelis 
constant has a metabolic analogy in the molecular form of competitive inhibition, because 
effectively the inhibition (or activation) changes the affinity (i.e. KM) of the substrate to the 
active site of an enzyme. The simultaneous control by the Vmax and KM could be explained by 
the above mechanisms of non-competative and competitive inhibition that take place at the 
same time in vivo. 
 Interesting are the physical aspects of this way of the optimal control implementation 
into Michaelis-Menten formal scheme. For example, from the comparison of Fig.6.2.5H and 







curve of the first integral H*(s,u)=0, u>0, in Fig. 6.2.5H. In double reciprocal coordinates, 
Fig.6.2.7C, the dotted line represents the Lineweaver-Berk plot for scaled (Vmax=1.0 and KM 
=1.0) Michaelis-Menten process. One can see that this line is a tangent to the curve ―a‖ which 
corresponds to an optimal curve when the Hamiltonian equals to zero (so the first integral 
equals to zero as well). The similar comparison for logarithmic form of the cost, Fig. 6.2.6B,D 
and Fig.6.2.8A,B, accordingly, shows the similar result for curve ―a‖, what means that energy-
like first integral (because it concedes with Hamiltonian expression in the case of the 
Pontryagin maximum principle) is, in fact, the Hamiltonian function H. From the mechanical 
point of view, the Hamiltonian and energy cannot be negatively defined. On the other hand, 
from the Pontryagin maximum principle the Hamiltonian function for the optimal trajectory is 
maximal, and in our case it equals to zero.   
 In the case of optimal control by the Michaelis constant, from the comparison of Fig. 
6.2.9E (Fig.6.2.11B in the case of logarithmic cost) and Fig.6.2.10A (Fig.6.2.11C in the 
logarithmic penalty case) correspondingly, it can also be seen that curve ―a‖ in Fig.6.2.10A 
(Fig.6.2.11C in logarithmic case) corresponds to the zero value of the Hamiltonian H(s,u). In 
the double reciprocal plot, Fig.6.2.11D (Fig.6.2.13B,D in logarithmic case), the corresponding 
curve ―a‖ is the closest to the ideal dotted line for pure Michaelis-Menten kinetics (without 
control) scaled by KM =1.0 and Vmax=1.0, also. As well as, the continuation of these curves 
from data points closed to the equilibrium point until crossing with the vertical axes 1/V gives 
the Vmax values equal to 1.0 (Fig.6.2.11D), as was initially set in the system (6.2.55) or system 
(6.2.56) in the case of logarithmic form of the cost. It is topologically clear, that near the 
equilibrium the picture for logarithmic form of cost poorly differs from those for the square-law 
cost. The same picture is observed for the trajectories H*=0 (corresponding to zero-value of the 
first integral) when logarithmic approximation is applied to both for the metabolic control cost 
T(u), as well as for the metabolic/thermodynamic losses (costs for deviation from equilibrium 







=1.0, as well as maximal reaction velocity Vmax , also close to unit, as is initially set in the 
system of equations (6.2.60) for numerical calculations.  
 All the plots discussed above show one, among the family of these curves, truly 
optimal curve matching to the first integral that corresponds to the Pontryagin maximum 
principle H*=0. It is also typical that such curves in the plot of double reciprocal coordinates 
are tangent to the line directly corresponding to standard Michaelis-Menten scaled system. 
Moreover, its continuation until crossing with the vertical axes 1/V, as is known, gives two 
values: the Michaelis constant KM and the maximal reaction velocity Vmax . As it is clear from 
the figures, if to determine these values from the corresponding curve (H*=0) in reciprocal 
coordinates, the KM and Vmax  are close to the values initially set in cost for control, which 
confirms the correctness of the approach in the case of the introduction of control.  
 Thus, the introduction of the optimal control does not also change the topology of 
kinetic variables on standard plots. Furthermore, in the optimal case when the Hamiltonian 
function (the first integral) is equal to zero H*=0, the results of optimal control introduction 
quantitatively agree with the well-known results as one can see from double reciprocal plots. 
The condition H*=0 that follows from the Pontryagin maximum principle (Pontryagin et al., 
1962), is needed for problem of the maximization of the Hamilton functions. In mechanics, and, 
generally in physics, the physical sense of the Hamiltonian is energy. Taking into account that 
the potential G(s) describing the metabolic losses, has direct energetical meaning related to 
thermodynamic form of penalty of being not in the equilibrium state (particularly in logarithmic 
approximation), it is possible to suggest that the first integral has the energetical sense, too, 
which does not contradict to physical logic. The way in what the optimal control can be applied 
to the Michaelis-Menten kinetics creates good background to use it for the study more 
complicated metabolic chains.  
 At the same time, the introduction of optimal control expands formally the conceptual 
opportunities of the consideration and the interpretation of the experimental data. It does not 







velocity or both, but that this control is carried out in an optimal way toward minimal metabolic 
expenditures for the regulation. Thus, the introduction of control into enzyme kinetics extends 
(in a sense related to thermodynamic one) the standard kinetics views and the suggestion about 
the enzyme control of activity in the cell.  
 Regarding to the consideration of two optimal control methods (Pontryagin maximum 
principle and direct variational Lagrange multipliers method) used in this section we should 
note the following. The last method seems to be also interesting with respect that the Lagrange 
multipliers (momenta) can be singled out and it is possible to concentrate on the direct relation 
of the substrate concentrations to the control parameters u or v , when the control is introduced 
by the maximal reaction velocity or the Michaelis-Menten constant in equations (6.2.33, 6.2.34, 
6.2.50).  
Similar to the static optimal control problem widely explored in economical 
applications, the dynamic Lagrange multipliers (or costate variables) assign the marginal 
increase (or decrease) in terms of metabolic utility (or metabolic profits) if there is an alteration 
in the state variables. In this sense, the scheme of variational approach or the Pontryagin 
maximum principle is to build a set of costate variables that evaluate the influence on the state 
variables in the manner that maximizes the total value of the Hamiltonian.  
 Thus, the introduction of optimal control into the standard enzyme kinetics scheme 
(Michaelis-Menten) can be considered by employing direct Lagrange variational approach and 
the Pontryagin maximum principle to the optimal control problem formulated. As a conclusion, 
we can state that three considered ways (by maximal reaction velocity Vmax, by the Michaelis 
constant KM and simultaneously by Vmax and KM) of introduction of optimal control into the 
Michaelis-Menten scheme of the enzyme kinetics can be considered without any contradictions 
to the classic enzyme kinetics results. Described optimal control models are biochemically 
acceptable representations of simple enzyme kinetics, moreover, they broaden the interpretation 
of the pattern of regulation. Extended from the Michaelis-Menten equation, the dynamical 







real trajectories can be chosen under physical demand of non-negativity of first integral 
(energy) and the Pontryagin maximum principle, when Hamiltonian function is equal to zero 
for the optimal trajectory. The results on different ways of enzyme activity regulation can be 
also employed to get a snapshot of the different types of regulation contributions. A good 
agreement between optimal control results and classical enzyme kinetics in Lineweaver-Burk 
plots can be seen.  
 
 
6.3  Optimal control and multi-enzymatic kinetics 
6.3.1    Optimal control method in modelling of multi-enzymatic chains  
Optimal control approach is widely applied to study the regulation of homeostasis 
(Pörtner and Schäfer, 1996; van Riel et al., 2000; Visser et al., 2004). There are a number of the 
optimal control models based on the Michaelis-Menten kinetics that in relation to modelling, 
discuss feedback control - chemostat models or batch-kinetics models (Lenas and Pavlou, 1995; 
Van Impe and Bastin, 1995;  Rahman and Palanski, 1996; Cacik  et al.,2001; Sengupta and 
Modak, 2001; Keesman and Stigter, 2002; Srinivasan et al., 2003; Valentinotti et al., 2003; 
Smets et al., 2004, Gadkar et al., 2006; Mohseni et al., 2009; Yüzgeç et al., 2009), with the 
perspective of overall output control in biotechnological production. Optimal control methods 
have shown to be useful in the control of different treatment optimisation (Liang et al., 2008; 
Itik et al., 2009; Chávez et al., 2009), and blood glucose level regulation (Eren-Oruklu et al., 
2009; Acikgoz and Diwekar, 2010).  
However, even from the perspective of regulation in the short chains/fragments of 
overall cellular metabolic network, it is essential to investigate the optimal aspects of regulation 
within these fragments as an optimal control problem. Following this, the developed experience 
could be extended to a description or to OC metabolic engineering to optimise metabolic 
regulation in vivo; from the perspective of minimising metabolic expenses for an optimal 







minimum of thermodynamic potentials. In this sense glycolysis is one of the basic metabolic 
pathways and further studies are required to revise and extend the understanding of optimal 
controllability, comparing results with alternative regulation approaches where appropriate. 
 It is well known that enzymes are structures that affect the rate of chemical reactions 
without shifting the thermodynamic equilibrium, see for example, Cannon, 2002. The models in 
this section employ the glycolysis model as one of the basic models (good working examples) 
in metabolic network kinetics. The goal of the present consideration is to illustrate that the 
spectrum of dynamical behaviour after the introduction of optimal control into this kinetics 
does not change the topology of the main, metabolically sensible and steady state/equilibrium 
taking place within the system without explicit control. Optimal control interpretation of the 
extended model in terms of metabolic/catabolic costs/losses is another area of focus in this 
section.  
 
6.3.2 Optimal control introduction into the Bier and coauthors–Volkenstain (BTKW-V) 
model of glycolysis   
The results in previous sections encourage one to apply the proposed approach to study 
a more complicated system. It would be interesting to consider a well-investigated pathway of 
biochemical reactions, and when the behaviour in this pathway is imposing the requirement of 
optimal control on the pathway regulation. A good example could be the model of glycolysis, 
well-investigated from many aspects including biochemical, evolutionary and mathematical. It 
is also known, that glycolysis contains more than 20 intermediate stages (Neilsen et al., 1997; 








Fig.6.3.1 Metabolic glycolytic pathway: FBP – Fructose1,6bis-phosphoglycerate is inhibited by 
a reaction of phosphorfructokinase (PFK); combined with hexokinase (HK), which needs ATP, 
see Higgins, 1967, or Selkov, 1968; or Bier et al., (1996, 2000). This reaction is incorporated in 
x1. 
  
 The system of kinetic equations, first proposed by Higgins, 1967, and Selkov, 1968,  
can be taken as a formal mathematical model of glycolysis. This model was modified by Bier 
and co-authors in Bier et al., (1996, 2000) for the glycolytic dynamics in a yeast cell to the 













          ,                          (6.3.1) 
where  x  is the concentration of glucose  (fructose-6-phosphate), y  is the ATP concentration, 
Vin   represents the constant inflow of glucose, k1  represents the phosphofructokinase activity, 
KM  is the Michaelis constant for pyruvate kinase (PK), ν  is the stoichiometric ratio; ν=1 the 
system described by Volkenstain, (Volkenstain, 1989) and ν=2 for the model described by Bier 
and co-authors (1996), BTKW-model. In Fig.6.3.2 the numerical solutions are illustrated for 
the Volkenstain and the Bier systems (with parameters described in Bier et al., 2000); one can 









Fig.6.3.2 The numerical solutions of system (6.3.1) in double logarithmic coordinates. Red 
curves - the system described by Volkenstain, (1989) (stoichiometric ratio ν=1). Blue curves - 
model described by Bier and coauthors (Bier et al., 2000), (stoichiometric ratio ν=2). KM=2, 
k1=0.5, kp=3.5, Vin=0.250. Curve ―1‖, x(t0) =9.0, y(t0) =0.5. Figure adopted from Moroz, 2011. 
 
As it was pointed out in Bier at al., 1996, model (6.3.1) has only limit cycle steady state 
in the range of constants employed by authors, which gives the oscillation trajectories, 
Fig.6.3.2. The spectrum of steady states and conditions of this  system was also studied in detail 
by Volkenstain, 1989. Therefore the interest of our consideration was to study the robustness of 
this limit cycle at the OC by the rate constants. 
 
6.3.3 Direct optimal control outline  
To study the effect of the OC implementation with respect to the control of system 
behaviour, we used the Pontryagin maximum principle in the way as it was used within 
Michaelis-Menten system, Section 6.2. Let us formulate the problem of the introduction of 
optimal control into the BTKW-V model (6.3.1) by k1 and kp. Then the constrain system of 















.   (6.3.2) 
Let us consider the optimal control problem for this system, taking into account the 
metabolic losses for control T(u,v) and the metabolic losses for not being in thermodynamic 
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.       (6.3.5) 
By using the last two equations it is possible to reduce the canonical system to 4 equations – for 
2 state and 2 costate variables. For the square-law cost for the deviations of the constants k1 and 
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Numerical solutions of the system show the existence of the torus-like steady near former two-
dimensional limit cycle. Fig.6.3.3 shows the trajectories for state variables x,y; momenta px, py 
(costate variables), and control u,v for system (6.3.5).  
 
Fig.6.3.3 Trajectories for state variables x,y; momenta (costate variables, px, py and control u,v 
for system (6.3.7). x(t0)=1.5, y(t0)=0.5, px(t0)=py(t0)=-0.01, Vin=0.250, 2MK , k1=0.5, 
kp=3.5, Vin=0.250, potential (k=0.01). Figure adopted from Moroz, 2011. 
 
 The limit cycle phase plots, which characterise the 6-dimensional phase space of 2 state 
variables, 2 co-state variables and 2 control variables, together 6 variables, is illustrated in 
Fig.6.3.4 for the system (6.3.7) at square-low potential and at the values of constants, specified 
directly in the figure. The plots are shown as a graphical matrix, where just a half of it, as it is 
shown in figure, can fully characterise the 6 dimensional limit cycle.  The first row contains 2 
dimensional graphs for the vertical x coordinate versus all other coordinates (e.g. y, px, py, u, v) 
spanned horizontally. The second row contains vertical (y) coordinate against px, py, u and v; y 
against x already is plotted in the first row. Effectively, the combination of any pair of 
coordinates can be found using the designations for correspondent row (at first left plot in the 
row) and for the correspondent column (at the bottom at any column). For example, the top row 








Fig.6.3.4 The behaviour of the limit cycle (6.3.7) in the phase space by projection of it into x,y 
2-dimensional plane. The red trajectories are for starting values x(t0)=1.5, y(t0)=0.5. Blue 
curve, for x(t0)=4.0, y(t0)=0.1. Constants were chosen following BTKW-V model (Bier et al., 
1996; 2000); Vin =0.250, k1=0.5, kp=3.5; KM =2.0. Figure adopted from Moroz, 2011. 
A      B 
C     D 
Fig.6.3.5 The phase-plot of the limit cycle illustrating the effect of different constants in the 
system (6.3.7) on the limit cycle. A, the effect of Vin (green colour –Vin=0.1; blue – Vin=0.2; red 
– Vin=0.3; other constants (k=0.01, xeq=1.3, yeq=0.2, k1=0.5, veq=3,5, KM=2.0).  B, the effect of 
xeq (green colour –xeq=1.2; blue – xeq=1.5; red – xeq=2.0; other constants (Vin=0.1, k=0.01, 
yeq=0.2, k1=0.5, veq=3,5, KM=2.5). C, the effect of yeq (green colour –yeq=0.01; blue – yeq=0.1; 
red – yeq=1.0; other constants (Vin=0.1, k=0.1, xeq=1.5, k1=0.5, veq=3.5, KM=2.5). D, the effect 
of KM (green colour KM=1.8; blue – KM =2.0; red – KM=2.5; other constants (Vin=0.1, k=0.01, 








The effect of a number of constants is illustrated in Fig.6.3.5 for system (6.3.7); the 
phase plot for control variables is not included. The plots are shown as matrixes, similar to 
Fig.6.3.4. 
As one can see from Fig.6.3.5A, an increase in Vin in the range which shown in figure 
reduces the limit cycle. A span in the value of xeq through the equilibrium point of the system 
(6.3.7) leads to the collapse of the limit cycle, Fig.6.3.5B. Similarly, the span in yeq through the 
equilibrium point of the system also leads to the collapse of the limit cycle, Fig.6.3.5C. 
Fig.6.3.5D indicates that the increase in KM (inhibition) leads to a reduction in the size of the 
limit cycle. However, a simultaneous change of the parameters of the system (6.3.1/6.3.7) in the 
effect of the robustness (stability of the equilibrium points of the system) will be illustrated 
further in this section.  
A B 
Fig.6.3.6 The comparison of the limit cycle in the phase plane of state variables for different 
systems. The limit cycles in the logarithmic coordinates, incert in normal coordinates for 
comparison. Cyan curve - original system (6.3.1) without OC; magnolia curve – system (6.3.7) 
with the OC introduction, no potential term (k=0), initial momenta (px=py=0.0); green curve - 
system (6.3.7) in the presence of OC, no potential term (k=0), startin momenta px=py=-0.5; 
blue curve – OC, potential (k=0.01), initial momenta (px=py=0.0);  red dashed curve – OC,  
potential term (k=0.01) and initial momenta px=py=-0.5. Constants were chosen following Bier 
et al., 1996; Vin =0.10, k1=0.5, kp=3.5; KM=2.0. The axes are as in Fig.6.3.2. Figure adopted 








It can be useful to illustrate the comparison of the effects on the limit cycle in normal 
and logarithmic coordinates, Fig.6.3.6. While the normal coordinates clearly show what is 
happening at large values of the state variables (Fig.6.3.6A), the logarithmic coordinates 
(Fig.6.3.6B) efficiently illustrate what is happening at the very low values of the state variables. 
Particularly, for the systems (6.3.1) and (6.3.7), one can see that implementation of the optimal 
control and demonstrating that a quadratic form of the penalties does not significantly change 
the character and robustness of the limit cycle. However, by using the standard method we are 
limited in analysing the effects of the parameters on the character of stability in a wide range. 
 
6.3.4      Monte-Carlo method to study the robustness 
To study the character of the equilibrium points in a wider range of parameters, one can 
span these parameters in a range, keeping all others at certain values, as illustrated in Fig.6.3.7. 
One can also see the existence of a limit cycle (designated as ―o‖) in quite a wide range of 
parameters. However, it does not show the complete picture of the parameter‘s role in the 
equilibrium. 
A     B 
C    D 
Fig.6.3.7 The illustration of parameter scanning in model (6.3.1) at Vin=0.25, k1= 0.5, kp= 1.0, 
KM= 1. A, scanning Vin; B, scanning k1; C, scanning kp; D, scanning KM. Designations: dots – 







On the other hand, the stability of the system can be studied in the following way: one 
can generate a set of random combinations of all the parameters (Vin, k1, kp and KM) employing 
the Monte-Carlo method for statistical investigation of the equilibrium points of this system 
(6.3.1), with the purpose to compare to the extended by the OC system. The Monte-Carlo 
simulation results are shown in Fig.6.3.8 at range of parameters (Vin, k1, kp and KM) are much 
more informative. From Fig.6.3.8 one can see main characteristic states (the designations are 
shown in Fig.6.3.8F). One can also clearly see borders between main areas, which indicating 
the transitional surfaces between areas of different types of equilibrium. Results, obtained by 
this method, can be considered as being in good agreement with analytical results from Bier 
and coauthors, 1996, 2000.  
 
Fig.6.3.8 The results of equilibrium simulation study of the system (6.3.1), described by Bier 
and coauthors, [117, 118] for the range of parameters (Vin=10
-4
-1.5; k1=0-10; kp=0-10; 
KM=0.001-10.0). 2D scatter plot in the plane first two canonical variables, KM=1.0. Insert - 3D 
scatter plot, KM=1.0; C, KM=1.0-10.0 (inhibition); The equilibrium point designation: ―.‖ –
stable node, ◊-  stable focus, ―x‖ saddle, ―o‖ unstable focus, ⁪ - unstable node, ⌂ limit cycle. E, 
dataset in 2D plane of 2 first canonical variables, designations: ―.‖(green) – stable node, 
―d‖(red)-  stable focus, ―x‖ saddle, ―o‖(cyan) unstable focus, ―s‖(blue) - unstable node. Can1, 








 Well known that different equilibrium scenarios follow from the spectrum of eigenvalues 
of the Jacobian matrix at an equilibrium state, see Fig. 6.3.8F for a 4-dimensional system. The 
transitions between qualitatively different states (bifurcations) are also of immense interest 
because they indicate qualitative changes in the system dynamics, suggesting that a closer look 
on the robustness and equilibrium of the system is needed. 
 
A        
B 
Fig 6.3.9 Results of numerical calculations of (6.3.7) when the OC in implemented by k1 and kp.  
A, the scatterplot in plane of state variables x and y (k=0) and B, 3D plot no potential (k=0). 
The parameter ranges in this simulation are Vin= 10
-7
-1; xeq=0.0-0.2; yeq=0-2; k=0-2; kp=0-5; 
KM=1; k= 0- 1.0. Designation of equilibrium points is from Fig.6.3.8. Figure adopted from 
Moroz, 2011. 
 
 As it is possible to see, the scatter plots, shown in Fig.6.3.9, qualitatively reproduce 
plots for the reduced Bier model, Fig.6.3.8, however the difference is in the character of 







Eqs.(6.3.1) and (6.3.7). One can see that with different fixed levels of potential Fig.6.3.9 (B, 
k=0; C, k=0.1 and D, k=1.0) the 3D scatter plot of the dataset becomes more not-transparent 
(Fig. 6.3.9B-D) in the sense of the different character of equilibrium areas. Fig. 6.3.10A shows 
that when the Monte-Carlo method is applied to randomly generate the values of the variable k 
(potential weight) and KM, the scatter plot of dataset is not transparent. However, by applying 
the canonical correlation analysis (CCA) , Hotelling, 1936, method to the dataset it is possible 
to distinctly observe the regions of stability in the plane of two first canonical variables, Fig. 
6.3.10B.  
Parameter Can1 Can2 
Vin 1.2 -1.6 
k1 0.1 0.5 
kp -0.3 -0.3 
KM 0.4 0.2 
 
Table 6.3.1 The raw canonical coefficients for first two canonical variables (Can1, Can2) for 
system (6.3.1). 
 
Fig.6.3.10 Results of numerical calculations of (6.3.7) when the OC in implemented by 
k1(changed to u) and kp(changed to v). B, scatterplot of dataset of 10K points in the plane of 
first two canonical variables, Can1, Can2, generated by Monte-Carlo method at the range of 
parameters: Vin=10
-6
 -1.0;  xeq= 0.01-10.0; yeq =0.01 - 10.0;  k1=0.01-10.0; kp=0.01- 10.0; KM= 
0.01-10;  k=0.0-1.0.  The equilibrium point designation as in Fig.6.3.8. Figure adopted from 
Moroz, 2011. 
 
 In Table 6.3.1 the results of applying of the Monte Carlo method (Metropolis and 
Ulam, 1949 ) that we used to study the character of stability of the equilibrium points (x,y) for 







combinations of parameters in the range (see, Fig.6.3.9) were generated, and the frequency ratio 
was calculated: (./d/o/s/x) – 0.58/0.33/0.03/0.06/0.0004. The first three eigenvalues obtained, 
were 0.8345, 0.0766 and 0.003 with F-statistics values 669, 121 and 11 correspondingly, and 
the probabilities levels less than 0.0001 each. As it is shown in Table 6.3.1, the raw canonical 
coefficients for the first canonical variable, Can1, indicate that the classes differ most widely on 
the linear combination of the centered variables 1.20*Vin+0.10*k1-0.26*kp +0.38* KM. Thus the 
results indicate the crucial role of Vin on the character of stability.  
 Results in Fig.6.3.9 relating to the existence of different areas of stability, qualitatively 
agree with the numerical results for system (6.3.1), which is without the OC, Fig.6.3.8. The 
cooperative form indicates the goal of the optimal adaptive regulation that in the metabolic 
network could strengthen the rigidity of the regulation around macroscopically important state. 
 
Parameter Can1 Can2 
Vin 2.2 -1.1 
xeq 0.05 0.01 
yeq -0.005 -0.1 
k1 0.02 0.18 
kp -0.3 0.15 
KM 0.2 0.2 
k 0.5 -0.7 
 
Table 6.3.2 Raw canonical coefficients for first two variables (Can1, Can2) when the OC by k1 
and kp is implemented. 
  
To study the stability character of the points of equilibrium (x, y, px, py) of the system 
(6.3.7), when the control variable u and v are eliminated, the Monte Carlo method was also 
employed. 5 thousand random combinations of parameters were generated, and the relative 
proportions (./+/o/x) were correspondently 0.045/0.564/0.334/0.045. The 4 first eigenvalues 
were 0.86, 0.11, 0.04 and 0.005 with the Fisher statistics F values 242, 67, 35 and 8.9 with the 
corresponding probabilities less than 0.0001 each. As one can see from Table 6.3.2 for the raw 
canonical coefficients, the first canonical variable, Can1, shows that the linear combination of 
the centered variable Can1=2.2*Vin - 0.05*xeq - 0.005*yeq + 0.02*k1 -0.3*kp + 0.3*KM + 0.5*k 







Finally, one can conclude that the first canonical variable Can1 explains more than 
75% of total variability. It is mainly laded by Vin and k, which means that the rate inflow and 
the coefficient in the term of energetical penalty k for alteration from a steady state play the 
main role in determination of the robustness of the steady state. The Michaelis constant KM and 
the rate constant kp play the minority roles.  
 
6.3.5 Optimal control by KM in the BTKW-V model of glycolysis 
The optimal control implementation into the Bier et al model (1996, 2000) of 
glycolysis by KM can be done in a similar way, by replacing KM  with  u in (6.3.1) and apply 
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and the dynamical constrains in the form  
yu
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kxykyxykVx pin 11 2;  .     (6.3.9) 












































  (6.3.10) 
The results of numerical calculations are shown in Fig.6.3.11, when the random combinations 
of parameters Vin, k1, kp, xeq and yeq are generated by the Monte-Carlo method, Fig.6.3.11A-B.  
 We studied stability of the real roots (x, y, px, py, u) of the canonical system for the 







applied to G(x,y) and T(u), similar to (6.3.6). 5K points were generated, and relative frequency 
ratio for the equilibrium points designated accordingly to Fig.6.3.8 as (./+/o/p) was – 
162/1950/2958/17. The first three eigenvalues were 0.7881, 0.0544 and 0.0075 with the Fisher 
statistics F values 173.83, 25.98 and 7.6 the probabilities less than 0.0001 each. As shown in 
Table 6.3.3, the raw canonical coefficients for the first canonical variable, Can1, show that the 
classes differ most widely on the linear combination of the centered variables 2.5*Vin-
0.1*xeq+0.1*yeq+0.2*k1-0.37*kp +0.37* k1+1.0*k. 
 
Fig.6.3.11 Optimal control by the Michaelis constant, KM; Monte-Carlo numerical experiment. 
The scatterplot of dataset for the range of randomly distributed parameters: Vin=10
-6
 – 1.0, k1= 
0.01-10.0; kp=0.01-10.0, xeq=0.01-10.0; yeq= 0.01-10.0; KM= 0.001-10.0; k=0.00001 - 1.0 from 
equation (6.3.6). Canonical discriminant analysis of dataset (5K points) shown in the plane of 
first two canonical variables, Can1, Can2. The equilibrium point designation as in Fig.6.3.8. 
Figure adopted from Moroz, 2011. 
 
Parameter Can1 Can2 
Vin 2.5 -0.25 
xeq -0.1 0.2 
yeq 0.1 -0.2 
k1 0.2 0.1 
kp -0.37 -0.03 
 KM 0.37 0.2 
k 1.0 -2.0 
 
Table 6.3.3 Raw canonical coefficients for first two canonical variables (Can1, Can2) when the 







 The results in Fig.6.3.11 show that the combination of the Monte-Carlo method 
together with the statistical canonical analysis method can be useful in study of the character of 
equilibrium points of a dynamic system, also significantly reducing the dimensionality of the 
data analysed. However, other alternative methods could be useful to establish the relationship 
between the rate or control parameters and the indexes of equilibrium of characteristic points of 
a dynamic system.  
 
6.3.6      Optimal control and multi-enzyme kinetics 
 The introduction of the optimal control into the basic kinetic BTKW-V (Bier et al., 
1996; 2000; Volkenstain, 1989) model of glycolysis can been considered by employing the 
Pontryagin maximum principle to the formulated the OC problem. As a conclusion, one can 
state that the introduction of optimal control into the basic glycolysis model BTKW-V can be 
performed without contradicting to the classic glycolysis kinetics results. The 6-dimensional 
limit cycle in dimensions (x, y, px, py, u, v), obtained in the OC model, gives the projection to 
(x,y) plane the standard 2D cycle (see diagram for x,y from Fig.6.3.4), characteristic for 
modelling glycolitic oscillations. However, the OC consideration in terms of state, costate and 
control variables extends not only the dimensionality of the system, but also provide the OC 
interpretable regulatory pattern from the energetical perspective, linked to the maximum energy 
dissipation principle. Physically speaking, the control variables (related to the rate constants, 
see Eq.6.3.2) are some variable constants that can be changed by enzymes in a metabolic 
network. The Lagrange multipliers (or thermodynamic momenta from thermodynamic 
perspective, could be called the kinetic momenta) can be interpreted as partial energetical 
costs/penalties for deviation of metabolic mechanism from an optimal one.  The extended 
equations for these variables can been obtained as a result of the Euler-Lagrange equations, or 
canonical equations in the case of Pontryagin maximum principle, Eqs.(6.3.5), (6.3.7). The real 







according to the additional demand of the Pontryagin maximum principle, when the Hamilton 
function is equal to zero for the optimal trajectory. 
The implementation of the optimal control into the BTKW-V model of glycolysis, 
which is performed in the same methodological way as it was done for pure Michaelis-Menten 
system, extends the interpretation of the controlability of this system in a general sense. 
Statistical method canonical analysis has been employed in the study helps to range the 
influence of model parameters on the stability of near steady state. The introduction of the 
metabolic penalty G for being in a non-steady state identifies the character of stability 
(qualitatively illustrated by Fig.6.3.9B,C,D-6.3.10). As one can see from Table 6.3.2 the effect 
of xeq and yeq on the first canonical variable Can1 is the smallest.  The parameter Vin influences 
in the highest way and k (characterising the impact of cost for not being in an optimal/steady 
state) is second. This effectively means that inflow into this metabolic chain is the most 
important factor and the metabolic penalty for being in not-steady/optimal state influences the 
system stability is second, from a physical perspective. Effectively, one can see the similarities 
to the OC model when the control is introduced by KM, Table 6.3.3 (as well as from comparison 
of Fig.6.3.10B  and Fig.6.3.11C). The load on the first canonical variable Can1 is highest for 
Vin and second highest for k, what actually there is in agreement with the control by the rate 
constants k1 and kp. The effect of xeq and yeq is smaller, the rate (k1 and kp) effect has the same 
order as for the control by the rate constants. One can note that the Vin has the highest load also 
for the system without control, Table 6.3.1. However, one should bear in mind that this was 
performed within a specific parameter range, and can change if the range is altered and an 
systemic analysis is needed. This consideration illustrates that the canonical analysis with the 
combination of the Monte-Carlo method can be useful when studying the equilibrium and can 
significantly reduce the dimensionality of the analysis.  
 Additionally, the method that has been applied to study the stability is of particular 
interest because of possible universality. The method is based on statistical canonical analysis 







complex nonlinear model when the number of parameters in the system is significantly large 
(>10-20). Such  analysis could link the parameters characterising the equilibrium points (the 
linear combination of the eigenvalues) from one hand and the rate constants parameters 
incorporated into the model (their linear combinations), ranking these linear combinations with 
respect to the effect on the variance. 
 It is well known, that in the long path of substrates and products the metabolic 
regulation is carried out by so-called "key-points‖ (for example, Hsu et al., 2000). In the sense 
of the variability of data when such a path/network is studied it could be statistically interpreted 
as variables that maximally load the canonical variables. Perhaps this circumstance testifies for 
the benefit of optimal control and could simplify the formulation of the optimal control problem 
in case of the more complex chain or a network,  for example, glycolysis. In this case the 
adaptive optimal control by number of mechanisms – competitive, non-competitive, allosteric 
ones, provides vast flexibility of adaptation of whole network from oscillations to other states 
with different stability character in optimal manner. One can see that such a selective control 
could solve a twin problem: making the network or chain flexible and rigid at same time. 
 Finally, the optimal control introduction into more complicated system like the yeast 
glycolysis model comparably to the Michaelis-Menten/Monod system, makes the resulting 
dynamical system more complicated, the stability character of the equilibrium points of the 
system changes. Then the multivariate statistical methods can also be useful to study the altered 
system when the optimal control is explicitly presented. The canonical analysis can be a 
particular useful method to study the character of robustness because of dimension reduction 
possibility that this analysis simplifies. Canonical spaces, manifolds, other linear and nonlinear 
combination of variables could be the key-subspaces, of the optimal regulation of the metabolic 
network or its part. This is when metabolic system needs to be controllably and optimally 
moved from one qualitative mode of behaviour to another, for example in cases of an optimal 
therapy. However, statistical studies need to be considered to complete the global vision of the 







6.4  Approaches to dynamic OC model of bone turnover 
6.4.1   Introduction 
Having undertaken the study of behaviour of the models in sections 4 and 5 in different 
range of rate constants and the optimal control applications to simple models in sections 6.1-
6.3, it was decided to apply the method to formulate the OC approach to investigate the bone 
remodelling models. The interest was dictated by the possibility to alter the BMU behaviour, 
and to control it in accordance with some criteria.  Initially, the model of bone remodelling 
described in Chapter 4 was considered as a good example for investigation.  
 To study the effect of the optimal control implementation, the OC method can be used 
based on the Pontryagin maximum principle. The problem of the introduction of optimal 
control into model (4.1) by parameter s can be formulated in the same way as it was done in 





















.    (6.4.1a) 
The OC problem for this system can be formulated by taking into account the 
metabolic losses for control T(uj) and metabolic losses for not being in thermodynamic steady 
state/equilibrium as G(xi) in the same way as it was done for the glycolitic model.  The 





i ,      (6.4.1b) 
The optimal control problem will be formulated as (6.4.1b) subject to (6.4.1a), and the 
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 .       (6.4.3) 
Solving this system one could optimise the biological properties incorporated into functional 
6.4.1b.   
 
6.4.2 Optimal control in cellular model 
















   (6.4.4) 


























   (6.4.5b) 

















      (6.4.6) 
Then on the basis of Pontryagin Maximum principle the conditions for minimum of the 


















































































































  (6.4.8) 
This system was studied in the same way as system (2.1.3) at the range of parameters: 
a1, 1000-100000 day
-1





















; a3, 2300-66000 day
-1





; k1, 0.01-0.50 day
-1
; k2, 0.0003-0.0030 day
-1























100.01 BMn  
Fig. 6.4.1 The scatteplot of calculated points of equilibrium of osteocells (Ocl, osteoclasts; OB, 
osteoblasts; Oct, osteocytes) against the total bone mass (BM) for the system (6.4.8). 
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Fig. 6.4.2 The graphical matrix illustrates the scatterplot of populational densities of Ocl, Obl, 
Oct, BM (designated as ―Bone‖) in 4D space of these quantities at the uniform distribution of 
the rate constant for the system (6.4.8). Calculations were performed using the set of 
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Fig. 6.4.3 Scattreplot of the eigenvalues of the Jacobian matrix for the linearised system (6.4.8). 
Calculations were performed using the set of parameters in Fig.6.4.1. 
 
Fig.6.4.3 illustrates the character of the equilibrium point‘s stability. One can see that 
the first and second eigenvalues are complex-conjugate, as well as the third and fourth 
eigenvalues. The same symmetric picture characterises the 5th-8th eigenvalues. From the 
perspective of OC that means that the introduction of OC as it was done in (6.4.1-6.4.8) 
introduces instability into the system. However, it is still possible to link this to the method, 







position of equilibrium and its character with the values of the rate constants. However, to 
obtain statistically significant results the range of the rate constant needs to be reduced as it was 
illustrated in Section 4 and 5. 
 
6.4.3 Short range of the rate parameters: Monte Carlo method  
The illustration of the method, applied in Sections 4 and 5, to the system (6.4.8) within 
the shorter range of the rate parameters ( a1, 7100-9850 day
-1






















a3,   79000-90000 day
-1




; k1, 0.3-0.4 day
-1
; k2, 0.0023- 0.0025 day
-1
) is shown in 
Fig.6.4.4-6.4.6 and Table 6.4.1. Fig.6.4.4.indicates the scatterplot of the osteocell‘s population 
concentration against the total bone mass (BM), which shows a significant reduction in the 
scatter. This is seen comparably to Fig.6.4.1. That means that the regression of the equilibrium 
position and the relaxation characteristics can be calculated with some confidence. 
 
Fig. 6.4.4 Scatteplot of calculated points of equilibrium of osteocells (Ocl, red, osteoclasts; Obl, 
green, osteoblasts; Oct, blue, osteocytes) against the total bone mass (BM), for the system 
(6.4.8) and system (4.4) without optimal control (magnolia, brown and cyan colours, 
correspondingly). Calculations were performed using the same set of the rate parameters: a1, 
7100-9850 day
-1





















; a3, 79000-90000 day
-1




























































Fig. 6.4.5 The graphical matrix illustrates the scatterplot of populational densities of Ocl, Obl, 
Oct, BM(bone ) in 4D space of these quantities at the uniform distribution of the rate constant 
for the system (6.4.8). Calculations were performed using the set parameters, Fig.6.4.4. 







Fig.6.4.6. The scattreplot of the eigenvalues of the Jacobian matrix for the linearised  system 
(6.4.8). Calculations were performed using the set parameters, Fig.6.4.4. 
 
 
Ocl Obl Oct BM Re1 Re5 Re6 Im1 
R-square 0.990 0.997 0.995 0.996 0.996 0.997 0.999 0.998 




     
-0.008 0.006 -0.006 





0.648 0.789 -0.235 0.634 -0.008 0.751 
b2 0.020 0.007 -0.608 -0.739 0.224 -0.612 0.008 0.008 
b23 
  
-0.027 -0.026 -0.707 
   a3 -0.012 
 
0.657 







 k1 -2.737 
 






Table 6.4.1 Summary table of the Monte-Carlo method application to the system (6.4.8) within 
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Fig. 6.4.7.  Typical trajectories for state variables, time in days. A, short range, no OC; B, OC. 
 
 
Mean Minimum Maximum Range Std.Dev. Error 
OCL 11.646 10.409 12.560 2.151 0.228 0.006 
OBL 2243.9 1879.4 2674.3 794.9 143.6 3.9 
OCT 12222 9272 14706 5434 1029 28 
BM 1.080 0.947 1.405 0.458 0.080 0.002 
Table 6.4.2 The average population concentrations, maximum and minimum values and 
statistical deviations for the osteocells (cell/mm
3
) and the relative bone mass, BM, for the 
model (6.4.8) for the short range of the rate parameters as in Fig.6.4.4.  
 
Indeed, as it is seen from the Monte Carlo results, Table 6.4.1, the position of the 
equilibrium point and the relaxation characteristics can be calculated from the values of the rate 
constants with a good (R-square >0.99) confidence level. The regulatory pattern of the model, 
indicated in Table 6.4.1 by the values of coefficients and their signs matches the regulatory 
pattern of the system (4.3) without the OC, even though the system significantly changed after 
the OC implementation. The scatterplots (Fig.6.4.6) of the real and imaginary parts of the 
eigenvalues of the system (6.4.8) indicate that the equilibrium points in 8-dimensional space of 
4 state variables and 4 costate variables is unstable. This means that solutions of the system are 
unstable and the optimal control problem in form (6.4.1-8) should be revised.   
Thus, the introduction of the dynamic optimal control in such a way as it was done in 
(6.4.1-6.4.8) leads to a loss of stability of the main equilibrium point in new combined phase 







6.4.4 Optimal control formulation for allosteric cellular-and-molecular model 
Following the development in Section 5 of the allosteric cellular model (with some 
modifications) which includes the molecular regulation loop, which for notion simplification 





















   (6.4.9) 










   (6.4.10a) 





















   (6.4.10b) 























     (6.4.11) 
Then on the basis of Pontryagin maximum principle the conditions for minimum of the 








































































































and H*(τ)=0 and 0ip . However, to study this system is quite difficult and it is planned for 
further work.  
 
6.4.5 Summary 
The first section reviews the molecular binding kinetics from the perspective of optimal 
control and variational description. Based on Pontryagin maximum principles an introduction 
of optimal control within the Hill kinetics model has been illustrated. The dynamical system 
has been obtained as a result of the Euler-Lagrange equations and canonical equations, in the 
case of the Pontryagin maximum principle approach. The numerical solutions have been 
obtained and discussed.  
 The Michaelis-Menten model of enzyme kinetics can be revised employing the optimal 







into different ways within this model. The section discusses the problems where regulation is 
introduced by the reaction velocity, by the Michaelis constant and simultaneous optimal control 
by both of them. Corresponding dynamical systems can be found as a result of the Euler-
Lagrange equations and canonical equations. The numerical solutions have a good agreement 
of  the results without the optimal control. The biochemical allosteric regulatory aspects of 
optimal control models have been discussed.  
Based on the Pontryagin maximum principles and the Lagrange method the possibility 
of the optimal control extension of the yeast model of glycolysis kinetics has been illustrated. 
Corresponding dynamical systems have been obtained as a result of canonical equations in the 
case of the Pontryagin maximum principle approach. The biochemical aspects of the optimal 
control explicit implementation have been discussed. Statistical canonical analysis is a 
particularly useful method to study the character stability dependences because of the 
dimension reduction possibility that simplifies analysis. The canonical spaces – the linear 
combinations of real variables (concentrations, rate constants, activities) could be the key-
spaces of optimal regulation of the metabolic network or its part when system needs to be 
controllably moved from one qualitative mode of behaviour to another. 
The OC problem can be formulated for the BMU functioning model. However, the 
instability of the main point can be observed. Further studies are needed to describe the OC 

















7 Conclusions and further work  
 
7.1 Cellular model 
The introduction of the osteocytes‘ regulation loop is necessary from biological perspective. 
Many authors (Landry et al., 1997; Martin, 2002; Noble, 2003) discussed possible 
mechanisms of this regulation, including some molecular mechanisms. However, the 
introduction of the osteocyte pathway into remodelling regulation loop in the mathematical 
model increases the dimensionality of the model and makes it more difficulty to validate. The 
number of terms that needed to be taken into account and the dimensionality of parameters to 
be measured both increase. This in turn demands precise measurement in-vivo, which can be 
difficult when conducting experiments with hard tissue.  
 The mathematical model of bone remodelling, that has been discussed in Chapters 4-
6, formally introduces a level of octeocytes‘ regulation which certainly is more realistic from 
a cellular, biochemical and bio-cybernetic perspective (Frost, 2001), since the osteocytes are 
considered to participate actively in regulation of the BMU. This introduction was based on 
the assumption that the osteocytes‘ level of regulation is a primary part of bone remodelling, 
as it allows the completion of the loop of spatial control of BMU initiated from the bone 
marrow. 
The introduction of the osteocytes‘ loop into cellular model increases the spectrum of 
behaviour described from relaxational and periodical to a chaotic mode. The cellular model 
has quite robust behaviour in the wide range of parameters implemented into model. The 
chaotical mode can be also interesting, however further studies need to establish the real 
relevance of this type of behaviour to the remodelling process in bone tissue. 
 Cellular models displays steady relaxational behaviour when employing the range of 
rate constants with certain biological sense. The existence of stable focus type of equilibrium 
in four-dimensional osteoclast–osteoblast–osteocyte-bone space indicates formally that there 







constant characterises the recovering property of the bone tissue. This is related to the 
continuously operating, genetically predetermined BMU and provides a measure of the 
recovering potential of the BMU following mechanical and biochemical damage to bone.  
One of the advantages of the cellular model is related to the model validation. Due to 
the simplicity of the model the low-dimensional kinetic constants are expected to be 
estimable. In this case simple measurements based on the population densities of cells can be 
employed.  
 
7.2 Allosteric model 
The model of the bone turnover cycle that has been developed in Chapter 5 introduces 
a non-linear, non-multiplicative cellular control loop, which is more rational from a 
biochemical and osteo-homeostatical perspective, since the osteocytes are considered to 
participate in regulation of BMU by producing the molecular messengers. As well as the 
effect of local factors on osteo-cells production and activity can have nonlinear sigmoid 
character. This development was based on the assumption that the nonlinear allosteric form of 
control is a vital part of bone remodelling, as it allows the modelling of the natural loop of 
control of BMU.   
The allosteric molecular model also shows different modes of behaviour; relaxational 
and quasi-periodical with damping within a wide range of rate constants that can be 
interpreted biologically. In the sense of dynamic systems, the majority of equilibrium points, 
obtained in this range of parameters, using Monte Carlo method, can be characterised as the 
stable focus.  At some constants the main equilibrium point attains the form topologically 
equivalent to a stable cycle.  
 However, in the framework of a very well known mechanism of nonlinear regulation 
(Michaelis-Menten) the stable focus, formerly described for pure cellular model (Chapter 4), 
prevails in a wide range of the rate constants. Moreover, it becomes a more physiological in 







linear, not just multiplicative, feedback regulation from the osteocytes. That means also that 
the robustness of the system is maintained from the simple cellular level to the allosteric-like 
regulation, related to molecular and biochemical level of regulation. This implementation, 
based on the assumption that the allosteric form of control is a vital part of bone remodelling, 
provides the completion of the natural loop of control of BMU initiated from the osteocytes‘ 
networks. Simulations of the model demonstrate four-dimensional relaxation when employing 
the range of rate constants that can be interpreted biologically.  Moreover, at the same time 
the existence of periodical modes of behaviour could provide the basis for the explanation of 
Paget‘s-disease-like physiological situation of overfeeding of the bone remodelling cycle.  
Cyclic modes might be play greater role in Paget‘s disease or maintaining plasma Ca
2+
 
physiological concentration. Hence, the combined allosteric and cellular hybrid models 
represent some insights into the bone remodelling mechanisms of regulation. However, the 
validation of these kinds of models is a significant problem since, for example, the parameters 
of receptors should be estimated in vivo.    
 
7.3 Optimisation problem formulation for the BMU  
Molecular binding is the first stage of any biological regulation, including bone 
remodelling. Therefore it is important to understand its functioning from an optimal control 
perspective. The Section 6.1 reviews the molecular binding kinetics from the perspective of 
the optimal control and creates the basis to understand regulatory optimality. Based on 
Pontryagin minimum principles and the Lagrange method, an introduction of optimal control 
within the Michaelis-Menten kinetics model has been illustrated in the section 6.2. The 
dynamical systems have been obtained as a result of the Euler-Lagrange equations and 
canonical equations, in the case of the Pontryagin principle approach. The numerical solutions 
have been obtained and discussed. The results indicate that the cooperativity can be 
considered as the rigidity of the control. The cooperativity, implemented in many regulatory 







the most vital parameters. In the bone remodelling regulation there are also indications of 
positive cooperativity, which one can see from Fig.5.2. That is why allosteric mechanisms 
were considered at the regulation of bone remodelling. Optimal control outline of 
cooperativity, undertaken in this project, allowed molecular binding and cooperativity of 
molecular binding to understand from energetical optimality perspective.   
 Enzyme kinetics is also an important part of regulation functioning, including the 
regulation of bone remodelling. Therefore, the basic enzyme kinetics model, the Michaelis-
Menten kinetics, has been revised employing the optimal control, considering the introduction 
of control into different ways within this model. The Section 6.2 discusses the problems 
where regulation is introduced by the reaction velocity, by the Michaelis constant and 
simultaneous optimal control by both of them. The dynamical systems have been found as a 
result of the Euler-Lagrange equations and canonical equations. The numerical solutions have 
been obtained. The biochemical allosteric regulatory aspects of optimal control models have 
been discussed. Biochemical parallels to these two ways of OC introduction were also 
considered. In this context two main biochemically-sensible interpretations were discussed: 
the OC by maximal velocity is analogical to the non-competitive inhibition, OC by Michaelis 
constant is analogical to competitive inhibition with respect of enzyme kinetics. The 
Michaelis-Menten regulation was considered also in the variant of allosteric model of BMU. 
As an intermediate OC model on the way to build the optimal control BMU model, 
the basic model of two-level metabolic system, the Bier and coauthors model of glycolysis 
was employed. Based on the Pontryagin maximum principles and the Lagrange method the 
possibility of the optimal control extension of the yeast model of glycolysis kinetics has been 
illustrated. Corresponding dynamical systems have been obtained as a result of canonical 
equations in the case of the Pontryagin maximum principle approach. The biochemical 
aspects of the optimal control explicit implementation have been discussed. Statistical 
analysis is a particularly useful method to study the character stability dependences because 







Finally, the OC formulation for cellular BMU model and hybrid molecular-and-
cellular allosteric model of BMU was performed in Section 6.4. The control by the load rate 
constant and the Michaelis constants was considered. Due to the complexity of the model 
further work is required to study all of the implications of the models developed. 
The results and their analysis also illustrate the complexity of the relationship 
between the system level of regulation and local factor regulation in hard tissue considering 
the steady tissue remodelling. Even after simplification and reduction in the number of the 
model variables, the behaviour of tissue shows multiple modes of behaviour that sometimes 
have limited relevance from a biological perspective.  
In summary, the results from the OC (Section 6) are encouraging and the regulatory 
model of BMU is expected to be the subject of future work. Modelling of BMU, including 
hierarchical modelling that involves system and local regulatory loops, could be particularly 
useful for development optimised tissue engineered bone substitutes.    
 
7.4 Conclusions 
This study shows the complexity of formalisation of the metabolic processes, the relations 
between hierarchical subsystems in hard tissue where there are a relatively small number of 
active cells.   
 The different types/modes of behaviour have been compared in the study: 
relaxational, periodical and chaotic modes. All of these types of behaviour can be found even 
tissue such as bone. However, a periodic mode of behaviour is one the hardest to verify 
although a number of periodical phenomena have been observed for bone and skeletal 
development. Implementation of the molecular loops into the cellular model results in the loss 
of the chaotical behaviour/modes. In this way it improves the robustness and predictability 
and control of the system. 







1. The cellular and combined allosteric-cellular regulation approaches to modelling of 
bone turnover (based on the osteocyte involvement/regulation by apoptosis) can be 
developed using dynamic systems. 
2. Within both approaches, the different modes of behaviour can be found.  
3. Different approaches to model validation can be considered as useful, including 
approaches based on the Monte-Carlo simulation of random combination of model 
parameters (rate constants) and further arrangement of regression analysis to establish 
the relation between parameters and character of equilibrium points.  
4. From the model validation perspective, the cellular class of models is preferable, 
since it has less parameters (the rate constants) to analyse. The rate constants in 
particularly are difficult to estimate for the bone tissue in vivo.   
5. In both types of models the mechanical stress parameter can be included. 
6. On the basis of fundamental OC models (Hill model, Michaelis-Menten model, 2D 
glycolysis model), the optimal control framework for regulation of bone remodelling 
can be proposed. This framework can be essential for development with respect to 
application to hard scaffold adaptation.  
7. Future works in the improvement of the models and their application to modelling 
resorption and formation of scaffold/bone tissue have been considered. 
 Developed models can be a first step in a hierarchical model of bone tissue (system 
effects versus local effects). Limited autonomy of any organ or a tissue implies the 
differentiation of regulatory level as well as physiological functions and metabolic 
differences. An implementation into the cellular phenomenological model of molecular loop 
of regulation has been performed. The results show that the robustness of regulation can be 
inherited form the phenomenological model however the regulatory degrees of freedom 
considerably increases.  
 An attempt to correlate the main bone disorders with different modes of behaviour 







general skeleton disorders leading to periodical changes in bone mineral density  reported by 
some authors (Mazzuoli et al., 2002,2006).  However additional studies are needed to make 
this hypothesis significant.     
 When studying a multidimensional phenomena as a bone tissue is, the visualisation 
and data reduction is important for analysis and interpretation of results. In the study two 
technical methods have been proposed. First one is the graphical matrix method of 
transforming/visualise/project the multidimensional phase space of variables into diagonal 
matrix of regular combination of two-dimensional graphs. That significantly simplifies the 
analysis and in principle makes possible to visualise the phase space higher than three-
dimensions.  
 The second important technical development is the application of the Monte-Carlo 
method in combination with statistical methods (principal component and regression) to study 
the character of stability of the equilibrium points of a dynamical system. The advantage of 
the method is that it allows the large number of parameters/constants of the dynamical system 
the most influential parameters (or their linear combinations) that effect the character of 
stability of the equilibrium point and in wide range of constant values to be found. This makes 
the interpretation of parameters and conceptual verification of the model much easier.   
 Summarisingly, the novelty of this study was: 
 For first time the OCts feedback of regulation was considered in the BMU model. 
 The 4D model was proposed, which includes allosteric-like control 
 OC approach illustrated for simple kinetics, 2D model of glycolysis and BMU model 
 The method, based on combination of Monte-Carlo generation of model parameters 
simulation and regression analysis, was proposed to study the relationship between 
the character of equilibrium of dynamic system and parameters of the model.  
 Graphical matrix method was proposed for visualisation dynamic systems D>4 
 The method of optimal control of performance of the model with respect to some 







7.5  Overall implications of this research 
This research conducted in this PhD study clearly indicates that while building mathematical 
model of bone remodelling (BMU functioning) the role of osteocytes has to be taken into 
account. The osteocytes play vital role in the producing signal for osteoclasts arrangement: 
differentiation, maturation and bone resorption, (Landry et al., 1997; Martin, 2002; Noble, 
2003), therefore their role should not be ignored. The cellular model, developed in this 
research offered the osteocytes‘ regulatory loop together with the extended spectrum of 
functional behaviour. In this research the combined cellular and allosteric regulation 
approaches to modelling of bone turnover (based on the osteocyte involvement/regulation by 
apoptosis) have been considered. Within both approaches different modes have been 
investigated. 
Important conclusion is that osteoblastic activity has indirect negative feed back 
regulatory loop, which phenomenologically contains the osteocytes and its molecular 
explanation could be based on sclerostin production by osteocytes. So inclusion of osteocytes 
phenomenological loop of regulation can be relevant to sclerostin action. However detailed 
molecular mechanisms are unclear. 
The research creates a platform for the development a general method to introduction 
of the optimal control into a small biochemical or cellular network, like the bone remodelling 
network. The optimal control approach to interpret molecular binding from energetical 
optimality perspective, to consider the Michaelis-Menten basic enzyme model, and 
application to the glycolytic network provides good technical basis to consider a metabolic 
network from energetical and functional optimality.  The models developed and the 
underpinning approach to control bone remodelling has implications for bone graft 
substitute‘s development and optimisation.  
 This study also has some implications on some technical methods used in the 
dynamic systems research. That is first of all the statistical approach and reduction of 







parameters (rate constants) and further arrangement of regression/canonical correlation 
analysis to establish the relation between parameters and character of equilibrium points.  
Another important development is the visualisation technique of graphical matrixes, 
proposed for analysis of dynamic systems behaviour when dimensionality is higher than 3. 
This visualisation method can be implemented as a graphical analysis instrument for dynamic 
systems software. 
 
7.6 Further work 
The limitations of the study and time factor and resources did not allow to build a full 
formal picture of the processes involved in bone remodelling.  
Significant improvement that can lead to use the osteocyte‘s regulatory 
model/approach and can lead to develop criteria for scaffold design, it will be the spatial 
model of remodelling. It can be based, for example, on the cellular automata technique or the 
partial differential equation technique. 
 Further structural robustness study on the models 
 Incorporation of different allosteric feedbacks into osteocells‘ regulation 
 Implementation of Hill-like feedback function with effective cooperativity 2. 
 Development of approaches to build the spatial models, describing 3D properties of 
bone tissue remodelling  
 Cellular automata. 
On the basis of spatial models, further development of dynamic optimal control approach to 
bone grafts and bone substitutes design can be achieved.  
Based on the results generated from this study, in future research the methodology for 
a common mathematical framework based on the optimal energy regulation needs to be 
considered. This principle leads to formulate the energetical effectiveness at different levels 
of biochemical/physiological organisation in the organism, tissue or ecological system. 







manifest adaptive and energetical effectiveness properties through synchronisation processes 
as a product of coupled nonlinear dynamic behaviour. 
Due to the multivariable nature of the data that can be obtained from experiments in 
bone tissue, and the multileveled nature of studying tissue and processes, their descriptions 
and methods of data reduction and visualisation are an important technical issue that should 
be considered for further development.   
Regeneration of damaged bone tissue remains an important problem, the field of 
tissue engineering looks to provide structural support for the regenerating material via bone 
tissue scaffolds.  Optimisation of scaffold properties, known as scaffold variables, is closely 
related to the study of remodelling properties. Developing a mathematical model that can be 
used as a dynamical constraint for optimisation of remodelling, as well as the study of the 
usefulness of dynamic optimisation in developing resorbable implants/scaffolds can also be 
considered as a further research area. 
 The mathematical modelling of bone is an important part of mathematical physiology 
as bone remodelling is a highly organised physiological process that occurs in bone tissue and 
supports many physiological processes in the body. Researchers with a strong 
interdisciplinary and integrative interest in life support systems must have a clear vision of the 
role of bone tissue and its remodelling process as these processes are actively involved at the 
systemic regulation level of all metabolic processes. The modelling of ―artificial bone‖ needs 
to take into account not only the mechanical properties of tissue but also consider that this 













Acerenza L., Mizraji E. 1997. Cooperativity: a unified view, Biochimica et Biophysica Acta 
1339, 155–166. 
Acerenza, L. 2000.  Design of Large Metabolic Responces. Constrains and Sensityvity 
Analysis. J. Theor. Biol. 207, 265-282. 
Acikgoz, S.U., Diwekar, U.M. 2010. Blood glucose regulation with stochastic optimal control 
for insulin-dependent diabetic patients. Chem. Eng. Sci. 65(3), 1227-1236. 
Adair, G.S. 1925. The hemoglobin system. VI. The oxygen dissociation curve of haemoglobin. 
J. Biol. Chem. 63, 529-545. 
Agnati, L. F., Tarakanov, A. O., Guidolin, D. 2005. A simple mathematical model of 
cooperativity in receptor mosaics based on the ―symmetry rule‖. Biosystems 80(2), 
165-173. 
Albright F., Bloomberg E., Smith P.H. 1940. Post-menopausal osteoporosis. Trans Assoc Am 
Physicians. 55. 298-305. 
Anderson P.A., May B.K., Morris H.A., 2003. Vitamin D Metabolism: New Concepts and 
Clinical Implications Clin Biochem Rev 24, 13-26. 
Atkins, G.J., P.H. Anderson, D.M. Findlay, K.J. Welldon, C. Vincent, A.C.W. Zannettino, P. D. 
O'Loughlin, H. A. Morris 2007. Metabolism of vitamin D3 in human osteoblasts: 
Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3 . 
Bone,  40, 1517-1528. 
Bailon-Plaza A. and van der Meulen M. C. H. 2001. A Mathematical Framework to Study the 
Effects of Growth Factor Influences on Fracture Healing. JTB, 212(2), 191- 209.  
Bailon-Plaza A., van der Meulen M. C. H., 2003. Beneficial effects of moderate, early loading 
and adverse effects of delayed or excessive loading on bone healing. J Biomech 36(8) 
1069-1077. 
Bakker, A.D., Soejima1, K., Klein-Nulend, J., Burger, E.H., 2001. The production of nitric 
oxide and prostaglandin E2 by primary bone cells is shear stress dependent. J. 
Biomech. 34, 671–677. 
Bakwin H., Eiger M., 1956. Fragile bones and macrocranium. J. Pediatr. 49. 558–564. 
Bax B.E., Wozney J.M., Ashhurst D.E. 1999. Bone morphogenetic protein-2 increases the rate 







Beaudreuil, J., Balasubramanian S., Chenais J., Tabeulet J., Frenkian M., Orcel P., Jullienne A., 
Horne W.C., de Vernejoul M.C., Cressent M., 2004. Molecular characterization of 
two novel isoforms of the human calcitonin receptor. Gene 343, 143–151. 
Beaupre, G. S., Orr, T. E. and Carter, D. R. 1990. An approach for time-dependent bone 
modeling and remodelling - theoretical development. J Orthop Res. 8, 651-661. 
Bender I.B. 2003. Paget‘s Disease. J Endodontics, 29 720-723. 
Bier, M., Bakker, B.M. and Westerhoff, H.V. 2000. How Yeast Cells Synchronize their 
Glycolytic Oscillations: A Perturbation Analytic Treatment. Biophys. J. 78, 1087–
1093. 
Bier, M., Teusink, B., Kholodenko, B.N., Westerhoff, H.V. 1996. Control analysis of glycolytic 
oscillations. Biophys. Chem. 62, 15-24. 
Bitsakos, C. Kerner J., Fisher I., Amis A. A.,  2005. The effect of muscle loading on the 
simulation of bone remodelling in the proximal femur. J Biomechanics, 38(1), 133-
139. 
Blair H. C., Simonet S., Lacey D. L., Zaidi M., 2008. Osteoclast Biology, Osteoporosis (Third 
Edition), 151-167. 
Blair, J.M., Zheng, Y., Dunstan, C.R. 2007. RANK ligand. Int. J. Biochem. & Cell Biol., 39(6),  
1077-1081. 
Blobe, G.C, Schiemann WP, Lodish HF. 2000. Role of transforming growth factor beta in 
human disease. N Engl J Med. 342(18).1350-1358. 
Body J.-J., 2002. Calcitonin for the long-term prevention and treatment of postmenopausal 
osteoporosis. Bone, 30, Suppl1, 75-79. 
Bohr, C., Hasselbach, K.A., Krogh, A. 1904. Ubereinen in biologischen Beziehung wiechtigen 
Einfluss den die kohlensauresparnung de bluter auf dessen sauerstoff binduing Lift. 
Skand. Arch. Physiol. 16, 401-412. 
Bonewald, L.F., 2004. Osteocyte biology: Its implications for osteoporousis, J. Musculoskel. 
Neuron. Interact. 4(1), 101-104. 
Bosetti M., Boccafoschi F., Leigheb M., Cannas M. F. 2007. Effect of different growth factors 
on human osteoblasts activities: A possible application in bone regeneration for tissue 
engineering Biomolecular Engineering,  24, 613-618. 
Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., Wu D., Insogna K., Lifton 
R.P. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N. 
Engl. J. Med. 346, 1513– 1521. 
Braddock, M., Houston, P., Campbell, C., Ashcroft, P. 2001. Born again Bone, Tissue 







Brosch S., Redlich K., Pietschmann P. 2003. Pathogenesis of osteoporosis in rheumatoid 
arthritis. Acta Med. Austriaca. 30(1), 1-5.  
Bulstra S.K., Geesink R.G.T., Hoefnagels N.H.M. 1999. Osteogenic activity of OP-1, bone 
morphogenetic protein-7 (BMP-7), in a human fibular defect model. Proc 45th Ann 
Mtg Orthop Res Soc, 62. 
Burger, E.H., Klein-Nulend, J. 1999. Mechanotransduction in bone- role of the lacuno-
canalicular network. FASEB J. 13 (Suppl.), S101–S112. 
Burgess T.L., Qian Y., Kaufman S., Ring B.D., Van G., Capparelli C.,  Kelley M., Hsu H., 
Boyle W. J., Dunstan C. R., Hu S., and Lacey D. L. 1999. The ligand for 
osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 145, 527-
538. 
Burr, D.B., Martin, R.B., 1993. Calculating the probability that microcracks initiate resorbtion 
spaces. J. Biomech. 26, 613–616. 
Cacik, F., Dondo, R. G., Marqués, D. (2001). Optimal control of a batch bioreactor for the 
production of xanthan gum, Comp. & Chem. Eng., 25, s2-3, 409-418. 
Canalis E., 1980. Effect of insulin-like growth factor I on DNA and protein synthesis in 
cultured rat calvaria. J Clin Invest, 66. 709-719. 
Cannon, W.R., Singleton,S.F., Bencovic, S.J. (1996). A perspective on biological catalysis.  
Nat. Struc. Biol. 3, 821-833. 
Cao X., Chen D., 2005. The BMP signaling and in vivo bone formation. Gene, 357,1-8.  
Carpio L. C., H. Shiau, R. Dziak 2000. Changes in sphingolipid levels induced by epidermal 
growth factor in osteoblastic cells. Effects of these metabolites on cytosolic calcium 
levels Prostagl, Leukotr Ess Fat Acids, 62(4) 225-232. 
Carter D.R., Orr T.E., Fyhrie D.P., Relationships between loading history and femoral 
cancellous bone architecture. J Biomech. 1989,22(3).231-44 
Carter D.R., Van der Meulen M.C.H., Beaupre G.S., 1996. Mechanical factors in bone growth 
and development. Bone, 18(1), Supplt 1,  S5-S10. 
Carter, D. R. (1987) Mechanical loading history and skeletal biologv. J. Biomechanics, 20. 
1095-1109. 
Carter, D. R., Fyhrie, D. P. and Whalen, R. T. (1987) Trabecular bone density and loading 
history: regulation of connective tissue biology by mechanical energy. J. 
Biomechanics 20, 785-794. 
Chambers, T.J., Magnus, C.J., 1982. Calcitonin alters behavior of isolated osteoclasts. J. 
Pathol. 136, 27– 39. 
Chávez, I.Y.S., Morales-Menéndez, R., Chapa, S.O.M. (2009). Glucose optimal control system 







Chen D., Zhao M., and Mundy G. R., 2004. Bone Morphogenetic Proteins. Growth Factors 22 
(4). 233–241. 
Chen, H.-R., Ji, S.-Q.,Wang, H.-X., Yan, H.-M., Zhu, L., Liu, J., Xue, M., Xun, C.-Q. 2003. 
Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-versus-host 
disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-
cell depletion. Exp. Hematol. 31, 1019–1025. 
Chien HH, Lin WL, Cho MI. 2000. Down-regulation of osteoblastic cell differentiation by 
epidermal growth factor receptor. Calcif Tissue Int. 67(2).141-50. 
Cho T.-J., Gerstenfeld L.C., Einhorn T.A. 2002. Differential temporal expression of members 
of the transforming growth factor B superfamily during murine fracture healing. J 
Bone Miner Res,17.513–20. 
Chow J.W., Wilson A.J., Chambers T.J., Fox S.W. 1998. Mechanical loading stimulates bone 
formation by reactivation of bone lining cells in 13-week-old rats. J Bone Miner Res, 
13, 1760–1767. 
Civitelli R., 2008. Cell–cell communication in the osteoblast/osteocyte lineage. 
Arch Biochem Biophys, 473(2), 188-192. 
Colopy S. A., Benz-Dean J., Barrett J. G., Sample S. J., Lu Y., Danova N. A., Kalscheur V. L., 
Vanderby R. Jr., Markel M. D., Muir P. 2004. Response of the osteocyte syncytium 
adjacent to and distant from linear microcracks during adaptation to cyclic fatigue 
loading. Bone, 35(4), 881-891. 
Compston J.E., 2002. Bone Marrow and Bone. J. Endocrin. 173, 387-394. 
Conover C. A., Rosen C., 2002.  The Role of Insulin-like Growth Factors and Binding Proteins 
in Bone Cell Biology Principles of Bone Biology (Second Edition),   801-815. 
Cornish-Bowden, A. 200). ―Fundamentals of Enzyme Kinetics.‖ 3rd ed. Portland Press, 
London. 
Davidson B. P., Cheng L., Kinder S. J., Tam P. P. L., 2000. Exogenous FGF-4 Can Suppress 
Anterior Development in the Mouse Embryo during Neurulation and Early 
Organogenesis. Dev.Biol,  221(1),  41-52. 
Davidson P. L., Milburn P. D. and Wilson B. D. 2004. Biological adaptive control model: a 
mechanical analogue of multi-factorial bone density adaptation. J.Theor Biol,  
227(2)  187-195. 
Davie M., Davies M., Francis R., Fraser W., Hosking D., Tansley R. Paget‘s disease of bone: a 
review of 889 patients. Bone, 24, (1999), 11S-12S 
Delezoide A.-L., C. Benoist-Lasselin, L. Legeai-Mallet, M. Le Merrer, A. Munnich, M. 
Vekemans and J. Bonaventure 1998. Spatio-temporal expression of FGFR 1, 2 and 3 







Delrieu I., 2000. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): 
an insight into an intracrine mechanism, FEBS Letters, 468, 6-10. 
Demongeot, J., Kaufman, M., Thomas, R., 2000. Positive feedback circuits and memory. Life 
Sci. 323, 69–79. 
Denhardt, D.T., Noda, M., 1998. Osteopontin expression and function: role in bone remodeling. 
J. Cell. Biochem. 30/31 (Suppl.), 92–102. 
Denley A., Cosgrove L. J., Booker G. W., Wallace J. C., Forbes B. E., 2005. Molecular 
interactions of the IGF system. Cytokin Growth Factor Rev, 16(4-5) 421-439. 
Dixon C.J., W.B. Bowler, C.A. Walsh and J.A. Gallaaher. 1995. Co-stimulation with ATP and 
PTH induces oscillations in intracellular free calcium concentration in single FURA-
2 loaded primary human osteoblasts. Bone 17, 557-596. 
Doblare M., Cueto E., Calvo B., Martínez M.A., Garcia J.M., Cegoñino J. 2005. On the employ 
of meshless methods in biomechanics. Comp Meth Appl Mech Eng, 194(6-8) 801-
821. 
Doblare M., Garcia J. M.. 2001. Application of an anisotropic bone-remodelling model based 
on a damage-repair theory to the analysis of the proximal femur before and after total 
hip replacement. J Biomechanics, 34(9)1157-1170. 
Doblare, M., Garcıa, J.M. 2002. Anisotropic bone remodelling model based on a continuum 
damage-repair theory. J Biomechanics. 35, 1–17. 
Dobnig, H., Turner R. T. 1996. Evidence that PTH induces modulation of bone lining cells to 
osteoblasts in vivo and that the therapeutic window for an anabolic PTH response is 
of short duration Bone, 19, Supplement 1, S 138. 
Dreux A. C., Lamb D. J., Modjtahedi H., Ferns G. A.A. 2006. The epidermal growth factor 
receptors and their family of ligands: Their putative role in atherogenesis 
Atherosclerosis, 186(1), 38-53. 
Duong L.T., Sanjay A., Horne W., Baron R., Rodan G.A. 2002. Integrin and Calcitonin 
Receptor Signaling in the Regulation of the Cytoskeleton and Function of 
Osteoclasts, Principles of Bone Biology (Second Edition), 141-150. 
Duque, G., El Abdaimi, K., Henderson, J.E., Lomri, A., Kremer, R. 2004. Vitamin D inhibits 
Fas ligand-induced apoptosis in human osteoblasts by regulating components of both 
the mitochondrial and Fas-related pathways. Bone 35, 57–64. 
Eaton, W.A., Henry, E.R., Hofrichter, J., Mozzarelli, A. 1999. Is cooperative oxygen binding 
by hemoglobin really understood? Nat. Struct. Biol. 6, 351–358. 
Elefteriou F., 2008. Regulation of bone remodeling by the central and peripheral nervous 







Elsner, L., Giersch, C. (1998). Metabolic control analysis: Separable Matrixes and 
Interdependence of Control Coefficients. J. Theor. Biol. 193, 593-599. 
Epstein S., 2006. Update of current therapeutic options for the treatment of postmenopausal 
osteoporosis Clinical Therapeutics 28, 151-173. 
Eren-Oruklu M., Cinar, A., Quinn, L., Smith, D. 2009. Adaptive control strategy for regulation 
of blood glucose levels in patients with type 1 diabetes. J. Proc. Contr. 19(8), 1333-
1346. 
Fakhry A., Ratisoontorn C., Vedhachalam C., Salhab I., Koyama E., Leboy P., Pacifici M., 
Kirschner R. E., Nah H.-D. 2005. Effects of FGF-2/-9 in calvarial bone cell cultures: 
differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and 
noggin, and enhancement of osteogenic potential. Bone, , 36(2).254-266. 
Fan, X., Roy, E., Zhu, L., Murphy, T.C., Ackert-Bicknell, C., Hart, C.M., Rosen, C., Nanes, 
M.S., Rubin, J., 2004. Nitric oxide regulates RANKL and OPG expression in bone 
marrow stromal cells. Endocrinology 145, 751–759. 
Farnworth, P.G., Harrison, C.A., Leembruggen, P., Chan, K.L., Stanton, P.G., Ooi, G.T., 
Rahman, N.A., Huhtaniemi, I.T., Findlay, J.K., Robertson, D.M., 2001. Inhibin 
binding sites and proteins in pituitary, gonadal, adrenal and bone cells. Mol. Cell. 
Endocrinol. 180, 63–71. 
Feister H.A., Onyia J.E., Miles R.R., Yang X., Galvin R., Hock J.M., Bidwell J.P.  2000. The 
expression of the nuclear matrix proteins NuMA, topoisomerase II-α, and -β in bone 
and osseous cell culture: regulation by parathyroid hormone. Bone, 26(3) 227-234. 
Fell, D.A. 1997. ―Understunding the Control of  Metabolism.‖ Portland Press, London. 
Fell, D.A., Thomas, S. 1995. Physiological control of metabolic flux: the requirement for 
multisite modulation. Biochem. J. 331, 35-39.  
Feng X. 2005. Regulatory roles and molecular signaling of TNF family members in osteoclasts 
Gene,  350, 1-13. 
Fernandes P. R., Folgado J., Jacobs C., Pellegrini V., 2002. A contact model with ingrowth 
control for bone remodelling around cementless stems. J Biomechanics, 35(2) 167-
176 
Fischer K. J., Jacobs C. R., Levenston M. E., Carter D. R. 1996. Different loads can produce 
similar bone density distributions. Bone, 19(2), 127-135. 








Frost, H.M., 2001. Cybernetics aspects of Bone Modelling and Remodeling, With Special 
Reference to Osteoporosis and Whole-Bone Strength. Amer. J. Human. Biol. 13, 
235-248. 
Fuller K, Owens J.M. and Chambers T.J., 1995.  Macrophage inflammatory protein-1 alpha and 
IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts J 
Immun, 154, 6065-6072 
Fuller K., Murphy Ch., Kirstein B., Fox S.W. and Chambers T.J. 2002. TNF-α potently 
activates osteoclasts, through a direct action independent of and strongly synergistic 
with RANKL, Endocrinology. 143, 1108–1118. 
Fuller K., Wong B., Fox S., Choi Y., Chambers T.J. 1998. TRANCE is necessary and sufficient 
for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med.188, 
997-1001.  
Fushitani, K., Imai, K., Riggs, A.F. 1986. Oxygenation Properties of Hemoglobin of the 
Earthworm, Lumbricus terrestris. J. Biol. Chem. 261(18), 8414-8423. 
Fushitani, K., Riggs, A.F. 1992. The extracellular Hemoglobin of the Earthworm, Lumbricus 
terrestris. J. Biol. Chem. 266(16), 10275-10281. 
Fyhrie D.P., Kimura J.H. 1999. Cancellous bone biomechanics. J Biomech 32  1139-1148 
Gadkar, K.G., Mahadevan, R., Doyle, F.J. 2006. III Optimal genetic manipulations in batch 
bioreactor control. Automatica.  42(10), 1723-1733. 
Gao, Y.H., Shinki, T., Yuasa, T., Kataoka-Enomoto, H., Komori, T., Suda, T., Yamaguchi, A., 
1998. Potential role of cbfa1, an essential transcriptional factor for osteoblast 
differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast 
differentiation factor (ODF). Biochem. Biophys. Res. Commun. 252, 697–702. 
Garcia J. M., Doblare M. and Cegonino J. 2002. Bone remodelling simulation: a tool for 
implant design. Comp Materials Sci,  25(1-2),  100-114 
Garcia-Aznar J.M., Kuiper J.H., Gómez-Benito M.J., Doblaré M. and Richardson J.B. 2007. 
Computational simulation of fracture healing: Influence of interfragmentary 
movement on the callus growth. J Biomechanics, 40(7) 1467-1476. 
Gelfand, I.M., and Fomin, S.V. 1963. ―Calculus of Variation.‖ Prentice-Hall, Englewood Cliffs, 
NJ. 
Geris L., Gerisch A., Sloten J. V., Weiner R. and Oosterwyck H. Van, 2008. Angiogenesis in 
bone fracture healing: A bioregulatory model. J Theor Biol, 251(1) 137-158. 
Gerwins P., Sköldenberg E., Claesson-Welsh L., 2000. Function of fibroblast growth factors 
and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev 







Giachelli C.M., Steitz S., 2000. Osteopontin: a versatile regulator of inflammation and 
biomineralization.  Matrix Biology,  19(7),  615–622. 
Giersch, C. 1998. Control analysis of metabolic networks 1. Homogeneous functions and the 
summution theorems for control coefficients. Eur. J. Biochem. 174, 509-513. 
Giuseppin, M.L.F., van Riel, N.A.W. 2000. Metabolic Modeling of Saccharomyces cerevisiae 
Using the Optimal Control of Homeostasis: A Cybernetic Model Definition. Metab. 
Eng. 2(1), 14-33. 
Goldring S.R., Gorn A.H., Yamin, M., Krane, S.M., and Wang J.T. 1993. Characterization of 
the structural and functional properties of cloned calcitonin receptor cDNAs. Horm 
Metab Res 25.477–480. 
Goltzman, D., 1999. Interactions of PTH and PTHrP with the PTH/PTHrP receptor and with 
downstream signaling pathways: exceptions that provide the rules. J. Bone Miner. 
Res. 14, 173–177. 
Govinden R., Bhoola K. D. 2003. Genealogy, expression, and cellular function of transforming 
growth factor-β. Pharmacology & Therapeutics,  98(2), 257-265 
Gronthos S., Simmons P. J., Graves S. E., Robey P. G. 2001. Integrin-mediated interactions 
between human bone marrow stromal precursor cells and the extracellular matrix, 
Bone 28, 174-181. 
Grover D. M., Chen A.A, Hazelwood S. J., 2007. Biomechanics of the rabbit knee and ankle: 
Muscle, ligament, and joint contact force predictions, J. Biomech 40, 2816–2821 
Harrigan T. P., Hamilton J. J., Reuben J. D., Toni A., Viceconti M., 1996. Bone remodelling 
adjacent to intramedullary stems: an optimal structures approach. Biomater 17(2) 
223-232 
Harrison C. A., Wiater E., Gray P. C., Greenwald J., Choe S., Vale W., 2004. Modulation of 
activin and BMP signaling Mol and Cell Endocriny,  225(1-2),  19-24. 
Hart, R. T. and Davy. D. T. 1989. Theories of bone modelling and remodeling. Bone 
Mechanics (Edited Edited by S. C. Cowin), pp. 253-277. CRC Press, Boca Raton. 
Hashimoto M., Koda M., Ino H., Murakami M., Yamazaki M., Moriya H. 2003. Upregulation 
of Osteopontin Expression in Rat Spinal Cord Microglia after Traumatic Injury J 
Neurotrauma. 20(3) 287-296. 
Hayman A. R.,
 
Cox T. M. 2004. Tartrate-resistant acid phosphatase: a potential target for 
therapeutic gold. Cell Biochemistry and Function 22 (5), 275 - 280. 
He G., Xinghua Z., 2006. The numerical simulation of osteophyte formation on the edge of the 








Heckman JD, Ehler W, Brooks BP, et al. 1999. Bone morphogenetic protein but not 
transforming growth factor-beta enhances bone formation in canine diaphyseal 
nonunions implanted with a biodegradable composite polymer. J Bone Joint Surg, 
81A. 1717–29. 
Heino, T.J., Hentunen, T.A., Vaananen, H.K., 2004. Conditioned medium from osteocytes 
stimulates the proliferation of bone marrow mesenchymal stem cells and their 
differentiation into osteoblasts. Exp. Cell Res. 294, 458–468. 
Heinrich, R., Holzhutter, H.-G., 1985. Efficiency and design of simple metabolic systems. 
Biomed. Biochim. Acta 44, 959–969. 
Heinrich, R., Montero, F., Klipp, E., Waddell, T.G., Melendez-Hevia, E. 1997.  Theoretical 
approaches to the evolutionary optimisation of glycolysis. Thermodynamics and 
kinetics constrains, Eur. J. Biochem. 243, 191-201. 
Heinrich, R., Schuster, S., Holzhutter, H-G. 1991. Mathematical analysis of enzymic reaction 
systems using optimisation principle. Eur. J. Biochem. 201, 1-21. 
Helgason B., Perilli E., Schileo E., Taddei F., Brynjólfsson S. and Viceconti M., 2008. 
Mathematical relationships between bone density and mechanical properties: A 
literature review. Clin Biomech,  23(2) 135-146. 
Hellmann, N., Weber, R. E. and Decker, H. 2003. Nested Allosteric Interactions in 
Extracellular Hemoglobin of the Leech Macrobdella decora. J. Biol. Chem. 278(45), 
44355–44360. 
Herbst R.S. 2004. "Review of epidermal growth factor receptor biology". Int. J. Radiat. Oncol. 
Biol. Phys. 59 (2 Suppl). 21-26. 
Hernandez C.J., Beaupre G.S. and Carter D.R., 2003. A theoretical analysis of the changes in 
basic multicellular unit activity at menopause. Bone 32 357–363. 
Hershey C.L., Fisher D.E. 2004. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor 
family essential for osteoclast development and function. Bone, 34, 689-696. 
Heymann D., Guicheux J., Gouin F., Passuti N., Daculsi G. 1998. Cytokines, frowth factors and 
osteoclasts. Cytokine, 10(3) 155-168. 
Heymann D., Rousselle A.-V. 2000. gp130 Cytokine family and bone cells. Cytokine, 12, 1455-
1468. 
Higgens, J. 1967. The theory of oscillating reactions, Indust. and Eng. Chem. 59(5), 19–62. 
Hill P.A., Orth M. Bone Remodelling. Brit J Orthodont 1998 25 101-107. 
Hill, A.V. 1910. The possible effects of the aggregation of the molecules of haemoglobin on its 







Hoare, S.R.J., De Vries, G., Usdin, T.B. 1999. Measurement of agonist and antagonist ligand-
binding parameters at the human parathyroid hormone type 1 receptor: evaluation of 
receptor states and modulation by guanine nucleotide 1, JPET, 289, 1323–1333. 
Hodsman A.B., Fraher L.J., Watson P.H., 1999. Parathyroid Hormone. The Aging 
Skeleton, 1999, 563-578. 
Hofbauer, L.C., Dunstan, C.R., Spelsberg, T.C., Riggs, B.L., Khosla, S., 1998. Osteoprotegerin 
production by human osteoblast lineage cells is stimulated by vitamin D, bone 
morphogenetic protein- 2, and cytokines. Biochem. Biophys. Res. Commun. 250 (3), 
776–781. 
Hofbauer, L.C., Khosla, S., Dunstan, C.R., Lacey, D.L., Boyle, W.J., Riggs, B.L., 2000. The 
roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of 
bone resorption. J. Bone Miner. Res. 5, 2–12. 
Hofbauer, L.C., Lacey, D.L., Dunstan, C.R., Spelsberg, T.C., Riggs, B.L., Khosla, S., 1999. 
Interleukin-1 and tumor necrosis factor, but not interleukin-6, stimulate 
osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25, 255–
259. 
Hofmeyr, J.H., Cornish-Bowden, A. 1997. The reversible Hill equation: how to incorporate 
cooperative enzymes into metabolic models. Comput. Appl. Biosci. 13(4), 377-85.  
Hofmeyr, J-G.S., Cornish-Bowden, A., Rochwer, J.M., 1993. Taking enzyme kinetics out of 
control; putting control into regulation. Eur. J. Biochem. 212, 833–837. 
Hogan BLM. Bone morphogenetic proteins: multifunctional regulators of vertebrate 
development. Genes Dev 1996,10.1580–94. 
Horowitz, M.C., Xi, Yo., Wilson, K., Kacena, M., 2001. Control of osteoclastogenesis and 
bone resorption by members of the TNF family of receptors and ligands. Cytokine 
Growth Fact. Rev. 12, 9–18. 
Horwood N. J., Udagawa N., Elliott J., Grail D., Okamura H., Kurimoto M., Dunn A.R., Martin 
T. J., and Gillespie M. T., 1998. Interleukin 18 Inhibits Osteoclast Formation via T 
Cell Production of Granulocyte Macrophage Colony-stimulating Factor. J. Clin. 
Invest. 101.595–603. 
Hotelling, H., 1936. Relations between two sets of variates. Biometrica 28, 321-377. 
Hsu, S. B., Yen-Sheng, L., Waltman, P. 2000. Competition in the presence of a lethal external 
inhibitor. Math. Biosci. 167, 171-199. 








Huber D.M., A. C. Bendixen, P. Pathrose, S. Srivastava, K. M. Dienger, N.K. Shevde and J. W. 
Pike, 2001. Androgens Suppress Osteoclast Formation Induced by RANKL and 
Macrophage-Colony Stimulating Factor. Endocrinology, 142(9) 3800-3808. 
Huiskes R., Boeklagen R.. 1989. Mathematical shape optimization of hip prosthesis design.  J 
Biomech, 22, Issues 8-9, 793-799. 
Huiskes R., Favenesi J., Gardeniers J., Pöttgens M., Slooff T. J. 1985. Mechanical properties of 
trabecular bone, an experimental and finite element study J Biomechanics, 18(7) 522 
Huiskes R., Weinans H., Grootenboer H.J., Dalstra M., Fudala B., Sloof T.J. 1987. Adaptive 
bone remodeling theory applied to prosthetic design analysis. J Biomech 20. 1135-
1150. 
Hurley M. M., Marie P. J., Florkiewicz R. Z. 2002. Fibroblast Growth Factor (FGF) and FGF 
Receptor Families in Bone Principles of Bone Biology (Second Edition), 825-851. 
Hynes, R.O., 2002. Integrins: bidirectional, allosteric signalling machines. Cell 110, 673–687. 
Ibbotson K. J., Harrod J., Gowen M., D'Souza S., Smith D. D., Winkler M. E., Derynck R. and 
Mundy G. R., 1986. Human Recombinant Transforming Growth Factor α Stimulates 
Bone Resorption and Inhibits Formation in vitro. Proceed Nat Acad Sci USA, 83(7) 
2228-2232    
Ikegame M., Ejiri S., Ozawa H. 2004. Calcitonin-induced change in serum calcium levels and 
its relationship to osteoclast morphology and number of calcitonin receptors 
Bone, 35, 27-33. 
Ishida Yo., Kawai Sh., 2004. Comparative efficacy of hormone replacement therapy, 
etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with 
osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Amer J Med, 117, 549-
555. 
Itik, M., Salamci, M.U., Banks, S.P. 2009. Optimal control of drug therapy in cancer treatment. 
Nonlin. Anals: Theory, Meth. Appl. 71(12), e1473-e1486. 
Jacobs C.R., Levenston M. E., Beaupre G. S., Simo J. C. and Carter D. R., 1995. Numerical 
instabilities in bone remodeling simulations: The advantages of a node-based finite 
element approach. J Biomechanics 28(4) 449-459. 
Janssens K., M. de Vernejoul , F. de Freitas , F. Vanhoenacker , W. Van Hul, An intermediate 
form of juvenile Paget's disease caused by a truncating mutation.  Bone   36 , 2005,  
542 - 548.  
Jaunberzins A., Stomat D., Gutmann J. L., Witherspoon D. E., Harper R. P. 2000, Effects of 
Calcium Hydroxide and Tumor Growth Factor-β on Collagen Synthesis in 







Ji X., Chen D., Xu C., Harris S. E., Mundy G. R. and Yoneda T. 2000. Patterns of gene 
expression associated with BMP-2-induced osteoblast and adipocyte differentiation 
of mesenchymal progenitor cell 3T3-F442A J Bone Mineral Metab, 18, 132-139. 
Jilka R. L. 2003. Biology of the basic multicellular unit and the pathphisiology of osteoporosis.  
Med Pediatr Oncol Sep,  41(3) 182-185  
Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., Manolagas S.C. 1998. Osteoblast 
programmed cell death (apoptosis): modulation by growth factors and cytokines. J 
Bone Miner Res 13 793–802. 
Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., Manolagas S.C. 1999. 
Increased bone formation by prevention of osteoblast apoptosis with parathyroid 
hormone. J Clin Invest. 104, 439–446. 
Johnson C.S, Jerome C.P, Brommage R. 2000, Unbiased determination of cytokine localization 
in bone: colocalization of interleukin-6 with osteoblasts in serial sections from 
monkey vertebrae Bone,  26,(5) 461-467. 
Johnson E.E, Urist M.R. 1998. One-stage lengthening of femoral nonunion augmented with 
human bone morphogenetic protein. Clin Orthop Rel Res 347, 105–16. 
Jones D.C., Wein M.N., Oukka M, Hofstaetter J.G., Glimcher M.J., and Glimcher L.H., 2006. 
Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science. 
312(5777).1223-1227. 
Jones G., 2002. Vitamin D and Analogs. Principles of Bone Biology (Second Edition), 1407-
1422. 
Jono S., Nishizawa Yo., Shioi A., Morii H. 1998. 1,25-Dihydroxyvitamin D3 Increases In Vitro 
Vascular Calcification by Modulating Secretion of Endogenous Parathyroid 
Hormone–Related Peptide.  Clin Invest Rep, 98, 1302-1306. 
Kakuji, J.T., Akapi, O. 1994. Pharmacokinetic model of intravitreal drug injection. Math. 
Biosci. 123, 59–75. 
Kameda H., Takeuchi T. 2003. Osteoporosis associated with rheumatoid arthritis Nippon 
Rinsho. 61(2), 292-298.   
Kanis J.A., Melton III L.J., Christiansen C., Johnston C.C., Khaltaev N. 1994. The diagnosis of 
osteoporosis. J Bone Miner Res, 9, 1137–41. 
Kapadia R. M., Guntur A. R., Reinhold M. I., Naski M. C.. Glycogen synthase kinase 3 
controls endochondral bone development: Contribution of fibroblast growth factor 
18. Develop Biol, 285, 2005, 496-507 
Kaskani E., Lyritis G.P., Kosmidis C., Galanos A., Andypas G., Chorianopoulos K., Giagiosis 
A., Iliadou K., Karagianis A., Katsimichas K., Koskinas A., Matsouka K. 2005. 







doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip 
region and biochemical bone markers in women with postmenopausal osteoporosis: a 
pilot study. Clin Rheumatol, 24(3), 232-238. 
Kassem, M., Harris, S. A., Spelsberg, T. C., and Riggs, B. L. Estrogen inhibits interleukin-6 
production and gene expression in a human osteoblastic cell line with high levels of 
estrogen receptors. J Bone Miner Res, 11, 193–199, 1996. 
Kato, Y., Boskey, A., Spevak, L., Dallas, M., Hori, M., Bonewald, L.F. 2001. Establishment of 
an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralises in the 
culture. J. Bone Miner. Res. 16(9), 1622-1633. 
Kawaguchi, H., Kurokawa, T., Hanada, K., Hiyama, Y., Tamura, M., Ogata, E., Matsumoto, T. 
1994. Stimulation of fracture repair by recombinant human basic fibroblast growth 
factor in normal and streptozotocin diabetic rats. Endocrinology, 135, 774–781. 
Keesman, K.J., Stigter, J.D. 2002. Optimal parametric sensitivity control for the estimation of 
kinetic parameters in bioreactors. Math. Biosci. 179, 95-111. 
Kelman A., Lane N. E. 2005. The management of secondary osteoporosis. Best Practice & 
Research Clinical Rheumatology, 19, 1021-1037. 
 Kerner J., Huiskes R., van Lenthe G. H., Weinans H., van Rietbergen B., Engh C. A., Amis A. 
A., 1999. Correlation between pre-operative periprosthetic bone density and post-
operative bone loss in THA can be explained by strain-adaptive remodelling. J 
Biomech, 32(7), 695-703. 
King G. J., Holtrop M. E., Raisz L. G., 1978. The relation of ultra structural changes in 
osteoclasts to resorption in bone cultures stimulated with parathyroïd hormone.  
Metab Bone Dis Rel Res, 1, 67-74. 
Kloen P., Di Paola M., Borens O., Richmond J., Perino G., Helfet D. L., Goumans M. J., 2003. 
BMP signaling components are expressed in human fracture callus. Bone, 33(3), 362-
371. 
Klotz, I. M. 1997. ―Ligand-Receptor Energetics.‖ John Wiley and Sons Inc., New York. 
Kneissel, M. The conundrum of Wnt/beta-catenin signaling in bone  Bone, 48, Suppl2, 2011, 
S60. 
Kobayashi Ya., Take I., Yamashita T., Mizoguchi T., Ninomiya T., Hattori T., Kurihara S., 
Ozawa H., Udagawa N., and Takahashi N. 2005. Prostaglandin E2 Receptors EP2 
and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from 







Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., Elner SG, 
Strieter RM. 1992. Interleukin-8 as a macrophage derived mediator of angiogenesis. 
Science 258(5089), 1798-1801. 
Kochupillai N., 2008. The physiology of vitamin D : Current concepts. Indian J Med Res, 127, 
256-262. 
Koegler, W.S., Griffith, L.G., 2004. Osteoblast response to PLGA tissue engineering scaffolds 
with PEO modified chemistries and demonstration of patterned cell response. 
Biomaterials 25, 2819-2830. 
Koka, S., Petro, T. M., and Reinhardt, R. A. Estrogen inhibits interleukin-1beta-induced 
interleukin-6 production by human osteoblast-like cells. J Interferon Cytokine Res. 
18.479–483, 1998. 
Komarova S.V. 2005. Mathematical model of paracrine interactions between osteoclasts and 
osteoblasts predicts anabolic effects of parathyroid hormone on bone. Endocrinology 
146 (8). 3589-95. 
Komarova, S.V., Shum, J.B., Paige, L.A., Sims, S.M., Dixon, S.J., 2003b. Regulation of 
osteoclasts by calcitonin and amphiphilic calcitonin conjugates: role of cytosolic 
calcium. Calcif. Tissue Int. 73, 265–273. 
Komarova, S.V., Smith, R.J., Dixon, S.J., Sims S.M., Wahl L.M., 2003a. Mathematical model 
predicts a critical role for osteoclast autocrine regulation in the control of bone 
modelling. Bone 33, 206-215. 
Kondepudi, D., and Prigogine, I. 1998. ―Modern Thermodynamics: From Heat Engines to 
Dissipative Structures.‖ John Wiley & Sons, Chichester. 
Kong, Y.-Y., Penninger, J.M. 2000. Molecular control of bone remodelling and osteoporosis. 
Exp. Gerontol. 35, 947–956. 
Koshland, D.E., Nemethy, G. & Filmer, D. 1966. Comparison of experimental binding data and 
theoretical models in protein containing subunits. Biochemistry 5, 365-385. 
Kostenuik P. J., 2005. Osteoprotegerin and RANKL regulate bone resorption, density, 
geometry and strength Cur Opin Pharmacol, 5, 618-625. 











 and Kneissel M., Osteocyte Wnt/β-Catenin Signaling Is Required for Normal 
Bone Homeostasis. Molecular and Cellular Biology, 2010, 30(12) 3071-3085. 
Kruithof B.P.T., van Wijk B., Somi S., K.-de Julio M., Pomares J. M. P., Weesie F., Wessels 
A., Moorman A.F.M., van den Hoff M.J.B. 2006. BMP and FGF regulate the 
differentiation of multipotential pericardial mesoderm into the myocardial or 







Kumar R., Panoskaltsis N., Stepanek F. and Mantalaris A. 2008. Coupled oxygen–carbon 
dioxide transport model for the human bone marrow Food Bioprod Process, 86(3) 
211-219. 
Kumar R., Stepanek F. and Mantalaris A. 2004. An Oxygen Transport Model for Human Bone 
Marrow Microcirculation Food Bioprod Proc, 82( 2) 105-116. 
Kumei Y., Shimokawa H., Katano H., Hara E., Akiyama H., Hirano M., Mukai C., Nagaoka 
S.,. Whitson P. A, Sams C. F., 1996.  Microgravity induces prostaglandin E2 and 
interleukin-6 production in normal rat osteoblasts: role in bone demineralization. J 
Biotech., 47( 2-3), 313-324. 
Kummer, B.K.F. 1972. Biomechanics of bone: Mechanical properties, functional structure, 
functional adaptation. In Y.C.Fung (Ed) Biomechanics: Ins Foundation and 
Objectives, 237 -271. Englewood Cleffs: Prentice-Hall. 
Lacey, E. Timms H., Tan-L., Kelley M. J., Dunstan C. R., Burgess T., Elliott R., A. Colombero 
D. L., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., 
Eli A., Qian Y.-X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo, J. J. and 
Boyle W. J. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast 
differentiation and activation. Cell. 93, 165-176. 
Laitala-Leinonen, T., Rinne, R., Saukko, P.,Vaananen, H.K., Rinne, A., 2006. Cystatin B as an 
intracellular modulator of bone resorption. Matrix Biol. 25, 149–157. 
Langton C.M., Haire T.J., Ganney P.S., Dobson C.A., Fagan M. J., 1998. Dynamic Stochastic 
Simulation of Cancellous Bone Resorption. Bone,  22(4),  375-380 
Langton C.M., Haire T.J., Ganney P.S., Dobson C.A., Fagan M.J., Sisias G., Phillips R., 2000. 
Stochastically simulated assessment of anabolic treatment following varying degrees 
of cancellous bone resorption. Bone, 27(1), 111-118. 
Lanyon, L.E., 1996. Using functional loading to influence bone mass and architecture. Bone 18 
(Suppl. 1), 37s–43s. 
Lari R., Fleetwood A. J., Kitchener P. D., Cook A. D., Pavasovic D., Hertzog P. J., Hamilton J. 
A. 2007. Macrophage lineage phenotypes and osteoclastogenesis - Complexity in the 
control by GM-CSF and TGF-β, Bone, 40 (2) 323-336. 
Lazarus J. E., Hegde A., Andrade A. C., Nilsson O., Baron J., 2007. Fibroblast growth factor 
expression in the postnatal growth plate, Bone, 40(3), 577-586. 
Lebman D., Edmiston J. 1999. The role of TGF-beta in growth, differentiation, and maturation 
of B lymphocytes". Microbes Infect 1 (15). 1297–304. 
Ledzewicz U. and Schättler H., 2007. Optimal controls for a model with pharmacokinetics 







Lemaire V., Tobin F.L., Greller L.D., Cho C.R. and Suva L.J. 2004. Modeling the interactions 
between osteoblast and osteoclast activities in bone remodelling. J Theor Biol,  
229(3) 293-309. 
Lenas, P., Pavlou, S. 1995. Coexistence of three Competing Microbial populations in a 
chemostat with periodically varying dilution rate. Math. Biosci. 129, 111-142. 
Lennon A. B. and Prendergast P. J. 2002. Residual stress due to curing can initiate damage in 
porous bone cement: experimental and theoretical evidence. J Biomechanics 35 
(3), 311-321. 
Lerner U., 1982. Indomethacin inhibits bone resorption in vitro without affecting bone collagen 
synthesis, Inflammation Research, 12, 466-470. 
Li J., Li H., Shi L., Fok A.S.L., Ucer C., Devlin H., Horner K. and Silikas N., 2007. A 
mathematical model for simulating the bone remodeling process under mechanical 
stimulus. Dent Materials,  23(9) 1073-1078. 
Li J., Sarosi I., Cattley R. C., Pretorius J., Asuncion F., Grisanti M., Morony S., Adamu S., 
Geng Z., Qiu W., Kostenuik P., Lacey D. L., Simonet W. S., Bolon B., Qian X., 
Shalhoub V., Ominsky M. S., Ke H. Z., Li X., Richards W. G. Dkk1-mediated 
inhibition of Wnt signaling in bone results in osteopenia. Bone 39 (2006) 754–766 
Li L., Pettit A. R., Gregory L. S., Forwood M. R. 2006. Regulation of bone biology by 
prostaglandin endoperoxide H synthases (PGHS): A rose by any other name… Cyt 
Growth Fact Rev, 17(3) 203-216. 
Liang, Y., Leung, K.-S., Mok, T.S.K. (2008). Evolutionary drug scheduling models with 
different toxicity metabolism in cancer chemotherapy. Appl. Soft. Comput. 8(1), 140-
149. 
Lineweaver, H., Burk, D. 1934. The determination of enzyme dissociation constants. J. Am. 
Chem. Soc. 56, 658-666. 
Linkhart, T.A., Mohan, S., Baylink, D.J. 1996. Growth factors for bone growth and repair: IGF, 
TGF beta and BMP. Bone, 19, 1S–12S. 
Little, R.D., Carulli, J.P., Del Mastro, R.G., Dupuis, J., Osborne, M., Folz, C., Manning, S.P., 
Swain, P.M., Zhao, S.C., Eustace, B., Lappe, M.M., Spitzer, L., Zweier, S., 
Braunschweiger, K., Benchekroun, Y., Hu, X., Adair, R., Chee, L., FitzGerald, M.G., 
Tulig, C., Caruso, A., Tzellas, N., Bawa, A., Franklin, B., McGuire, S., Nogues, X., 
Gong, G., Allen, K.M., Anisowicz, A., Morales, A.J., Lomedico, P.T., Recker, S.M., 
Van Eerdewegh, P., Recker, R.R., Johnson, M.L. 2002. A mutation in the LDL 
receptor-related protein 5 gene results in the autosomal dominant high-bone-mass 







Liu F., Aubin J.E., and Malaval L. 2002. Expression of leukemia inhibitory factor 
(LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: 
differential regulation by dexamethasone and LIF. Bone 31, 212-219. 
Liu X., Kirschenbaum A., Yao S. and Levine A.C. 2006. Interactive Effect of Interleukin-6 and 
Prostaglandin E2 on Osteoclastogenesis via the OPG/RANKL/RANK System, in 
Anals of the New York Academy of Sciences, 1068 Skeletal Development and 
Remodeling in Health, Disease, and Aging, 225-233. 
Loveringe N. 1999.  Bone: More than a Stick, J. Anim. Sci. 77, suppl.2/J 
Lowik C W, van der Pluijm G, Bloys H, Hoekman K, Bijvoet O L, Aarden L A, Papapoulos S 
E. 1989. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate 
interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in 
osteoclastogenesis. Biochem Biophys Res Commun.162, 1546–1552. 
Luginbuehl V., Meinel L., Merkle H.P., Gander B. 2004. Localised delivery of growth factors 
for bone repair. Eur. J. Pharm. Biopharm, 58, 197-208. 
Luo, B.H., Carman, C.V., Springer, T.A. 2007. Structural basis of integrin regulation and 
signaling. Annu. Rev. Immunol. 25, 619–647. 
Maalmi, M., Strieder, W., Varma, A. 2001. Ligand diffusion and receptor mediated 
internalization: Michaelis–Menten kinetics. Chem. Eng. Sci. 56, 5609–5616. 
Machwate M., Harada S., Leu C. T., Seedor G., Labelle M., Gallant M., Hutchins S., Lachance 
N., Sawyer N., Slipetz D., Metters K. M., Rodan S. B., Young R., and Rodan G. A. 
2001. Prostaglandin Receptor EP4 Mediates the Bone Anabolic Effects of PGE2. Mol 
Pharmacol, 60, 36-41.  
Maldonado S.Y., Findeisen R. and Allgöwer F. 2008. Understanding the process of force-
induced bone growth and adaptation through a mathematical model. Bone, 42, 
Suppl1, S61. 
Malthus T.R. 1798. An essay on the principle of population. Oxford World Classic reprint. 
Maniscalco P., Urgelli S., Gatti S. and Bocchi L. 2004. Trombocyte growth factors from 
platelets concentrate and intramedularry nailing in diaphyseal lower limb 
pseudoarthroses: preliminary report. J Bone Joint Surg, 87-B, 66.  
Mannstadt M., Juppner H., Gardella T.J. 1999. Receptors for PTH and PTHrP: their biological 
importance and functional properties. Am J Physiol, 277(5 Pt 2) F665–675. 
Manolagas S. C. 1995. Role of cytokines in bone resorption. Bone, 17( 2), Suppl.1,  S63-S67. 
Mao Yo., Schwarzbauer J. E., 2005. Fibronectin fibrillogenesis, a cell-mediated matrix 
assembly process, Matrix Biology, 24 (6),  389-399 
Margetic S., Gazzola C., Pegg G.G., Hill RA 2002. "Leptin: a review of its peripheral actions 







Marie P.J.  2006. Strontium ranelate: A physiological approach for optimizing bone formation 
and resorption.  Bone, 38, Suppl 1, 10-14. 
Marie, P.J. 1999. Cellular and molecular alterations of osteoblasts in human disorders of bone 
formation. Histol. Histopathol. 14, 525–538. 
Mariette X. 2004. Emerging biological therapies in rheumatoid arthritis. Joint Bone 
Spine, 71(6)   470-474. 
Marques, M. B. and Meirelles, N.C. 1995. Erythrocruorin of Glossoscolex paulistus (Righi) 
(Oligochaeta, Glossoscolecidae): effects of divalent ions, acid-alkaline transition and 
alkali and urea denaturation. Comp. Biochem. Physiol. IIIB(2), 311-318. 
Martel-Pelletier J., Di Battista J.A., Lajeunesse D., Pelletier J.P. 1998. IGF/IGFBP axis in 
cartilage and bone in osteoarthritis pathogenesis. Inflamm Res, 47, 90–100. 
Martin R.B. 2000. Does osteocyte formation cause the nonlinear refilling of osteons? Bone, 26, 
71–78. 
Martin R.B., 2002. Is all cortical bone remodeling initiated by microdamage? Bone 30(1) 8-13. 
Martin T. J. and Sims N.A. 2005 Osteoclast-derived activity in the coupling of bone formation 
to resorption. Trends Mol Med 11 76-80.  
Martin T.J. 2004. "Does bone resorption inhibition affect the anabolic response to parathyroid 
hormone?". Trends Endocrinol. Metab. 15(2) 49-50. 
Martin, M.J. and Buckland-Wright J.C. 2004. Sensitivity analysis of a novel mathematical 
model identifies factors determining bone resorption rates. Bone, 35(4), 918-928. 
Martin, R.B. 2000. Towards unifying theory of bone remodeling. Bone. 26, 1-6. 
Martin, R.B. 2007. Targeted bone remodeling involves BMU steering as well as activation, 
Bone. 40, 1574–1580. 
Martinez P., Moreno I., Miguel F. De, Vila V., Esbrit P. and Martinez M. E. 2001. Changes in 
osteocalcin response to 1,25-dihydroxyvitamin D3 stimulation and basal vitamin D 
receptor expression in human osteoblastic cells according to donor age and skeletal 
origin. Bone. 29, 35-41. 
Massague J. 1998. TGF-b signal transduction. Annu Rev Biochem. 67, 753-91. 
Massague J., Wotton D. 2000. Transcriptional control by the TGFb/SMAD signaling system. 
EMBO J ,19, 1745-54. 
Massicotte F., Fernandes J. C., Martel-Pelletier J., Pelletier J.-P., Lajeunesse D.l. 2006. 
Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral 
bone osteoblasts. Bone, 38(3) 333-341. 







Matsuura Y., Oharu S., Takata T. and Tamura A. 2003. Mathematical approaches to bone 
reformation phenomena and numerical simulations. J Comp Appl Maths, 158(1), 107-
119. 
Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R, Taketomi S, Mizoguchi, J., and Kato, K. 
1993. In vivo stimulation of endosteal bone formation by basic fibroblast growth 
factor in rats. Growth Factors, 9, 73–80. 
Mazzuoli G., Diacinti D., D'Erasmo E., Alfò M. 2006. Cyclical changes of vertebral body 
heights and bone loss in healthy women after menopause. Bone, 38(6), 905-910. 
Mazzuoli G., Marinucci D., D‘erasmo E., Acca M., Pisani D., Rinaldi M. G., Bianchi G., 
Diacinti D., Minisola S. 2002. Cyclical behavior of bone remodeling and bone loss in 
healthy women after menopause: results of a prospective study. Bone, 31(6), 718-
724. 
McCarthy T.L., Centrella M., Raisz L.G. and Canalis E. 1991. Prostaglandin E2 stimulates 
insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat 
bone, Endocrinology, 128, 2895-2900. 
McCarthy T.L., Centrella, M. 2001. Local IGF-I expression and bone formation. Growth 
Hormone IGF Res. 11, 213–219. 
McCarty M. F. 2003. Estrogen agonists/antagonists may down-regulate growth hormone 
signaling in hepatocytes–An explanation for their impact on IGF-I, IGFBP-1, and 
lipoprotein(a). Med Hyp, 61(3), 335-339. 
McKeehan W. L., Wang F., Kan M. 1997. The Heparan Sulfate-Fibroblast Growth Factor 
Family: Diversity of Structure and Function. Prog Nucl Acid Res Mol Biol 59, 135-
176. 
McQueeney K, Dealy C. 2001. Roles of insulin-like growth factor-I (IGF-I) and IGF-I binding 
protein-2 (IGFBP2) and -5 (IGFBP5) in developing chick limbs. Growth Horm IGF 
Res. 11. 346–63. 
Meinel L, Zoidis E, Zapf J, Hassa P, Hottiger MO, Auer JA, R. Schneider, B. Gander, V. 
Luginbuehl, R. Bettschart-Wolfisberger, O. E. Illi, H. P. Merkle, B. von Rechenberg. 
2003. Localized insulin-like growth factor delivery to enhance new bone formation. 
Bone, 33. 660-672. 
Metropolis, N., Ulam, S. 1949. The Monte-Carlo method. J. Amer. Stat. Ass. 44(247), 335-341. 
Michaelis, L., Menten, M. L. 1913. Die kinetik der Invertinwirkung. Biochem. Z. 49, 333-369. 
Miki Y., Suzuki T., Sasano H. 2007. Aromatase inhibitor and bone Biomedicine & 
Pharmacotherapy, 61, 540-542. 
Miyazono K. 1999. Signal transduction by bone morphogenetic protein receptors: functional 







Mizuno Y., Hosoi T., Inoue S., Ikegami A., Kaneki M., Akedo Y., Nakamura T., Ouchi Y., 
Chang C., Orimo H.1994. Immunocytochemical identification of androgen receptor 
in mouse osteoclast-like multinucleated cells. Calcif Tissue Int, 54, 325–326. 
Mohseni, S.S., Babaeipour, V., Reza Vali A. 2009. Design of sliding mode controller for the 
optimal control of fed-batch cultivation of recombinant E. coli. Chem. Eng. Sci. 
64(21), 4433-4441. 
Monod, J., Wyman, J., Changeux, J., 1965. On the nature of allosteric transitions: a plausible 
model. J. Mol. Biol. 12, 88–118. 
Montero A., Okada Y., Tomita M., Ito M., Tsurukami H., Nakamura T., Doetschman, T., 
Coffin, J.D., Hurley, M.M. 2000. Disruption of the fibroblast growth factor-2 gene 
results in decreased bone mass and bone formation. J Clin Invest, 105, 1085-1093. 
Moroz A, Wimpenny D I. 2007. Bone Turnover Cycle Model with a Torus-like Steady State‖. 
In ―Matematical Modelling of Biological Systems. Vol 1. A Deutsch, L. Brusch, H. 
Byrne, G de Vries and H-P Hercel (eds). Birchauser, Boston, 261-270. 
Moroz, A. 2009. A variational framework for nonlinear chemical thermodynamics employing 
the maximum energy dissipation principle. J. Phys. Chem. B. 113, 8086-8090.  
Moroz, A. 2010. Cooperative and collective effects in light of the maximum energy dissipation 
principle. Phys. Lett. A. 374, 2005-2010. 
Moroz, A. 2011. The Common Extremalities in Biology and Physics. Elsevier Insights, in 
press. 
Moroz, A., Crane, C.M., Smith, G., Wimpenny, D.I. 2006. Phenomenological model of bone 
remodeling cycle containing osteocyte regulation loop. BioSystems 84, 183–190. 
Moroz, A., Wimpenny, D.I. 2007. Allosteric Control Model of Bone Remodelling Containing 
Periodical Modes, Biophys. Chem. 127(3), 194-212.  
Moseley, T.A., Haudenschild, D.R., Rose, L., Reddi, A.H. 2003. Interleukin-17 family and IL-
17 receptors. Cytokine Growth Fact. Rev. 14, 155–174. 
Mozarelli, A., Bettati, S., Rivetti, C., Rossi, G.L., Colotti, G., and Chiancone, E. (1996). 
Cooperative Oxygen Binding to Scapharca inaequivalvis Hemoglobin in the Cristal. 
J. Biol. Chem. 271(7), 3627-3632. 
Mullender M. G., Huiskes R. 1997. Osteocytes and bone lining cells: Which are the best 
candidates for mechano-sensors in cancellous bone? Bone 20(6) 527-532. 
Mundy G.R., 1993. Cytokines and growth factors in the regulation of bone remodeling, J. Bone 
Miner. Res. 8, Suppl. S505–S510. 
Mundy G.R., Boyce B., Hughes D., Wright K., Bonewald L., Dallas S., Harris S., Ghosh-
Choudhury N., Chen D., Dunstan C., Izbicka E., Yoneda T., 1995. The effects of 







Nakamura I., Jimi E. 2006. Regulation of Osteoclast Differentiation and Function by 
Interleukin-1. Vitamins & Hormones. 74, 357-370. 
Nakamura T., Hanada K., Tamura M., Shibanushi T., Nigi H., Tagawa M., Fukumoto S., 
Matsumoto T. 1995. Stimulation of endosteal bone formation by systemic injections 
of recombinant basic fibroblast growth factor in rats. Endocrinology, 136. 1276-
1284. 
Nakamura, H., Kumei, Ya., Shimokawa, S., Ohya,K., Shinomiya, K. 2003. Suppression of 
osteoblastic phenotypes and modulation of pro- and anti-apoptic features in normal 
human osteoblastic cells under a vector-averaged gravity condition. J. Med. Dent. 
Sci. 50, 167-176. 
Nakamura, I., Pilkington, M.F., Lakkakorpi, P.T., Lipfert, L., Sims, S.M., Dixon, S.J., Rodan, 
G.A., Duong, L.T., 1999. Role of alpha(v)beta(3) integrin in osteoclast migration and 
formation of the sealing zone. J. Cell Sci. 112, 3985–3993. 
Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, KitamuraY, Oikawa S, Ono K, 
Takaoka K. 1994. Transient and localized expression of bone morphogenetic protein 
4 messenger RNA during fracture healing. J Bone Miner Res, 9. 651–659. 
Nanes, M.S., 2003. Tumor necrosis factor: molecular and cellular mechanisms in skeletal 
pathology. Gene 321, 1–15. 
Neer R. M., Arnaud C.D., Zanchetta J. R., Prince R., Gaich G. A., Reginster J.-Y.s, Hodsman 
A. B., Eriksen E. F., Ish-Shalom S., Genant H. K., Wang O., Mitlak B. H., Mellstrom 
D., Oefjord E. S., Marcinowska-Suchowierska E., Salmi J., Mulder H., Halse J., and 
Sawicki Z.A.j, 2001. Effect of Parathyroid Hormone (1-34) on Fractures and Bone 
Mineral Density in Postmenopausal Women with Osteoporosis. New England J Med 
344.1434-1441. 
Neilsen, P., Srensen. G., Hynne, F. 1997. Chaos in Glycolysis. J. Theor. Biol. 186, 303-306. 
Nemoto E., Koshikawa Yo., Kanaya S., Tsuchiya M., Tamura M., Somerman M. J., Shimauchi 
H., Wnt signaling inhibits cementoblast differention and promotes proliferation. 
Bone, 44, 2009, Pages 805-812 
Nichols, J., Evans, E.P., Smith, A.G. 1990. Establishment of germ-linecompetent embryonic 
stem (ES) cells using differentiation inhibiting activity. Development, 110, 1341–
1348. 
Nicholson G.C., Moseley J.M., Sexton P.M., Mendelsohn F.A., and Martin T.J. 1986.  
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and 
autoradiographic characterization. J Clin Invest. 78(2) 355–360. 







Noble, B.S., Stevens, H., Loveridge, N., Reeve, J., 1997a. Identification of apoptotic changes in 
osteocytes in normal and pathological human bone. Bone 20, 273–282. 
Noble, B.S., Stevens, H., Mosley, J.R., Pitsillides, A.A., Reeve, J., Lanyon, L.E. 1997b. Bone 
loading changes the number and distribution of apoptotic osteocytes in cortical bone. 
J. Bone Miner. Res. 12 (Suppl. 1), s111. 
Notelovitz M., 2002. Androgen effects on bone and muscle. Fertil Steril, 77, S34-S41 
Nowlan N. C., Prendergast P. J. 2005. Evolution of mechanoregulation of bone growth will 
lead to non-optimal bone phenotypes. J Theol Bio. 235(3) 408-418. 
Nugent M.A., Iozzo R. V. 2000. Fibroblast growth factor-2. Int J Biochem Cell Biol, 32, 115-
120. 
Nyman J. S., Yeh O. C., Hazelwood S. J., and Martin R. B., 2004. A theoretical analysis of 
long-term bisphosphonate effects on trabecular bone volume and microdamage. 
Bone. 35, 296–305. 
Oh C.D., Chun J.S. 2003. Signaling mechanisms leading to the regulation of differentiation and 
apoptosis of articular chondrocytes by insulin-like growth factor-1. J Biol Chem 278, 
36563–36571. 
Okada Yo., Montero A., Zhang X., Sobue T., Lorenzo J., Doetschman T., Coffin J. D. and 
Hurley M.M. 2003. Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 
Null Mice in Response to Parathyroid Hormone. J. Biol. Chem., 278, 21258-21266.  
Okazaki H, Kurokawa T, Nakamura K, Matsushita T, Mamada K, Kawaguchi H. 1999. 
Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis 
bone lengthening of rabbits. Calcif Tissue Int, 64, 542–546. 
Olivier, B.G., Rohwer, J.M., Snoep, J.L. and Hofmeyr, J.-H.S. 2006. Comparing the regulatory 
behaviour of two cooperative, reversible enzyme mechanisms. IEE Proc.-Syst. Biol. 
153, 335-337.  
Omdahl J.L., Morris H.A., May B.K. 2002. Hydroxylase enzymes of the vitamin D pathway: 
expression, function, and regulation. Ann Rev Nutr, 22, 139–66. 
Onufriev, A. and Ullmann, G. M. 2004. Decomposing Complex Cooperative Ligand Binding 
into Simple Components: Connections between Microscopic and Macroscopic 
Models J. Phys. Chem. B. 108, 11157-11169. 
Ornitz D.M. 2000. FGFs, heparan sulfate and FGFRs: complex interactions essential for 
development. Bioessays, 22, 108– 12. 
Ortega, F., Agenda, L. 1998. Optimal metabolic control design. J. Theor. Biol. 191, 439–449. 
Paget J. 1877. On a form of cronick inflammation of bones (osteitis deformans). Trans med-







Palmqvist P., Persson E., Conaway H. H. and Lerner U. H. 2002. IL-6, Leukemia Inhibitory 
Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of 
Receptor Activator of NF- B Ligand, Osteoprotegerin, and Receptor Activator of 
NF- B in Mouse Calvariae. J Immunol. 169, 3353-3362. 
Parfitt A.M., 2003. Parathyroid hormone and periosteal bone expansion. J. Bone Miner. Res. 17 
(10) 1741-1743. 
Parfitt, A.M., 1994. Osteonal and hemi-osteonal remodeling: the spatial and temporal 
framework for signal traffic in adult human bone. J. Cell. Biochem. 55, 273-286. 
Parfitt, A.M., 2001. Targeted and non-targeted bone remodelling: relationship to basic 
multicellular unit organisation and progression. Bone, 30, 2–7. 
Pauwels, F., 1965. Gesammelte Abhandlungen zur Funktionellen Anatomic des Bewegungs-
apparates. Berlin. Springer-Verlag. 
Pearl, R . and Reed, L. J. 1920. On the rate of growth of the population of the United States 
since 1790 and its mathematical representation. Proc. Natl. Acad. of Sci. S.A. 6, 275-
288. 
Pearson, K. 1901. On Lines and Planes of Closest Fit to Systems of Points in Space. 
Philosophical Magazine 2(6), 559–572.  
Pena E., Calvo B., Martinez M.A., Palanca D., Doblare M., 2005. Finite element analysis of the 
effect of meniscal tears and meniscectomies on human knee biomechanics. Clinic 
Biomechanics, 20(5), 498-507. 
Perutz, M.F. 1990. ―Mechanisms of Cooperative and Allosteric Regulation in Proteins.‖ 
Cambridge University Press, Cambridge. 
Pontryagin, L.S., Boltyanskii, V.G., Gamkrelidze, R.V., Mischenko, E.F. 1962. ―The 
mathematical Theory of Optimal Processes.‖ Interscience, New York.  
Poole K, Reeve J., 2005. "Parathyroid hormone - a bone anabolic and catabolic agent." Curr 
Opin Pharmacol , 5(6), 612-617. 
Pörtner, R., Schäfer, T. 1996. Modelling hybridoma cell growth and metabolism - a comparison 
of selected models and data. J. Biotechnology, 49, s1-3, 119-135. 
Pothuaud L., Fricain J.-C., Pallu S., Bareille R., Renard M., Durrieu M.-C., Dard M., Vernizeau 
M. and Amédée J., 2005. Mathematical modelling of the distribution of newly 
formed bone in bone tissue engineering. Biomaterials, 26(33), 6788-6797. 
Potts, J.T., Jr., and Jüppner, H. 1997. Parathyroid hormone and parathyroid hormone-related 
peptide in calcium homeostasis, bone metabolism, and bone development: the 
proteins, their genes, and receptors. In Metabolic bone disease and clinically related 








Priestwood, K., Duque, G. 2003. Chapter 75: Osteoporosis. In: Hazzard et al. (Eds.), Hazzard‘s 
Textbook in Geriatric Medicine, fifth ed. McGraw Hill, New York. 
Putra, D., Bingbing, J., Patton, R., Genever, P., Fagan, M. 2010. Simulation of the BMU 
remodelling cycle using a new predator-prey algorithm. Bone, 47.  Supplement 1, 
S95. 
Qian, H. 2003. Thermodynamic and kinetic analysis of sensitivity amplification in biological 
signal transduction. Biophysical Chemistry, 105,  585–593. 
Qian, H. 2008. Cooperativity and Specificity in Enzyme Kinetics: A Single-Molecule Time-
Based Perspective. Bioph. J., 95, 10-17. 
Qin L., Raggatt L. J., Partridge N. C., 2004. Parathyroid hormone: a double-edged sword for 
bone metabolism. Trends in Endocr Metab, 15(2) 60-65. 
Quinn J.M.W., Morfis M., Lam M.H.C., Elliott J., Kartsogiannis V., Williams E.D., Gillespie 
M.T., Martin T.J., Sexton P.M., 1999. Calcitonin receptor antibodies in the 
identification of osteoclasts. Bone, 25, 1-8. 
Rahman, A.K.M.S., Palanski, S. 1996. On-line optimisation of batch processes with nonlinear 
manipulated input. Chem. Eng. Sci. 51, 449-459. 
Rattanakul C., Lenbury Y., Krishnamara N. and Wollkind D. J. 2003. Modeling of bone 
formation and resorption mediated by parathyroid hormone: response to 
estrogen/PTH therapy. Biosystems, 70(1),  55-72 
Rawadi, G., Vayssiere, B., Dunn, F., Baron, R., Roman-Roman, S. 2003. BMP-2 controls 
alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine 
loop. J. Bone Miner. Res. 18, 1842-1853. 
Reddi, A.H. 2001. Bone morphogenetic proteins: From basic science to clinical applications. J 
Bone Joint Surg, 83-A(Suppl).S1–S6. 
Regmi A., Fuson T., Yang X., Kays J., Moxham C., Zartler E., Chandrashekhar S., Galvin 
R.J.S. 2005. Suramin interacts with RANK and inhibits RANKL-induced osteoclast 
differentiation, Bone 36, 284–291. 
Reina J.M., García-Aznar J.M., Domínguez J. and Doblaré M. 2007. Numerical estimation of 
bone density and elastic constants distribution in a human mandible. J 
Biomechanics, 40(4) 828-836. 
Rennel E., Cross M. J., Klint P., Bai X., Arbiser J.L., Gerwins P.. 2003. Regulation of 
endothelial cell differentiation and transformation by H-Ras. Exp Cell Res, 291(1), 
189-200. 
Rico-Ramirez V., Diwekar, U. M., Morel B. 2003. Real option theory from finance to batch 







Rietbergen, Van, B., Huiskes R., Weinans H., Sumner D. R., Turner T. M., Galante J. O., 1993. 
The mechanism of bone remodeling and resorption around press-fitted THA stems. J 
Biomech, 26(4-5), 369-382 
Rodan G.A., Martin T.J. 2006. Role of osteoblasts in hormonal control of bone resorption - a 
hypothesis. Calcif Tissue Int, 33, 349-351. 
Romas E., Gillespie M. T., Martin T. J. 2002. Involvement of receptor activator of NFκB ligand 
and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone, 30(2), 
340-346. 
Rosen C.J. 2000. IGF-I and osteoporosis. Clin Lab Med, 20 591–602. 
Rosen C.J. 2002. Growth Hormone and Insulin-like Growth Factor-I Treatment for Metabolic 
Bone Diseases. Principles of Bone Biology (Second Edition), 1441-1453. 
Rosen, C.J. 2003. The cellular and clinical parameters of anabolic therapy for osteoporosis. 
Crit. Rev. Eukaryot. Gene Expr. 13, 25–38. 
Rougier F., Cornu E., Praloran V. and Denizot Y., 1998. IL-6 and  IL-8 production by human 
bone marrow stromal cells, Cytokine, 10(2) 93-97. 
Roux W., 1895. Gessamelte Abhandlungen uber Entwicklungsmechanick der Organismen, vol. 
I and II. Leipzig: Wilhelm Engelman. 
Ruffoni D., Fratzl P., Roschger P., Klaushofer K. and Weinkamer R., 2007, The bone 
mineralization density distribution as a fingerprint of the mineralization process. 
Bone, 40(5) 1308-1319. 
Ruimerman R., P. Hilbers, B. van Rietbergen and R. Huiskes, 2005, A theoretical framework 
for strain-related trabecular bone maintenance and adaptation. J Biomechanics, 38(4) 
931-941. 
Sakou T, Onishi T, Yamamoto T, Nagamine T, Sampath T, ten Dijke P. Localization of Smads, 
the TGF-_ family intracellular signalling components during endochondral 
ossification. J Bone Miner Res 1999,14, 1145–52. 
Sanjay, A., Houghton, A., Neff, L., DiDomenico, E., Bardelay, C., Antoine, E., Levy, J., Gailit, 
J., Bowtell, D., Horne, W.C., Baron, R., 2001. Cbl associates with Pyk2 and Src to 
regulate Src kinase activity, avb3 integrin-mediated signaling, cell adhesion, and 
osteoclast motility. J. Cell Biol. 152, 181–195. 
SAS/STAT® 9.2 Users Guide, Second edition. 2009. 
Schendel P.F., Turner K. J. 1998. Interleukin-11 Cytokines, 169-182. 
Schmitt J.M., Hwang K., Winn S.R., Hollinger J.O. 1999. Bone morphogenetic proteins: an 
update on basic biology and clinical relevance. J Orthop Res,17, 269–278. 
Schuster, S., Heinrich, R. 1987. Time hierarchy in enzymatic reactions chains resulting from 







Schuster, S., Heinrich, R. 1991. Minimization of intermediate concentrations as a suggested 
optimality principle for biochemical networks. I. Theoretical analysis. J. Math. Biol. 
29, 425-442. 
Sel‘kov E.E. 1968. Self-Oscillations in Glycolysis. 1. A Simple Kinetic Model. Europ. J. 
Biochem. 4, 79-86. 
Sengupta, S., Modak, J.M. 2001. Optimization of fed-batch bioreactor for immobilized enzyme 
processes. Chem. Eng. Sci. 56, 3315-3325. 
Seto H., Aoki K., Kasugai S., Ohya K. 1999. Trabecular bone turnover, bone marrow cell 
development, and gene expression of bone matrix proteins after low calcium feeding 
in rats. Bone, 25, 687-695. 
Shao, Y.Y., Wang, L., & Ballock, R.T. 2006. Thyroid hormone and the growth plate. Rev. 
Endocr. Metab. Disord., 7(4), 265–271. 
Sharma P.K., Thakur M.K. 2006. Expression of estrogen receptor (ER) α and β in mouse 
cerebral cortex: Effect of age, sex and gonadal steroids.  Neurobiol Aging, 27(6) 880 
- 887  
Shefelbine S. J., Augat, P.  Claes L., Simon U. 2005. Trabecular bone fracture healing 
simulation with finite element analysis and fuzzy logic. J Biomech, 38(12) 2440-
2450. 
Sheppard, D., 2000. In vivo functions of integrins: lessons from null mutations in mice. Matrix 
Biol. 19, 203–209. 
Shi Ya.-Ch, Worton L., Esteban L., Baldock P., Fong C., Eisman J. A., Gardiner E. M.,   2007. 
Effects of continuous activation of vitamin D and Wnt response pathways on 
osteoblastic proliferation and differentiation. Bone, 41, 87-96. 
Sibonga J.D., Evans H.J., Sung H.G., Spector E.R., Lang T.F., Oganov V.S., Bakulin A.V., 
Shackelford L.C. and LeBlanc A.D., 2007. Recovery of spaceflight-induced bone 
loss: Bone mineral density after long-duration missions as fitted with an exponential 
function. Bone, 41(6) 973-978. 
Silver J., Epstein E. and Naveh-Many T. 1996. Oestrogen deficiency—does it have a role in the 
genesis of skeletal problems in dialysed women? Nephrol Dial Transplant, 11, 565-
574. 
Simeoni I., Gurdon J.B. 2007. Interpretation of BMP signaling in early Xenopus development. 
Dev Biol, 308(1), 82-92. 
Simon A. M., Goodenough D. A., 1998. Diverse functions of vertebrate gap junctions. Trends 
in Cell Biology, 8(12) 477-483. 
Simonet W. S., Lacey D. L., Dunstan C. R., Kelley M., Chang M. -S., Lüthy R., Nguyen H. Q., 







A., Tan H. -L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes 
T. M., Hill D., Pattison W.,  Campbell P., Sander S., Van G., Tarpley J., Derby P., 
Lee R., Amgen EST Program, and Boyle W. J. 1997. Osteoprotegerin: A Novel 
Secreted Protein Involved in the Regulation of Bone Density. Cell, 89(2) 309-319. 
Singh B., Berry J. A.,
 
Vincent L. E., Lucci A., 2006. Involvement of IL-8 in COX-2-mediated 
bone metastases from breast cancer. J Surg Res, 134, 44-51.  
Skerry, T.M., Bitensky, L., Chayen, J., Lanyon, L.E. 1989. Early strainrelated changes in 
enzyme activity in osteocytes following bone loading in vivo. J. Bone Miner. Res. 4, 
783–788. 
Smets, I.Y., Claes, J.E., November, E.J., Bastin, G.P., Van Impe, J.F. 2004. Optimal adaptive 
control of (bio)chemical reactors: past, present and future. J. Process Control 14, 
795-805. 
Smets, I.Y.M., Versyck, K.J.E. Van Impe, J.F.M. 2002. Optimal control theory: a generic tool 
for identification and control of (bio)-chemical reactors. Ann. Rev. Contr. 26, 57-73. 
Smink J.J., Koster J.G., Gresnigt M.G., Rooman R., Koedam J.A., Van Buul-Offers S.C., 2002. 
IGF and IGF-binding protein expression in the growth plate of normal, 
dexamethasone-treated and human IGF-II transgenic mice. J Endocrinol, 175, 143–
53. 
Southwood L.L., Frisbie D.D., Kawcak C.E., Ghivizzani S.C., Evans C.H., McIlwraith C.W. 
2004. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect 
fracture rabbit model. J Orthop Res, 22(1), 66-72. 
Srinivasan, B., Palanki, S., Bonvin, D. (2003). Dynamic optimisation of batch processes I. 
Characterisation of the nominal solution. Comp. Chem. Eng. 27, 1-26. 
Stein G. S., Lian J. B., Stein J. L., Van Wijnen A. J. and Montecino M., 1996. Transcriptional 
control of osteoblast growth and differentiation. Physiol. Rev. 76. 593-629. 
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., Martin, T.J., 1999. Modulation 
of osteoclast differentiation and function by the new members of the tumor necrosis 
factor receptor and ligand families. Endocr. Rev. 20, 345–357. 
Suzuki H, Nakamura I., Takahashi N., Ikuhara T., Matsuzaki K., Isogai Y., Hori M. and Suda 
T., 1996. Calcitonin-induced changes in the cytoskeleton are mediated by a signal 
pathway associated with protein kinase A in osteoclasts. Endocrinology, 137, 4685-
4690. 
Swarthout J.T., D'Alonzo R.C., Selvamurugan N., Partridge N.C. 2002. Parathyroid hormone-







Taboas, J.M., Maddox, R.D., Krebsbach, P.H., Hollister, S.J. 2003. Indirect solid free form 
fabrication of local and global porous, biomimetric and composite 3D 
polymerceramic scaffolds. Biomaterials 24, 181-194. 
Takahashi, N., Yamana, H., Yoshiki, S., Roodman, G.D., Mundy, G.R., Jones, J.S., Boyde, A., 
Suda, T., 1988. Osteoclast-like cell formation and its regulation by osteotropic 
hormones in mouse bone marrow cultures. Endocrinology 122, 1373– 1382. 
Taylor D, Kuiper J.H. 2001. The prediction of stress fractures using a ―stressed volume‖ 
concept. J Orthop Res, 19(5), 919–26. 
Taylor D., Casolari E. and Bignardi C. 2004. Predicting stress fractures using a probabilistic 
model of damage, repair and adaptation J Orthopaedic Res, 22(3), 487-494. 
Taylor, D., Hasenberg, J.G., Lee, T.C. 2003. The cell transducer in damage-stimulated bone 
remodeling: a theoretical investigation using fracture mechanics. J. Theor. Biol. 224, 
65-75. 
Tayyar S., Weinhold P. S., Butler R. A., Woodard J. C., Zardiackas L. D., St. John K. R., 
Bledsoe J. M., Gilbert J. A., 1999. Computer simulation of trabecular remodeling 
using a simplified structural model. Bone, 25(6) 733-739. 
Teitelbaum S. L., 2004. Postmenopausal osteoporosis, T cells, and immune dysfunction. Proc 
Natl Acad Sci U S A. 101(48). 16711–16712. 
Theoleyre, S.,Wittrant, Y., Couillaud, S., Vusio, P., Berreur, M., Dunstan, C., Blanchard, F., 
Redini, F., Heymann, D. 2004. Cellular activity and signaling induced by 
osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor nB 
ligand and MAPK.  Biochem. Biophys. Acta, 1644, 1–7. 
Thomadakis, G., Ramoshebi, L.N., Crooks, J., Rueger, D.C., Ripamonti, U. 1999. 
Immunolocalization of bone morphogenetic protein-2 and -3 and osteogenic protein-
1 during murine tooth root morphogenesis and in other craniofacial structures. Eur. J. 
Oral Sci. 107, 368–377. 
Thomas D. M., Udagawa N., Hards D. K., Quinn J. M. W., Moseley J. M., Findlay D. M., Best 
J. D. 1998. Insulin receptor expression in primary and cultured osteoclast-like cells 
Bone, 23 181-186. 
Thompson, T.B., Cook, R.W., Chapman, S.C., Jardetzky, T.S., Woodruff, T.K. 2004. Beta A 
versus beta B: is it merely a matter of expression? Mol. Cell. Endocrinol. 225, 9–17. 
Tiegs, R. D., 1997.  Paget's disease of bone: indications for treatment and goals of therapy 
Clinical Therapeutics, 19, 1309-1329.  
Tirapegui J. 1999. Effect of insulin-like growth factor-1 (IGF-1) on muscle and bone growth in 







Tohyama, M., Patarinska, T., Qiang, Z., Shimizu, K. 2002. Modelling of the mixed culture and 
periodic control for PHB production. Biochem. Eng. J. 10, 157–173. 
Tomkinson, A., Reeve, J., Shaw, R.W., Noble, B.S. 1997. The death of osteocytes by apoptosis 
in human bone is observed following estrogen withdrawal in human bone. J. Clin. 
Endocrinol. Metab. 82, 3128–3135. 
Troen B. R., 2003. Molecular mechanisms underlying osteoclast formation and activation. Exp 
Gerontology, 38(6),  605-614. 
Tsubota K., Adachi T. 2005, Spatial and temporal regulation of cancellous bone structure: 
characterization of a rate equation of trabecular surface remodelling. Med Eng & 
Phys, 27(4), 305-311. 
Tsubota K., T. Adachi and Yo. Tomita, 2001. Cancellous bone adaptation in proximal femur 
predicted by trabecular surface remodeling simulation. BED-Vol. 50, Bioengineering 
Conference ASME 2001, 299-300.  
Turner A.W.L., Gillies R.M., Sekel R., Morris P., Bruce W., Walsh W.R. 2005. Computational 
bone remodelling simulations and comparisons with DEXA results. J Orthopaed Res, 
23 705–712. 
Ueno K., Katayama T., Miyamoto T., Koshihara Y. 1992. Interleukin-4 enhances in vitro 
mineralization in human osteoblast-like cells. Biochem Biophys Res Comm, 189(3), 
1521-1526. 
Vaibhav B., Nilesh P., Vikram S., Anshul, C. 2007. Bone morphogenic protein and its 
application in trauma cases: A current concept update. Injury, 38(11), 1227-1235. 
Valentinotti, S., Srinivasan, B., Holmberg, U., Bonvin, D., Cannizzaro, C., Rhiel, M. and von 
Stockar, U. 2003. Optimal operation of fed-batch fermentations via adaptive control 
of overflow metabolite. Contl. Eng. Prac. 11, 665-674. 
Van Impe, J.F., Bastin, G. 1995. Optimal adaptive control of fed-batch fermentation processes. 
Control Eng. Pract. 3(7), 939-954. 
Van Riel, N.A.W., Giuseppin, M.L.F., Verrips, C.T. 2000. Dynamic Optimal Control of 
Homeostasis: An Integrative System Approach for Modeling of the Central Nitrogen 
Metabolism in Saccharomyces cerevisiae. Metabol. Eng. 2(1), 49-68. 
Vanderschueren D, Bouillon R. 1995. Androgens and bone. Calcif Tissue Int, 56, 341–6. 
Vashishth, D., Gibson, G., Kimura, J., Schaffler, M.B., Fyhrie, D.P. 2002. Determination of 
bone volume by osteocyte population. T. Anat. Rec, 276, 292–295. 
Vatsa A., Smit T. H., Klein-Nulend J. 2007. Extracellular NO signalling from a mechanically 
stimulated osteocyte. J.Biomechanics, 40, Suppl1, S89-S95. 
Verhulst P.F. 1838. Notice sur la loi que la population suit dans son ccroisement. Corr. Math. 







Vestergaard P., Hermann A. P., Gram J., Jensen L. B., Eiken P., Abrahamsen B., Brot C., 
Kolthoff N., Sørensen O. H., Nielsen H. B., Nielsen S. P., Charles P. and Mosekilde 
L.  2001. Evaluation of methods for prediction of bone mineral density by clinical 
and biochemical variables in perimenopausal women. Maturitas, 40(3), 211-220. 
Vignery A, McCarthy T.L., 1996. The neuropeptide calcitonin gene-related peptide stimulates 
insulin-like growth factor I production by primary fetal rat osteoblasts 
Bone, 18, 331-335. 
Visser, D., Schmid, J. W., Mauch, K., Reuss, M., Heijnen J. J. 2004. Optimal re-design of 
primary metabolism in Escherichia coli using linlog kinetics. Metabol. Eng. 6(4), 
378-390. 
Voet, D., Voet, J. G. 1995. ―Biochemistry.‖, 2
nd
 ed. J. Wiley and Sons, New York.  
Volkenstein, M.V. 1989. ―Biofizika‖ Nauka, Moscow (in Russian). 
Vozzi, G., Flaim C.J, Bianchi, F., Ahluwalia, A., Bhatia, S. 2002. Microfabricated PLGA 
scaffolds: a comparative study for application to tissue engineering, Mat. Sci. and 
Eng. C, 20, 43-47. 
Vozzi, G., Flaim C.J, Bianchi, F., Ahluwalia, A., Bhatia, S., 2003. Fabrication of PLGA 
scaffolds using soft lithography and microsyringe deposition. Biomaterials 24, 2522-
2540. 
Wada S, Martin T.J. and Findlay D.M., 1995. Homologous regulation of the calcitonin receptor 
in mouse osteoclast- like cells and human breast cancer T47D cells. Endocrinology, 
136, 2611-2621. 
Wada S, Udagawa N., Nagata N., Martin T.J. and Findlay D.M., 1996. Calcitonin receptor 
down-regulation relates to calcitonin resistance in mature mouse osteoclasts. 
Endocrinology, 137, 1042-1048.  
Wang F.-S., Ko J.-Y., Lin C.-L., Wu H.-L., Ke H.-J., Tai P.-J.. Knocking down dickkopf-
1 alleviates estrogen deficiency induction of bone loss. A histomorphological study 
in ovariectomized rats. Bone 40 (2007) 485–492. 
Wang F.-S., Ko J.-Y., Weng L.-H., Yeh D.-W., Ke H.-J., Wu S.-L. Inhibition of Glycogen 
synthase kinase -3β attenuates glucocorticoid-induced bone loss. Life Sci., 85, 2009, 
685-692 
Wang L., Liu S., Quarles L. D., and Spurney R. F. 2005. Targeted overexpression of G protein-
coupled receptor kinase-2 in osteoblasts promotes bone loss. Am J Physiol 
Endocrinol Metab, 288. E826–E834.  
Wang, D.S., Miura, M., Demura, H., Sato, K., 1997. Anabolic effects of 1,25-dihydroxyvitamin 







osteoblasts and by growth factors produced by endothelial cells. Endocrinology 138, 
2953–2962. 
Wang, D.S., Yamazaki, K., Nohtomi, K., Shizume, K., Ohsumi, K., Shibuya, M., Demura, H., 
Sato, K., 1996. Increase of vascular endothelial growth factor mRNA expression by 
1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J. Bone Miner. Res. 11, 
472–479. 
Wang, F., McKeehan W. L. 2003. The Fibroblast Growth Factor (FGF) Signaling Complex, 
Handbook of Cell Signaling, 265-270. 
Wang, F.S., Ko, J.Y., Lin, C.L., Wu, H.L., Ke, H.J., Tai, P.J.  (2007)  Knocking down 
dickkopf-1 alleviates estrogen deficiency induction of bone loss. A 
histomorphological study in ovariectomized rats. Bone, 40, 485-492.  
Watkins, B.A., Seifert, M.F. 2000. Conjugated LLinoleic Acid and Bone Biology. J Amer Col 
Nutr. 19(4) 478S-486S. 
Weber, R. E., Hourdez, S., Knowles, F. and Lallier, F. 2003. Hemoglobin function in deep-sea 
and hydrothermal-vent endemic fish: Symenchelis parasitica (Anguillidae) and 
Thermarces cerberus (Zoarcidae). J. Exp. Biol. 206, 2693-2702.  
Weinans, H., Huiskes, R. and Grootenboer, H.J. 1992. The behaviour of adaptive bone-
remodeling simulation models. J Biomechanics, 25(12), 1425–1441. 
Weinans, H., Huiskes, R. and Grootenboer, H.J., 1994. Effects of Fit and Bonding 
Characteristics of Femoral Stems on Adaptive Bone Remodeling. J Biomech Eng, 
116, 393-400. 
Weiss, J. N. 1997. The Hill equation revisited: uses and misuses. FASEBJ. 11, 835-841. 
Westendorf, J.J., Kahler, R.A., Schroeder, T.M., 2004. WNT signalling in osteoblasts and bone 
diseases. Gene, 341, 19–39. 
Whitfield J.F., Morley P., Willick G.E. 2002.Bone growth stimulators. New tools for treating 
bone loss and mending fractures. Vitam. Horm. 65. 1-80. 
Whyte M.P., Singhellakis P.N., Petersen M.B., Davies M., Totty W.G., Mumm S. 2007. 
Juvenile Paget's disease: the second reported, oldest patient is homozygous for the 
TNFRSF11B "Balkan" mutation (966_969delTGACinsCTT), which elevates 
circulating immunoreactive osteoprotegerin levels. J. Bone Miner. Res. 22, 938–946. 
Wingfield, P., Pain, R.H., Craig, S. 1987. Tumour necrosis factor is a compact trimer. FEBS 
Lett. 211, 179–184. 
Wipff P.-J., Hinz B. 2008. Integrins and the activation of latent transforming growth factor β1 – 







Wluka A.E., Davis S.R., Bailey M., Stuckey S.L., Cicuttini F.M. 2001. Users of oestrogen 
replacement therapy have more knee cartilage than non-users. Ann. Rheum Diseas. 
60, 332-336. 
Wolff J. 1986. The law of bone remodelling (1892, Das Gesetz der Transformation der 
Knochen, Hirschwald,) (Maquet P, Furlong R, Trans.). Springer, Berlin. 
Wozney J.M. 2002. Overview of bone morphogenetic proteins. Spine. 15(16), Suppl. 1. 2-8. 
109.  
Wozney J.M., Rosen V. 1998. Bone morphogenetic protein and bone morphogenetic protein 
gene family in bone formation and repair. Clin Orthop, 346.26–37. 
Wu, Y. and Kumar, R. 2000. Parathyroid hormone regulates transforming growth factor b1 and 
b2 synthesis in osteoblasts via divergent signaling pathways. J. Bone Miner. Res. 15, 
879–884. 
Xiao Y-T., Xiang L.-X., Shao J.-Z. 2007. Bone morphogenetic protein, Biochem Biophys Res 
Comm. 362, 550-553. 
Xinghua Z., He G., Bingzhao G. 2005. The application of topology optimization on the 
quantitative description of the external shape of bone structure. J Biomechanics, 
38(8) 1612-1620. 
Xinghua Z., He G., Dong Z., Bingzhao G. 2002. A study of the effect of non-linearities in the 
equation of bone remodelling. J Biomechanics, 35(7) 951-960. 
Yakar, S., Rosen, C. J., Beamer,W. G., Ackert-Bicknell, C. L.,Wu, Y., Liu, J.-L., Guck T Ooi, 
Jennifer Setser, Jan Frystyk, Yves R Boisclair, Derek LeRoith et al. 2002. Circulating 
levels of IGF-1 directly regulate bone growth and density. J. Clin. Invest., 110(6), 
771–781. 
Yamaguchi A., Komori T., Suda T. 2000. Regulation of osteoblast differentiation mediated by 
bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 221, 393–411. 
Yamashita H, ten Dijke P, Heldin C-H, Miyazono K. 1996, Bone morphogenetic protein 
receptors. Bone 19, 569–74. 
Yamauchi N., Ohishi K., Nishikawa S., Nagata T., Kataoka M., Shinohara H. and Ishida H. 
 2006. Expression and characterization of parathyroid hormone receptors on fetal rat 
calvaria cells in culture. J Bone Miner Metabol, 12, S33-S37.  
Yan, Y., Xiong, Z., Hu, Yu., Wang, S., Zhang, R., Zhang, C. 2003. Layered manufacturing of 
tissue engineering scaffolds via multi-nozzle deposition. Mat. Let. 57, 2623-2628. 
Yildirim, N., Akcay, F., Okur, H., Yildirim, D. 2003. Parameter estimation of nonlinear models 
in biochemistry: a comparative study on optimization methods. Appl. Math.Comp. 







Yonetani, T., Park, S., Tsuneshige, A., Imai, K. and Kanaori, K. 2002. Global Allostery Model 
of Hemoglobine. J. Biol. Chem. 277, 34508-34540. 
Yonetani, T., Tsuneshige, A. 2003. The global allostery model of hemoglobin: an allosteric 
mechanism involving homotropic and heterotropic interactions. C. R. Biol. 326, 523–
532. 
Yoshida K., Oida H., Kobayashi T., Maruyama T., Tanaka M., Katayama T., Yamaguchi K., 
Segi E., Tsuboyama T., Matsushita M., Ito K., Ito Yo., Sugimoto, Yu. Ushikubi F., 
Ohuchida S., Kondo K., Nakamura T., and Narumiya S. 2002. Stimulation of bone 
formation and prevention of bone loss by prostaglandin E EP4 receptor activation. 
PNAS, 99, 4580–4585. 
You, L-D., Weinbaum, S., Cowin, S.C., Schaffler, M.B. 2004. Ultrastructure of the Osteocyte 
Process and its Pericellular Matrix. T. Anat. Rec. 278A, 505-513. 
Yucel-Lindberg T. and Brunius G. 2006. Epidermal growth factor synergistically enhances 
interleukin-8 production in human gingival fibroblasts stimulated with interleukin-
1β, Archives of Oral Biology, 51, 892-898.  
Yue J., Mulder K. M. 2001. Transforming growth factor-β signal transduction in epithelial cells 
Pharmacol Therap, 91(1), 1-34. 
Yüzgeç, U., Türker, M., Hocalar, A. 2009. On-line evolutionary optimization of an industrial 
fed-batch yeast fermentation process. ISA Trans. 48(1) 79-92. 
Zaidi M., Inzerillo A. M., Moonga B. S., Bevis P. J. R., Huang C. L.-H. 2002. Forty years of 
calcitonin - where are we now? A tribute to the work of Iain Macintyre, FRS.  
Bone 30, 655-663. 
Zhang J., Dai J., Lu Y., Yao Z., O'Brien C. A., Murtha J. M., Qi W., Hall D. E., Manolagas S. 
C., Ershler W. B., Keller E. T., 2004. In vivo visualization of aging-associated gene 
transcription: evidence for free radical theory of aging. Exp. Geron 39(2), 239-247.  
Zhang, J., Fua, M., Mylesa, D., Zhua, X., Dub, J., Caoc, X., Chen, Y.E. 2002. PDGF induces 
osteoprotegerin expression in vascular smooth muscle cells by multiple signal 
pathways. FEBS Lett 521, 180–184. 
Zofkova I. 2003. Pathophysiological and clinical importance of insulin-likegrowth factor-I with 
respect to bone metabolism. Physiol Res 52, 657–79. 
 
 
 
 
 
